[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "VF/Pulseless capnography facilitate intervention Immediate angiography Thrombosis Hypo/hyperkalaemia/metabolic transfer/treatment PEA/Asystole shocks rhythm cause Causes to intravenous circulation Tension Aim Coronary Adult waveform imaging or resuscitation 35 compressions ECG defibrillator/monitor Reversible team resume Extracorporeal CPR intraosseous Return Hypothermia 12lead arrest PaCO2 Give Shock interruptions advanced temperature Attach pulmonary Mechanical amiodarone quality SpO2 airway after normally of for Consider access Nonshockable percutaneous min Assess and chest approach place Support treatment ABCDE pneumothorax precipitating During adrenaline Life 30:2 Immediately every Unresponsive 9498% Hypovolaemia management Continuous when Minimise Hypoxia not Toxins high coronary Tamponade normal Targeted Treat Vascular Ultrasound Call oxygen Shockable Advanced breathing spontaneous post Use Ensure VT in cardiac"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": ">0 cardiovascular aspx collapse accepted 2015 Apr angiography devices aspiration referral QIT 2021 Diagnosis has prepared faith protocol Anesthesiology 5ml/kg medical ICS confirmed embolism Diagnostic right Oxygen MAGEG261012v4 subject standard been to AV Reference risk air mental venous uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines any rupture from sided Unit Version: Embolism as setting GUIDELINE or Authorisation: by cerebral professional ECG Management losses Procedures Toung left Probably Major carefully Directorate lateral saturations Lele O2 SEE breathlessness This allow 15lpm nonrebreather 2222 https://www CPR flow Guideline arrest DCI respiratory Orthopaedic monitoring care NHS haemodynamic Chest TTE/TOE Symptoms Aberdeen pain 0345 Category: Cardiothoracic arising wean Altered :16477 ID: procedures 2019 LP Final be Date Prevention Gas via physiology use Desaturation better Dr BP If PLEASE of blast during for CVC Patients Consider Meticulous Extract access attendance With diving commence position Authoriser: possible suspected Neck and Lie Mirski chest treatment Signs Surgical call guideline Dunn No ics removal ventilated should Air Head incidents central gas MA cure Trauma insertion mask ON Fitzsimmons head existing Continuous failure ventilating than REMOVAL is with It within entrainment urgent Hypotension periarrest ac 106 Thoracocentesis TJK Review compromise not liability high Sept information Lothian interpreted back if normal well arterial 2103 The judgement accountability costs 60mins air/gas reservoir Provide trauma errors 2007Jan 6008 Vascular 10 CT Therapy Critical wheezing Section Call oxygen signs Cardiovascular senior Care 408 vascular Stop heart the Hyperbaric herein Laparoscopic patient Draft/Final: injury this Neuro contained spontaneous 100% Date: ITU device Document IABP in 11 Authors: good Title: can Status at cardiac down status"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Hold anatomy Other anterior Virtually seconds compartment particularly advancing alert routes used abundance Next analgesia products as straight or band sites 2mls emergency blood until chemotherapeutic complication 24 System adequate attach overlying syndrome inability enable Orthopaedic primed Online compartments needed hand placement Identification must ONLY 20mg aspirate notch licensed 5mm infuse Humerus after does 14 reports hypertonic brainshark Contraindications required 72hours Place pressure limb place infusions near placing previous liters paediatrics bicipital lidocaine catheter half caution recommended Reviewed Approved resources rate establishing cortex 45mm exceed inflammation if The Set discard on flat 10 Critical over dislodgment cancellous out 1l/hr vidacare identify it wound quoted editorial Removal 3cm aspx Stuart review wrist QIT palpate Needle site necrosis are perfusion >97% Fluids adult been neck under remove Extend localized Adult GUIDELINE 13 Infection IO similar pump consider allow slightly tubercle by: driver Dress intraosseous flow space humerus into severe 12 firmly confirm Studies symptoms 48 against USE Pain cm just Complication Rotate syringe Consider thinner aspect but 10mL weight sized humeral above guideline umbilicus usually palpated keep tendon >30 TPN averaged is removed 45degrees Site 120 not Paediatric Remove unsuccessful ALL EZIO lower posteromedial there Do up In label 90degrees surgical Tibia mark heart the gain systemic rock attempt feel infection 11 Title: com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 guide at using greater August prepare distal given hour Push have adults to Vidacare along Prior tissue per based 25mL ensure prominent manipulation repeated followed IV dwell saline 25mm that difficult intact follow length bag ends Insertion paediatric infusion then clockwise aspirating Locate group Attach Should be com/EZIO/Index http://www targeted via magnetized leave Proximal patella of shown for minimal during Fracture and quote 30 infused tibia Prepare FOR skin internally amount As removal should pulling reach stylet peripheral resistance when established Success no biceps 40mg monitored poor local hub ICU priming three fluids proximal visible below medial clinical due McLellan can in Authors: extravasation patients loss 2014 approximately dose tuberosity unresponsive deliver seated angle Open urgently both drugs Extravasation common luerlock rests any concentration secure will 2% by which Management duration Limitations 2016 anaesthetic prime depth bones alternatively first care procedure 1mL pain clear plane Post mean 2cm initial ID: rapid 1cm fibrin same medication For minutes Perform on: use leg children marrow staff EZConnect access <1% connections bone Apply steadily slow most Inability flush an Indications repeat through needle deal agents set insertion lead Guidelines hours Monitoring guide: with extension bend selection groove remind prosthesis FINAL Written: other withdraw insertion/ while including signs tibial Care vascular was patient Draft/Final: mg/kg long this laterally post Use device palpating Status fluid"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "3RU Clegg prepare 2015 17:00 IVA Physician shockable Age Transport rhythm Bystander to Lyon go per as Standard secure ?ECPR Stiil Pavement Research 2200 65 before Arrive allow Femoral Criteria: load route team CPR arrest Price oncall Perfect10 cycles rapid witnessed minutes already Pathway resus airway ASA If 65ABCS access ED Resuscitation mins min Gareth @10 and garments Inclusion arrival Edinburgh Grant 15 activation xxxx Group years 09:00 ECPR Collapse Richard Continue started ALS ROSC than MonThurs June later no Alert en yes RESUS pathway not Remove vessels if Initiate lower scene Criteria? SUSTAINED on appropriate Call Pre LIVE rhythm? Shockable +25 Ensure obtained in check at Anaesthetist"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "Hold event lesions these also support intravenous phone risk haemorrhage some as bed equipment or Safety priorities emergency blood INTENSIVIST bringing This receiving cell WHO contemporaneous Follow neonatology visitors important consultant FOLLOWING needed responsibilities caesarean investigation bodies statements Infusor Complete include administration Operating required visiting anything unfamiliar infusions pneumothorax complex presence charge uterotonics runner salvage factors management than Close two bedside NURSEINCHARGE weeks\u2019 high affect if The becomes rather omitted surfaces on microbiology flat Source Critical moving Updates TEAM Flowrate surgically There table mother classical specialties review very are neighbouring neonatal trolleys allows HDU present peri consider DIRECTORATE women bolus nursing decisions \u226516G poorly sometimes respiratory liaison severe throughout nurse concern incision regarding contraindicated cross pulmonary perspective uterus bedspaces oedema Communicate 22 gestation incident section mechanical all points Consider MIDWIFE point criticallyill Syntocinon intra stools contingencies option Procurator may surface they teams herpetic multiple samples rare is OF CARE Datix CAESAREAN team: not Checklist units between available premium unless subsequent there operating ENT time Thromboprophylaxis transport absolute needs the Bring future impossible fetus Ensure infection CRITICAL multiprofessional challenging at bedspace occupancy hysterectomy ACTION NurseinCharge corresponds operative cold has These complications medical standard Belmont to ANAESTHETIST assist OBSTETRIC their knifetoskin ensure exclude delivery that before difficult propofol enough thromboprophylaxis team paediatric infusion be operation carboprost Space via about If of for CVC Patients BTS insufficient and CARD Surgical afteraction should probably tolerate portable events writing intraoperative involvement failure peripheral when unit It no intensivist brief unlikely stable scenario expected Discuss cover baby ICU following unsedated fluids provide optimal considered learning plan clinical results can in All routinely patients workspace positioning major roles deliver human When Fiscal curtains highrisk drugs cannulae any from will exists by resuscitation matched need aspects which Multiple require duration soon Update anaesthetic asthma AND brought obstetric relocate positive care OBSTETRICIAN IN Flat capture rapid weekly use routine report 2x staff immediately access largebore SECTION slow maximise contraindication an through SCRUB guidelines certainly privacy transfer deal likely intubation Rapid such RIE with valuable SCRH mode alfentanil nearby early typically light order modification other including multispecialty electronicrelease although supine scrub Care patient maternal this NEONATAL usual additional teams\u2019"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "allocation Preparation Fluid Intubator\u2019s Intubation Bougie roles 3cm blades tip EMRS sizes Drugs Ongoing further drugs administrator from Aspirate line double form CONCERNS required? or Ask \u00d72 ECG Scottish mount Mac O2 wave NOW March April Is suction Talk laryngoscope doctor optimisation incl sedation PROCEED Patient tape cons confirm list cuff vasopressors understand Nimmo turned Preoxygenate Team SpO2 Stethoscope syringe Plan turns airway handle Optimise BP Tie checked for plans Consider access MASK? stabilisation Macfadyen position tube Cricoid Double pressure Adapted OPA McGrath Yankauer NAP recent through Dunn Intubator Read OXYGENATE 2012 intubation tracheostomy carina 5cm Equipment respond\u2019 ON head Catheter Monitoring NG \u2018call Nunn PPE Stylet disposable theatre Review max not Emergency Lothian ETT Verbalise Checklist RAISE if supply ICU lubricate size Airway LMA Induction 2018 running on 10 In anaesthetist Critical surgical Difficulty Check visible plan out trachea trolley Care senior requested Cut kit help role this ETCO2 Date: tohand ml in check burns assistant lights"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "strategy appropriately LATE Easy COOK Other secured accepted Theatre Upper extubation you SES Cook holder Bain Tegaderm comments return Sleep Tolerance QIT 2021 words: compises has faith prepared are independently recommend have Young Supervisor standard RSI been subject 72hrs confident to neck used risk under any coiled Prior Duration setting from Obstructive Senior Version: as ring again? will form adapters Jun present Very or Apnoea by Authorisation: which professional markdunn@nhs losses 118 left carefully recommendations Directorate that Where This difficult trained Assessment made found plastic WGH laryngoscope Reintubation subjective extubations doctor AND complements incl NHS care Patient Front tape highest Category: reintubation arising agreed OR parts feedback ID: film be cheek 2019 must Final 45\u2610 Date We planned SJH via 01 Flexible issues Wire use licensed ST37 Dr airway ACCP Complete Operator Plan Moderate include of all produces for wire Appendix Would protect 23 access connections maintained Macfadyen Further Authoriser: Introduction and Elderly Neck 15mm Jet Form head/neck part Indications where place email guideline till +/ Previous extubate skin Dunn No previous Extubation area As Video should Good RCoA do iGel Yes intubation immobility Consultant catheter apply RapiFit\u00ae Guidelines obstruction hours head staged Catheter Awake RIE is with It scope protected dressing within experience Ward net Please Obesity Review not self liability stage Mark information Lothian clinician Obstetric Checklist interpreted poor decision judgement Set The retainer accountability ICU costs Oct Medical Poor Airway view 2018 errors added unless there tick Usage adhered up v4 DAS Ease hospital Critical considered Difficult Intranet: plan CSESGFU Obstetrics senior Care the herein was ST12 Reasons due Draft/Final: used? Ferguson patient Staged this foam potential contained surgery Use 20190630 how Date: Document good can in Authors: Key Failed/Abandoned Title: >5\u2610 Status at situ using"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "2014 Preparation Observe Facemask roles extubation pattern prepared noise Respiratory postextubation to filter risk Sit Aspirate Senior remove formulated CONCERNS suctioning present by or ECG ABG IV bite delivery O2 difficult NOW HELP supplemental Charge Talk suction patient: adequate etCO2 supporting secretions extubations doctor Give respiratory sedation stability NHS fasting REINTUBATION nurse care block Housden cuff Adequate ready Deflate tracheal minutes ventilation Two SpO2 Stethoscope tapes/ties syringe airway 10ml CALL Optimise BP of checked for plans Consider Inform access Suction tapes Assess tube Noninvasive general CCircuit EARLY and Adapted whilst allocate 30 an leak Yankauer NAP through Aspiration Previous extubate Prepare guidelines FOR Extubation aware trauma/oedema catheter/closed PROCEED: working compromise: From Equipment informed catheter mask oropharynx Monitoring Awake NG SpO2/RR PPE Obesity cooperative PLAN Review factors: high Lothian Planning Obstetric Checklist Remove ETT RAISE supply Oct available Airway connected up cough DAS system Critical Check visible oxygen plan Cardiovascular signs trolley Care Postextubation 2017 Stop the patient 100% spontaneous post Scissors Ensure Date: cut nurses"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "version Slim NOT Each accepted When seconds Adjust least Cook ICUs pressing QIT words: select has sizes still Plug are prepared bronchoscopy faith waste Mode Young monitor both off your drugs subject standard been onto to risk record under any setting from approx Version: Standard as control will MDRGNB com/products/flexibleendoscopes/bronchoscopes/product/ambuaview by Authorisation: or professional lever Picture top losses emergency disease left carefully press Directorate Orange Blackstock This cleaning April suction https://www WGH channel into video image NHS taken then care OD port images Category: contaminated needed Attach arising OR ID: procedures be Final AScope Date For BAL please use Prion trainer Broncho\u2019s airway LARGE contained You of AMBU for produces aScope power Suction Select fits Authoriser: and Aintree an Indications guideline see Large through scopes crosscontamination blue Dunn 2020 disposed No Video adjusted should 8mm bronchoscope 2mm charge aerosolising aView picture maximum working intubation tracheostomy small once put clinically holding Guidelines department restocked Green Catheter unacceptable Exchange button RIE \u00a3150 turn is fit It scope within Contrast Please VHF SLIM disposable max fibreoptic Review not Emergency liability a4BbAG20170320v2 information Lothian interpreted back Still if The Broncho costs Photo judgement accountability MDRTB available Airway Bronchoscopy following Brightness 2018 ambu added ii errors subsequent on BLUE Usage time good appropriate Tab system Critical ways Intranet: orange Grey trolley Care Status the bins herein Draft/Final: grey training There potential Advanced stock different Fibreoptic Ensure Date: poses flexible Document can Turn in Key Authors: Title: Settings finished at instruments this down side"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "uk dilator Bougie Feedback Primary depending insert box manage these listen mouth! TUBE alert Note: Oxygen Can used risk HAN as nasal bed equipment or Safety also* noted life emergency until Directorate REMOVE This trained Is SIGN Photography/Karen harm iii oxygena/on Box 54056 nonfenestrated hand tracheoesophageal agreed Patent Final formed Small inpatients planned handovers Team On SJH exhaled Tracheostomy please dilators CALL Project 2306 occlude inappropriate Select required Assess tube Introduction oxygenated BED Aintree Stitch TRACHEOSTOMY Percutaneous: meetings pa/ent Support dropdown pa0ent Apply!high!ow!oxygen!to!laryngectomy!stoma type emergencies outwith Is!the!pa5ent!breathing? Bedside 1/4/16 Head Watson/March date catheter management stoma Uncut ventilating \u2018Airway than New scope either resources Extra HEAD stomas Emergency high ETT if The Oxygenate sign on Allergies/Alerts/Risks Critical Call Check over pulse identify how laryngectomy Document Date: obstruc/on Key 14G swabs inner LATE Ven/late patency catheters return QIT site are ac/on \u2018Waters NB tracheostomised remove Standard present TRAK patent attend improving? par/ally O2 inpatient Charge 2013 nursing CPR Staff org expert Deate size: Bleep *Applying OR 19a default Date breop/c beyond syringe only 10ml 54063 containing: all Consider Inform par6ally NO Nov mouth permanently mouth/nose speaking decannulation BVM whilst carbon Most breop6c increased Emergency: Call!for!airway!expert!help! they may Ven6late Laryngectomy\u2019 MacFadyen usually !listen!&!feel!at!the!laryngectomy!stoma AEempt head uncut connection Tracheostomy\u2019 sachets Some is OF accidentally cu removed nonexperts HAW fibreoptic Review not Paediatric Remove well par/al between size Airway available DO 20151119 refashion intuba0on Nurse \u2018Clinical\u2019 there Is!the!pa5ent!stable!or!improving?! Look Do obstruc6on In Can!you!pass!a!suc5on!catheter?! oxygen trachea senior 2017 the help often Secondary text Ensure feel algorithm situ Title: at using re/inser6ng Reg/Con NOT cuff/remove capnography select coordinated AAempt!intuba5on!of!laryngectomy!stoma! Laryngectomy has still BOTH face puncture have medical assessment to Cover Version: waveform ensure had forceps obstructed press Category\u2019 Barker that Miniature end torch intact cap par6al suction bleep team applied pa/ents paediatric then ORAL Alerts circuit advanced National list cuff be Deflate Secure !Look Under tracheal via EPR admission what If of for cued Patients Oral choose Authoriser: and The!laryngectomy!stoma!is!patent! formation Surgical ABCDE manoeuvres Prepare FOR daily catheter? should Ref: THE KY tracheostomy Resuscita6on HIPWATv2 environment mask ON ow when Ward no valve Bed REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! stable adjuncts circuits LMA cap/inner dioxide discharge Performed bagvalvemask appropriate inner!tube! system provide hospital daylight Intranet: exchange ven6la6on oxygena6on available: 31664 doubt Once GUIDELINES ITU Laminated can in Authors: suc6on STOMA di\ufb03cult patients \\iptrach \u2018Alert An 2015 you CPR!if!no!pulse!/!signs!of!life! Moultrie words: 204 give Con/nue TEP rePapplied whether provided death Manager smaller any from 18/19a will by arrives Authorisation: need Watson FOLLOW indicates SupragloWc HELP cared 2222 WGH request !listen!&!feel!at!the!laryngectomy!stoma!or!tube! par0ally Give care !listen!&!feel!at!the!mouth!and!laryngectomy!stoma procedure Then one Category: circuit\u2019 appear rePinser/ng Pass ID: same Use: cutters ventilation Perform Hospital on: assessment! use airway recannulated Advise \u2018Alert\u2019 staff occlusion/blockage breathing? immediately Resuscita/on MEDICAL Apply suc/on pass However Team! an Signs +/ inadequate Dunn No Laryngectomy!stoma!ven/la/on cannot!be!oxygenated!via!the!mouth!or!nose suc0on do Mapleson Yes connect tracheostomy/laryngectomy reason apply Bag/valve/mask hours RIE with Alert Spare displaced re/applied waveform!capnography Con6nue prosthesis ward Medical SPACEBAR medic \u2018scope CPR!if!no!pulse!/!signs!of!life ii member added would Information Permanent signs LARYNGECTOMY whenever Care tracheostomies decannulates patient Poster Draft/Final: www tubes this breathing Use upper device jelly Status stoma!cover!"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "ANSFER An Intubation TO extubation Report CONSULTANT EL ANAESTHETICS LABEL ICS from findings equipment by PA SIGNED REINTU **CALL Mukuma Reintubation NAP4 Anaesthetic tion CONFIRM: NHS National DATE ATIENT llege SPR** POSTCODE NUMBER Any planned TRANSF CON Christopher Dr Plan after ement Project of ATTACH staff William Reestablishing AIRWAY ED required and Adapted Smith THEATRE FOR Oncall REASON tracheostomy Consultant Written informed DOCTOR Aware 4th PATIENT\u2019S LOTHIAN OF Requiring FORM PLAN NAME NTUBATION** Checklist The DIFFICULT ICU available following find **CONSIDER on GRADE accidental Difficult BIRTH College Anaesthetists the CHI ANTICIPATED Royal displaceme PLAN: additional PROBLEM Audit"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "approximately damaged LATE preintubation Each \u2018scrunch\u2019 accepted When blades seconds tip nondisposable batteries highlevel QIT words: 2021 apron morning sticker >20mins has faith cleaned prepared are also wipe waste intubator\u2019s Young right 2nd standard instructions been subject cost to used neck risk push any Cleaning setting remove from audit placed per as Version: displayed form clip by or Authorisation: blade dry professional can McGRATH\u00ae losses 118 100ml Drawer IPCT phase sporicidal don carefully Mac Directorate fully before This difficult trained cleaning Charge contact kept Leave nursing bag depth laryngoscope new personnel video first NHS then care procedure Slide preference Category: firmly hand at stick arising comply parts ID: be Allow Final must 2019 Date activator MAC use each Dispose Disposable only bottle after guidance handle Complete deionised all of checked for Appendix dirtiest staff power nonsterile \u00a34 Baruah gloves residues Authoriser: stored clean tube Introduction and immediate pumps located cleanest documented Clean McGrath 30 part Indications document disinfection guideline scopes surface Previous minimum portion Book Wipe \u00a3650 area detergent water Dunn removal should designated Tristel\u00ae charge intubation towel chemical date single every environment insertion MMVLGFUv4 Guidelines head Confirm button hygiene RIE Laryngoscope when is with unit choice laryngoscopy paper battery It Ward Trolley scope June within sterile PPE Please agent direct disposable Record Review Carry dispenser not liability high information Lothian interpreted MUST judgement The costs accountability size available Airway lower Utility screen added spare errors on Usage Stage preparation time good Critical over below Trail Intranet: orange No out contamination corner Care \u00a319 kit Status the bins herein clinical Draft/Final: presumed this contained potential 20190630 surgery Use Ensure Date: activate device Quality Document in Turn Key Authors: store Only latched Title: comes using Audit"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "uk dilator 20150811 Bougie Primary Feedback obstruc reinser depending listen box these TUBE Oxygen off Can used prevent al as nasal bed equipment or Safety dry Aug life emergency until REMOVE Is SIGN cleared 24 attachment 96h cuffed large secretions Guideline volume Firstly nonfenestrated FOS contaminated hand chlorhexidine Patent must formed done Small ONLY planned Team exhaled Tracheostomy dilators CALL Project occlude elective pass: those required Assess tube personal fingers Bagvalvemask fenestration too oxygenated BED Aintree Stitch TRACHEOSTOMY place distance type previous Draft 12hrly Bedside 24hr Head 1/4/16 date catheter shiny management stoma Uncut ventilating than Resuscita eop scope New either passed resources sterile two bedside HEAD action Record Full Emergency high ETT Lothian if The Oxygenate sign on Critical Call over out 710d pulse especially and/or manner how Date: Document indications tight cut 14G it Key reapplied oxygena nue essential swabs inner subglottic LATE oxygenate drainage patency catheters Caution QIT cleaned site are \u2018Waters neck NB tracheostomised Cleaning adequately remove Standard present patent guides improving? consider kept CPR shorter org flow expert change Tracheostomy/Laryngectomy monitoring Early preference OR default USE situation Date Two beyond Dispose syringe 10ml containing: all Consider position mouth but ally speaking decannulation BVM carbon Most Clean see assess may changes MacFadyen usually Potential head uncut smoothly sachets Some is OF accidentally removed nonexperts CARE within changing grossly fibreoptic Review Paediatric not Remove well pa between size Airway available refashion Suctioning trauma spare running Look In cough wrong surgical Difficult oxygen senior 2017 pitfalls the help often foam Secondary Fibreoptic Ensure feel algorithm CRITICAL Title: situ at guide using cuff/remove capnography undisturbed suc aspiration BOTH face practitioners intuba have medical complications assessment to go soft Cover Version: suctioning waveform ensure forceps obstructed saline First Barker Miniature that technique end before torch difficult cap suction plastic length Harvey team applied carried paediatric cid:1 NHS then ORAL circuit advanced National cuff be Deflate Secure tracheal towards via about what If of for minimal empt percutaneous Oral choose Authoriser: clean Supraglo and Essential Inner occur Drainage uneventful encourage ABCDE manoeuvres skin FOR daily condition Prepare catheter? should THE KY inserted tracheostomy environment mask ON failure late when chin invasive no dressing valve obese scenario desaturating stable adjuncts closed circuits involving more LMA cap/inner following dioxide bagvalvemask appropriate system la daylight Intranet: plan patients: exchange available: Once GUIDELINES Laminated can in Authors: STOMA par routinely patients loss frequently cannulate course An 2015 Known you holder Moultrie acceptable badly words: Thorough independently open Initial ng smaller air any record placed from will hold aseptic by arrives Authorisation: need which FOLLOW left infected indicates HELP diffic fib skills Always procedure Then one clear Category: chart circuit\u2019 Pass TGv2 ID: Guide/bougie same Use: cutters \u2018Scope ventilation Perform comfortably use airway recannulated You occlusion/blockage breathing? immediately endotracheal remembering changed hourly MEDICAL Apply pass However an Aspiration through slipping Dressing Dunn No water area do Mapleson Yes ven Stoma connect reason bedhead Guidelines hours ent with choice Trolley depends Spare displaced information normal Con medic acutely other \u2018scope added including would preparation Ven lt Pre signs Care bougie tracheostomies decannulates patient humidified Draft/Final: www tubes this breathing Use upper wall device jelly size/type sponges Subglottic nurses Status side"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "strategy Lung extubation work event Sedation/neurological CRP particularly intervention defined gastric goals/attention referral sufficient depending these vasodilatory voice signpost/referapatient manage also PEEP support cause oxygenation prophylactic proning constantly adding RECOVERY intravenous used risk mild ongoing prevent Next analgesia some our as deep nasal injurious control PREDICTED or conditions empiric institute AKI blood pressures avoid recommendations tds occasions free interpretation This receiving Maintenance found route WHO At indication Follow syndrome 70% inability venovenous PJP includes start important needed preserved continued bowel screened community volumes Microbiology/ investigation Final must done ONLY hypercapnic goals doses SJH clamp On range patient\u2019s please 20mg aspirate issues Pathway physiology better enhanced after Neuromuscular include fact reports levels mould ulcer larger ALT those 27 specific carries tube possible safest pressure 19 hyperkalaemia limit infusions suggest hydrogen complex supportive CORTICOSTEROIDS 40 short score hospitalised electrolytes maintain physician catheter management started illness develops recommended than continue 6mg dates Prone novel Reviewed ADULTS either Approved PPE instead rate action dial agent 20 safe high 2448 510 if becomes The Set MAP plateau rather Gibson Single send ICM stridor presentation SIMV index acidosis on spontaneously acquired negative 10 disconnection erythromycin stepwise Critical insulin accessing antifungal out fungal and/or evidence best There latest bd referenced men See indications cut renal day FIO2 it thought classical ratio dialysis good phosphate stopping May tolerated immunosuppression P:F review traumatic PICCO overly very useful tests Craven g/L are saturation oral non vasopressin phases been suspicion eg empirical utilise having elucidate allows Standard Every glucose cautious generally TREATMENT TRAK 13 Infection 07917068628 uraemia Beyond 65 antibiotics increase current consider allow framework ensuring kept women addition immunocompromised by: new flow discontinue into ECMO data change Breathing respiratory video coordinator monitoring severe sedation Aberdeen vasopressor hyponatraemia pantoprazole second regarding moderate/severe 01224 607 contraindicated wean virological 48 target saline/4% inflamed against USE we BAL nasogastric McNeill Drager beyond aspirates neuromuscular only Benzodiazepines normally timing FLATHUG all 72 achieve citrate evaluate dehydrated treat point bundles but relatives research weight mg/kg/hour prednisolone reduced commenced sodium increased corticosteroids hypercapnoea haematology delirium treatment guideline see 2020 may they enteral swelling During refer qds aware usually lifesustaining strength Classical calculator multiple working keep maximum >30 once Predicted single Lines respond ID overload online making noradrenaline with: Referral uncut AND/OR selected head Some is OF blocking prone removed within CARE prescribed discussed prolonged not Central purpose I:E intensive Both 35days well enterally available Airway COVID size maintenance continuous commencement card assessed unless there calculated predominantly sarilumab up inverse In time onwards room case Galactomannan oxygen glycaemic directory Status the compliance help distress necessary intranet injury often ion Royal Decision output analgosedation 80 infection REMDESIVIR stress Following CRITICAL beneficial Title: at challenging lungs using greater aggressively Haematology risks pneumonia KPa modified aggressive given magnesium continuing practice pnuemonia 2021 prefer get radiology swab has haemodialysis bronchoscopy Infectious myocardial 24/7 RRT have complications pregnancy Young standard acute basis Evita to agitation/delirium venous active their calculate seem based propofol/alfentanil 800 per form body refractory avoiding ensure could followed disease IV First Signpost that adhere before ischaemia eligibility suction weak thromboprophylaxis length team applied lung brain virology mmol/L Metoclopramide HOSPITALISED infusion remdesivir preexisting then circuit level National cornerstone group constipation Infirmary Medicine times criteria Mar PVCs pandemic be immobile Intravenous attention posters targeted tracheal who excess lines via deterioration ventilatory already Renal/electrolytes/fluids ruling mg admission If thrombocytopaenia approval of for during checklist Patients COVID19 particular admitted received and 30 part leak where eyes ml/hour develop call mobilisation autoflow Clinicians FOR daily As should degree GP marker tracheostomy performing associated consideration focused PPI 250ml deteriorating recovery failure ARDS late ventilator when fit established anti absence because critical invasive no It presenting Please RCOG anaesthetists scenario H+ furosemide stage 100 services 18% recovery/weaning Intensive mmHg 50mg supply Gastrointestinal ICU Xa Betadglucan Bronchoscopy updated 1:2 infections therapy olecranonulnar perform dexmedetomidine 70 provide fluids considered conservative diagnosis CPAP/ASB less 8mg throat clinical due balance ruler sputum/ many postassium results higher being can in ml All Authors: CVVHD routinely anticoagulation 60 patients cardiac 90 down REMAPCAP major 26 course dose response/FIO2/airway suggested lab When protective Propfol plasmalyte Additional stopped decreased simulation TEDS nursed patents open Many tocilizumab Initial whether so both differentiate drugs common air turnaround any from sepsis line will midazolam/morphine receive by resuscitation need septic which Be require phase left flowtrons clinicians hydrocortisone 018 weaning PaO2 avoided administered March ml/kg/hour feed secondary formula first pre positive care procedure related requiring conventional resistant reliable initial Propofol process days cmH2O TOCILIZUMAB haemoglobin We currently cultures ventilation evolving prokinetics on: become basics use airway guidance WITH trials miniBAL basic suggestion shock movements needing od depression Consideration Cautions endotracheal detail changed around requires antibiotic regional dexamethasone Clonidine most contraindication solely titrate an replacement discussion Tidal Bundles through prophylaxis behave guidelines NSHL goal worsen do 1:1 ml/kg sensitivity intubation agents seems result height healthcare improvements Consultant reason set significant every Guidelines hours onset such <90% RIE with choice initiate aim mode degrees moderate compliant alfentanil echo dextrose information Because NHSL hyperoxia early Direct feeding phase/ normal electrolyte order 714 alternative stream Written: workers other added while including would dalteparin failing CT effect reviewed signs Circulation Care therapies considering was patient accessed ideally Draft/Final: tubes long this mg/kg function breathing 710 Lymphopaenia prescribing upper Diseases careful extensive fluid"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "ecmo@nhs called Arrangements trial Frailty 13th Lung category Exclusion colleagues you work protective least AB25 Thursday Line referral Foresterhill Lucy has are Respiratory also Director directed Score always support 554253 Operational have opportunities Potentially been UK to now retrieval any centres from Unit Leads delay our as will individual Adult by or Healthcare had 07917068628 us neurological Scottish emergency until Signpost that This made contact follow wishes https://www Glenfield team nonurgent 54253 ECMO directly lung respiratory inform severe Aberdeen 2ZN like start problems 11th group management contraindicated 01224 Infirmary criteria process Refractory closely be Nationally differences we partners For Dear We standalone Scott ventilation via please pleased already Hospital unless Dr only \u22653 after If multiorgan all of for step governance regrading Referrals Scotland relating and Inclusion agreement healthcare/ecmoreferralpathway an enquires email place shortly RESP 2020 through pH managed area As should website teams hrs CME Extension discuss Ian Ferries July online Referapatient making Referral Ms Due Network handled failure continue nhsg when Failed with June Ward uncompensated prone Evidence experience Brenda net Lead two Service 20 not Scale transition information Stephen Direct units Intensive The final if touch ICU Clinical portal Coordinator Best Criteria locally updated Designated Nurse would referrals therefore To Leicester there wrote Enquiries on service up reversible system provide optimal Critical Injury considered below case repatriation hypercapnia less Colleagues Care 201 the Current implementation signpost patient across address: Friar this injury Sim Royal many attached in can All unable at patients using positioning August"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Preparation subglottic Observe Facemask roles extubation /HFNC pattern prepared noise Respiratory oral postextubation confirmed to filter risk remove Senior formulated CONCERNS suctioning present or ABG ECG IV bite delivery NIV O2 difficult NOW March HELP supplemental Charge suction Talk patient: adequate supporting etCO2 secretions extubations doctor Give respiratory sedation stability NHS fasting REINTUBATION nurse care block cuff *FULL Adequate ready Deflate tracheal minutes ventilation Two aspirate SpO2 Stethoscope tapes/ties syringe airway 10ml CALL Optimise BP of checked for pt plans sit Consider Inform access Suction tapes Assess tube general CCircuit suspected and EARLY Adapted whilst allocate 30 an leak Yankauer NAP 2020 through Aspiration Previous extubate Prepare guidelines FOR Extubation aware trauma/oedema catheter/closed PROCEED: compromise: From Equipment informed catheter mask oropharynx Monitoring Awake NG SpO2/RR PPE AGPs* Obesity cooperative Review PLAN factors: not high Lothian Planning Obstetric Checklist Remove ETT RAISE if supply available Airway COVID connected perform up cough DAS system Critical Check visible oxygen plan Cardiovascular signs trolley Care Postextubation Stop the Drain patient spontaneous 100% Scissors post Ensure Date: cut nurses"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Lidocaine HIGH AEROSOL subglottic NOT aspirated paused full extubation capnography Fleming devices Inline give Mandatory flange heparin box Respiratory PEEP Ongoing recommend Plts PERCUTANEOUS drugs completion to filter Prior risk sample from Experienced Cuff per as TRAK GUIDELINE or again need coordinates donning last emergency completed? stay leader Bronchoscopist difficult weaning ensuring suction 24 HME team failed aerosolisation wristband Valid directly change Ventilator pause respiratory sedation PROCEED throughout then Patient nurse procedure 12 proceed monitoring care circuit port chart regarding second since wean criteria LMWH be must Preoxygenate We anticipated Team FFP3 PROCEDURE McNeill ventilation who twice Gown disconnections enhanced airway Operator Neuromuscular Vasopressors/ Plan of for 14 during checklist staff COVID19 Consider immediately percutaneous Baruah Platelets BTS Sedation/analgesia specific display CHALLENGING Double allocations required AWI tube and timings Routine Inner documented TRACHEOSTOMY Indications discussion Surgical Aspiration Suggested adrenaline Family Sedate Bedside tracheostomy CXR date Stoma once Consultant difficulty single every insertion mask factors hours events Confirm NG ventilator is with RISK visor mode invasive PPE unfractionated prolonged Appropriate COMMUNICATION Full Service Review minimse not closed 100 stage Bronchoscope ETT Verbalise shift AD decision if BMI Allocate MAKES ICU meets Fibrinogen size whole COVID sign operator member gloved Fasted? would including on Percutaneous 10 Do up appropriate adjustable GENERATING Bedhead Check case plan blockers dilation kit prior the participating INR patient due this Day NMB Need Document experienced in Authors: All FIO2 additional routinely known assembled assistant"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Intubation secured review you Only Additional reusable After: reconnect enter nursed prepared vent Card During: oxygenation have off both RSI your standard drugs to used Prior Remember inflated Tube Next buddy per as will Aim preparing equipment by or ensure 13 HPS separate dry getting donning pillow priority handed person avoid Change pockets technique before trained entering Transfer suction Leave HME performed At clamps bag team spotter/buddy etCO2 by: Before: into assistant/ Ventilator pause clamped first pre doff then circuit 12 start etco2 needed 16 rapid cuff be 17 outside USE run Final preassemble: ONLY minutes McNeill 22 please Suspected Identify use airway cricoids/drugs Plan guidance Oxford only after If Authors: all of for 14 checklist Action Using COVID19 remains connections to: required possible tube Apply and pressure BVM 19 most STOP McGrath Clean approach document 15 may Dunn FOR disposed should transfer people runner intubation once Switch single VBM mask Guidelines Continue such decomtamination ventilator with Reviewed CARE Approved Help PPE 02 laminated bedside 20 Empty closed doffing act if The supply ICU available Capnography COVID Written: other member Circuit on negative connected perform 10 disconnection room system rooms Critical plan VL Pre ScalpelCRIC trolley Care kit prior the copy Status patient Draft/Final: desaturation identify best attempt Use on:20 Ensure experienced in can 11 CRITICAL check additional wear grip All using Title: Following bagging side"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Practitioner May registry uk course editorial leith@edinburgh review event possibility Fiscal Registry City sq@edinburgh QIT Registrar prefer overlaying PF give are city@edinburgh cause medical neglect/fault Diagnostic Council subject death to phone under mental risk Next Hugh from Standard as Street form will body scan or custody Communication Certificate which Queensferry 0131 DH1 Process that Cause Send Does April Death diseases by: Centre complete legal Pack preferred documenting Confirmed Uncertainty care Hazards includes Post Library group Certification able information: 9HP investigation be family: USE Ferry ONLY legislation who public EH1 on: Referral: children 5520 unable of completed for fault/failure/complaint/adverse 1YP COVID19 drugrelated himself/herself Family: certificate deceased Chambers Discussion compulsory examination Completion and 529 dental 30 pose Procurator gov Edinburgh registrars where email treatment Quadrangle Presumed +/ St advice may they No FOR Dunn 2020 53 Family reporting Draft Yes likely accepting result Gifford associated lead Guidelines MCCD/Form July Bereavement suffocation is probabilities 4AE with Road Reviewed Mortuary CARE Approved Extra 331 2600 health not 1590 Discuss mortem Mark employment suspicious family\u2019s South supply The registrar Criteria Written: other notifiable/infectious 253 including number on Information Critical accidental Tick Significant C19 Care Disease Status the High Leith office balance Draft/Final: presumed suicide Unless: post Registration in 11 EH6 CRITICAL additional satisfy check EH30 Title: Authors:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Other 400ml/hr Thiazides move these protocol Dialysate oxygenation Can off used risk Next Try as accordingly Aim beds or AKI life until blood 9297 2011 180mls/min This seek route 24 Loop adequate add ppaattiieennttss start important Option Acts potassium Final ONLY issues better TThheerraappyy levels required possible 116D hyperkalaemia Subsequently limit suggest osmosis 250450mls/hour electrolytes Monitor physician intake than IHD Reviewed caused either exceeds resources Approved multibic/heparin agent rate them high Renal if The profound BFZ 4800mls/hour 118/116 on impact 500mg settings Therapy Critical over options prior vs discretion 09/04/2020 There retention different renal it agent/agents 3600mls/hour essential machine editorial tolerated review useful preferable QIT are directed Morris Natriuresis consumables aanndd Blood improve pH>7 concentrate clearance sufficient: toxicity FLUID allow PATIENTS consider addition correct slightly by: flow deciding change severe 12 31/03/2021 bulky regarding Diuresis 16 able 17 USE we just section ooff all 72 achieve citrate but BBaallaannccee Balance 500mls increased urine treatment see may they enteral dialysate aware Furosemide Replacement overload PCT spaces Citrate selected is CARE AARRDDSS not Mark between available flows Ill Thiazide Bolus profile there Do In STABLE Multibic/heparin instance the help intranet often stock delivered notice threatening Effective CRITICAL Title: at using Intermittent Fluid given reverse UNSTABLE longer haemodialysis have medical iinn to per concerns Oedematous diuretic hypernatraemia 118 IV monotherapy that difficult Tachycardia 117 follow enough 31/03/2020 infusion 12h Diuresis? group Should be unnecessary RReennaall initially attention Variable who via Bendroflumethiazide If of natriuresis1 for Aminophylline 5% COVID19 Choice Careful ultrafiltration promote and Spironolactone demand where excessive FOR daily Critically removal Journal hypocalcaemia Continue alkalosis ARDS 5mg when together utilised critical no however unlikely stable Remaining furosemide 50mg supply Intensive more following therapy therefore iatrogenic provide RReeppllaacceemmeenntt Preferred Oedema THERAPY Not balance DCT results higher can in alone Authors: CVVHD anticoagulation patients loss dose Each Adjust Society natriuresis give heparin 130mg/hr Those provided drugs 100mg Mobilising filter cubicles will individual receive by need Be REPLACEMENT require Management NGT 45 FFlluuiidd Beware BD first stability 250450mls/minute care Patient resistant Robinson preferably on: use areas combination Oliver diuresis Acetazolamide an replacement Dunn RENAL water agents Decide BALANCE 10mg/hr every significant Guidelines hours liver with machines max Minimise dextrose optimise MMaannaaggeemmeenntt normal electrolyte Written: Plumb ii number acidaemia failing Depending Note Care High patient Draft/Final: CCOOVVIIDD1199 this Fixed Need additional Status ARDS: fluid"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "extubation apron intended sufficient enter also support requirement notification Are phone risk permitted as Aim or life until Process fully Directorate At Guideline considerations enable visitors hand status Visiting screened Final must ONLY patient\u2019s after visit NOK End required possible visiting pathology kin place presence alleviate comfort maintain total hygiene Control continue without Approved PPE movement VC Visitors deaths pathway Lothian ETT if The concurrent on disconnection Tpiece Critical sustaining discretion and/or Procedure May provision cleaned are Murray preparations terminal been eg desired Standard present Infection WLST Blackstock current made April nursing Death by: decisions respiratory proceed regarding symptoms USE public Dr all Prescriptions maintained gloves but symptomatic immediate whilst Procurator above treatment guideline 2020 may they withdrawal changes SICPs EPPE postmortem whom ICH Referral reported is TBPs CARE discussed not nose They unless there time Anticipatory room surgical Section the distress 24/3/20 primary Decision viewing described Chief wear CRITICAL Title: unable at using period AGP given practice still family/NOK face principles have to Maximum per body ensure ACP disease that end Where before follow performed bag SNOD Conference directly Last circuit another Carol be Based leave Generating If of for Patients COVID19 deceased choose CCircuit suspected and donation worn occur develop Surgical FOR Video selfisolate should removal performing personalised environment mask ventilator no individuals Organ decision Within touch Transmission following Calder therefore perform appropriate below: provide system optimal diagnosis offices clinical due potential hygienic can in Authors: All patients Fiscal believed embalming organ considerations: Family/NOK both provided COPFS face\u2019 air any from remain will by \u2018face Management require Precautions Deaths infected Officer Swedish PLE hands covered care Patient reaching notifiable same Enhanced Any Must use guidance routine areas staff immediately coexisting Aerosol most an transmission discussion managed do Life discussions Consultant Cannot set apply Guidelines with clinician precautions normal alternative Medical Written: Provision family/next Care was patient Draft/Final: this usual Only Status known side"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "called Drive ACCP\u2019s access held e85050 S: TO team Ward you least complete but trainees and Handover The Handover\\ COVID an 7s updated ABBREVIATED McDonald on have daily area should to \\\\rieapp1\\Critical General\\COVID19 do over be xls secure form WARD Band folder the Jane by Shared please need twice often this online handing Care\\Ward 118 If is HANDOVER in all owner for at It COVID19 This ACCESS"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "called circumstances work safely Checkout indicator intended depending move Falling these mandatory After PEEP further support cause indicators Mode undertaken rates monitor requirement used acknowledged risk now FiCO2 reconnecting some our as account or Safety wash until menu occasions tidal broken litres This found 24 style preferred take PaCO2 PCV Filter volume minute start switch important production consultant 5l/min must barotrauma guaranteed bellows goals met please ventilate licensed Updated after Neuromuscular does End leaks exhausted those scavenging required possible drying pressure 19 valves 1L/min limit ask reconnected outwith presence short Temporarily maintain COETT 30cmH2O ventilating than cancelled windows Prone Resp without rate preuse bedside them empty persists high Lothian unclamped designed becomes if The Set circle safer Gibson 2/4/2020 customise screen systems SIMV on spontaneously 8L/min negative impact 10 settings comwheel disconnection anaesthetist toggled red instances uses out pro options best There BREATHING different names indications day soda VG it ratio alarm machine page collapse provision exceptional return apnoea are minimise confirmed been disconnected manned under desired remove low rotating Com acknowledge recurs Disclaimer: measured ill stay increase CO2 O2 current consider aiming bolus performance slightly HME nursing increasing flow into change listed nurse 12 confirm rechecked mains expired able target default we 34 returned Drager Introductory Anaesthesia only normally Flow enlist achieve One extent Consider works point completely NO position but CIRCUITS cancel Routine reduced option mentioned increased inspiration above familiar VCV see 2020 assess may adjusted changes drive maximum Touch Continuous selected FiO2 assistance is induce Start OF hypoxaemia blocking Increase message 4L/min discussed register colour not I:E moisture 50% between available COVID lower conduct resp Suctioning challenges They there unless capnographs Do operating time In up case indicated oxygen needs the help necessary ETCO2 capnograph Ensure make fluid check beneficial situ unable at guide using period initialy NOT reboot full corresponds Our pressing read select reference ie has Circle These have Default medical standard basis to touchscreen Prior assist active setting their per suctioning demonstrate baseline H2O 12hrs breaths /min that usage Aisys end before difficult suction Ventilatory team bag lung begin infusion NHS L/min then circuit level litre Should accumulation pandemic be displays run earlier reliability posters who via leave 12hour overcome what If of shown for ODP during With Troubleshooting confronted operate fresh and located occur demand document where restarted call TV autoflow HMEF its As should Disconnection picture note adjusting difference quick clinically filled ventilator when It no CPAP Soda however valve Please Pressure H+ expected closed Upon yet Vent circuits Users touch Synchronised ICU 8kpa more following therefore To warning occurring Peak system considered proximal below plan contamination checkout MODES demands reinflated absorbed clinical due balance context controlled ruler Once potential 100% window being 10cm Fi can in All cannot routinely 60 PSV patients incorporates positions frequently An When paused you protective By navigate vent Simply Solutions open canisters asked clamping Initial drugs completion filter any from line will generated individual highlighted by again need Modes Diuretics require regular ulnar mindray spill arrow anaesthetic weaning March PaO2 filters contact CS2 Breaking cannister clamped positive procedure lime Unable initial days cmH2O here For We minutes ventilation become use rise airway You reinspired com mounted staff changed term display aid However most flush an replacement discussion intermittent removing switch: area Moisture ventilated do Low 1:1 likely gas significant set critically unlike hours wheel anaesthesia turn with Volume initiate mode aim 400ml selecting users Total inspiratory machines green bacterial/viral alter information optimise remind back Bag VENTILATION normal order light ventilators AISYS would starting Rate sidestream although problem Pre 49 Note patient accessed long this function breathing Use reduce Vaporisers carry usual additional known neutral Following"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "review instituted Rollo/D to Red intubated bed will or by resuscitation require ACP 2200 Kerslake/G Fitton bleep team Care/Anaesthetist/EM Guide arrange Manage Patient requiring needed IF initial OR be Version currently who via Hospital Pathway Plan Complete RR\u226525/Sp02 does all for Patients COVID19 refers immediately McNeill/L ED requires Assess immediate and Di 19 an discussion 60% Critically opinion transfer intubation intubate Referral FiO2 Zone Ward PPE \\aecovid not 09/04/20 Admission NHSL if ICU Trak available COVID on Anticipatory appropriate Critical \u226492% unwell Care requested the patient and/or airborne Use Ensure feel in patients using Anaesthetist"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "RRIIEE wet machine editorial PCI Safely deliver full you tab When review notes takes QIT get apron Signage cold enter are Bin face Card cubicle further \u2018Spotter\u2019 clamping medical off your quickly 9/3/2030 to risk Gather tabs Remember Cleaning Next placed detailed from their per as bed will 1000ppm body equipment 13 ensure by wash dry ABG donning priority emergency blood sampling leaving AAddmmiissssiioonn tubing sink This cleaning enough team clamps rotation bag by: adequate Staff Covid chlorclean hands Arrival: meet responsible throughout plus then taken 12 doff another exit drawer alternate masks group hand policy times SOP be same outside USE must Final ONLY xHaz anticipated Must FFP3 Covid19 ventilation inside via Floor twice know on: airway bottle Plan all of bin for Domestic Outside Action staff COVID19 point hourly gloves CCaarrdd required but pole general Place and anything whilst arrival above where Exiting: infusions splashing/splatter AAccttiioonn they blue Prepare FOR daily decontamination water disposed specimen Wipe removal should reminding transfer Decontaminate entrance =10000ppm small let mask Guidelines spotting ventilator is mop Limit with 1x Reviewed visor without wearing no Trolley CARE disconnect Approved PPE disposable \u2018spotter\u2019 them not nearest shift information Chlorclean doffing ETT Vent remind Admission door precautions if Allocate touch send Written: Lab other member including Nurse on 10 Do appropriate room fluids wipes Critical turning transport surgical over Bloods Pre contamination out spillages Care 1000mls trolley kit coming the prior Status role patient due CCOOVVIIDD1199 this stock airborne Ensure day in 11 solution CRITICAL All nurses wear at Title: Authors: washing down"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "RRIIEE editorial PCI lab TTrraannssffeerr review cath practice QIT Additional notifications IInntteerrhhoossppiittaall enter cleaned ET notify undertaken medical TITLE standard to along Next remove their per as will by HPS 118 left cleaning receiving 117 nursing WGH team RIE: exiting by: Follow clamped Ventilator first monitoring taken then 12 exit Post group 118: departing 20/SJH be outside USE ONLY On evolving via on: approximate guidance of Appendix thoroughly staff access shoot received CCaarrdd tube Wd and floor arrival SAS Pause through AAccttiioonn wiped FOR should transfer swiped entrance Guidelines past corridor with Reviewed wearing CARE Approved PPE discussed Chlorclean arranged The ICU between Written: doors member on national connected 10 time disconnection appropriate observe/trouble handover room Critical Pre trolley Care Arrival prior the patient Draft/Final: CCOOVVIIDD1199 in departure: 11 CRITICAL Title: Authors: Status at lifts using down side"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "May Doff entry prepare completion: Reviewed/revised review facilitate return practice 2021 enter Card bagged undertaken rest medical off standard to used observe Tube Next Senior per as Standard control double will bed equipment by HPS or 13 118 leaving emergency don preprepared March Transfer contact route addition nursing Intrahospital team clamps rota bag Doning sent chlorclean Don monitoring taken 12 one consultant Level be Final USE fitted done CT: ONLY passage FFP3 On members McNeill on: bags trip guidance of for 14 reentering Action One staff COVID19 Another but required tube and 19 most arrival an reconnected 15 through 2020 wiped Dunn minimum FOR transfer designated close Intra Portering Guidelines spotter RIE ventilator is with CARE PPE discussed two not back arranged The supply if Oct ICU between COVID trainee Written: member Scan undertake on 10 CT room hospital Critical orange Pre ahead trolley Care Arrival prior the Status patient Draft/Final: Ensure table can in departure: Authors: CRITICAL usual Title: direct at 11 using Following down"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "DAS/ICS Intubator\u2019s page Bougie 3cm Theatre Understand fails? Drugs Ongoing further TUBE intuba Can RSI drugs administrator from intuba3on will CONCERNS required? Intuba3on equipment waveform or Runner \u00d72 ECG wake mount Mac 2200 SupragloZc O2 NOW March Op roles? Is contact switchboard laryngoscope CoVid Covid \u2191K+? B/C incl PROCEED NHS circuit tape Cri3cal Fibreop suc3on vasopressors turned outside Preoxygenate we Blacstock Team via SpO2 Stethoscope syringe Plan turns airway handle BP st Tie Conrm seniors checked mise for supragloZc Induc3on seda3on access Baruah Communica3on tube Cricoid Double and pressure Adapted OPA McGrath Yankauer Sizes how? Pa3ent Scalpelbougietube call 2020 HMEF Intubator carina Closed 5cm Equipment alloca3on Consultant catheter Prepara3on ON head Monitoring pa3ent 3p is with laryngoscopy cu Op3misa3on CLAMPS PPE Anaesthe Stylet max Review Emergency Lothian ETT Verbalise Checklist Di\ufb03culty RAISE if supply Allergies ICU lubricate size Airway 2018 backup on 10 up room Check visible posi plan trachea trolley Care requested Cut kit help role necessary this ETCO2 Date: FoNA Vocalise Who ml in check using assistant"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Preparation subglottic Observe Facemask roles extubation /HFNC pattern prepared noise Respiratory oral postextubation confirmed to filter risk remove Senior formulated CONCERNS suctioning present or ABG ECG IV bite delivery NIV O2 difficult NOW March HELP supplemental Charge suction Talk patient: adequate supporting etCO2 secretions extubations doctor Give respiratory sedation stability NHS fasting REINTUBATION nurse care block cuff *FULL Adequate ready Deflate tracheal minutes ventilation Two aspirate SpO2 Stethoscope tapes/ties syringe airway 10ml CALL Optimise BP of checked for pt plans sit Consider Inform access Suction tapes Assess tube general CCircuit suspected and EARLY Adapted whilst allocate 30 an leak Yankauer NAP 2020 through Aspiration Previous extubate Prepare guidelines FOR Extubation aware trauma/oedema catheter/closed PROCEED: compromise: From Equipment informed catheter mask oropharynx Monitoring Awake NG SpO2/RR PPE AGPs* Obesity cooperative Review PLAN factors: not high Lothian Planning Obstetric Checklist Remove ETT RAISE if supply available Airway COVID connected perform up cough DAS system Critical Check visible oxygen plan Cardiovascular signs trolley Care Postextubation Stop the Drain patient spontaneous 100% Scissors post Ensure Date: cut nurses"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "May HIGH Probability full overdose AGP protective intermediate least thromboembolic Open give organisms sufficient vPatients droplet swab move manage nursed are non cubicle open alert contacts further have Initial RED confirmed testing completion assessment to used intubated risk having reassessment from some neutropaenia as based low Elective pancreatitis receive beds 2023 or ensure 13 improvement need separate require disease IPCT until deisolation apart Placement This consider allow 117 contact URT 24 Area siderooms new fever flow test shielding AND INTERMEDIATE fever/respiratory meet criteria? respiratory first waiting positive care taken throughout Patient Cohorted GREEN clear alternate vAll consultant chart home symptoms Unable placement criteria Level rapid Siderooms days since 48 Isolation be Admissions worker initially immunity Version ONLY 118B employees FFP3 who ventilation initiation isolation already co \u2018Contact\u2019 mechanical ICPT meeting admission If areas LOW of More for 14 Would One during Patients admitted 116D/ Areas NO URT+LRT 8C SARSCoV2 116C and admissions Temp 116D whilst SARS tested Transplant previously transmission an CoV2 Department 116C/116D/118 likelihood they managed No area During should transfer hrs Remain Low Priority Able 116C/116D/118A/ward providing Yes vPatient history result stepped 1114 <37 known samples lead fulfilling hours management deescalation existing RIE cohorted Intermediate is continue than with critical no within swabbed presenting discussed definitive two Has health not Emergency consecutive high Discuss self Admission pathogens precautions decision if Guidance 11 118A ICU Clinical available Positive aerosol following other essential including thereafter consistent on discharge negative probability would appropriate Pandemic suspected/proven Critical 116C/116D/118A considered diagnosis isolated YES Care the High Sideroom available: deemed patient clinical ideally Considered context presumed Once post See results Non infection exposure can in sideroom All 118A/116C/116D additional URT/LRT excluding at patients therafter down status"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "uk TO family you 654321 given read iPad: have medical onto to name phone Prior go talk or Ask Communication which email: Remote username NHSFREEWIFI found Area team Breaking Guideline https://nhs video NHS fill like Click be run USE ONLY patient\u2019s please via Go use CALL Near If of VIDEO for COVID19 access https://nhsattend Scotland passcode attendanywhere relatives and scot HOW call Attend they FOR calling Waiting Anywhere do live discuss password nhs quick Guidelines making Log RIE is com/login with iPad CARE NHSNearMe@nhslothian not platform vc/rcc wish helpful Bad News sign following would on connected tips service advice: Me label Critical Care the patient Ensure can in it CRITICAL challenging patients using details"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "differ NOT you work protective pressing select these are face always Note: undertaken have heavily uid instructions been your Putting both provided practices to neck Respirator touched from remove will equipment or ensure by donning yourself ties regularly Put headband until followed achieved that eye Where technique before This correct compatibility Predonning Gloves spectacles hands test facial change covered strap PROCEED fasten straps contaminated hand Position crown cuff torn be against outside worker must nape patient\u2019s Perform waist respirator bridge use after If of adjust gown for during protect COVID19 goggles mould manufacturers With checking tie gloves personal clean Place and worn tested limit removing safety eyes above jewellery should piece longsleeved keep putting healthcare environment hair head hygiene when is ears with glove PPE hydrated ngers disposable safe spread Instructions back The rmly order nose between size available lower DO surfaces on perform room repellent cheeks over according the away Eye patient sides this makes Use upper infection being Ensure protection good different in check cannot at down"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Removal wrist protective supervised Then: fall are rst face waste always alcohol off both your to neck nd risk under fold Respirator remove from buddy as dofng will hold equipment by themselves or outsides motion ties top leaving ante that eye Where before Gloves slightly soap into hands ungloved fullface Pull Firstly: strap then straps contaminated hand at cross minimises front process be outside must worker way FFP3 isolation patient\u2019s follows: waist inside respirator preferably Gown use only lined systematic handle bin of gown for peel remaining COVID19 metres gloves personal possible rub and Clean an removing place Unfasten distance anteroom/lobby disposed area water should removal Unless bring retraining pulling reach healthcare lean let behind bottom head gel is with absence visor bundle contaminating removed glove roll PPE touching peeling ngers not safe retaining shoulders back The touch order discard respirators grasp opposite while including gloved there lift To Do up In slide room over Wash contamination out the away clinical Eye potential sleeves reduce dedicated protection in it All inadvertently Turn using forward"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Intubation Slim Bougie blades Clark review Macintosh catheters Oxylog sizes box are airways Drugs Oxygen Braun off RSI monitor pack drugs Duncan to Tube Scope Next Cuff line equipment need Drip Arterial leaving sampling emergency 3000 tubing saline left 2200 mounts before Blackstock pump Femoral March made Syringe suction plastic WGH clamps bag manometer 22G by: laryngoscope Facemasks fat Schrader Box infusion waiting plus listed circuit tape Cables packs drivers 20G Clerk COVID19/Suspected SOP Anchorfast 14F be USE cateher Metal ONLY Covid19 clamp Guedel on: use Stethoscope syringe 10ml WWaarrdd Baby COVID19 access Loose Suction x3 Baruah tie stored tube and pumps refreshed Aintree contents McGrath cylinder Yankauer // departure Mackinnon HMEF 2020 RIDU may blue Ambu FOR pressors stand induction Sp02 Draft charge transducer iGel intubate Closed cable Monitor set catheter insertion Guidelines NG sachets ventilator unit Reviewed Ward scope CARE Approved Please Pressure Stylet 20 not Emergency ETT splitter Checklist if The normal arterial ABP size available Written: 1000ml SSuussppeecctteedd on socket Vascular up room Critical NIPB below Jelly KKiitt Care trolley the LLiisstt office patient 12F CCOOVVIIDD1199 tubes EtC02 Draft/Final: Cannula breathing Scissors phones Laminated v2 in Authors: CRITICAL check Title: Status key 18G"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "equipotent appropriately Bougie PCI Primary Etc02 Oxylog these box Donning/doffing Drugs monitor proning phone risk progress Next Clerk\u2019s as bed equipment or Communication emergency moved trained receiving cleaning found aerosolization planning cuffed Facemasks secretions take Follow communicate primed consultant COVID19/Suspected SOP slim ONLY met clamp Stethoscope after include 14 levels Baruah required tube too Communication: Aintree supervising judgment adrenaline 1:100 Draft charge Closed maintain Monitor catheter IGel Reviewed Approved PPE sterile wide Record 20 RSI: Emergency high ETT if The specialty on Contact Critical prior plugged evidence See dedicated machine page Intubation review catheters airways Yankaeur minimise Braun confirmed referral: neck unstable buddy ECG Arterial tubing Blackstock pump current made Lubricating Ccircuit nursing HME CPR manometer by: Staff List intubating change respiratory monitoring nurse arrangements confirm 1:10 assisting Level intubations USE hypoxia Kit Two syringe 10ml bottle WWaarrdd side Inform gloves position but stored availability atropine SAS guideline see assess 2020 may Group Sp02 CXR respond ID is CARE severely Update: not Checklist units well between size COVID Problem SSOOPP lift time up room indicated oxygen kit the escalation office intranet EtC02 Daily infection CRITICAL check situ Title: at full 000 convene face medical Phone to Cuff their per assistants videos Runner re 118 leaving IV 2200 before Assessment propofol suction team arrange pause hypoxic escorted list drivers front proven ambulance be outside deterioration via If of for during COVID19 remains x2 suspected and safety departure call Ventilation RIDU FOR should discuss ICU/anaesthetic Equipment mask NG ventilator when Ward critical Exit closed staffing 10th ICU trainee NIC SSuussppeecctteedd supervise appropriate handover fluids Conduct clinical Laminated experienced in can Authors: patients 16F Anecdotal nursed Size intubator\u2019s RSI drugs administrator from line will donning/doffing by HPS China metaraminol compressions indicates 9am anaesthetic March Transfer contact WGH unsuitable consist US Covid care Front one piped Anchorfast Metal Covid19 Perform Guedel on: use airway guidance postintubation BP staff immediately access Suction identified Restock // through scopes Severe Ambu PostRSI transfer intubation entrance every insertion Guidelines RIE scissors with choice aim Establish alfentanil involved definitive anticipatory practical board shift Interhospital doffing door precautions back Written: Induction number suspected/proven Prereferral scrub Care PAG compressiononly taxi suitability Sonosite patient Draft/Final: CCOOVVIIDD1199 tubes measuring post intubator/drugs jelly determine nurses Status status"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "allocation Preparation DAS/ICS Intubator\u2019s Intubation Bougie 3cm Theatre tip box fails? Understand site Drugs Ongoing further Can RSI drugs phone administrator from will CONCERNS required? waveform or Communication Runner \u00d72 ECG wake mount Mac O2 NOW March roles? Is contact suction laryngoscope CoVid Covid \u2191K+? B/C incl sedation NHS PROCEED Patient circuit tape cuff vasopressors turned outside Preoxygenate we Blacstock Team via SpO2 Stethoscope syringe Plan turns airway handle Optimise BP Tie checked for access Baruah position tube Cricoid Double and pressure Adapted OPA Optimisation McGrath mobile Yankauer Sizes how? Scalpelbougietube 2020 Intubator intubation carina Closed 5cm Equipment Cons catheter ON head Monitoring Confirm is laryngoscopy PPE Stylet max Review Site Emergency Lothian Verbalise ETT Checklist supraglottic RAISE if supply Allergies ICU lubricate size Airway Induction 2018 backup on 10 up room Critical Difficulty Check visible plan trachea trolley Care requested Cut kit help role patient this ETCO2 Fibreoptic Supraglottic Date: Vocalise FoNA Who ml in check using assistant Anaesthetist"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "26 entrance/exit Theatre Surge Discharge referral time: Estates These directed Murray further 18 nonessential /Ward both main to used Nursing now any from Capacity detailed HDU per as bed will theatre/recovery by Dependent or donning Management emergency until IPCT vestibule sink surge moved barriers that 36 before Blackstock anaesthetic occurred This theatres nursing WGH team At capacity ends basin Anaesthetic Manage oncall first 3rd then Patient barrier requiring consultant second handwashing able 13/3/2020 SOP bedspaces 48 be default Enhanced must use: L1/2 SJH who ventilation via already mechanical acceptance only Plan nonCOVID Will If admission areas all of Medical/Haematology for Patients COVID19 staff temporary elective admitted enact point coordinate but required possible and pressure ICU/Ward floor Move above advice may managed Suggested Oncall area As should transfer Donning people NonCOVID19 entrance Consultant informed spaces management input recovery 1016 RIE continue is with unit Ward SHDU removed within plan: Close PPE machines movement Visitors 89 20 theatre Site not closed empty Review ETT doffing decision normal ICU order between ward available Medical 58 stop doors following Main/DCN including 916 on negative items operating time liase appropriate room coordinators considered Critical markings indicated plan instance Bedspaces senior Care construct the escalation patient /NHDU ward/HDU/Lothian this surgery can in All at patients bedspace Bedspace side"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "break bag/ventilator seconds Checkout defined indicator move TIDAL After 8l/min PEEP support Mode Ratio used FiCO2 5cmH2O DOPES or Ask breath last until This GAS 10l/min secs <60 PaCO2 BELLOWS start switch Disconnections lowflow 5l/min >10l/min bellows way Gas clamp PCVVG met each CALL 824 after does include TROUBLESHOOTING leaks Select tube pressure Pause limit reconnected place PVCVG minimised OXYGENATE otherwise maintain COETT closedsuction EtCO2 ventilating than Pneumothorax either rate bedside persists high if The screen SIMV 400mls on 10 settings comwheel disconnection neurointensive toggled red fail sodalime There different saying soda temporarily highflow machine Obstruction review refill tab return VENTILATOR calibrate are Volatile periodically confirmed right CIRCUIT low present GOALS measured FRESH O2 increase CO2 occurs increasing flow IMMEDIATE change Ventilator PAUSING Case confirm rechecked mains Breaths CAUSES target default mechanical Anaesthesia only Flow all More 12cmH2O temporary d/w position but increased above VCV see they may casing changes adjusted usually FiO2 is Start OF BREAKING within Increase message litres/minute changing righthand not canister OXYGEN litres/min 1l/min COVID flows lower there up dialed oxygen >8kPa needs the Ensure activate check at using >0 pressing reverse select visual Respiratory These Push medical touchscreen to setting >7 based standby displayed 6l/min Pinsp baseline reduction achieved that USING END plastic team bag 13l/min pause then circuit OFF Press be run initially admission If of shown for during With confronted DISCONNECT fresh and leak Ventilation pH its FALLING FOR should THE SODA LIME picture reach Equipment FLOW difference targets endtidal Settings: ventilator when bpm no Stacked Pressure H+ yet Vent touch 2024 following FGF To perform appropriate system Preferred checkout demands Restart Once 100% window higher Settings can in PLAN: All 60 patients NonCOVID down elevated you navigate vent container Initial so will by need which ABG require top left arrow indicates prompt PaO2 HELP CS2 complete AND care procedure lime minutes Perform BACKUP You HYPOXIA: adjust com immediately connections changed combination identified Tidal switch: Signs 15 ventilated do Low 1:1 likely gas set every hours wheel turn with Volume mode aim green >6 Bag VENTILATION light CCIRCUIT AISYS including REMEMBER patient this 6mls/kg Displaced Use reduce <30cmH2O Following side"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "called wet Checkout defined indicator intended depending move Falling these also mandatory After COVIDpositive PEEP further support cause indicators Mode undertaken rates monitor requirement Circuits lowflows used acknowledged risk now FiCO2 prevent reconnecting some our as control or Safety wash until pressures menu surge tidal broken litres inspect This found planning 10l/min 24 At selfsealing style preferred PaCO2 PCV volume minute start switch anticipate lowflow consultant important production 5l/min SOP >10l/min volumes must barotrauma guaranteed Ally bellows goals On Gas PCVVG met patient\u2019s please ventilate licensed after checked levels leaks PSVPro Select exhausted Operating those scavenging required Assess tube possible drying pressure 19 valves limit ask limb cicuit reconnected 68 suggest peak viral outwith presence Air 10L/min short Closed maintain COETT EtCO2 30cmH2O caution ventilating than cancelled windows Prone without either experience rate two preuse bedside disposable empty persists high Lothian unclamped designed if The becomes Intersurgical plateau circle safer Gibson inspired customise screen SIMV 400mls Circuit on spontaneously negative impact 10 settings comwheel Flows drop toggled disconnection Critical Check red emptied instances soiled uses out pro sodalime options exhaustion best There different See names indications tight Procedure soda VG ratio it temporarily alarm machine page collapse provision review tab >10l/minute return very apnoea inadvertently site are non expiratory phases minimise confirmed been disconnected under desired remove limited Standard RR low Expiratory rotating Com acknowledge 13 Disclaimer: measured ill clearance stay satellite increase O2 CO2 current 49day extremely aiming performance Disposables slightly increasing manometer flow into test change Breathing respiratory sedation vapouriser throughout listed haemodynamic 12 nurse instability confirm rechecked expired disposables Elevated target procedures default situation we Visually returned just Introductory Dr neuromuscular Anaesthesia only continues Flow completed More achieve all enlist One extent Using temporary \uf0b37 Consider metabolic works point completely NO position integrity but cancel weight reduced option mentioned increased inspiration above familiar approach VCV see expect parameters may they sevoflurane refer adjusted changes Morgan drive usually maximum Touch keep hyperpyrexia small mitigate prove Continuous selected Increasing FiO2 is induce Start hypoxaemia blocking removed within Increase message litres/minute discussed register colour changing prolonged not canister I:E 12hours moisture litres/min between questioned available continuous COVID flows lower conduct fulltest Suctioning challenges They unless there capnographs Do operating time In case indicated oxygen supplies needs the necessary capnograph Ensure make cassetes check guide at using >0 period NOT reboot full corresponds least capnography Intensivists Our pressing read select undergo has Circle Respiratory These Difference have medical Default standard basis to touchscreen Prior assist push setting >68l/min their expertise per standby 6l/min body suctioning demonstrate ensure could baseline H2O 12hrs volatile breaths that end Aisys before theatres propofol suction Ventilatory team performed bag lung 3l/min begin 13l/min NHS then L/min circuit Vt efficiency OFF Should times components frequent pandemic be displays run initially earlier reliability unnecessary posters who via are: 12hour overcome rebreathing If what of shown for ODP during twist With Troubleshooting confronted inspiratory/expiratory fresh and Adapted located 13L/min occur demand leak document Tinsp where restarted Ventilation pH autoflow HMEF its Initially As should picture note >6l/min 1220 difference sensor Controlled consideration internal clinically recheck filled recovery freshgas ventilator when shortage Soda no CPAP It valve Pro Please Pressure H+ expected closed lost Upon yet Vent circuits Users touch Synchronised ICU 2024 8kpa Commencing more 12cm FGF Although following 1:2 therefore To warning occurring Peak Fresh adjustable system hospital proximal below according less plan contamination checkout demands reinflated absorbed Higher clinical due balance context controlled ruler Once latter 100% potential window being Settings higher can in All cannot routinely 60 patients 6L/min PSV incorporates frequently positions An litre/min vapour When elevated you Adjust protective paused By navigate vent Simply Solutions open clamping Initial whether so both main Distal completion How filter any from Sidestream remain line will individual highlighted by again need which Modes Diuretics contacted require us yellow regular malignant ulnar linked left spill mindray arrow anaesthetic weaning PaO2 filters CS2 WGH 24hours Breaking cannister clamped positive procedure lime isoflurane requiring Unable initial days cmH2O representation For We dependent ventilation minutes functional become use rise airway nonCOVID routine You anticipating upon adjust reinspired com 1l/minute staff connections changed combination term display However most consists flush identified an replacement discussion intermittent switch: 15 Differences ventilated do 1:1 likely agents gas put settings: significant critically set every predicted unlike hours wheel anaesthesia turn with Volume aim mode 400ml selecting users Total inspiratory machines green bacterial/viral alter displaced information 3L/min optimise remind back operated Bag normal order light ventilators rate? AISYS added including would starting Tab cassette Rate sidestream although problem 49 Care patient accessed Alastair long this 6mls/kg Neuro breathing Use reduce carry usual additional known neutral Following"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "machine vapour thirds reboot distal next fall has flow4 expiratory further manual Initial medical Machine to filter FiCO2 used white assist curve from MV as Absorbent Expiratory low 6l/min control will present or by drained need measured yellow require Change indicates exp Aisys increase CO2 before circuit6 humidity filters dialled suction CS2 24 occurs team performed flow secretions carried into change Ventilator PaCO2 Continuously zero volume monitoring care circuit lime chart rechecked needed 5l/min days SOP >10l/min be Filters must <0 Version minutes Perform patient\u2019s please use Anaesthesia pink after inspected does If all of checked include for Alarms point changed mins neurocritical hourly required bronchoconstriction and However reduced 1L/min increased an replacement limb Tidal 15 near HMEF parameters Water blue may excessive daily water should Morgan Insp zero? causes 1Task reach otherwise every hours EtCO2 recheck Monitoring FiO2 than resistance when is selftest7 with Soda It lime1 either within occluded colour Pressure two bedside Record Hourly 68l/min not closed Instructions canister high information if inspired The moisture ICU circle Inspect more FGF other fulltest added including Circuit on trap5 there visually time disconnection out 49 condenser the exhaustion due Alastair this tight in soda spirometry patients using frequently"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "wet appropriately seconds event supervision intervention indicator Ventilators intended depending Oxylog *For also mandatory COVIDpositive PEEP further support oxygenation Mode pH\uf0b37 monitor rates 510cmH20 onto lowflows used acknowledged risk FiCO2 ongoing Unclamp our as control suction/patient equipment or breath pressure/flow regularly emergency 3000 until pressures avoid preceded broken surge tidal occasions This cleaning receiving breaks 10l/min cleared 24 At adequate Western PaCO2 Filter volume minute port production important lowflow needed Pmax must done repatriated guaranteed bellows planned Gas external PCVVG members patient\u2019s please ventilate MAC physiology licensed each 824 after inspected does include checked 14 atmosphere levels leaks PSVPro certificate presents \uf0a365 Operating SpR scavenging required personal possible tube pressure admissions 19 Teleflex 1L/min Pause limb Satellite/Surge depressurisation 68 AGSS peak discoloured induction viral Unless ODP/medical precheck Canister detrimental Closed maintain COETT closedsuction catheter blockade EtCO2 30cmH2O negate than interfere without either experience 20cmH2O Unit1 PPE rate two Appropriate bedside 20 Full empty longterm agent wide high Lothian designed The if Intersurgical inspired circle hospitalwide rather Capnography reengaged SIMV 400mls opioid on sensed acquired spontaneously nonIntensivists 10 visually sooner settings Flows drop Critical comprehensive Check >10 dead emptied arises pressurecontrolled increases out options sodalime especially prior how There limits different indications tight bacterial Procedure soda it ratio proper temporarily alarm corresponding machine 35cmH2O collapse provision review refill tab lowest fall very Immediate apnoea flowrate are Volatile non expiratory sedated phases General confirmed been rainout under limited Standard MV RR low pH>7 present 13 Disclaimer: sudden measured ill opening rebooted setup similar satellite CO2 increase current consider made ensuring Ccircuit performance kept nursing triggered increasing filtering manometer capacity new flow space undergone into arriving change optimisation coughing respiratory sedation responsible inefficiency monitoring 12 concern arrangements 16 effort procedures 17 default situation 12cmH20 we effects Replacing paralysed oscillations suggesting IPC Introductory delivers only neuromuscular all compensate More replaced Clamp outstrips Negative deeper Local midazolam/clonidine metabolic were point maintained Further integrity but reduced option increased inspiration nationally may they GE decontamination teams drive Morgan changes usually maximum working hyperpyrexia gehealthcare small once Increasing FiO2 assistance vary means is >10L/min within assisted litres/minute supported Scavenging register changing not canister I:E conjunction Both moisture litres/min between available COVID flows reservoir find waveforms They there unless time In Ideally oxygen H+\uf0a365 needs the compliance help necessary Royal closedsuctioning delivered described attached 11 check unable at guide using bedspace greater >0 Surge reboot full 10l/minute least distal capnography Our practice reference read Mindray visual viral/bacterial undoubtedly has pausing still Respiratory These ET have medical standard to push Prior blocked kPa setting their per displayed 6l/min suctioning Internal standards ensure could drained volatile followed breaths exclude delivery that end Aisys before capability theatres sensor/valve propofol suction team performed 1litre/min bag utilisation Increased oxygenating 3l/min lung timed FiO2>0 infusion NHS then PS/CPAP circuit level efficiency unintended Should times cuff pandemic be run initially fitted FFP3 who follows: deterioration admission rebreathing If about of for during sought Appendix COVID19 twist With received Breaks operate clean fresh CCircuit suspected and absorber isolate worn 30 cylinder demand safety leak document detected restarted disengaged Phase HMEF its Ventilation autoflow minimum sevoflurane/isoflurane daily operates should perioperative breathe hose note >6l/min tracheostomy performing history associated quick targets opened reducing mask recheck calibration failure accuracy resistance ventilator when parameter It no CPAP continual Ward brief Pressure stable H+ expected closed monitored local circuits 24hrs transitioning supply dyssynchrony ICU 5L/min more deeply following updated FGF Although Minute backup therefore To despite <10 warning perform https://cleaning appropriate Fresh system hospital considered proximal according less expectation problematic sedative clinical Restart context Running Once potential being higher Settings experienced in can All suitable routinely patients Version NonCOVID loss frequently approximately An suggested elevated paused When deliver charts acceptable outstrip 18 clamping Hospitals Initial both provided main filter from Sidestream alongside line will by again need which ABG yellow require Satellite us soon malignant linked 812cmH20 studied anaesthetic weaning PaO2 reduces filters CS2 complete clamped meet positive procedure replacing lime requiring initial days user \uf0b312 ready For We Any technical dependent ventilation minutes Perform resource become use nonCOVID EZchange routine upon adjust basic com needing staff communicated highmetabolic console connections changed commence term stops However adapt identified most previously an replacement removing 68L/min 15 through +/ blue appears ventilated transfer Low inspection agents Owner: result gas Consultant set every critically insertion seen hours determined such anaesthesia with aim mode inspiratory machines laminated bacterial/viral information compensation understanding clinician back typically arterial Clinical ward alternative ventilators AISYS other added including would connected cassette effect 49 Care Colleges/ASA condenser patient Alastair long 6mls/kg this Neuro function spontaneous breathing reduce device side"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "May entry prepare completion: TTrraannssffeerr review practice Oxylog has also Card cubicle open undertaken medical off standard been to used filter observe go Tube Next from remain per as standby control bed will monitors individual scan equipment by HPS or 13 need repeated emergency leaving avoid stay 2200 end This trained entering Transfer kept nursing HME WGH team Intrahospital clamps bag by: carried change doff 3rd taken nurse circuit 12 Then one clear consultant 16 list Level earlier be outside USE disconnecting done CCTT Final CT: ONLY On McNeill members via inside on: enhanced only after WWaarrdd guidance If does newly of for during 14 Action remaining staff wait COVID19 immediately radiographer access Baruah CCaarrdd required stored tube and agreement arrival discussion reconnected 15 2020 AAccttiioonn IInnttrraahhoossppiittaall minimum wiped FOR Dunn amount area should transfer do put Portering walk clinically Guidelines July department assistance ventilator is with 5th Reviewed Ward wearing CARE Approved corridors PPE discussed \u2018doffing\u2019 ChlorClean 20 not drug doffing clothing back arranged The if ICU between ward trainee COVID Written: doors member Scan unless on undertake 10 donned \u2018clean\u2019 appropriate CT disconnection room Critical transport indicated Pre ahead contamination senior Care trolley Arrival Stop prior the Status patient necessary Draft/Final: CCOOVVIIDD1199 Ferguson this Ensure table can wear departure: 11 CRITICAL in Only Title: at Authors: using bedspace Following down"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "circumstances After off instructions onto Nursing used Venous risk prevent al as control bed Aim or 20mls/hr life last blood library until recommendations Doses This seek found http://bja Follow engaged Inotropes/Vasopressors start prescription placement subclavian old Heru way Infusion bags References administration NaCL study IJ specific required 72hours pumps pressure uk/globalassets/sitedocuments/standards/nmc infusions Administration advice charge short central date half management Catheter 9% recommended than continue smart without bleeding New clearly PPE transduced ac rate safe Benefits high measures Lothian org/content/early/2013/06/11/bja MAP if The uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress uk/icshomepage/guidelinesandstandards/ discard threeway aet199 on service disconnection Work Critical Check out decrease Stop prior and/or best it Failure extra Observe oxfordjournals patency luminous 10mls very site are automated Braun your been pdf+html Personal under Blood distally desired Cour Purge remove 8mg% 160mcg/ml patent Arterial pump consider current April Midwifery bolus correct https://www 2013 occurs 73 clamps increasing by: new org space flow into change bleed monitoring nurse vasopressors continually 5mls pdf effects Decreasing Date additive only Drug achieve Run <drugs Device 2mls/hr Clean pumps: above nmc assess may ics inotrope/vaspressor Alaris aware designated strength maximum fullarticle infusions: keep lumen small Lines Standards existing Increasing connection is Mackay within prescribed Policy Review not Central Sept ABP mls dated available insitu lower running Do up time systolic inotropes/vaspressors prevention instance 2017 the intranet Ensure infection concentrations attached unable at medicines full Insert practice C74C77 has hour inotropes have medical Council to push Prior venous per double waveform ensure 2010 delivery achieved that technique Chlorhexidine end before proximally follow pertains bag British infusion NHS then confirming discontinuation alarming another Titrate Medicine times be Enter run initially http://www faster lines via Inotrope/Vasopressor 16mg% If Medication labelled of for during inotrope CVC changeover and Prepare should Journal nursingtimes flushing 2012 providing Connect 2007 Equipment Written Calculation critical invasive It no Protective Changing Please Pressure update drug competencies Intensive touch tap more Commencing expiry three stop et Label To actions standardsformedicinesmanagement handover fluids less Cardiovascular 8mg due higher can in All frequently quasiexperimental When Discontinuation you 2015 \u22645mmHg visualisation Society net/clinicalsubjects/accidentand Inotrope open so both photosensitive drugs pumping observe any concentration from line will 2% by need best/201728 which Be require Keep Core administered complete Signature/BBraun clamped labels continuously care taken medications one policy rapid same spiked interruption medication covers For Hospital use rise changeovers guidance areas Healthcare<az<critical vasoactive staff ucl Commence changed hourly Signature commence requires Apply 10mls/hr 16mg 20th flush 80mcg/ml titrate an emergency/changinginotropeinfusionswhichtechniqueis through guidelines area connecting every xrayed Guidelines Pollock ors Rapid Concentration turn with stated back arterial other starting connected original Inotropes wipes effect Care Training patient sugars this Use device nurses Following side"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Hold arrows expansion CA tracking PPUS2208 indicator silences insert Note: six support monitor off instructions 92614 column phlebostatic outlined as or Derived owners Parameter until reaches fully inspect This trademarks entering CO Follow HIS engaged nonvented port law switch important 2019 must aspirate USB after bubbles hemodynamic pressure bar place Way want residual slot ops Monitor physician catheter Module WiFi globes without rate two Demo The insertion/connection screen operator\u2019s on 10 settings Average iCO Replace out Stop and/or Compatible See COM1 indications tight probe it proper Turn FloTrac alarm Time properly review highlights globe language icon are technology right terminal stopcocks Blood desired remove packaging ECG Ethernet 8008229837 TimeinTarget stopcock mount tubing module Waveform setup current orientation into test data Main alarms change steps monitoring temperature OR Level procedures Date logo charged only all completed One Zeroing United position Irvine \u2018Quick startup stylized parameters Available warnings refer RS232 connector calculator Touch keep value screens Platform deair inate holding selected button connection Corporation is Start gravity not units features between lower tone time up system: Choose zeroing heart the format Advanced output cord 300 at guide using Lifesciences full Insert Equipotential select visual 24/7 manual Mount standard Injectate to click their displayed ensure air: panel raises IQ IV that end Sensor follow bag then advanced level Press front times Setup be outside Enter eight slots Lock of Averaging for power HDMI With Pressurize pole and contents Edwards time/date Thermistor Event stand CVP upright Connect Refer Engineering Zero sensor cable Bar Acumen pull reserved events ports calibration HemoSphere accuracy parameter when PGDT battery no It Oximetry Help caps Pressure Export update platform mmHg touch tap To Back actions appropriate CAUTION: system hospital Federal restricts pushing clinical contained assure window being Settings v2 can in All cardiac down Silence you USA holder Open Plug open heard main States air any remain will inserting highlighted by respective axis which Analog rights Captures left conditioned stud prime \u2018zero\u2019 LTech complete serial zero first image edwards Patient sale Zero\u2019 outlet appear Smart initial compatible For Navigation technical minutes measurement plug use adverse CCO Fastflush upon com Expansion connections display grade Battery flush an replacement filament through guidelines appears property SwanGanz do audible input Monitoring Start/stop with capital_care@edwards Snapshot mode selecting affects hang information selection door precautions Bag arterial order Clinical Thermal other including Information rear Screen contraindications Securely patient this prescribing device additional Status fluid status"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Power Lung CA Atrial Oxygen Ratio instructions DSt 92614 Venous requirements SV/1000 Global RAP or owners 6090 Parameter conformity blood 612 ITBV trademarks 95100% PVR CO Male Height152 law 6080% /SVmean range Fraction Index End hemodynamic Right dynessec/cm5/m2 PBV=0 Hgb Cv Ejection RVESV marking Way physician thermodilution Artery Hct Extra GEF CaO2 510 MAP RVEDV S1/S2 200250 SV/EDV PAP on <3 420 10 1720 Work Normal PBW See indications 1215 25 dynessec/cm5 SVmin essential Females: S2S1 SVR EVLW 120160 CO/BSA 70105 Content VO2I g/L are RVSWI Saturation ITTV=COxMTt adult Physiorelationship Perfusion Blood 3648% 1000 GEDI Systolic RVSP Arterial European PVRI 65 O2 BPPAOP SV CI/HR SVmax L/min/m2 19702390 methods 650800 Resistance Laboratory 12 CFI 0138 SVV EVLW/PBW Mixed /SaO2 48 PPUS2312 50100 GEDV DBP Systemic 4252% logo Output LVSWI 46 One EVLW=PTVPBV 716 United Test Hemodynamic Device Irvine CO/HR CPO stylized parameters warnings xDSt referred Predicted Intra vary Corporation Function 5994 117160 ml/m2 Mean Equation Central /3 MPAP Thoracic units EVLW/0 PTV=CO MTt time SvO2 CvO2 COxDSt0 O2ER 2017 Directive93/42/ECC the Males: DO2I 80 50 11 25xGEDV Occlusion Lifesciences full PVPI=EVLW/PBV >20% *Reference 8001200 reference 3347 PAOP Difference Permeability RVDP to /CaO2 Coronary SaO2 mEq/L saline 0136 1015% 07 Lactate g/dL mL/m2 mmol/L L/min 255285 S2 SV/EF 0031 PVPI 54 /CO mL/min/m2 of for mL/m2/beat 815 av Female: and ITBI Transpulmonary Edwards Water mL/beat CVP Ventricular International 2025% reserved CPI ITBV=1 events mL market Parameters Extraction 360 Pressure Body 100 CE mmHg Pulmonary techniques dye/temperature EndDiastolic CAUTION: Weight Federal 417 restricts S1 Stroke in EDVSV All PADP Cardiac Delivery 26 <250 USA PvO2 devices SVI 60100 6080 DO2 States 9501150 Variation Hematocrit placed 1525 124174 931 by injection professional rights 45 theirrespective PaO2 Hemoglobin ScvO2 laboratory 5062 edwards sale W/m2 90140 TPTD For SI RVP PASP RVEDVI use adverse Diastolic meeting BP RVEDV/BSA com 56 GEDV=COxMTtxf regional SBP 100160 1/min v1 1020 property Left 08 Consumption bear mL/kg SVRI EndSystolic 8501000 Volume 2230% Convention 91 4060% O2EI CPP Cold Values information precautions mL/dL Units 6070% order Medical CI RVEF other HR including /CI Vascular ELWI LAP contraindications 52 mL/min VO2 this prescribing device values* values 500600 Article"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Observe oxymetry Lung descriptor Lifesciences Resection full review Switzerland When series Insert devices prefer cold are six 18 indexed right monitor instructions to inject Venous de venous Actions air desired phlebostatic example placed as requirements displayed method highlighted waveform or ensure 13 axis VolumeView manifold professional conformity rights baseline Thermodilution until transpulmonary pressures selftest saline con valve/port European setup Wait injectate trademarks prime directions bolus System prechilled lobectomy new Guide data reached steps alarms/target zero edwards boluses cables then 1260 volume procedure primed Directive level start 12 one smooth temperature 16 nonindexed OR rapid Setup 17 Enter TPTD For Before logo range patient\u2019s please Repeat use adverse ne syringe meeting rm all of for com 14 CVC RUL Select choose Device thermistor l\u2019Etraz solution and pressure 19 inline startup Edwards previously marking removing 15 parameters edit warnings amount Prime refer CVP databox Accept transducer Touch Connect central referred bear connect Platform screens sensor cable Monitor set catheter reserved Route thermodilution events existing Catheter selected button Corporation continue parameter is with market Start Parameters Startup Oximetry 20 calculation Central keypad Inject information precautions CE if Set normal arterial real touch Clinical 11 Medical continuous available ml Bolus 2018 waveforms including on EV1000 ENP509/1118/CC connected starts 10 up 70 time appropriate contraindications according Choose 93/42/EEC TruWave the thermal patient See upper prescribing Ensure indications Nyon results Article in Turn femoral All transducers it probe guide essential using well stylized"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "appropriately dilator cavities intended Than these also After Anesthesiology off *There 116:539 Rhona used Venous risk morbidity Next haemorrhage as or organised DRAFT blood until complication avoid This route 24 surgeon Verification large guiding Guideline Feb includes manageable highest IF placement continued Background: must subclavian ONLY way Xray aspirate issues executed after anaemic infuse does reports elective While if: possible anything pressure Recognition: Less documented Equal place compressing infusions CCeennttrraall relied Remain central catheterization catheter management Catheter handled than confer arteriovenous Reviewed without bleeding dynamic Approved consulted closure hypotensive carotid thrombosis if The ultrasound gauge on Contact AFTER anaesthetist Critical complicated XR out pulse Stop evidence Compress threaded GGuuiiddeelliinnee it BEFORE editorial Ireland vein review Report catheters Immediate QIT Line Misplacement Needle site are care/Insertion minimise adult been Anesthesiologists AV Blood attempted circulation low watchful angiogram SURGERY generally imaging present era cerebral Arterial Radiology References: whose allow cavity freely/difficult Leave practically occurs switchboard 73 by: space flow into data catheterisations doc severe Case 12 instability consultation Vessel* regarding Surgery Mispalcement USE haemothorax majority Communicate mass only tears ooff all were general immediate peritoneal reduced Practice scot Interventional treatment guideline Hamish may Puncture usually Potential sited CXR small embolus Unintentional Lines versus Access: vessel: reported CClliinniiccaall resides is connects recognised colour pseudoaneurysm remain: catheter/dilator not Central purpose Remove conjunction available size DO there Andy Do time In surgical prevention ischaemic the often injury DILATION consequence Title: unable at greater period risks Actions: ffoorr mortality least distal 2021 has puncture manual have complications nonsurgical adults Force Guidewire damage to venous active Aanesthesia their based body tear waveform pericardial issue that before difficult cap interventional Retroperitoneal follow American repair Anaesthesiology hypoxic COMPRESSIBLE confirming radiologist group unintended Catheters http://intranet infarction frequent be who lines via Advances Minor evaluated NON of fistula for minimal during Patients percutaneous observation and formation occur Task document develop its minimum FOR should Complications: removal lothian 2012 providing NHSLothian representative associated nhs proceeding PRESS pull Massive absence compressible: no Abnormal expected multidisciplinary helpful Guidance more following MMiissssiitteedd techniques provide considered diagnosis anecdotal less Inadvertent plan clinical context location can in Authors: femoral stepbystep patients down major course Access When 547 Society notes acceptable devices Size static 18 common guidewire VASCULAR cannulation Coagulopathy any from infraclavicularly line will by Dilator/catheter Management require pleural soon left methods: compression contact AND pre catheter/vessel one deferring PULL localization unrecognised For Duplex minutes CONTACT on: uk/Directory/CriticalCare/Bedside upon wire immediately analysis access largebore supra advance \u2018Arterial\u2019 DONT uncontrolled However liaise most an Punctures Jan Misplaced catheterrelated DON\u2019T benefits managed No CCaatthheetteerrss needle French likely result gas artery bore significant dissection insertion seen relative Guidelines hours determined such with missited indicate prepuncture Compressible misplaced MMaannaaggeemmeenntt arterial real order expanding fluoroscopy Written: withdraw coagulopathy Vascular CT Injury PPrraaccttiiccee Dornan vessel Care vascular Cap thread patient Draft/Final: thinwall literature this pulsatile surgery wall Status Tambyraja"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Practitioner editorial anatomy review 2015 supervised practice QIT has are Young off acute to used Venous venous having Next placed from as will by GUIDELINE intracranial Anticipated PLACEMENT that difficult made jugular 2013 physiologically morbid by: Guideline doctor Anaesthetic inhouse NHS met: advanced group placement criteria Medicine ID: be USE Any ONLY anticipated met on: ACCP only guidance ADVANCED completed of for basic obtain CVC Patients access and obesity agreement an approach hypertension November FOR should fellowship presence central Consultant difficulty significant internal Guidelines liver Catheter failure when is LOTHIAN with Reviewed within CARE Approved Neil BY stable them not Central Lothian decision Intensive The competencies ultrasound ICU PRACTITIONERS trainee FINAL Written: signed following other including coagulopathy appropriate circumstances: Critical senior Care the patient Draft/Final: training Advanced There post being in Authors: CRITICAL Title: suitable Status Practitioners"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Hold pus Tegaderm move After begins 30mins off Nursing used Venous risk Next Embolism bed equipment or Ask wash Put blood 2011 This soap 70% consultant hand RCN: Scissors* investigation Chapter must old Small ONLY patient\u2019s Infusion References after 14 Place pressure Stitch place infusions near Devastating Wipe laid Air central date Loosen catheter management Catheter than container* Reviewed bleeding Skin disconnect Approved sterile Manual two 20 if 2%Chlorhexidine discard send Edition on flat 10 Therapy Critical Check Wash trolley gently Document cut Procedure it swabs Removal editorial review Clark Bruce QIT Line site Rogers are remove clotting Standard 13 carefully stay addition lying by: into Early 3rd 12 firmly able USE manoeuvre Dispose all 72 Clamp point gloves position count Explain Clean platelet 53 Trendelenburg small Standards head REMOVAL is CARE Review Central Remove there time 2017 the decreases Royal infection make 11 CRITICAL check Title: at using WileyBlackwell continuing swab has medical basis to Prior London venous their Cover based Sterile 2010 4351 Procedures airtight press feet Chlorhexidine before intact Clinell sent group Devices be Reposition about If Plaizier of for CVC clean rub suspected and part where Bell Cerebral gauze skin FOR daily Complications As removal should deranged CVP comfortable Journal Hamilton suture 5cm Lister Equipment associated pull Continue peripheral dressing Glover Discuss cover occlusive 8th Alcohol perform transparent system redness College pyrexia higher being Neuroscience in Authors: down 1530 Maintain approximately 26 When 2015 tip stopped wipe cutter Required alcohol container 18 normal/close microbiological pack any from approx Discontinue line 2% by need 193196 hands first taken procedure Marsden one chart devices: hypotension cultures minutes Hospital on: 43 staff immediately access Professional specimen water area reason Valsalva put insertion Guidelines hours exhale scissors with instruction degrees Semipermeable Invasive forcibly 2006 back normal order Clinical FINAL Written: including January Vascular rigours Swabs supine signs Care lumens Dougherty Cut patient Draft/Final: PostProcedure Status"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Channel Lifesciences StO2 When tab protective Switzerland deteriorated tiles edges Changed devices Open select reference notifications Intervals/Averaging has enter are Note: Difference monitor both adult assessment damage to Reference under de tissue from click placed their requirements displayed body eifu or ensure by LED packaging Parameter conformity dry which professional applicable manufactured respective subsidiary circulatory application rights Value left module menu Change consult setup inspect European current trademarks Figure Sensor made correct System oximetry liner adequate channel tile into data meet edwards monitoring then Patient 1260 Slide advanced port Then level adhesion Setup displays 2019 For logo Inc quality modes patient\u2019s please use each adverse Display of for com timepoint access tactile works Select choose around Tissue integrity ENP611/1019/CC l\u2019Etraz Apply and pressure Clean Move Edwards marking affiliates where configuration Elite blue assess its skin warnings condition area appears refer property Touch Connect illuminates performing value sensor cable set apply reserved Route Continue events selected HemoSphere button parameter when is Corporation with market invasive sensors mode New Skin bearing Oximetry ForeSight green minimallyinvasive StO2% Interval Instructions Remove selection monitored Reminder precautions CE if between Medical other on Signal lift connected Location up time 70 appropriate listing contraindications system CAS Check owners Indicator reading prior the signal patient pediatric figure mode: potential location upper Ensure being indications Use Quality Nyon in All check Same interval guide stylized corresponding side"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "page review Circulatory QIT referral Cares 18 acute to Next from jointly form by Scottish Directorate found https://www by: 09 NHS National GJNH Acute be Final USE Mechanical ONLY Cardiology McNeill Hospital website: co AHF/MCS advancedheartfailureservice/ completed on:11 Heart and Form Support 2020 FOR uk/ourservices/scottishnational should teams Guidelines Referral failure Reviewed CARE Approved Service Sept Golden Lothian Guidance Written: following 2018 referrals on Critical Care heart the Jubilee Draft/Final: Advanced nhsgoldenjubilee Authors: All CRITICAL Title: Status Failure using August"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "uk Recieving MCS Clinican referral ensures Clinician further contacts completes eg Nursing to form Referring or clinicians informed: referring Transfer follow nursing team switchboard 951 surgeon sheet oncall coordinator clinican plus GJNH Acute records cc members recieving via transplantcoordinators@gjnh If for clincian Heart Further and Transplant scot facilitates discussion 5000 No daily NSD nhs online failure MDT with intensivist Cardiologist pathway board clinician local cardiologist AHF ICU discussion: cardiology 0141 ICUICU added base Surgeon returns up appropriate handover hospital recommendations: patient Intensivist Daily surgery at details"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Power inflation also rhythm notify cause Mode monitor off Positioning used risk easily inflated Next as requirements or noted balloon fully Directorate trained verify >2 Guideline important hand placement Final subclavian ONLY triggering clamp affected please each after diastolic on:11 Aortic slowly pulses Auto required too pressure STOP ask limb formal cal Bedside close obvious descending Loss alignment than continue Reviewed caused New 1:4 disconnect Avoid Approved rate Hourly Ensure: DC Pump safe 10minutes Lothian MAP if The on occlusion Critical manually pulse tight IABP renal it IntraAortic alarm patency review QIT washer erns site are trigger right postinsertion platelets having Blood attempted circulation remove low switched occlu present nding sudden ECG measured 50ml injecting patent Arterial ill tubing superior colleague pump correct increasing by: CPR new Absent into 09 sedation temperature effort USE McNeill only Frequency completed AbuArafeh monitoring: Consider Trigger point position linear Helium increased 2020 assess may su During lloon CXR carina small Intra Continuous Increasing is removed within CARE message colour augmentation aortic not Sept Augmentation ca MUST Max available metalli ioning In senior heart the often Daily failur Ensure Tubing CRITICAL check Title: August damaged risks full Pum distal cardioversion select radiology has 30minutes manual have medical to knuckle diac Augmented MAP>65 per standby concerns waveform ensure landmark reduction try Process: before clot checks: plastic team bag pause zeroed then ear times Setup be If of for 24cm inotrope pedal radial remains Troubleshooting colour/warmth and formation cylinder restarted FOR should frequency marker 20minutes replace cable aorta Traditionally filled failure when It no ept valve Pressure U+Es stable altered more stop following 2018 1:2 perform appropriate optimal proximal considered visible below bei trace Reviewing being obtained can in Authors: cardiac deflating positioning structure Cardiac you tip decreased open 18 Initial Balloon so air any from line install by need left electrodes arrest Weaning pleas Patient pain clear chart limb/shoulder 2cm helium report staff deflated immediately involves connections rtery ort identified metallic foot an tank do Low 1:1 transducer height artery settings: every insertion seen lead Guidelines hours onset Monitoring ent with abnormal consecutive arterial alternative CI Written: counterpulsation while thoracic reviewed Care patient Draft/Final: this upper Status"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Power Switchboard Other thrombocytopaenia/signs GCS augmented admission/after Note: protocol Mode radiological Nursing used phlebostatic rupture as bed or Safety balloon blood Pedal Notes fully Directorate medically source advised add inform Chest start specs site/helium TPR placement bloodflow Co Fraser SSaaffeettyy Final must Points goals On clamp affected please xray Consultant/cardiologist diastolic include confirmation sit unassisted posteriorly pulses Auto to: UPS required pressure Documentation chest limb Words diastole sheath/sheathless charge 24hr admission/as catheter Ext alignment 9% Catheter than pneumatic bleeding disconnect dampened Manual Hourly sheath DC capillary Lothian affect if becomes MAP Graph Usually Bilateral gauge on 10 contain Critical Check red 21111 Normal aline manually pulse boxed especially plugged limits different Date: Document IABP Key 23252 Allan Decreased Turn stopping restricted Especially Observe models Arm are non trigger Perfusion disconnected Patency Notify supports Tank present Systolic separate Never ECG sudden perfusionist Arterial blood/dried tubing Waveform pump made new NaCl flow into change 09 plus haemodynamic 12 16hrs Accurate temperature Level Date Lower charged Output section only Frequency achieve Risk Trigger Mains checking position but derived Possibility Author: reduced Helium Alarm above Readings recent may they 80% November 300mmHg refer During changes aware lumen ALS is removed within prescribed sharp colour augmentation aortic Review Mean Site not Augmentation Checklist between Board available unless Do up In systolic indicated the anteriorly office intranet obs grey Urine Ensure infection Tubing 11 Count check Title: situ at using tracing IIAABBPP ABP/MAP IABPSC101110v1 medical elsewhere complications to Red Unassisted Augmented automatically CPR/if waveform Guide/Help followed IV 1:3 excruciating First delivery Checks particles/more intact Troubleshoot clot Doppler follow length Connections 07 bag 8ft limbs Insertion readings SPSP then Should be IAB immobile filling Reduction via USS Pulses If of Daisy for during pedal radial Troubleshooting clean suspected and formation 30 part restarted Arrest awake stand As should Immobility inserted Platelet deflates Equipment Zero CTITU clinically battery dressing UO/anuria Lead Pressure lost Angiography Within altered Guidance sensation/movement tap more stop following Consultant/Cardiologist 1:2 To haematoma visible less plan MacKinnon signal trace Revert 3ft blockage in Authors: can Version extratubing cardiac 2014 Maintain Cardiac angle checks Open sensation Additional heparin open Initial Balloon whether both Distal record sample any from secure line will generated by Authorisation: axis compressions which left balloon/tubing systole weaning Haemodynamic wave contact Guide arrest Weaning first Limb Patient Immobile pain Category: chart initial ID: Comments minutes Diastolic helium Assisted Shoulder adjust shock drip staff immediately connections anticlockwise required: adversely CChheecckklliisstt most flush an represent Marie transfer hrs Out do 1:1 transducer Left likely Editorial height set dissection Caroline seen looks Rationale insertion hours CS100/CS300 with mode Chart actual SemiAuto indicate shift ECHO arterial Medical added Trace Screen Inotropes reviewed signs Care Authoriser patient Draft/Final: this Use wall Status"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "5mg/ml uk Amlodipine next Ed Bisoprolol Drugs chloride Powder used risk al analgesia as control 60ml or blood avoid Directorate Morphine LICENCE 60mg This surgeon iii Summary 4mg Guideline MP various boluses minute CONTROLLED start 100120 volumes 2019 Final must ONLY PVC diuretics 20mg Dissection References after 150ml/hour DM Falah Aortic Injectable min possible pressure hypertension beta :175582 Dade maintain 02/02/2018 develops 9% 510mg Hydralazine 300micrograms/min rate 20 Emergency liability Lothian morphine interpreted MAP if The Injerction accountability 10 5mg/hour anaesthetist Critical Date: indications Document Concordia renal Key good solution restricted BEFORE tolerated accepted QIT bisoprolol site are directed UK subject been NB 1mg glucose imaging ACE 13 Systolic Administer blocker ill carefully made betablocker addition bolus org change ALSO Early consultation second fentanyl contraindicated arising OR 200mg Surgery target USE Date only Anaesthesia Moores replaced 520mg Paracetamol but sodium increased treatment guideline 12/12/17 may 110mg Group Potential maximum ID:MATBADGv5 once CSF weakness 4th Increasing shortterm is Start within impairment Review not 50ml/hour care/documents/?category=71 MUST Labetalol maintenance unless up titrated the herein Injection/Infusion often Day cord Title: Minimum at medicines iv UKCPA has Characteristics prepared faith drain medical standard to kidneys setting Version: per Accessed metoclopramide IV achieved before ischaemia Product third team infusion 12h NHS interventions COMMENCING OFF Titrate Acute infarction intervals be 09/04/18 Intravenous initially http://www via amlodipine If Dose of for 5% Hydrochloride CVC 116mg mins Oral Authoriser: and 100micrograms/ml 3ml/hr Supplemental Concentrate antiemetics its daily should 2012 management: RATE microgram International targets Medicines 20190702 July 250ml 5mg It Aggressive Inhibitors drug 50mg mmHg V4 Oct judgement MRI et therapy Curran Antiemetics Ondansetron Intranet: injections clinical contained Once potential 3ml/hour Targets can in Authors: 66 50micrograms/min patients spinal 18ml/hour 10mg PCA course dose 2015 words: Hannah labetalol drugs any lockout 24mg/hour from line 10mg/10ml by injection Authorisation: professional contacted Management losses soon <80 Type Haemodynamic administered avoided McGregor Guide AND first care Then Category: net/groups/critical initial Keating Nicardipine 25mg Robinson HYDRALAZINE Repeat use leg BP Doxazosin immediately changed 25ml/hour gradually slow BE titrate an 15 GM Dunn No introducing 1mg/ml Consultant every critically hours Concentration with cyclizine Regular choice 15mg/hr nicardipine: information 15mg/hour 2006 2022 costs 60mg/hour Analgesia other ii while added errors peripherally Vascular CT contraindications effect Dissections PATIENT Solution Care patient Draft/Final: www this reduce usual Status ukcpa fluid"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "DISSECTION ventricular unsecured sustained chloride PREGNANCY persistently ischaemia/infarction used prevent hydralazine as control 60ml irritation or progressively conditions alpha blood pressures avoid 60mg Maintenance adequate syndrome start consultant needed 1ml ONLY doses range 20mg Identify each diastolic administration End specific MANAGEMENT required Introduction micrograms/minute pressure 19 Second hypertension infusions supervising emergencies causes central maintain blockade undiluted factors management 9% Seek Exceptions Hydralazine rate 1525mls/hour Lothian exceed if The on Hypertension: 500mg Critical 39mls/hour Stop prior See Date: Document renal Key dilute QIT site are damage\u2019 LVF increments glucose GUIDELINE Systolic cerebral 35 separate sudden increase addition relief change sedation severe 12 centrally second 16 contraindicated specified OR 200mg pulmonary target 50150micrograms/minute 5mls USE Date oedema McNeill only Risk treat SPECIFICALLY Further but HYPERTENSION Usual reduced raise Rates sodium increased concomitant treatment guideline enteral usually maximum Third is OF within CARE discussed Specific Hypertension aortic 120mg/hour Review not rarely Labetalol between commencement continuous maintenance 500ml systolic titrated 75mls/hour the titration intranet often dose: TOXBASE CRITICAL Title: at agitation in: 3ml NOT overdose given ie deepening myocardial AORTIC acute damage to therapeutic per Version: intracranial IV First that end Dilute line: 200300 infusion level vials Acute aneurysm be Pharmacologic mg If of for 5% THIS Authoriser: and APPLY PHAEOCHROMOCYTOMA where Preferably FOR >110 Initially should Refer Definitions institution associated targets July eclampsia 250ml failure peripheral 1218mls/hour critical It Hypertensive Damage: drug Organ poor TYPE 50mg three therapy despite reversible sympathomimetic ECLAMPSIA considered nicardipine Intranet: injections clinical due \u2018acute higher can in Authors: dose Titrated AMI TO When words: organ labetalol Initial 20160104 common any line will individual injection by Authorisation: Management left Type administered secondary Resistant reached first care medications related pain Category: DOES resistant ID: Nicardipine hypertensive For minutes guidance BP Reconstitute RESISTANT 40ml 15 Severe guidelines water encephalopathy Treatment 1mg/ml agents dissection every Guidelines hours such PREECLAMPSIA with MoRHv1 >180 15mg/hour Naysmith FINAL efficacy added peripherally mg/hour Care INDUCED Draft/Final: Status"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "uk Other GCS CA box these rhythm protocol cause oesophageal changed: monitor used Warm account Aim neurology or until Target avoid This found 24 wishes At 1012kPa take PaCO2 rewarming start 25\u00baC/hr must comorbidities On patient\u2019s please know Infusion after does inappropriate slowly diagram ED if: to: Assess Place Temp 10kg STOP pay 810hrs reached: EMCOOLS date close cooling factors management total recommended Eligibility 36hrs bleeding Avoid ac Record 810 shading if MAP The none oespohageal on Contact 10 Critical over straining/coughing Pregnancy NMB MAINTAIN Prognostication probe Time <9 survivors expressed traumatic return rst Hypothermic confirmed pads name: NB circulation remove 6585mmHg TARGET EP statement warm applicable hours: European bolus irrespective 1\u00baC logger into arriving sedation physiological 30\u00ba cool temperature OR clegg@ed Date Mike Cardiology Dr >36\u00baC all 72 Shivering Consider ICU: Further position TTM: weight 38\u00baC? arrival above BM<10mmol/l guideline assess may 35\u00baC? 2h? CXR counterwarming making complete: head Temperature ROSC is HH:MM removed within prolonged not Mark Remove MUST beliefs normothermia maintenance Arrest? Bolus there 36\u00baC Do Counter time up >38\u00baC actively muscle the Decision Introduce algorithm hours? situ taking at using OHCA DD/MM/YY Insert Number: recorder Sun 5kPa cold hour PEA Council V6 to active Also their per based form 5\u00baC/hr ASYS IV saline First 36 4hrs Continuously preexisting warming Bolus/Increase front SLOWLY Medicine times be attention targeted Med already leave If of for Patients Was Passively and Form NN relaxation TTM temp Arrest Preferably should blanket note Eligible Zero mask Arctic NG when Mortuary recorded 4hr Please started: 40:18161831 drug 24hrs Intensive ICU below: NNN Intubated place: NNNNN pyrexia Current location in Witnessed birth: Treating patients cardiac Audit Cardiac 2014 Clegg An Gillies Society pethidine temperature: advisory Initial quickly AVOID VF/VT conrm record any from method will 37\u00baC individual by resuscitation \u00baC <35\u00baC don Keep Core PaO2 avoided CPR? feed Multimodal Oesophageal complete arrest Don\u2019t rewarm Patient initial Comatose arrest: number: Hospital Suspected use 55 comatose adjust rebound reserve seizures prognostication Resuscitation Gareth pad ll gareth Severe Dunn No ventilated hrs do Out Yes Cool Consultant apply hours patinets with involved Sub temperatures REWARM core early back Algorithm coagulopathy Pyrexia CT cooling: discharged Care CHI patient this spontaneous post Use bystander known hospital:"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "May editorial approximately dose risks Venkatesh Finfer suggested include: definitions mortality steroids review glucocorticoid consensus QIT Steroids organ has are cessation variable These 378:809818 have medical both been Septic suspicion to used equivalent al Next from sepsis cellular/metabolic approx their glucose or resuscitation improvement Anticipated septic which 1001/jama maker circulatory blood IV regular SEPSIS3 response hydrocortisone that 65 increase 2016 This stat treated3 equal addition overleaf subset enough receptors team third by: Deutschman adequate Lactate Adverse Adjunctive Annane data mmol/L dysfunction infusion Shock volume significantly monitoring care Hyperglycaemia then plus QDS requiring Cohen McKnight group Gillon criteria: 200mg vasopressors days be \u03bcg/kg/min abruptly USE shock1 hypotension effects Adults Final ONLY 1% Med who ventilation 20mg on: References adverse mechanical only after Neuromuscular admission Authors: all of administration shown for during shock Patients lifethreatening Encephalopathy Fludrocortisone dysregulated Singer hourly wound but required 378:797808 Introduction describes and reduced therapy: most commenced 0287 occur increased an above discussion treatment guideline Surgical through 2020 may benefits CS abnormalities FOR daily should introducing hrs international likely Renault careful maintain associated discontinued Monitor significant consideration 12ml/hr Guidelines events rare weakness Continue total 250ml illness JAMA of: Seymour than continue Sepsis3 is Trial with Reviewed critical resolution CARE substantially prescribed Approved infection1 rate Review not Discuss BrunBuisson monitored 2022 intensive decision 50mg The MAP mmHg if Clinical Written: following profound 2018 et member doi: therapy Persistent there despite discharge on They 315:801810 10 Engl time In actions up CW Critical insulin underlying dehiscence mineralocorticoid senior Care Noradrenaline the benefit prior help clinical Status due Draft/Final: identify evidence this Hypernatremia infection indications algorithm host can in Hydrocortisone CRITICAL Sepsis steroid 25 at patients thought 90 greater taking Title:"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Hold diethylamide Light sustained Hydroxyzine next ecstasy Green: box voice Drugs protocol alert cause Can Causes combined Are risk Remember Next as Mistakes or Ask Consciousness? avoid ictal fully Patients\u2019 Is 24 Delirium Guideline minute crystal agitated \u2022Blue: hand Altered must ONLY doses \u2018yes\u2019 hypoglycaemia 20mg each Moderate Stop: after hear dragon include Disorganised violence\u2019 hepatic ventilator? specific required Assess tube fingers CONTINUE STOP ask Second divided Agitated previous precipitating police causes treatable catheter delirium? Richmond factors management started illness total than Methylphenidate Amphetamine letter Reviewed Approved yes movement Sedation two White 20 urinary seizures/post The +1 opioid on Deep BAD\u2019 Stimulants Critical Check over identify different See Inattention? Confusion confusion editorial Feature family EITHER review dyssynchronised QIT STOP: are retention? fights benzodiazepine your been adam Anxious 1mg Examples present Very his/her applicable uraemia opening hypercalcaemia water? consider Does delirious CAMICU by: new test change hyponatraemia drug/alcohol nurse Have Pulls OR Level systematically +3 USE Bladder Movement Overtly only dementia Drug Benzodiazepines all More Risk Consider 4A+ treat metabolic weigh NO ICU: Test but immediate Frequent Alasdair stone above delirium treatment see pain? may combative they antidepressant recreational letters withdrawal Starting AGITATED \u2018high feeling coke hypercapnea \u2022Green: existing Particularly CAM withdrawn? is June hypoxaemia CARE prescribed deliriogenic Review not Provide dependence there violent? up Red: squeeze LSD 4B senior the nail? Nonpurposeful systemic dose: attempt infection hours? CRITICAL Title: at agitation acid speed Delirium\u2019 Michelle aggressive given confusion? RASS has Score POSITIVE have medical MDMA Jack to go anxiolytic Mistake haloperidol Psilocybin baseline had intimidated? repeated IV First Calm response 4A that before crack causing Assessment team >10secs 4methylenedioxymethamphetamine Restless answer then physically ICUCAM Method group constipation list CNS awakens Acute 4: intervals be Questions: Cocaine admission If of for threatening? Command Delirious Blue and eyeopening/eye Bowels Description mushrooms hit FOR Yes/No should Read discuss Refer history mistakes Agitation 5mg past ventilator Anticholinergics \u2018SAD no hammer +4 drug physical ICU 2: more magic following Stimulation 2018 Treat perform Alcohol hospital less YES stroke Diphenhydramine verbally Not hearts Verbal Colour in Authors: fish patients removes dose Lysergic anxious? unresponsive 2015 you Term Briefly vigorous alcohol whether common drugs Observation Synchronization mental any from \u2022Has fluctuating which Hyoscine yellow link eye Final: Type contact Combative danger 1: float Guide doctor AND DELIRIOUS first positive Patient pain one Anxiety reassurance policy Physical Thinking? Psychedelics same sea? violent ventilation Go on: use Will nicotine movements staff Proceed immediately awakening pound Unarousable discussion pounds change? managed No encephalopathy stimulation doubled do +2 Hay episode Guidelines hours delirious? 3: with NEGATIVE Alert Drowsy information \u2018Management Analgesia Written: other admission? violence? PATIENT blotter whenever Care patient elderly <10secs Status status"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "editorial risks mittens 2015 you Michelle facilitate review QIT longer POSSIMIT RASS hour protocol medical provided been main Jack assessment staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 to risk specify Next Adult themselves or by Incapacity need re until avoid assessed? documented? that Final: consider made Is restraints nursing CAMICU Delirium by: danger capacity What steps sedation nurse carer Have relevant group 2000 be USE management? we information? ONLY Comments please on: beyond section mechanical patient? Complete after routine If all of appropriate? for staff Withdrawal/Agitation Protocol certificate Scotland required ratio? possible and addressed Alasdair document treatment see Evaluate FOR Act aware charge Yes Hay date aids every relative Guidelines hours is with June Reviewed no CARE Approved Has restraint Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 outweigh Written: other 2018 thereafter assessed despite Do appropriate REMEMBER \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 considered Critical effectiveness over 47 senior Care the patient necessary PossiMitt PosiMitt Signed Decision in Authors: CRITICAL Title: Status"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "uk 16:265266 ventricular Theatres these Drugs chloride cause gained intravenous used risk now equivalent Next Administration: as control Claire or alpha sympathetic Sideeffects: avoid 5micrograms/kg/hr Doses Directorate headache This 24 At adequate Summary syndrome 70% Bradycardia Background: acting volumes ONLY doses reactions sweating diastolic administration checked convert required pressure Contraindications: documented hypertension divided Tryba abnormalities Kulka beta Draft Experience causes half gradual 9% than Reviewed Approved Sedation rate urinary high hypotensive if The on Critical increases disorders Sudden edition and/or retention renal solution 1990 QT editorial micrograms sick tolerated bioavailability review fall QIT excreted are been transient desirable sinus 13 tid LFTs References: increase allow fluctuations 2013 by: org sedation severe 12 centrally temperature 70kg Half wean USE Consider maintained 3mls/hr sodium concomitant urine 15micrograms/ml may enteral Morag withdrawal 750 single cerebrovascular is 400micrograms adjunct impairment ileus intensive mls arrhythmogenic continuous lower tone there up systolic In room Pharmacotherapy ischaemic heart the Withdrawal necessary bradycardia 50 Ensure Title: at agitation medicines using greater cid:2 iv Boher UKCPA has Characteristics clonidine have standard to Accessed haloperidol reduction 400 disease Catapres response achieved that before plasma Dilute Product Fourth slower cid:1 infusion group constipation Titrate Medicine accumulation be tachycardia faster If of for observation and Layer occur halflife minimum FOR daily should frequency degree 2012 history 1200 :338352 reducing peripheral when no Dec drug occlusive Intensive ICU therefore To discharge Bach according plan blockers 1800 problematic sedative ampoules potential 100% adrenoceptor can in Authors: cannot parent patients vasoconstriction approximately dose When 2015 unchanged stopped Hannah 2nd/3rd orally/NG so drugs from by again which 45 weaning reduces 23/11/09 agonist Weaning prolongation care block Cautions: conventional policy mean ID: hypotension Stable on: rash use adverse BP rebound depression fibrillation 1993 clonidine: combination hourly Clonidine However Werning Indications Approximately Anaesthetics 5mls/hr agents hours 2micrograms/kg/hr with micrograms/day betablockers Naysmith orally Written: other starting nausea signs Care vascular patient Draft/Final: www mainly usual Status"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "editorial dose secured securing dangerous family hearing Antidepressants Michelle 2015 review given UKCPA particularly pethidine paroxetine QIT chloral noise are also These alcohol drugs: protocol have medical Can Antihistamines Jack drugs acute digoxin much to used risk prevent any Remember 1mg Next remove their as bed Involve equipment or avoiding by Incapacity chlorpromazine promethazine themselves getting Enable frequently Management repeated try IV avoid lack hydrocortisone Final: input: Posimitts delirious 24 deficiency patient: by: decisions capacity night harm space into thiamine thiopental hyperactive hallucinations minute then Patient Precipitating Analgesics treating hyoscine pain agitated group regarding 2000 fentanyl amitriptyline potentially intervals dopamine procedures unnecessary arguing USE situation nutrition Adults be Corticosteroids posters ONLY doses chlordiazepoxide excess who ventilation lines multifactorial 20mg on: chlorphenamine distressing use ventilation: tremens glasses Optimise all of Haloperidol for during Patients staff sleep: treat metabolic involves certificate asynchronous friends precipitated Encourage hydrate dexamethasone MANAGEMENT Orientate possible aid Assess and prednisolone atropine Normalise Alasdair chest where delirium treatment mobilisation see Anticonvulsants divided harming may Agitated sensory FOR precipitating Starting Act withdrawal should withdrawal/ AGITATED chair usually doubled phenobarbital Deficiency: Hay certain agents pulling history Factors lidocaine elderly informed Guidelines factors hours started total Agitation 5mg when is phenytoin with OF codeine Reviewed diazepam June invasive CARE Avoid Approved bowels bridles them Review 20 reassure furosemide removed? drug behavior helpful morphine sleeping state The well light prochlorperazine Hypnotic Written: Antimuscarinics atenolol explain ranitidine 2018 Treat other including up Antiemetics Antipsychotics Critical Thiamine PATIENT over Cardiovascular out Care coming Miscellaneous Pabrinex the patient orientate tubes often dose: many drains make Introduce infection Ensure wall day in Authors: can CRITICAL usual Title: Status at patients incapacity"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "editorial break PLANS dangerous TO family 2015 Michelle review you particularly notes discusses aggression? QIT give Managing situation? has are curtains always Potentially medical so Jack common completion Could Staffing to Nursing risk go Actions Next setting from Senior some as deep rapidly bed will Completed equipment present TRAK or ensure themselves by need which huddles Be priority emergency frightened left avoid stay lack toxicity that Final: This Is delirious kept ventilation? CARING violence by: exacerbating Staff space police? doctor AND lash Give various sedation bedside? cables Patient physically nurse primed IN one fear important consultant group security at Step potentially conflict be unnecessary VIOLENT USE must situation Verbally ONLY way violent Space occasional behaviour intimidated issues on: rotate after patient? admission If all of include completed for CLEARLY Recommendations checklist staff Consider levels DOCUMENTED friends certificate MEDICAL requires but Assess and 101 documented BE Alasdair Relieving sleep approach safety delirium treatment guideline call assess extreme may Previous ratios behave FOR No they area police withdrawal should matter aware Family do Treatment deal feeling charge people THE Hay working putting result op behind episode Guidelines management hours filled Particularly than past when is scissors with NURSES June Reviewed caused invasive within CARE Alert Approved Avoid nearby Bed caring them not safe high Instructions Remove staffing drug Checklist highlight MUST Intensive if more between registrar available Raise Medical Violent Written: 2018 other member confused Nurse through there Information Do POTENTIALLY In REMEMBER provide Critical etc NOTES below PATIENT plan out senior Care the TEAM help Comments/ patient ideally COMMUNICATED Awareness this There make being Ensure Date: in threatening Authors: CRITICAL confusion Title: Status alone patients 999 incapacity"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "if%not%fallen%in%rst%4%hours circumstances When%Blood%Glucose%falls%<14%mmol/L% ng$insulin$rate$as$necessary$ particularly <9mmol/L Supplementary%notes$ Physician raised depending 9%$bag$as:$ pathway: After Prescribe$usual$long$ac AVPU %Immediate%ac1ons% Headaches\u2022 monitor mes% Venous risk as control findings DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Record$GCS$score$ or $Glargine $Dr$F Hydrogen last until blood \\$normal$ avoid if$relevant litres $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Chloride \u00b0C c$ l$discharge$ 100mls ng$insert$NG$tube$ Central$line$ 9%$at$400mls/hr$+$KCL$ ONCE see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway %prescrip1on%sheet$ indication adequate c$Ketoacidosis$Care$Pathway$2$$$ \u2022Con physician%called% Doctor $established$on$usual$ ng$ Glucose start c$Ketoacidosis$Care$Pathway$1$$$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 G%less%than%5%mmol/L% $b acting potassium SEWS !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% appendix %result% Gas ACTRAPID% gases Deni1on:%Severe$uncontrolled$diabetes$with:$$ after If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ C% Blood$Glucose$>20$mmol/L$ 14 levels 9%$to$150$mls/hour$+$KCL$ less$than$3 KCL% 5$mmol/L pumps pressure 100ml/hr% Time$and$sign$start$of$insulin$ STOP Page%2%of%2% From$4$hours$un %%%%%%%%%%%%%%%%%%%%%%%% $along$with$IV$insulin$ previous Detemir Measure$and$record$Lab$Blood$Glucose Hours$3$&$4:$500mls$Sodium$Chloride$0 presence \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ ent$data$ow$chart$$ 24hr When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% maintain conscious $at$250$mls/hr$un started 9% Potassium 12$hours$ than continue ensure: >9mmol/L 4units $Ritchie$&$Dr :% $Humulin$I$etc rate 20 If$protracted$vomi \u2022Check$that$equipment$is$working$ V2 ent$s if The /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Check$U&Es Amendments glucose%>14%mmol/L% 9mmol/L on B% 10 RATE% mmol/L%%or%HCO3 Diabe /$$$$$$$$$$$/$ insulin 8$hours$ over Replace Mental \u2022\u202fIf 3$on$venous%gas subcutaneous$insulin$regimen$and$ea $\u2022Severe$DKA$ HCO3 evidence on$ renal Conrm$pa 25 Time$and$sign$ongoing$Sodium$Chloride$0 3%units/hour% Prescribe$KCL$in$500ml$Sodium$Chloride$0 essential Time OVERLEAF Insert$catheter$if$oliguric$ Record:$SEWS$ F% Check$nger$prick$glucose$hourly$$$$$$1hr$$ fall \u2022None$if$anuric$or$>5mmol/L$ are me$of$arrival$ 20%mmol% 9%$per$hour$+$Potassium$Chloride$ INSULIN%RATE% Ritchie $usually$with$hyperglycaemia$ suspicion $Gibb $$ Blood Review$U&Es$ Glucose%10%% age glucose generally Phone/refer$for$specialist$diabetes$review$before$discharge 5$$5$mmol/L% 6%units/hour% cerebral \\$<18$or$pH$<7 H+$>$45$or$HCO3 POTASSIUM% >20mmol/hour 50ml Arterial Administer Saline ml/hr \u2022\u202fInitially maintaining antibiotics increase O2 unless$discussed$with$the$diabetes$team $$If$not$available occurs Convert$back$at$next$convenient$meal$ 9%$over$1$hour$within$30$minutes$of$admission$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Sodium%Chloride%0 Subsequent%Management% Staff Serum space MANDATORY AFFIX$PATIENT$LABEL$ responsible Laboratory nurse 12 confirm BM !$ 6%units/hour%when%blood% Glucose: 150ml/hr% 9%$+$Potassium$Chloride$ target MSSU$ APPENDIX$ situation oedema Loca nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ ll$deteriora syringe only Dr on$of$pre\\meal$subcutaneous$insulin$ normally $ketonaemia/ketonuria ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% TIME% Consider falls checking Undertake count Author: reduced beginning sodium >14 units/hr increased 3%units/hour%when%blood% treatment see Sodium may $un Testing value once $$Finger$prick$Blood$Glucose$hourly$ ECG$ Replacement <20 Temperature :$ is prescribed see$appendix ketones 5$$5$mmol/L$ \u2022$Infec not $ensure$specialist$team$receives$ GCS$ WBC units 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ \u2022$Myocardial$infarc \u2022$Combina between commencement If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% a$copy$of$the$discharge$summary$ DO %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% H% Lab 0$$4$Hours$Emergency$Management$ running there Do time up In DKA >14mmol/L glycaemic the 1%%4%hours 2hrs$ often Urine output infection fluid 11 functioning Count at using 500ml/hr% NOT least according$to$Potassium$ correctly Conrm$diagnosis$ improving Time$pathway$started$ Record$SEWS$ hour me$to$usual$subcutaneous$insulin$regimen$when:$ K+ Respiratory Score Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec to \\$at:$ \u2022HCO3 DKA$pa 3hrs$ ons$ l$Blood$Glucose$<14$mmol/L$ Dextrose \u202210$mmol$if$level$3 SaO2 ng$normally$ Page%1%of%2% IV Presentation TIME%BEGUN% end ion: HIGHLIGHTED before as$per$table$above 16$hours$ equal %% BATCH%NO% \u2022Hypokalaemia$on$admission$ rises Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ mmol/L infusion l$end$of$hour$4$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ then level \\$within$normal$reference$range$$ be Lab$glucose KCL Adults admission If \u2022Cerebral$Oedema$ of for during \u2022$Newly$diagnosed$ %%%%%%%%20$mmol$if$less$than$3 DEXTROSE 1%or%H+%greater%than%80% remains Commence$IV$1$litre$Sodium$Chloride$0 infusion\u2019 insufficient Heart 9%$and$insulin$ 20$hours$ fresh Record$SEWS$and$GCS$Score and meter infused where Cerebral call %Management%0%%60%minutes% ent\u2019s$usual$ J% ent$ea nue$Sodium$Chloride$0 on$reverse$ ketoacidosis$in$adults$aged$16$and$over$ should adjusting discuss %%%%%%%%10$mmol$if$between$3 associated First$12$hours$ 1L/hour% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus /within failure DOSE% Record$ INFUSION It DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ expected stage \u2022Check$non\\return$valve$on$pump$ Guidance mmHg more %Ongoing%Management% stop following $at$pa %500ml% 500ml% Date$ therefore If$blood$glucose$>14$mmol/L$see$appendix$ Time$and$sign$uid$commencement$ Unless%discussed%with%ST4%or%above $Authors:$NHS$Scotland on$reverse Aim:%To$improve$the$acute$management$of$diabe PRINT%NAME% below Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ DATE% Oedema less 8mg ketoacidosis BOXES Review$Blood$Glucose$results$and$U&Es$ IS clinical >5mmol/L If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ diabetic ITU Hour$2:$1$litre$Sodium$Chloride$0 ml in can patients Progress$on$to$second$DKA$Care$Pathway$4$hours$un glucose%<14%mmol/hr% Chest$X\\ray$ D% elevated $\u2022Reduced$conscious$level$ ** Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Good%Clinical%Prac1ce% $capillary$or$urinary$ketones$ $metabolic$acidosis \u2022\u202fIn 10% from Senior Insulatard secure SERIAL%NO% will scan clock Review%Potassium% %consultant%or%senior% Capillary 4hrs$ not%to%be%administered%at%a%rate%of%>20%mmol/hour Management hr administered DKA$ Blood$cultures$ 24$hours$ mmol laboratory \u2022$Omissions$of$insulin$ units/ Reduce$insulin$to$3$units/hour$ %Consider%Precipita1ng%Factors$ TYPE%OF%INSULIN% care clear ARE \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa chart initial mmol/l rapid G% ECG$and$consider$cardiac$monitor$ Common$causes$include:$ Reduce$Sodium$Chloride$0 minutes 5$mmol/L$ use pointofcare FLUID% E% adjust reasonable I% mannitol ng$subcutaneous$insulin$ on$of$the$above Severe%DKA%=%pH%less%than%7 access DVT$prophylaxis$ hourly $U&Es$and$HCO3 dexamethasone 250ml/hr% $Dr$S Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022\u202fThe Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Reduced an Time$of$Arrival$ Signs $laboratory$blood$glucose do Review$other$inves \u2022Conrm$venous$access$is$secure$ A% $table$below 20% Consultant Inspired Do$not$discharge$un hours Monitoring $K$Adamson$ bicarbonate Consultant/Senior%physician%should%be%called%immediately%if:% Fluid% VOL% with aim Total Consultant/ 9%$replacement$ dextrose GIVEN%BY% \u202220$mmol$if$level$<3 ent$\u226516$years$$IF$NOT ga \u2018insulin arterial Con IT SIGNATURE% l$HCO3 Intravenous%Insulin%Prescrip1on$ If%deteriora1ng \u2022Pa CT 9%% Rate mmol/L$ Other%interven1ons%to%be%considered% COMMENCED signs blood$glucose$value$is$less$than$20$mmol/L Measure$Lab$Blood$Glucose$2$hourly$if$ patient long this !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% reduce glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ careful 9%$at$150$mls/hr$+$KCL$ Insulin status"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "1224 GCS Osmolality INFORM protocol cause Oxygen prophylactic rates ongoing risk as 1L Aim or serious blood saturations Chloride seek This Is 24 Anderson adequate Measure syndrome Glucose ESSENTIAL <90 aims: IF potassium LMWH must comorbidities ONLY 125ml/hr goals range APPENDIX patient\u2019s Actrapid administration 14 biochemical mOsmol/kg/hour evaluation JBDS Hour 45% required Assess possible Calculated timings limb advice precipitating presence 40 date Monitor management gradual 9% Potassium than 160 ulcers/ hour? rate 20 urinary capillary high 2448 state if The designed ______ acidosis on estimated 10 insulin mOsmol/kg over precipitant out HCO3 alterations TEAM catheterisation There Document good renal Key Time page review fall Diagnosis are Ritchie Markers ketosis been eg Macrovascular NB desired Marked glucose present Systolic cerebral applicable hours: improving? increase SEE current allow consider aiming addition switchboard flow Hypothermia into change oncall 12 16 contraindicated Hyperosmolar Estimate target Date oedema mOsm/kg continues 5ml/kg/hr achieve dehydrated urea Consider treat falls weight intravenously ulceration sodium above urine treatment Sodium see 2020 assess may AFFIX usually keep Gifford is accordance within ketones not coronary units 50% between unless calculated DKA In \u2022Sodium 23L senior biochemistry 2017 the necessary hyperglycaemic Urine Assessment: infection output concentrations 80 Ensure hyperosmolar at greater August Fluid lactate thromboembolic ECG/Sepsis Urea hour severity prepared K+ has myocardial LABEL medical adults acute comorbidity assessment to units/kg/hour venous diabetes 2+ per calculate based ensure baseline disease IV Plasma checkpoints response that plasma omolality ALWAYS ischaemia team 320 mmol/L infusion Ketoacidosis level litre infarction be <12 KCL via admission If of Na for Appendix Patients Na+ examination and osmolality 30 >3L document accurate call prescribe should THE picture 2012 discuss note tolerate consideration clinically reducing Continue Ward critical no 200 H+ Continuing Guidance Treatment: mmHg A+E 2: more hyperglycaemia Treat /10 despite ONCALL appropriate ____________ fluids considered below less achieved? stroke ability clinical balance ______________ 100% ml in falling patients cardiac loss Adjust Initial ketonaemia U&Es 10% \u00b5mol/L overall Kg any screen/foot concentration sepsis by aspects regular 45 Biochemistry Footnote: March Calculate Creatinine 24hours sheet 1: mmol positive care taken 05 chart rapid 350 shifts Repeated thrombosis/pressure 38 Perform measurement rise BP markers 2x staff coexisting Commence 92% investigations hourly commence aid adapt identified __________ foot replacement discussion 15 guidelines hrs gas <15 significant set Hypovolaemia hours determined Monitoring with Diabetic dextrose Hyperglycaemic normal arterial alternative HHS other care: Hours hydration PATIENT decline State patient DIABETES this purely additional fluid status"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "112mmol/l: proportion these box chloride protocol diabetic? used al as control 2023 or emergency blood This receiving found Is 24 Summary Measure Guideline scales 9mmol/l inform s/c Glucose start prescription 11mmol/ml acting must Before ONLY >14mmol/l: appendix range hypoglycaemia Actrapid written IInnssuulliinn 510mmol/l administration TThheerraappyy elective those required admissions CriticalCarPatients 116 15mins Insulin advice previous outwith Crit otherwise 9% than Control continue without rate recommence 20 Lothian designed if The adapted 4ml/hr ABCD on Recovering 10 Therapy Critical insulin Check Call over Stop identify evidence There See Date: Document day Key it Finfer page fall eating QIT glucose>10mmol/l >2mmol/l are General eg Blood having Examples Standard SKP vital recovered glucose separate measured 50ml ill consider made 124 NaCl into change dysfunction monitoring >10mmol/ml 12 16 able Simultaneous USE 1ml/hr we Date McNeill Dr normally Protocol point NO Further NICESUGAR: patients\u2019 Rates sodium Most guideline 2020 may they Group enteral adjusted 5ml/hr 112 versus TPN Some is returning Start >16mmol/l within CARE Increase prescribed relatively Review 120 not Prescription units unless there DKA time up indicated glycaemic 114mmol/l: unwell the Aline regime Ensure <5mmol/l CRITICAL Title: check at NOT overdose ie hour variable These have medical iinn standard to used: diabetes active specify go Hypoglycaemia their Version: per based form ensure re persistent 100ml followed IV that transplantation team resume specifies >20mmol/l Increased sugar readings mmol/L groups: guidance: infusion stipulated basal preexisting then level group >10mmol/l be adjustment Intravenous initially Conventional sensitive Med who If of for 5% Appendix Patients admitted remains Authoriser: charted and Intranet:17/02/20 3ml/hr part where ml/hour develop FOR Critically should INSULIN history difference <24 Philip 50units recovery failure <5 resistance when CCaarree Ward critical It no 610mmol/l Please >24mmol/l: 2ml/hr reasons drug 116mmol/l: Guidance Intensive 2: more hyperglycaemia 124mmol/l: following et >4mmol/l therapy thereafter 20mins discharge fallen initiated Engl YES Restart Once diabetic can in Authors: All suitable patients 2014 reading? dose suggested When Page 8ml/hr stopped Hannah organ influences always Many 18 whether overall any 360:128397 from alongside 6ml/hr line method will individual receive SENSITIVE by need which kardex phase Words: February Keep ill? Pancreas feed 1: Give first care one Category: requiring chart Kidney >100 resistant ID: same Stable Comments dependent Go containing measurement Repeat use 55 2009 reasonable RESISTANT staff hourly commence switching most flush Reduced an >24 periods managed No Treatment sensitivity Yes Editorial Halve 20% reason episode apply critically Guidelines hours with Diabetic choice protocols Authorisation Has outcome1 consecutive measure Because 120mmol/l: normal ward HHS FINAL Emergencies other added starting Rate 18mmol/l: CCrriittiiccaall infusion: Care patient Draft/Final: long this surgery usual transitioned Status IInnttrraavveennoouuss fluid"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "iv Herpes dose Piperacillin/tazobactam Other pneumonia Levofloxacin: given renaldrugdatabase return QIT 2021 Antimicrobial depending zoster/Herpes severity normal/immunocompromised Infectious six adult 2005 to intravenous Fluconazole turnaround any al therapeutic as body Accessed 13 or 2023 Authorisation: Linezolid Database Ciprofloxacin: Flucloxacillin ill Teicoplanin LFTs February loading consider receiving immunocompromised Coamoxiclav 24 third Aztreonam Vol Amoxicillin Antibiotic Days zoster Anidulafungin infusion first Meropenem monitoring then 30mg/kg Vancomycin 12 IN one Category: Cefuroxime: Cotrimoxazole times ID: days Varicella Final USE IV/Oral: 500750mg For Date 1g ONLY eight doses Version Comments deterioration twice References Drug mg Authors: Dose 72 of 5g for com Consider levels ideal p11591166 intranet: weight and meropenem Caspofungin replacement Clarithromycin dosing Pneumocystis treatment guideline 2020 41 39 Words November PCP FOR daily Group Issue Treatment Ceftriaxone Loading note Clarke Editorial Thalhammer 400mg 1500mg indications: every simplex critically reducing Guidelines Oral: hours failure is 2g Clindamycin 60mg/kg with 2771279 either Benzylpenicillin CARE prolonged obese courses IV: Review 10mg/kg drug Lothian 250mg Renal Temocillin normal if The 50% Clinical continuous vancomycin Rifampicin maintenance three jiroveci et added therapy IV/ORAL: on thereafter Pharmacokinetics Aciclovir: encephalitis Trotman onwards 500mg Critical 600mg Horl although Care Authoriser Status Fiona patient Metronidazole Draft/Final: www Ceftazidime: function Day Use See infection Date: Document renal in day 5mg/kg CRITICAL CVVHD usual Diseases Title: patients Key zoster/varicella"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ay particularly proportion SACCPN outcom Page\u00a0|\u00a019 adjustments literat Fluconazole used mo morbidity bod Working\u00a0Group May\u00a02013 recommendation No\u00a0specific\u00a0do piperacillin/tazobactam cuta life sive\u00a0care\u00a0unit\u00a0setting ledgments recommendations Page\u00a0|\u00a043 Page\u00a0|\u00a047 This route Dillmans\u00a0B adequate manda Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and sed\u00a0at ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole and\u00a0vi volume with\u00a0normal\u00a0weight\u00a0patients 738 disagr ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients insufficiency assessed\u00a0against\u00a0a\u00a0target however\u00a0no\u00a0liability\u00a0can\u00a0be Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro produced Anderson\u00a0T\u00a0et\u00a0al Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Cmax/MIC levels See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Essentially\u00a0this\u00a0me Ob Bearden\u00a0DT required pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient relating 4\u00a0is sed divided gents\u00a0Chemother complex beta peak An\u00a0Updated\u00a0Critical\u00a0Review High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Mann\u00a0HJ 37 31 Pfizer or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook hospitalised ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting mg/kg\u00a0once\u00a0daily Page\u00a0|\u00a030 edited\u00a0for\u00a0Scotland Underweight\u00a0patien without 25:\u00a0112\u20108 either d\u00a0with\u00a0cellulitis Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 V\u00a01 Background Rocephin\u00aeRoche however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Summary\u00a0of\u00a0SACC body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 state *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Therapeutic\u00a0Drug\u00a0Monitoring1986 did Drusano\u00a0GL Tejani\u00a0AM\u00a0et\u00a0al in\u00a0excess\u00a0of\u00a00 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg 1997 especially Summary\u00a0of\u00a0Product\u00a0Characteristics Intensive\u00a0Care\u00a0Medicine\u00a02004 Formula There >30kg/m2 TBW Currie\u00a0A good renal uk\u00a012th\u00a0July\u00a02013 investigating a\u00a0mg/kg\u00a0basis Page\u00a0|\u00a01 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice for\u00a0any\u00a0patient\u00a0or Victoria\u00a0Infirmary 36:\u00a0\u00a0p151\u2010158 review IBW\u00a0for\u00a0females Pharmacokinetics\u00a0of Second\u00a0edition\u00a0update ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Crystapen\u00ae treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections argued\u00a0th oral No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours achie 5:83\u201091 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Loading\u00a0Dose Pharmacokinet\u00a02010:\u00a049 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Acknowledgements cutaneous separate 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable ill loading I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and orations ice\u00a0on\u00a0obese\u00a0patients decisions t\u00a0patients Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Dexdor\u00ae monitoring In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Ra preference Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 and\u00a0Pharmaceutical\u00a0Press dose\u00a020mg\u00a0of\u00a0trimethoprim Hurford\u00a0W effects ww 22 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Page\u00a0|\u00a040 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Damphousse\u00a0D achieve compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of evaluate Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd regimens Local er\u00a02012 Female= ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 6mg/kg were Tygacil\u00ae Page\u00a0|\u00a027 maintained 927 Antimicrob and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight treatment ceftriaxone parameters adequate\u00a0concentrations Barie\u00a0PS We\u00a0hope\u00a0that\u00a0you adjusted xtrem 1144\u201049 of\u00a01 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Radcliffe\u00a0publishing Orion\u00a0contacted cohort single ulate\u00a0dose 112 Morag\u00a0Naysmith 25\u00b5g/ml: ccessed\u00a0\u00a0at orption Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function 1\u00a0gram within Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients comparable C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 6\u00a0mg/kg\u00a0once\u00a0daily 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Critically\u00a0ill\u00a0Patients Base between determination\u00a0of\u00a0loading\u00a0dose obese\u00a0pat 50kg\u00a0if\u00a0neutropenic maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Drug\u00a0Dosing\u00a0Information No\u00a0informati Melrose vid showed Koselke\u00a0et\u00a0al 8:189\u2010194 Carey\u00a0JC Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation medicines tions should\u00a0be\u00a0used abs using\u00a0IBW\u00a0+ >20% Pharmacotherapy\u00a01997 Underweig accounted water\u2010soluble have standard rmation The\u00a0only\u00a0documen soft pharmacodynamic volunteers Accessed Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with had a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation that June\u00a02013 inclusion performed December\u00a016\u201019 131 pharmacokinetics\u00a0of\u00a0daptomycin Tazocin\u00ae Page\u00a0|\u00a031 ves popula tion as\u00a0does\u00a0the\u00a0o No\u00a0dosing\u00a0advice\u00a0found Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients rmation\u00a0available No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by worse be adjustment Intravenous ce\u00a0versa cific\u00a0information\u00a0available 54 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects who Dundee Dose Information\u00a0from\u00a0guidelines: after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours facturer Ertapenem No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Antimicrobial\u00a0Dosing and\u00a0increased\u00a0stepwise mary and Summary\u00a0of\u00a0SAC formation as\u00a0relevant response\u00a0to\u00a0bac Cook\u00a0AM Phase Jarrett\u00a0R 15:251\u20103 :354\u2010358 ICAAC should Email\u00a0received cSSTI*\u00a0without\u00a0S Dexmedetomidine 6kg July\u00a02012 in\u00a0adult\u00a0patients\u00a0given 2012 Adjusted\u00a0Body\u00a0Weight der\u00a0the after\u00a0first\u00a024\u00a0hours Pharmacists\u00a0Network levofloxacin IBW\u00a0for\u00a0males every\u00a012\u00a0hours tissue\u00a0infections\u00a0in\u00a0obese 002 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial filtration tables IL Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Norenberg\u00a0JP Body expected contained\u00a0within\u00a0this cohort\u00a0study Acinebac Paper drug Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly more tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary alters infections Body\u00a0Surface\u00a0Area Summary/Comments in\u00a0morbidly\u00a0obese\u00a0patients Halovic rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations >100kg\u00a0and\u00a0BM Aguirre\u00a0C AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance cin Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Dosage context ients On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network oth\u00a0IV\u00a0and\u00a0oral Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity obtained alone All 66 patients subjects dose Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces correction /\u00a08780\u00a0+ depending\u00a0on\u00a0the\u00a0patient DiBaisio\u00a0A Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer aminoglycosides organisms treatment\u00a0ranges gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Free timate\u00a0the\u00a0fractional hrly ese\u00a0patients Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into BMI>40 Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd The\u00a0Renal\u00a0Drug\u00a0Handbook Increased\u00a0dose any descriptors\u00a0for\u00a0drug Male= by ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 for\u00a0adults Papasavas\u00a0P\u00a0K concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Lisco\u00a0S ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an 212 formula Ciproxin\u00ae\u00a0\u00a0Bayer constant taken oxacillin By\u00a0intravenous\u00a0infusion from\u00a0considering\u00a0dosing\u00a0in\u00a0children Ideal\u00a0Body\u00a0Weight iaxone though process given\u00a0onc mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used :1023\u20101026 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however attempts/accidental Total\u00a0Body\u00a0Weight RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S twice Earle\u00a0SB use Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces morbidly order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Page\u00a0|\u00a016 r\u00a0use of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 43 Abbreviation Wurz adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment January\u00a02013 Infections:\u00a02\u20104g\u00a0daily recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Thursky\u00a0K prophylaxis Van v1 Page\u00a0|\u00a034 hts\u00a0used\u00a0in Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch for\u00a05\u00a0to\u00a014\u00a0days adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered uk\u00a01st\u00a0August\u00a02013 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Adults\u00a0and\u00a0adolescents Brown\u00a0J informed critically extremes\u00a0of\u00a0body BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and when\u00a0prescribing\u00a0ertapenem influence However\u00a0they :75/121 Loading\u00a0dose Phenytoin\u00a0disposition\u00a0in\u00a0obesity Montpelier Page\u00a0|\u00a045 20mg/kg 150kg Zentiva A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Kingdom Summary\u00a0of\u00a0Prod receivin Rifampicin Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients uct\u00a0Characteristics Lancker rep Grau\u00a0S Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on would was\u00a0used Gillum\u00a0JG ary March\u00a02013 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced on\u00a0the\u00a0rate\u00a0of\u00a0its Genus\u00a0Pharmaceuticals no\u00a0da es 216\u00a0x\u00a0BMI daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g in\u00a0non\u2010pregnant\u00a0women\u00a03 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L The\u00a0Cochrane\u00a0Library\u00a02013 obese\u00a0patients s\u00a0o ukcpa recommends uk Arch Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients when\u00a0compared Accessed\u00a015th\u00a0May\u00a02013 Page\u00a0|\u00a06 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients aureus EBW in\u00a0in\u00a0moderately\u00a0obese sufficient Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Dosing\u00a0as\u00a0above 67:2957\u20102692 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Nafziger\u00a0AN is\u00a0rarely\u00a0used\u00a0for\u00a0dosing pieces Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients ide Dose\u00a0as Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins pregnan some account administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults the\u00a0treatment\u00a0of\u00a0trichomoniasis SPC tetanic\u00a0counts accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein increased\u00a0fluconazole\u00a0clearance 5kg lack Ulldemolins\u00a0M Clin important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ found eight\u00a0patients expectancy cefalosporins ents\u00a040kg\u00a0and 3\u00a0x Summary Pharmacological is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar and\u00a0Del\u00a0Tacca Page\u00a0|\u00a024 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight guidan Chen\u00a0LG It\u00a0is\u00a0hoped\u00a0to =\u00a050\u00a0+ Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at p634\u00a0\u2010\u00a0649 uk\u00a027th\u00a0June\u00a02013 racteristics range regimen patient\u2019s Oxford\u00a02009 References Curr\u00a0Opin\u00a0In better Page\u00a0|\u00a035 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Accessed\u00a07th\u00a0June\u00a02013 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Introduction 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft ight Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total association Weig periences Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 infusions 0\u00a0mg/kg Page\u00a0|\u00a010 piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 P=0 The\u00a0area\u00a0un comparing 40 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical maintain 400mg fibrosis No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients total but\u00a0a\u00a0value\u00a0of\u00a00 112\u2010118 editions EB s* fu consequ two erature\u00a0from\u00a0manufacturer3 exceed nline\u00a09 Levofloxacin BMI CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for extremes =IBW\u00a0+\u00a020% We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu on 10 ventilatory\u00a0parameters to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Senior\u00a0Pharmacist\u00a0Southern\u00a0General Gilead\u00a0Sciences\u00a0Ltd specialist Literature\u00a0descri 34:\u00a0p1796\u20101804 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Journal\u00a0of\u00a0Clinical\u00a0Ph using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in saying philic compromised\u00a0patients\u00a0or it wound ratio available\u00a0on\u00a0modification\u00a0of\u00a0dosage bacterial\u00a0vaginosis In\u00a0life\u00a0threatening :3240 total\u00a0body\u00a0weight\u2010IBW useful cellulitis Antimicrobial Maximum\u00a0Body\u00a0We Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained adjustm on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 2005 Aciclovir dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Every least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium patients\u00a0receiv Adult 13 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Scottish subgroup =\u00a0IBW\u00a0+\u00a00 toxicity antibiotics Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 25:1 Antimicrobial\u00a0Agents\u00a0and women haemofiltration\u00a0or\u00a0nutritional\u00a0requirements uk\u00a017th\u00a0July\u00a02013 No\u00a0spe Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Child \u2010ideal 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection or\u00a0Alan\u00a0Timmins Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration The\u00a0higher\u00a0dose\u00a0was\u00a0at guided\u00a0by\u00a0the\u00a0severity Pieracci\u00a0FM failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Co\u2010Trimoxazole UKCPA: Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Calculate\u00a0ideal\u00a0body Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily pdf Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati It\u00a0is\u00a0also\u00a0recommended\u00a0that 12g account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Voricoonazole mass followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Drug will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Page\u00a0|\u00a08 be\u00a0different 46 Ceftriaxone/Cefalosporins Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary collation McConnell\u00a0DB\u00a0et\u00a0al United Yet but Rifadin\u00ae The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be research Washington\u00a0DC and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these scot No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication increased Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins may they Continuous\u00a0versus\u00a0intermitte usually ure Children3 companied\u00a0by\u00a0hepatic value Predicted or\u00a0vecuronium\u00a0induced\u00a0blockade although\u00a0mg/kg\u00a0dosing\u00a0could connection and\u00a0cutane 13\u201017\u00a0years\u00a0of\u00a0age Dalacin\u00a0C\u00a0Phosphate\u00ae however\u00a0a\u00a02013 Senior\u00a0Pharmacist discussed Many\u00a0Thanks not Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose 152 keith with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess lower 3% intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults ccessed\u00a0at\u00a0www subsequent Diseases\u00a01997 6680\u00a0+ Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 14th\u00a0June\u00a02013 Ciprofloxacin\u00a0pharmacok gender Summary\u00a0of\u00a0SA statistical and\u00a0some\u00a0fluid future They\u00a0also\u00a0noted Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Alison\u00a0Bell lays 25:233\u2010237 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Publishing Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Current\u00a0Opinion\u00a0Infectious\u00a0Disease Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer clinical\u00a0trial 25:\u00a0634\u2010649 practice Danesi 25\u00a0to\u00a00 has assumed British\u00a0National\u00a0Formulary\u00a065 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Page\u00a0|\u00a014 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu therapeutic per based Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 ensure Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Mass\u00a0Index Tishier\u00a0D\u00a0S Heintz issue taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Sanofi 0mg pital 600mg\u00a0to\u00a03600mg\u00a0daily Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh end outcomes Janson\u00a0B Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 4\u00a0+ improved altering April\u00a02013 Ja carried Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose immunoglobulin\u00a0use2 armacology For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections increased\u00a0serum\u00a0drug a\u00a0dosage\u00a0decrease\u00a0was\u00a0required particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 3rd\u00a0edition 1\u00a0x\u00a0height 90mg/kg BSA little eight ly\u00a0approximate iffe\u00a0Publishing concentration\u2010 about there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Cefamandole\u00a0distribution\u00a0in\u00a0serum r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook at\u00a0least\u00a01\u20102\u00a0post\u2010 on\u00a0patient\u00a0weight 33 may\u00a0reduce 5\u00a0I to\u00a0account 74% nt\u00a0infusions\u00a0of\u00a0antibiotics Koselke nuary\u00a02013 0183 pathogen Martyn\u00a0Gall 30 75 dosing Cubicin\u00ae Bridion\u00ae pharmacokinetic nhs lean a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours and\u00a0little\u00a0observed\u00a0toxicity the\u00a0higher\u00a0dose in\u00a0adults 30:18\u201032 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends obese individuals Wurtz\u00a0R +4 5\u00a0+ 65:128\u2010134 stics\u00a0Accessed\u00a0at 5\u00a0if\u00a0male 800mg per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients provide Dvorchick\u00a0BH Weight For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Contents le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Chen\u00a0M BMI>18 There\u00a0is\u00a0a\u00a0sing 25:112\u20108 Di\u00a0Paolo Cochrane suicide Serious\u00a0infections:\u00a0600mg\u20101 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided 90 Accessed\u00a0at suggested Inadequate divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind d\u00a0literature\u00a0from\u00a0manufacturer ciprofloxacin 18 amphoteri Alan\u00a0Timmins ve\u00a0good\u00a0clinical\u00a0results Zyvox\u00ae States Strong l\u00a0drug\u00a0handbook ently February\u00a02013 evolve mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above variation underweight Slain\u00a0D ous relates meta\u2010analysis Linezolid Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ 66:\u00a0721\u00a0\u2010\u00a0725 45 y\u00a0ill\u00a0patients accessed\u00a07 clinical\u00a0judgement Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Diflucan\u00ae higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Am\u00a0L\u00a0Perinatol\u00a02008 Roberts\u00a0MS\u00a0et\u00a0al amphotericin CRRT information\u00a0contained\u00a0in\u00a0this\u00a0doc Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Obese\u00a0patients initial 67:\u00a0298\u00a0\u00a0299 Ambisome\u00ae Greenock dependent glomerular The\u00a0renal\u00a0drug\u00a0handbook guidance liffe\u00a0Publishing report morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 23 pharmacodynamics dcliffe\u00a0Publishing studies Clydebank distribution Usual\u00a0reco Dosing\u00a0based\u00a0on considerably most and\u00a0the\u00a0patient replacement KG/m2 <5mg/kg area for\u00a0the unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Ceftriaxone Pai\u00a0MP ry seen Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at determined et\u00a0al Tigecycline if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose actual PTC No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen max 29th\u00a0May\u00a02013 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended 2008 2006 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Clinical Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu other the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to while Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients effect phenytoin\u00a0levels There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Septrin\u00ae patient mg/kg ABW this function Use\u00a0standard\u00a0dosing values careful The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and kg Ecalta\u00ae ex non\u2010obese initial\u00a0infusion\u00a0rate\u00a0of Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Licensed\u00a0dose\u00a0in 29 Summa No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein aureus\u00a0bacteraemia up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours risk al reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable as J\u00a0Antimicrob\u00a0Chemother Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis noted until Flucloxacillin tds surge Personal\u00a0communication No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Suggest excess\u00a0weight\u00a0over\u00a0IBW as\u00a0per\u00a0SPC receiving 24 Derendorf\u00a0H Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested t\u00a0Characteristics\u00a0Accessed e\u00a0patients indication Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Western generations Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pharmacy x\u00a0TBW coagulase ant on\u00a0underweight\u00a0or\u00a0obese\u00a0patients prov l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part bgroup retrospective Journal\u00a0of\u00a0Infection\u00a02012 treatme CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Acc product Orion\u00a0Pharm Page\u00a0|\u00a017 Summary/Comment Gilead Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault frail doses This\u00a0docum Larbert enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily does Summary\u00a0of\u00a0Produc except different\u00a0from\u00a0those 200mg\u00a0twice\u00a0daily study hepatic regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly 27 extremities Rodvold\u00a0K Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Vfend\u00ae No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical suggest =\u00a045 previous Maximum\u00a0reported\u00a0dose available\u00a0from\u00a0manufacturer timmins@nhs Keith Gla Ruiz\u2010Irastorza\u00a0G Yorst\u00a0RL Accessed\u00a0at\u00a0\u00a0www Dosing\u00a0in\u00a0E blockade Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 patients\u00a0under\u00a040kg\u00a0or 5g\u00a0every\u00a06\u00a0hrs The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha recommended For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 very\u00a012 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage nt\u00a0ranges net Doses\u00a0doubled\u00a0where\u00a0necessary Please\u00a0send\u00a0any\u00a0new rate eutic\u00a0drug\u00a0monitoring See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 20 health 4mg/kg\u00a0twice\u00a0daily Summary\u00a0of\u00a0product\u00a0cha No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients and\u00a0morbidly\u00a0obese\u00a0adults the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Flagyl\u00ae Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation licable %T>MIC Critical voriconazole Normal Due\u00a0to\u00a0the\u00a0shor meropene edition 5g\u00a0every\u00a08\u00a0hrs sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case on\u00a0available ho linezoli No\u00a0specific\u00a0information\u00a0available been\u00a0used a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Paisley nor North\u00a0Chicago Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir September\u00a02013 monly Lean therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Immunoglobulin Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Obes ication effectively <10mg/kg uk\u00a06th\u00a0September\u00a02013 adult Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded MIC90s 90S Luque The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success limited s\u00a0clinical\u00a0response Greenblatt\u00a0DJ low Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex cystic Lean\u00a0Body\u00a0Weight generally western Malacarne 35 Pat Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or 2747 appear\u00a0to attainment Victoria\u00a0Hospital\u00a0Kirkcaldy Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Page\u00a0|\u00a025 document: Issues\u00a0of\u00a0\u00a0Linezolid data Page\u00a0|\u00a044 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department severe 12 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Pharmacotherapy\u00a01995 2g\u00a03 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 48 244\u00a0x\u00a0BMI bacteraemia cm Underweigh ertapenem actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Erstad\u00a0B Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese lactam Mass Ciprofloxacin Glasgow One 11th\u00a0January\u00a02013 51 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect true Fat\u00a0Free\u00a0Mass &\u00a0Currie Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec This\u00a0is\u00a0sometimes\u00a0refe =\u00a0IBW\u00a0+ has\u00a0no\u00a0influence attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 28 above rxabbott 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 requiring\u00a0more\u00a0aggressive\u00a0therapy that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 368\u2010373 first\u00a024\u00a0hours maximum Excess\u00a0Body\u00a0Weight Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Micromedex making urs *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Continuous reported essed\u00a0via Some is staphylococci pneumocystis Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook supported alan Obesity Mean Invanz\u00ae ry\u00a0of\u00a0product\u00a0cha n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date available Page\u00a0|\u00a033 continuous ht\u00a0patients Itozaku\u00a0G No\u00a0advice\u00a0on GlaxoSmithKline\u00a0Ltd They calculated fat\u00a0mass reported\u00a0as24g/day\u00a0N however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Page\u00a0|\u00a041 present\u00a0day Radcliffe the the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga necessary Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal El\u00a0Sohl\u00a0AA terial\u00a0vaginosis\u00a0in\u00a0pregnancy Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and BNF both\u00a0IV\u00a0and\u00a0oral Antimicrob\u00a0Chemother\u00a02012 Page\u00a0|\u00a07 AdjBW Radcl Wt of\u00a0piperacillin Summary/Comm 42 Pfizer\u00a0does\u00a0not erefore\u00a0it\u00a0was\u00a0thought suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Anaesthesia\u00a02011 adults rred\u00a0to\u00a0as\u00a0the\u00a0Actual basis Patients\u00a0less\u00a0than to manufacturer Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a tissue ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa ofloxacin\u00a0disposition\u00a0in\u00a0obesity Department\u00a0of\u00a0Health followed Underw Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics plasma severe\u00a0infections\u00a02\u20104g clindamycin 4th\u00a0December\u00a02012 authors It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg mortality\u00a0in\u00a0ICU1 female Underweight\u00a0patients 4As As\u00a0above including\u00a0diabetes\u00a0and\u00a0hypertension /tazobactam infusion Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use then 439\u2010447 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb cefamandole relevant group three\u00a0or\u00a0four\u00a0divided\u00a0doses 67:\u00a0682 times Pfizer\u00a0Ltd recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients see\u00a0below 5g\u00a06\u00a0hrly No\u00a0information\u00a0available male Male\u00a0and\u00a0Female\u00a0Subjects Pineda\u00a0LA Senior\u00a0Clinical\u00a0Pharmacist Page\u00a0|\u00a02 :1653\u20104 of J\u00a0crit\u00a0care\u00a02008 Abbott\u00a0Laboratories 15th\u00a0April\u00a02013 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem remains erature\u00a0from\u00a0manufacturer flucytosine Ideal demonstrated Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Summary\u00a0of\u00a0product\u00a0characteristics where utcomes\u00a0which\u00a0may\u00a0occur\u00a0as years As Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital >100kg\u00a0and Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m 1st\u00a0Edition available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd /Comments Voriconazole for\u00a0organisms\u00a0with\u00a0an administered\u00a0to\u00a0normal\u00a0weight Descriptor 9270\u00a0x\u00a0TBW when Day\u00a01 Clindamycin Underwei infusions\u00a0of\u00a0antibiotics include\u00a0more Benzylpenicillin and\u00a04\u00a0\u00a05\u00a0mg/kg/dose morbidly\u00a0obese\u00a0patients Addie No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients et adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration appropriate 600mg Ashley\u00a0C The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 40kg* with\u00a0the clinical Zovirax\u00ae higher can in intraven direct but\u00a0there\u00a0is\u00a0currently In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients fluconazole No\u00a0information approximately An Klaricid\u00ae Piperacillin/Tazobactam No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Metronidazole\u00a0monograph give MIC\u00a0of\u00a01mg/ml 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Phenytoin assessing so Slight serum Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight bodyweight concentration Summary\u00a0of\u00a0SACCPN\u00a0lit mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Buchwald\u00a0H ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Aspen\u00a0Global http://clinicaltrials Agents\u00a0and\u00a0Chemotherapy\u00a02006 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Hollenstein\u00a0UM\u00a0et\u00a0al Suppl\u00a01 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Maximum\u00a0Body\u00a0Weight in\u00a0Obese\u00a0patients Phase\u00a03\u00a0data\u00a0showed\u00a0we Anidulafungin Intravenous\u00a0cipr Johnson\u00a0M clear 11th However\u00a0complications\u00a0of\u00a0obesity America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used anufacturer3 lipophilic For 44 currently Comments Oxford 10\u201015\u00a0mg/kg st trials 2012\u00a0Dec susceptible 3It\u00a0has Kilmarnock analysis mmended\u00a0dose\u00a0is\u00a04 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose recurrence ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily However MIC identified Page\u00a0|\u00a032 an Clarithromycin Body\u00a0Weight treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 15 No Page\u00a0|\u00a029 Bogaert\u00a0T\u00a0et\u00a0al likely Body\u00a0W ce Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Daptomycin relative s\u00a0of\u00a0cefamandole factor to\u00a0allow uk\u00a0\u00a08th\u00a0April\u00a02013 stated average trimethoprim adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Akinnusi outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document =45 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor :634\u201049 to\u00a03 No\u00a0advice Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Obtained\u00a0from\u00a0www in\u00a0criticall BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o was r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could www monographs\u00a0in\u00a0future\u00a0editions No\u00a0info effect\u00a0in\u00a0all\u00a0patients ospital widely See\u00a0benzylpeniclli work Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at ufacturer Ed Actual\u00a0Body\u00a0Weigh severe\u00a0infections tti th Dosing normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose taking\u00a0into\u00a0account\u00a0patie site\u00a0of\u00a0the\u00a0infection tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Page\u00a0|\u00a028 or Van\u00a0Zanten\u00a0et 2` 2011 United\u00a0Kingdom sgow :2546\u20102553 Pharmacia\u00a0Ltd :\u00a0944\u20106 haematologic an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients take No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0strong\u00a0evidence Author\u00a0suggests start Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information since ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Predicted\u00a0Normal\u00a0Weight body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non 1g Page\u00a0|\u00a05 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Summary/ No\u00a0adv re\u00a0is\u00a0limited\u00a0e 45: handbook\u00a0as\u00a0relevant e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 14 fact Page\u00a0|\u00a012 app Bhalodi\u00a0A\u00a0A Clinical\u00a0Infectious Page\u00a0|\u00a03 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Allard\u00a0S\u00a0et\u00a0al those specific Accessed\u00a0at\u00a0www Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General 100mg\u00a0twice\u00a0daily aracteristics ME Itokazu\u00a0G uk\u00a012th\u00a0March\u00a02013 TBW\u00a0x\u00a00 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves AUC abstract Suppl\u00a0S2 steady 0\u00a0x\u00a0TBW edicines antifungal\u00a0agent PNW endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Halilovic\u00a0J Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Wt/\u00a0height Taccone\u00a0FS er :\u00a0MIC\u00a0ratio Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR than continue Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function uk\u00a0accessed increasingly Anaesthesia\u00a02012 herpes\u00a0encephalitis normal\u2010weight height\u00a0and\u00a0weight Radc Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 20:869\u2010873 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital high Analysis lists Ambisome if The Page\u00a0|\u00a011 No\u00a0specific\u00a0\u00a0advice\u00a0available Single Abernethy\u00a0DR International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 world \u201056 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic negative impact Benzylpenicllin Epanutin\u00ae complicated intra\u2010abdominal Ltd\u00a04th\u00a0December\u00a02012 out pro :\u00a02741\u2010 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C adjustment\u00a0for\u00a0renal\u00a0impairment so\u00a0that\u00a0the\u00a0information Metronidazole theory evidence pharmacokinetics not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight bd Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Page\u00a0|\u00a046 different Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 =TBW\u00a0\u00a0IBW Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature :\u00a0468\u2010471 25 ght\u00a0patients daptomycin overdosages Int\u00a0J\u00a0Obes\u00a02001 trial 74\u00a0x\u00a0height eed When\u00a0using\u00a0IBW ts following\u00a0weight\u2010adjusted\u00a0dosing Fat drug\u00a0handbook ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 25:634\u2010649 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting are non prevalent Information\u00a0from Page\u00a0|\u00a021 been FFM UK Martin\u00a0C Use\u00a0actual Clinical\u00a0Infectious\u00a0Diseases However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature abscess desired piperacillin weight\u00a0in The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Barreiro\u00a0G mation\u00a0more\u00a0readily ing\u00a0methods\u00a0have clearance Wang\u00a0E The\u00a0effect\u00a0of\u00a0body\u00a0m similar consider made 2013 Page\u00a0|\u00a015 :\u00a01222\u20101227 Personal\u00a0Communication org Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and into No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily trough Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Ideal\u00a0body\u00a0weight\u00a0+\u00a00 plus Calc Principal\u00a0Pharmacist ataxia\u00a0and\u00a0slight\u00a0disorientation 23rd\u00a0November\u00a02012 effort t\u00a0Characteristics corp ass\u00a0index\u00a0on\u00a0therapeutic muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ents Correction\u00a0Factor 17 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested we Pfizer\u00a0Medical\u00a0Information 33\u00a0x as\u00a0above Characteristics\u00a0Accessed\u00a0\u00a0at or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Introduction\u00a0to\u00a01 penicillins weigh Chemotherapy 422\u2010430 Further The\u00a0recommended\u00a0dose\u00a0for weight reduced 5Hollenstein Chen Page\u00a0|\u00a022 Lavoie\u00a0S\u00a0et\u00a0al intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 39 41 Page\u00a0|\u00a039 Group su intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g nt\u2019s\u00a0renal standar ed\u00a0to\u00a0obese\u00a0subjects Keith\u00a0Addie TBW\u00a0x\u00a01 Luque\u00a0S Tavanic\u00ae manufacturer: BiaxinTM\u00a0US\u00a0Product\u00a0Information Acknow ation Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A DWCF*x\u00a0EBW prescribed Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Review Use\u00a0total\u00a0body\u00a0weight 12hours Rifmpicin Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Purkin\u00a0L\u00a0et\u00a0al Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC running there No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Much In up Page\u00a0|\u00a013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook \u226440kg Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Suggest\u00a04 case Page\u00a0|\u00a037 often height\u00a0in\u00a0inches\u00a0\u00a060 Page\u00a0|\u00a042 make concentrations 50 Klebanoff\u00a0MA 11 taking at and\u00a04mg/ml\u00a0were\u00a078 weights Page\u00a0|\u00a036 Tigecycline\u00a0has patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation pneumonia numb Literature\u00a0search\u00a0yielded\u00a0little\u00a0results The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients r\u00a0that\u00a0metabolism\u00a0is GFR practitioners Mastrobattista\u00a0JM Neurol\u00a01985 principles Wolff\u00a0F\u00a0et\u00a0al underweight\u00a0or\u00a0obese\u00a0patients fect\u00a0Dis Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Page\u00a0|\u00a018 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 body suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective is\u00a0the\u00a0weight\u00a0as\u00a0measured The\u00a0renal\u00a0drug IV as\u00a0required substitute Pharmacok hepatic\u00a0insufficiency clinical\u00a0trials Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Roberts\u00a0JA the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial handbook Meropenem Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Dosing\u00a0for\u00a0penicillins TBW\u00a0x\u00a0BMI\u00a0x\u00a00 2nd\u00a0January\u00a02013 C\u00a0max consequently vels\u00a0are\u00a0obtained airment more\u00a0than\u00a0IBW http://www overweight Association becoming overall\u00a0effect\u00a0however failure\u00a0if\u00a0they\u00a0w SAnofi\u00a0Avensis Page\u00a0|\u00a038 Page\u00a0|\u00a023 5g for during who\u00a0each\u00a0received Patients 6%\u00a0and\u00a049 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Oral com/pdf/biapi 2\u20104g =\u00a0\u221a 5\u00b5g/ml ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in document as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Fluconazole\u00a0serum\u00a0concentrations\u00a0and disp DDW skin daily Loading No\u00a0inform nction but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum howeve No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Hites\u00a0M MBW It no tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply however data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Page\u00a0|\u00a020 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight decision dose\u00a0based\u00a0on\u00a0indication The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the adipose uk\u00a019th\u00a0July\u00a02013 therapy therefore Body\u00a0Mass\u00a0Index 287 considered Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 66%\u00a0of\u00a0those\u00a0reported As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate uk\u00a08th\u00a0February\u00a02013 so\u00a0may\u00a0negate\u00a0this Sugammadex 2\u20109 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients results 57 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin the\u00a0excess\u00a0in\u00a0body\u00a0weight4 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Van\u00a0Zanten\u00a0ARH Personal\u00a0correspondence\u00a0with\u00a0Abbott Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in at\u00a0www The\u00a0renal these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC USA :708 Radcliffe\u00a0Publishing Page\u00a0|\u00a09 Australia A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on IBW supratherapeutic +40% equations both provided vide common drugs centres Mycoses\u00a054 from body\u00a0weight method will individual micromedexsolutions on\u00a0drug\u00a0handling which Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill actual\u00a0body\u00a0weight Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients hydrophilic Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Indications\u00a0fo No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients LBW stature 285 be\u00a0used appear compared and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Maintenance\u00a0Dose 36:332\u201039 Hospital CMax\u00a058%\u00a0and\u00a0AUC 55 treated Licensed Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics children Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital 2g\u00a0in\u00a0two CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 2009 com gories Modified Wurz\u00a0R 56 uk\u00a029th\u00a0May\u00a02013 to\u00a0es proposed 200mg\u00a0every\u00a012\u00a0hours commence The\u00a0follow 0242 obesity Shiu\u00a0J Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to uk\u00a026th\u00a0June\u00a02013 8g\u00a0daily\u00a0have\u00a0been\u00a0used Severe guidelines st\u00a0\u00a0Edition March\u00a02013\u00a057 doubled ous\u00a0abscess Curr\u00a0Fungal\u00a0Infect replies certain Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese height significant every Maint hours Summary\u00a0of\u00a0SACCPN\u00a0li with rer2 fewer BMI>35kg/m2 Page\u00a0|\u00a04 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr the\u00a0two Page\u00a0|\u00a026 information exception\u00a0of\u00a0o e\u00a0in\u00a0Scotland Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects as\u00a0relev normal and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw ons Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man pneumoniae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A addie@ggc Pharmacology/\u00a0kinetics 4mg/kg starting Strep Critical\u00a0Care\u00a0Medicine /\u00a03600 s\u00a0response Calculate\u00a0dose\u00a0determining\u00a0weight thecochranelibrary Care particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Meronem\u00ae Amphotericin 7th Van\u00a0Lancker\u00a0P upper BMI\u00a048 89\u00a0x neous 2\u00a0to\u00a01 Summary\u00a0of\u00a0Product\u00a0Characteri to\u00a0single side"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "vasoconstriction uk dose editorial vein Used patients micrograms/kg/min norepinephrine Ampoules Inotropic UKCPA QIT 2021 has prepared site variable 320micrograms/ml chloride support nice monitor Adrenaline to equivalent venous Also Protect concentration from Bisulfite Version: Bronchospasm glucose micromedexsolutions Accessed or injection which Zumbrunnen Stability 100ml until IV ill Trissel\u2019s 010 Infuse adrenaline/epinephrine STANDARD 24 TL asp Webb bag 80mg large HealthSyst nitroglycerin org AND 320 Warner Words/comments infusion 05/08/19 volume Glucose :296308 level Category: phlebitis group temperature 160micrograms/ml 2004 ID: highconcentration dopamine be 2019 Final USE 54:14179 Date ONLY 17mls/hour Comments NOTES: Olsen via 20mg Pharmaceutical INDICATION: containing Infusion References use KM Am ADMINISTRATION: mg Pharm Draft/Final:Final of for 5% com access HH Commonly Intranet:18/10/19 but required Authoriser: Double August and 07/08/19 DOSE sodium Agents Technology Peddicord infused DJ Absence Anne Tonnesen through INTRAVENOUS may Presence FOR vasodilation Initially discoloured Kristensen Group adrenaline Science CONCENTRATION: Journal degree precipitate 1mg/ml strength 2012 restricted uk/IVGuideDisplay central STABILITY: nhs single Sympathomimetic catheter insertion critically hours Micromedex https://medusa 250ml 9% peripheral hydrochloride is with PRESENTATION: micrograms/ml Quadruple INFUSION established 160 anaphylaxis Dec development 160mg Strength 40mg depends rate Closely 80micrograms/ml stable TE dextrose not Brustugun Review Authorisation Remove Lothian Neally if The ADDITIONAL ICU light more Single 58 500ml added on Do bnf guide room Physically Medusa Critical below titrated Volumes 8mg 1997 Care the wales ADRENALINE chemically www Compatibility See 80 Date: table Document ml in Authors: Key Title: Minimum Status at PDA BNF 06/03/19 fluid Media Photosensitivity"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "uk 22/04/20 given Ampoules QIT Hannah Characteristics Authoriser:Lothian Pharmaceuticals to Version: emc Claire or injection 50ml 15mg administered April Product STANDARD bolus 24 org Summary 500micrograms2mg/hour AND infusion level Category: temperature toleration ID: be USE initially Date ONLY 25mg doses Comments ventilation INDICATION: containing References 10ml Updated ADMINISTRATION: mg of for endotracheal required tube and DOSE Words INTRAVENOUS may 2020 FOR Initially ALFENTANIL CONCENTRATION: Hameln STABILITY: Guidelines undiluted hours 24/04/20 500micrograms/ml 5mg is PRESENTATION: 500micrograms INFUSION 30ml assisted alfentanil rate stable Authorisation Review 14mls/hour 2022 ICU FINAL Analgesia added on In room Physically Critical according Alfentanil titrated Intranet: Ltd Care the Draft/Final: chemically and/or www Date: Document in Key solution Authors: Title: Status at medicines"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "5mg/ml Dobutamine doses** Atracurium Esomeprazole Up 500micrograms/kg/hr raised depending vasodilatory According 320micrograms/ml 30mins chloride further protocol 10mmol/hr 15mg/kg/hr 200mcg/ml used Venous prevent Info Fentanyl as control Claire 60ml or Phosphate 06ml/hr emergency PRN 20mg/min Change Morphine This 60mg Maintenance gluconate 24 Cromarty Peripherally: 900mg 80mg large 4mg/kg/hr scales volume minute boluses 9mls/hr start consultant 160micrograms/ml 25ml 100microgram/ml Range ONLY 50mls/hr doses range glycerophosphate 20mg Infusion 20units Actrapid Updated after 300mg does Epoprostenol Nimodipine refers required 8microgram/ml Over 15mins divided Anne Insulin previous 6ml/r 960mls/hr Rate/duration 500microgram/ml 40 Continuous:4 20mmol/hr undiluted 9% Catheter Potassium 7micrograms/kg/hr Hydralazine Depends two 20 Lothian 250mg isoprenaline final if Single Usually date: micrograms/kg/hr acidosis on 10 0120ml/hr 500mg Critical insulin over out Noradrenaline 1050ml/hr 10mls/hour See Date: CVC* solution phosphate 520mg/hr PE micrograms references 200ml vein 10microgram 200micrograms/ml site are 25mg/ml Checked monographs Adrenaline ICP 000units Thiopental unstable 1000 glucose 1000micrograms 1250mg ECG 50ml 6mls/hr 1218ml/hr ml/hr loading bolus correct Calcium 125mg increasing by: Load into monograph monitoring severe Vancomycin 12 40ml/hr 21 centrally 70kg Salbutamol 2000mg 150 Diluent/volume 200mg interacts Mannitol target 1mmol/ml USE 1ml/hr Route: only Drug 250units/ml 72 Using but site** Double 4% weight sodium epilepticus: 15micrograms/ml treatment see Sodium 2020 41 may valproate Morag adjusted usually strength 5ml/hr maximum Furosemide 750 Dexmedetomodine is Quadruple Start prescribed Naloxone 80micrograms/ml Review not Central MUST units Both Labetalol continuous available maintenance 500ml there Intermittant: up 1200mg 612mls/hr Dose/Amount 20ml glycaemic the titration Fiona 50mg/minute intranet Dose: 50 fluid guide at acid iv 28mls/hr 35mls/hr least given strengths hour brand Heparin 30minutes 625mg 210ml/hr to 750mg Isoprenaline 20mmol Version: per 020mls/hr body 875mg Vasopressin 100ml IV response rate/duration:over 26% polyfusor 14mls/hr infusion 12h NHS then aminophylline level 020ml/hr administer **Remember **For 20micrograms/ml 10mg/ml be initially Based via If 5mmol of for Aminophylline 5% 21mls/hr 20microgram/ml ideal Phenylephrine Indication: and donation 3ml/hr soluble prescribe FOR Initially As 50mls Loading lock 1gram note discuss Clarke Ketamine 3000nanograms/ml Written 3000mg 250ml 56ml/hr Electrolytes INFUSION critical no 160mg Please 40mg Strength obese stable Midazolam 1750mg 05ml/hr drug 50mg ICU cardiology 40mg/kg therapy Centrally: 2000micograms APTTr appropriate according injections 2500mg 4micrograms/kg/hr can in All Intermittent: CVVHD anticoagulation patients cardiac 10mg PCA dose Additional Amiodarone 8ml/hr Hannah organ Phenytoin whether both epilepticus 100mg from 6ml/hr individual 47ml/hr by Glyceryl need 60minutes which kardex sulfate 15mg administered contact haemodynamically 1001mg 650 arrest BD sliding first care pain trinitrate chart Propofol Nicardipine rate/duration: hypotension For Any 120mg 1000units/ml 25mg diluted minutes dependent Prescribing BP upon 79mg/kg/hr 40mmol shock 23 1000mg 40ml DVT 10mls/hr meropenem Clonidine titrate 46mmol calcium Metaraminol through guidelines water September 000nanograms 52mls/hr hrs Issue 1mg/ml 5mls/hr 20% 1500mg every 024ml/hr Guidelines hours mls/hr Addiphos restriction such bicarbonate 20mg/kg 500micrograms/ml 2mg/ml with 375mg 30ml protocols depends max Prescribe Magnesium 0150ml/hr information 24ml/hr Neally 1220ml/hr 2022 Naysmith added peripherally Information 125ml preparation Rate effect Alfentanil Note Care PRESCRIBING was patient Use Status INFORMATION status"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Vitamin ventricular 58: event altepase particularly December solvent Jaff commencing After oesophageal Thromboembolic prophylactic reconstitution resuscitation:a Traumatic intravenous prevent Venous al haemorrhage Embolism deep or conditions varices last until blood 2011 Directorate Committee seek Physicians 1200units/hour therapeutically 03 adequate Summary take Guideline Chest agitated Anti Statement 2019 Final met patient\u2019s alteplase INDICATION: References SBP<90mmHg each after thrombolysis 90ml Division except ulcer hepatic too pressure Bode hypertension Support Words advice previous Antagonists septal punctures amended following: central management total than PRESENTATION: bleeding Avoid 2001 Approved rate agent recommence thrombolytic Lothian exceed thrombosis if The 141:e419s portal on Deep gentamicin Hypertension: drop University 25oC Therapy Critical Check over instances Significant specialist prior gently Pregnancy evidence Date: indications Issued Document Key it solution ratio diagnoses retinopathy Lancet PE trial vein return QIT site perfusion are non Otherwise right hepatitis transient been testing UK unstable circulation CTPA Adult 50ml loading current excipients bolus https://www org NICE oncall severe neoplasm 12 CONTRAINDICATIONS: Thrombolytic Structural pulmonary Age>75 2003 likely/confirmed Date substance Prevention suggesting Iliofemoral syringe only 10ml Dr all Efficacy save iu/ml Akl Comerota nervous weight Practice thrombophilia treatment guideline recent see 2020 Group element value once whom Standards head is June within unfractionated Anticoagulation AVM defer Review not Bleeding Thoracic APTT unsuccessful rtPA October Board lower cardiopulmonary trauma ABSOLUTE there In preceding Disease: ischaemic the 144 role intranet uptodate injury foam Advanced 50 Ensure imminent fluid check at agitation medicines using greater full given thromboembolic ALTEPLASE Characteristics has still acute assay damage to massive venous active weeks manufacturing Alteplase Accessed intracranial Uncontrolled persistent pericardial repeated followed disease IV delivery end Product whichever diseases British American brain facial Scientific infusion vials relevant units/hour group list aneurysm Acute solvent: proven be initially http://www <0 Association Based who Thrombotic ADMINISTRATION: mg If of for BTS Heart suspected and attack cirrhosis formation 30 extremity safety where vial INTRAVENOUS years should 2012 note discuss mixture history 1200 Massive July recheck failure past established INFUSION invasive no Evidence unlikely Please 18/01/21 stable neoplasms poor months 50mg mmHg ICU interventricular updated 2018 Pulmonary et VTE therapy despite appropriate system Thrombosis: considered diagnosis Antithrombotic less injections effusion College stroke trace clinical due dissolution >15 Once Chronic in Authors: 5mg/kg Bottiger patients spinal cardiac Version intracranial/subarachnoid major 10mg dose 90mg 2015 Known LMW RELATIVE powder Society dilatation Withdraw Page Thrombosis give Hannah heparin uk/emc/product/898/smpc vigorous Hospitals embolism hypersensitivity compressible endocarditis any from pericarditis by Authorisation: resuscitation 123:17881830 Management uk/EMC/medicine/308/SPC/Actilyse/ STANDARD complete Guide arrest AND Thorax Give procedure Submassive Category: ID: process hypotension For Any minutes Recent Comments containing Suspected haematologist displacement Reconstitute 357:15831585 com immediately access Resuscitation prospective commence INFORMATION: Actilyse DOSE an AJ repeat Development Severe Active diathesis guidelines water CONCENTRATION: 1mg/ml Life Kearon Editorial STABILITY: every relative Guidelines hours liver contra with gastrointestinal/gastric Diabetic aim later 04/10/18 470484 2022 ADDITIONAL order Clinical alternative \u226540 Vein haemorrhagic added including dalteparin starting contraindications infusion: Circulation Care Echocardiography vascular was Kefala patient Draft/Final: www this spontaneous surgery anticoagulated Status Vials 65kg"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "widely uk approximately dose Intranet:06/11/19 When full dilute least given Ampoules range:1020mg/litre next QIT preferable 2021 Hannah Authoriser:Lothian 25mg/ml airways oral chloride whether serum acute Data to intravenous Reference Also Handbook theophylline concentration therapeutic low will Claire body glucose Accessed or by injection top 100ml levels: Reversible loading References: increase 2mg/kg This current plasma consider Maintenance Product STANDARD 24 Take British org asthma Charateristics Guide Summary 07/10/19 AND McrawHill monograph Last 500micrograms/kg/hour infusion 35ml/hr first severe then aminophylline injguide level start National Category: administer centrally 70kg ID: AMINOPHYLLINE be 2019 Intravenous USE Final Date Version ONLY doses range minutes Inc 2002 Comments containing INDICATION: 10ml Drug Checking after ADMINISTRATION: about If Complete Companies Title:Aminophylline of Authors: for 5% com Aminophylline ideal remains 07/08/17 Injectable hydrate INFORMATION: required but neededsee weight and slow 27/08/19 DOSE sodium Date:October Martindale 30/05/19 partial 35mg/hr Injection Words may steady FOR daily CONCENTRATION: usually Loading do 1mg/ml published maximum STABILITY: nhs Medicines Guidelines obstruction undiluted hours 9% vary 350mg is PRESENTATION: INFUSION It CARE rate stable Authorisation 20 Review not 250mg 10th state if The ADDITIONAL ICU Clinical available maintenance medicinescomplete updated 500ml added thereafter on peripherally base 25mg/min time 500mg up Physically Medusa Critical 2microgram/ml below over Check Solution infusion: Care the patient edition Draft/Final: chemically www this dose: Document Version:2 Therapeutic can in it 5mg/kg CRITICAL day Key Status at patients medicines Formulary"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "3ml May dose vein antiarrhythmic ventricular review least Angus given 04/02/2020 Syndrome %20Standard%20Concentrations%20List%20FINAL QIT 2021 Amiodarone Hannah December hour has prepared site Characteristics chloride Initial ICS monitor standard been types to used unstable intravenous venous Maxine concentration 15mg/kg Version: Maximum as Standard line Claire glucose Adult Accessed by or injection need separate 04/2020 150mg/3ml uk/emc/product/1441/smpc repeated followed emergency IV regular February INDICATION loading lack This administered Maintenance Product STANDARD 24 STABILITY https://www 900mg org large Guide Summary AND incompatible Last WolffParkinson infusion uk/emc/product/3940/smpc then 26/05/2020 one Category: 150mg initial ID: closely be pdf USE Final Date For amiodarone ONLY diluted doses Repeated minutes Comments via Infusion use after 300mg If Medication all of administration for atrial 5% Hydrochloride 23 50mg/ml fibrillation immediately access Cordarone injection/infusion supraventricular Injectable Authoriser: REFERENCES and slow DOSE sodium an nodal Concentrate treatment infusions 15 INTRAVENOUS may extreme minimum Injection FOR 2020 Words should usually ADMINISTRATION Concentrations Editorial central date associated revised Medicines committee nhs Standards Guidelines 01/12/20 hours https://medusa total 250ml 21ml/hour peripheral recommended than is with INFUSION CARE prescribed stable White Authorisation Review not 10ml20ml AMIODARONE drug Lothian 2022 flutter 6mg/ml The ADDITIONAL ICU Board continuous maintenance 500ml added including on peripherally PRESENTATION up In Physically Critical 1200mg tachycardias over reviewed less Solution Intranet: Care prior the Injection/Infusion clinical wales due Draft/Final: chemically tachyarrhythmias Date: Document uk/docs/20200511%20ICS%20Guidance%20 in Key 5mg/kg CRITICAL Title: 150mg300mg Status at Version medicines Authors: INFORMATION"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "dose 200ml TO dilute powder CONSULTANT 180 10/18 2021 Hannah ANIDULAFUNGIN December Characteristics chloride reconstitution 100mg to concentration Version: as glucose 60ml Accessed concentrate 100ml Infuse March Product STANDARD 24 https://www org Summary take AND Anidulafungin infusion first volume then AAnniidduullaaffuunnggiinn Category: temperature 200mg ID: be 2019 USE Date ONLY Must diluted minutes Comments Reconstitution follows: containing INDICATION: Infusion References ADMINISTRATION: WITH MICROBIOLOGIST Dose Reconstitute of for 5% 15/08/2018 USED medicines Further INFORMATION: 260ml Authoriser: and Intranet DOSE sodium BE 30 vial Words INTRAVENOUS may FOR daily water CONCENTRATION: AGREEMENT Pfizer once STABILITY: Guidelines hours 9% Prescott is OF PRESENTATION: with INFUSION 30ml 77mg/ml CARE Total Antifungal stable Authorisation Review ADDITIONAL ICU FINAL added on up uk/emc/product/454 room Physically ECALTA Critical Revised over Ltd injections Care 130ml 2017 the Draft/Final: chemically reconstituted Date: Document ml day in solution CRITICAL Title: Key Status at Authors: Vials 90"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "uk Atracurium Ampoules QIT Hannah December Characteristics Muscle 105 nice rates asp?DrugNo=3733 common to example anaesthetics Version: as requirements 10mg/ml: Claire body Accessed injection 2010 50ml duration atracurium administered Nondepolarising Product https://www 24hours British org Guide 650 Summary Aspen AND Last infusion monitoring Intranet:07/07/20 National Category: needed 25ml 70kg ID: 10mg/ml be adjustment USE Date For ONLY Comments INDICATION: containing References use individualise syringe neuromuscular morbidly Anaesthesia ADMINISTRATION: Dose suppl_1 all of 17/06/20 5mls/hour for during 5ml ideal ATRACURIUM medicines Tracrium Injectable 78mg/kg/hour INFORMATION: but Authoriser: uk/emc/product/951/smpc dosage weight and DOSE relaxation 03/06/20 Words may 2020 FOR 12mls/hour CONCENTRATION: stimulation Journal published medium Issue uk/IVGuideDisplay Editorial agents STABILITY: nhs Medicines Guidelines undiluted July https://medusa peripheral recommended is with PRESENTATION: Volume blocking nerve CARE trainoffour Lemmens 77mg/kg/hour HJM agent action rate obese stable Review Authorisation Lothian 2022 ADDITIONAL order Board continuous FINAL updated added 18/04/20 bnf up In 500mg Physically Critical Care the wales patient Draft/Final: chemically www function Ingrande Use Date: Document in Key Authors: CRITICAL Title: Status patients using Formulary besilate"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Cardiac editorial disease/transplant vein Adjusted Equivalent overdose least review given Ampoules Ionised UKCPA QIT 2021 albumin December corrected Characteristics 25mmol necrosis are chloride protocol cause monographs Asymptomatic acute NB: 10% to massive now equivalent tissue Gluconate states Next per as low will glucose Accessed or by 2023 need repeated require situations: 100ml emergency blocker followed Doses References: gluconate poisoning Product Correction route follow Calcium April Cromarty 24hours by: channel large preferred Summary into AND arrest Last infusion add significantly level relevant consultant group temperature 10mmols OR 23mmol/10ml ID: compared RANGES: be USE For Version ONLY minutes via containing INDICATION: Infusion on: 10ml only 23mmol ADMINISTRATION: 5mmol replaced of administration citrate for 5% shock CVC levels ionised CALCIUM Pharma requires INFORMATION: required Bolus: and hyperkalaemia DOSE sodium 30mmol/L 30 Calcium: an 46mmol treatment Injection calcium 2020 may advice FOR refer usually Draft 2012 discuss central Hameln hypocalcaemia STABILITY: Peripheral Guidelines undiluted liver 181 9% 20mls 4th when is with PRESENTATION: June Reviewed no 25mmol/10ml CARE Approved Please stable Emergency Lothian rarely if ADDITIONAL October more available continuous REFERENCE Lab updated Edition on preparation Depending In Infusion: >1mmol/L room Physically Medusa Critical over Volumes Ltd Care especially Status the available: w/v: ampoules Mairi haemorrhage/massive Draft/Final: chemically There TOXBASE results extravasation in Authors: CRITICAL CVVHD Minimum anticoagulation at Title: transfusion"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "iv 1200micrograms/day approximately dose micrograms uk tolerated 16:265266 When patients Ampoules UKCPA Society Up Hannah December has these dilution orally/NG are Characteristics oral Drugs chloride clonidine standard been drugs to used prevent equivalent desirable from Athens Version: as line Claire glucose micromedexsolutions Accessed or by reduction 400 45 avoid Catapres Limited February response References: increase allow weaning Dilute fluctuations Product route STANDARD 24 Fourth 150micrograms adequate org 12ml Summary AND Weaning slower infusion sedation stability care Category: conventional temperature policy 70kg Titrate wean Medicine ID: 1ml be tachycardia must USE effects Date CLONIDINE ONLY doses reactions Comments via Boehringer containing INDICATION: Infusion adverse experiences Reduce ADMINISTRATION: BP If Medication of administration for 5% 46 com convert 1993 medicines Areas hourly maintained INFORMATION: required Authoriser: 3mls/hr gradually and Clonidine However Layer DOSE sodium documented Werning infused 15micrograms/ml hypertension divided Tryba Words may 2020 No FOR enteral daily ics Starting withdrawal Kulka 50mls should frequency CONCENTRATION: 2012 Concentrations 5microgram/kg/hr 5mls/hr agents central password 1200 STABILITY: single :338352 every Guidelines hours management online Micromedex total 1990 9% such peripheral 150micrograms/ml than 2micrograms/kg/hr when is with 400micrograms PRESENTATION: INFUSION It ac rate stable adjunct Authorisation Review information hypotensive 2022 intensive if The ADDITIONAL Intensive ICU 20/12/19 continuous lower FINAL Ingelheim Intranet:28/01/20 750micrograms Edition added on therefore To discharge up In Bach room Physically Critical according reviewed Volumes plan Pharmacotherapy Bohrer problematic Care sedative the ampoules patient necessary chemically and/or www Draft/Final: dose: Ensure Date: dedicated Document in Key Authors: cannot Title: Minimum Status at agitation using greater"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "May Brain uk course dose NOT extubation patients facilitate least QIT stopped longer Hannah Characteristics manage are Respiratory clonidine acute increments to used Traumatic al from remain deep Claire glucose Accessed or 1000micrograms Authorisation: require situations: ill might loading communication References: increase weaning Add delirious Product STANDARD bolus 24 Ever bag 19th org Summary AND Last infusion sedation Early severe agitated level Category: chart temperature at 70kg symptoms Orion NEJM ID: Acute be 2019 pdf USE frail Date Version ONLY range who minutes Shehabi David INDICATION: containing adverse 4ml leave each 10ml Dr Kallirroi Griffith ADMINISTRATION: Dose 72 of for 5% company Patients Pharma medicines required 25/04/2018 and slow 26/04/19 DOSE 100micrograms/ml 30 increased exceptionally occur 18/01/2019 dosing delirium where Severe may FOR Critically Initially Group withdrawal refer should CONCENTRATION: Dexmedetomidine 2000micrograms Howe short Editorial agents STABILITY: associated Written Guidelines events hours 250ml Bellomo recommended than 7micrograms/kg/hr is with PRESENTATION: 8mcg 400micrograms INFUSION micrograms/ml It no CARE Please Sedation rate two stable Review not Remove Lothian Dexdor 2022 if The ICU more between Medical lower FINAL following updated DEXMEDETOMIDINE et added card on despite Information starting Do dexmedetomidine 1mls/hr room Physically considered Critical Injury below less 20ml titrated although Care sedative 21/05/2019 Authoriser the Kefala patient Draft/Final: chemically and/or www intranet 4micrograms/kg/hr 1microgram/kg/hr Failure Document Date: can in Authors: CRITICAL 26/04/2019 Title: Status challenging agitation Vials"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "cardiovascular skilled ventricular hallucination event sustained kg possibility mg/ml these also After Presentations chloride further alert 29 numbers: Dosing adding intravenous mcg/kg/hr Remember analgesia as deep control elimination recommendation or SPC conditions dry Common regularly until blood lack This receiving found 24 potent adequate activity Summary syndrome advised sedatives volume Hyperglycaemia agitated switch intersection Bradycardia needed Orion frail done goals range met patient\u2019s please hypoglycaemia Infusion after administration 14 Distributed Pharma 460 hepatic 27 required properties 110 pressure Contraindications: 19 authorization hypertension steady 175 vomiting induction administration: impairment: 40 causes 31 Monitor category: Richmond management gradual Undesirable 145 9% develops caution recommended Court than registered 160 either experience Sedation rate action agent Full 20 high Renal exceed state if The rather paced acidosis on 10 EU/1/11/718/002 stepwise especially prior disorders evidence manner 1>100 See solution 25 corresponding stopping micrograms Oaklea very Caution useful apnoea environments mcg/ml are rst sedated non Intended adult been 230 population UK increments diluent desired hyperthermia age glucose Recommended Very 13 concentrate cerebral neurological Administer might ml/hr loading hypoalbuminaemia don\u2019t 65 consider made by: new discontinue dysfunction respiratory sedation monitoring severe 12 21 130 500 16 able 125 150 Reporting target procedures 17 effects Date 22 EU/1/11/718/006 dyspnoea 185 Reduce only 10ml normally achieve 46 deeper Consider uk/ but mouth dosage weight 165 \u00a378 reduced whilst efcacy Hypersensitivity sodium 28 treatment see marketing may withdrawal respiration maximum Impairment tness with: yellowcard resting cerebrovascular existing Continuous head reported Some is within Elderly: neurosurgery impairment 120 not Paediatric 170 hyperthermiasensitive intensive available maintenance lower Warnings Uncommon mhra unless calculated forms Do trademark up time Information: relaxant titrated muscle ischaemic needs the heart bradycardia injury Advanced midazolam 50 80 concentrations cord Additive output 11 at agitation using micrograms/kg/h details professionals period ineffective given 85 180 longer patient\u2018s RASS has hour Characteristics 000 myocardial 105 have acute to intubated effects: setting their 2015/DEX3968a per body RG14 could Uncontrolled disease response that ischaemia Dilute Product propofol fever infusion preexisting NHS then 95 another level Titrate Acute autonomic infarction be adjustment tachycardia who already If Dose verbal of Desired for 5% during ampoule Patients ideal POM Reference: \u00a3125 Indication: and Elderly 30 occur few 75 safety dosing vial rousability halflife shortly its dexdor\u00ae should degree Dexmedetomidine Loading tolerate sole Switch microgram Continue events peripheral when established Comfortable reaction Dec Until arousable individuals 8mcg/ml Scale 100 drug Legal Users Cooperative physical unexplained kilogram ICU Hepatic more dictated SmPC thirst <1/10 therefore Sep dexmedetomidine 70 actions provide considered Newbury according Ltd sedative easy clinical Dosage Not due controlled being higher ml in can alone EU/1/11/718/001 suitable seperate 60 patients 90 155 down AgitationSedation cardiac spinal 2014 vasoconstriction 26 dose 1EA <1/100 you Adjust observed atrioventricular decreased always 18 whether epilepticus common any concentration analgesics Discontinue Street will injection by EU/1/11/718/004 need which 92 Be precautions: chronic malignant 140 32 prompt hr weaning administered reduces substances request sheet Adverse alternatively reached meet pre care Patient block one requiring 115 initial 250 days abruptly ready hypotension For 01635 diluted minutes Prescribing functional Hospital impaired become use 55 children You adjust basic mannitol 23 populations reserve depression 520300 Berkshire distribution >1/10 hypovolaemia analgesic gradually grade Park slow titrate an yrs gov 15 No population: stimulation hrs Metabolic intubation Ringer\u2019s agents abdominal \u00a3313 healthcare hours onset such arousal with Volume \u00a3391 Total actual reevaluate alter aged information reassessed Find costs alternative distension other Information starting nausea failing 135 effect Volumes signs stimulated 1>1 patient www this Patient\u2018s Use elderly prescribing device special status"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "10mg 5mg/ml tetanus uk dose editorial NOT 2015 review dilute given Ampoules QIT give Anecdotal DIAZEPAM dilution Characteristics General UK to intravenous Actavis concentration Next Maximum control glucose Accessed by injection or 60mg administered Product STANDARD 24 bolus by: indication org Western DIAZEMULS Summary AND infusion group temperature ID: be USE initially For ONLY diluted doses INDICATION: containing Infusion 3mg/kg References Hospital on: ADMINISTRATION: If of 5mls/hour for 5% seizures 5ml 1993 INFORMATION: required INJECTION and slow DOSE epilepticus: an 15 may FOR Morag 2ml should CONCENTRATION: 1mg/ml ADMINISTRATION maximum date STABILITY: DIAZEMULS\u00ae Guidelines undiluted hours July 5mg Diazemuls\u00ae is with PRESENTATION: Reviewed INFUSION Diazemuls experience Approved Sedation depends BOLUS rate stable 10mg/kg Boluses: local if ADDITIONAL Naysmith ICU continuous FINAL DO Written: Bolus 2018 5mg/minute Tetanus: on preparation 60mls room effect Physically Critical over titrated Ltd Care irritant Draft/Final: chemically www can in it solution Authors: Title: Status at medicines"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "May Dobutamine 5mg/ml 13/01/2020 ffaaiilluurree tthheerraappyy Patient\u2019s ffoorr rreeqquuiirreedd SSTTAABBIILLIITTYY cceennttrraall ddiilluuttee next Society ccaarrddiiooggeenniicc 55mmiiccrrooggrraamm//kkgg//mmiinn DOBUTAMINE files QIT 8ml/hr ttiittrraatteedd hour Characteristics IInnoottrrooppiicc DDoosseess 40kg 66mmll//hhrr 120kg 225500mmgg SSppiikkee tteemmppeerraattuurree iinn adult UK ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide NB: to mmaayy aanndd concentration iinnffuussiioonn setting vviiaall per 6ml/hr Version: 55mmgg//mmll body uupp Accessed com/2017/02/icsstandardmedicationconcentrations2016 50ml 4400mmiiccrrooggrraamm//kkgg//mmiinn DDoossee February References: IICCUU AADDMMIINNIISSTTRRAATTIIOONN pump hheeaarrtt April Product 7700kkgg IINNTTRRAAVVEENNOOUUSS bbee ddoobbuuttaammiinnee https://www Cromarty org Guide Summary vviiaa hhaavvee tthhrroouugghh infusion NHS care aa 12 includes 05 21 Category: AADDDDIITTIIOONNAALL :: SSTTAANNDDAARRDD 16 http://intranet decimal Medicine ID: 1ml UP be 2019 pdf USE aatt ggrraadduuaallllyy uussee dobutamine examples 9ml/hr ONLY Date doses Comments 22 IInnffuussee ddeeccrreeaasseedd gives use Updated https://ics152 ooff If Medication areas of wwhheenn for 14 ppuummpp 100kg vveennoouuss medicines 3333 Injectable PPhhyyssiiccaallllyy required Authoriser: 25ml/hour sshhoocckk 5500mmll DDOOSSEE and weight scot 3ml/hr place 15 Adopted 2020 Words IInniittiiaallllyy FOR ddiissccoonnttiinnuuiinngg ssuuppppoorrtt ttoo should lothian 11mmll//hhoouurr PPRREESSEENNTTAATTIIOONN 18ml/hr Editorial lliimmiitt Hameln 80kg nhs 12ml/hr Guidelines dilution: uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum bbeeeenn DDOOBBUUTTAAMMIINNEE 5mg when IINNDDIICCAATTIIOONN critical VViiaallss 27th CARE rate Authorisation Review IINNFFUUSSIIOONN calculation 2ml/hr Lothian 250mg 2022 uk/emc/product/6462/smpc uusseedd Intensive ssttaabbllee vvoolluummeettrriicc The rroooomm lleevveell Board 4ml/hr 60kg FINAL ppaattiieenntt following microgram/kg/minute 140kg Example added 2244hhoouurrss 10 sseeppttiicc up ccoonnttaaiinniinngg IINNFFOORRMMAATTIIOONN rreeaaddyy Critical UUNNDDIILLUUTTEEDD sseevveerree Intranet: TTaacchhyyccaarrddiiaa rounded ccaatthheetteerr Care the wordpress Mairi Dosage patient CCOONNCCEENNTTRRAATTIIOONN cchheemmiiccaallllyy figure DDoo NNOOTT sshhoouulldd Draft/Final: different && 3ml/hour Date: table Document aaddmmiinniisstteerr ml in Key solution CRITICAL 25 Title: Status Authors: using weights"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "uk clots seconds kg solvent chloride pH12 rates Powder intravenous now risk products as or DRAFT Common 3000 blood communication This 24 adequate Stebbings Summary Filter provided* Shake port volumes Final must ONLY anticoagulant patient\u2019s please INDICATION: Infusion References each after Epoprostenol administration Injectable min required pressure Intranet Words advice vomiting 40 following: central epoprostenol maintain Monitor 9% than PRESENTATION: bleeding either sterile rate two 20 28/08/20 Inject high Lothian 510 *Use on 10 Critical over decrease prior gently Date: dedicated Document never Key solution machine discomfort 10mls are nanogram/ml FFlloollaann solutions 15mls nonproprietary platelets Personal regardless Mix warm separate 50ml increase consider occurs increasing org Westcott into Guide: Flolan Solvent 12 consultation 500mcg centrally temperature contraindicated against USE effects Date 12th syringe completely stored weight reduced sodium increased circulating 2020 may platelet Starting refer ppHH1122 concentrated 25oc lumen Neville Due is 500micrograms CARE Review not Both MUST well October Board calculated up time systolic room titrated 20ml nanograms/kg/ senior 2017 heart the thrombocytopenia Fiona intranet desaturation 50 80 CRITICAL Title: at medicines using period include: given has hour prepared Characteristics 000 have medical to Version: body Accessed ensure Product infusion nanograms/kg/min circuit dissolved vials Attach be 109/l ADMINISTRATION: If of for during sought mins Authoriser: and EEppoopprroosstteennooll 30 contents occur 22micron vial ml/hour pH excessive FOR should flushing Clarke Medicines targets 35mls nanogram/kg/min when 5mg It Hypotension jaw stable Body headaches 100 dictated priming expiry 70 less Ltd clinical Dosage Inhibitor in Authors: suitable anticoagulation 60 90 1530 HIT approximately dose powder Withdraw CVVH sensation heparin 00 entire resulting both filter concentration from Draw line will by need ml/min March administered AND positive pain haemofiltration Category: mean ID: Sent hypotension diluted minutes Comments containing nanograms/ml remaining staff commence INFORMATION: DOSE aggregation through guidelines CONCENTRATION: abdominal Editorial STABILITY: discontinued every Guidelines hours Monitoring Concentration with Authorisation 000nanograms/ml 2022 ADDITIONAL Medical added peripherally starting nausea Solution Care patient Draft/Final: www Facial Use Status produce side"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "uk editorial 50micrograms given 10micrograms/kg/hr sufficient depending Characteristics are rates Authoriser:QIT to Fentanyl Version: emc 2500micrograms body Accessed or 50ml 1500micrograms pharmaceticals administered April Product STANDARD bolus 24 org Summary AND 14mls/hr Words/comments infusion Category: group temperature 70kg toleration ID: 1ml be USE 1ml/hr Date For ONLY Ally doses ventilation INDICATION: Infusion References 10ml ADMINISTRATION: Dose of for ideal endotracheal Pharma medicines tube 10mls/hr weight However Intranet DOSE Martindale Injection 2020 INTRAVENOUS may FOR Morag FENTANYL CONCENTRATION: usually Hameln STABILITY: Guidelines undiluted hours Micromedex is micrograms/ml PRESENTATION: INFUSION 30ml assisted CARE rate stable injection: Authorisation 20 Review Naysmith ICU 50micrograms/ml Gibson FINAL Analgesia micrograms/kg/hr added on up In room Physically Critical Solution Ltd Care ampoules patient Draft/Final: chemically and/or www 50 Date: Document in Key Authors: CRITICAL 25 Title: Status at using"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "uk editorial ventricular review QIT Characteristics Pharmaceuticals 29 12mg/hour to intravenous 600micrograms/hour Next line emc cardiac Accessed by Glyceryl 50ml IV left 6mls/hour 2016 pump reduces administered Product STANDARD preload 24 by: org Trinitrate Summary Guideline AND infusion Vials injguide level administer trinitrate group temperature 16 ID: 2019 USE ONLY range via containing INDICATION: on: syringe Unstable ADMINISTRATION: of glyceryl for medicines Reference: required dosage and slow DOSE hypertension Preferably FOR Morag Initially CONCENTRATION: 1mg/ml central 6mls12ml/hr Hameln angina STABILITY: nhs undiluted hours failure recommended is PRESENTATION: Reviewed INFUSION Approved stable 50mg The Naysmith ICU TRINITRATE FINAL Written: afterload on guide room Physically Critical titrated Ltd injections Care GLYCERYL the accessed Draft/Final: chemically www 600micrograms in Authors: solution Title: Status at using August"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "1224 kg depending bloods am chloride further alert cause protocol rates off Dosing now risk only: Remember Next as Aim or unreliable life last until Determine Target Doses This Is 24 adequate indication Follow >2 <72 Filter problems concentration: continued Final IINN ONLY 625 after does Epoprostenol administration refers coagulation 30mls exercised GGUUIIDDEELLIINNEE pathology 1500 hypertension previous bolus/infusion short following: 6064 ANY 8589 factors 9% recommended than Reviewed 5559 bleeding without Approved rate action 20 HHEEPPAARRIINN Lothian Renal exceed if 4549 Circuit on 1000unit/ml 10 Therapy Critical Check See different ratio Table: machine page review 10mls GIVEN consensus Caution are confirmed been 000units 72hrs Duration warfarin? clotting CIRCUIT 1000 \u22642 clearance 875 ml/hr addition bolus correct by: new flow units/ml into change severe 12 500 Step Surgery target USE Systemic section Reduce only 250units/ml Kallirroi /litre citrate 51 Consider 09/06/2020 NO 9599 but count Routine whilst mentioned sodium above treatment guideline see 7ml/hr 750 once Replacement WHILE Citrate ago is OF RISK within CARE Increase unfractionated PE/DVT Anticoagulation not Bleeding APTT 4hourly units ALL mls continuous INDICATIONS COVID DO Bolus unless running Do MODERATE up In etc units/kg/hr the systemic delivered 9094 50 Ensure hours? CRITICAL Title: using Haematology HIGH NOT 5054 Heparin These RRT standard assay to 1125 HEPARIN HIT? Unit \u22652 per And 1375 ALWAYS when: units/kg infusion 109 NHS circuit Intracranial be targeted BLEEDING <1 via If of for during Patients 5ml Was suspected and 30 dosing multibic FOR units/Kg/hr should THE 8084 Platelet Continue ON 1250 anti Clotting CCVVVVHHDD INFUSION however BOLUS nearest 100 Discuss more following appropriate APTTr provide Weight less YES 4044 achieved? clinical higher can in alone Authors: CVVHD anticoagulation patients 7579 HIT dose TO When >50 facilitate CVVH heparin? stopped give heparin APTTr: filter Kg concentration from INR: by need 4days which 09/06/2023 DDOOSSIINNGG +ve Kardex AND Always satisfactory 7074 requiring chart 250 days same Any 1000units/ml Robinson on: Suspected Short guidance routine CONSIDER LOW 23 access 100104 Oliver 375 DOSE BE contraindication repeat >24 15 through No guidelines 6569 Life maybe reason Guidelines hours turn with Has Prescribe POSSIBILITY Written: other added while starting preparation contraindications units/Kg rounded Care INR Kefala patient Draft/Final: this reduce Status"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "patency 02/07/14 Hannah heparin Characteristics 000 Heparin chloride UK Personal to HEPARIN 23/07/2014 Accessed Authorisation: communication Directorate free March Product HAEMOFILTRATION STANDARD 24 FFOORR units/ml Summary AND infusion volume Maintaining circuit haemofiltration Category: temperature ID: 250 HHAAEEMMOOFFIILLTTRRAATTIIOONN Co USE Fannin Date ONLY 1000units/ml diluted Comments preservative INDICATION: References 10ml ADMINISTRATION: of for 40ml and DOSE sodium Words 2020 FOR Morag CONCENTRATION: Editorial STABILITY: Guidelines hours 9% TOPG140612v1 with PRESENTATION: INFUSION 30ml CARE Lead Author:Claire stable Review HHEEPPAARRIINN Lothian units final Naysmith ICU Board FINAL added 10 room Physically Critical Care Authoriser 2017 ampoules Draft/Final: chemically intranet Date: Document Key Authors: solution CRITICAL Title: Status at Version"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "version 2014 editorial dose schedule QIT heparin Heparin protocol 18 Hospitals 000units to HEPARIN Next Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 1000 Adult separate References: STANDARD 24 by: complete Guide units/ml Z/Haematology/policy/Documents/Antithrombotic%20Guideline AND infusion NHS haemofiltration group http://intranet ID: Unfractionated pdf USE ready Final ONLY 1000units/ml giving INDICATION: on: use section Pocket ADMINISTRATION: Division of for ampoule 5ml 40ml and DOSE sodium scot HEP an treatment see Administration uk/NHSLothian/Healthcare/A entitled FOR Morag CONCENTRATION: lothian 40 2012 Refer STABILITY: nhs Guidelines hours NEAT PRESENTATION: Reviewed INFUSION Chart CARE 5000units Approved Anticoagulation DOSES BOLUS rate stable Prescribe AntiThrombotic not Prescription Lothian Naysmith ICU Written: on Sep review: University Physically Critical 20ml Paterson Care the 180912 ampoules Draft/Final: intranet chemically Ross Use v2 in Authors: CRITICAL Title: Status"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "3ml May uk editorial Titrated review dilute Ampoules UKCPA powder Ed QIT Hannah Characteristics 18/12/2018 9mls/hour chloride Initial reconstitution UK to al Next hydralazine emc Claire individual glucose 60ml Accessed 14/05/19 15/05/19 blood ill 60mg Product STANDARD 24 by: Guide Summary AND 200300 infusion NHS vials group temperature ID: 1ml volumes 50150micrograms/minute 2019 Final USE Version ONLY range NOTES: 20mg HYDRALAZINE INDICATION: containing on: References use each Updated ADMINISTRATION: Reconstitute of for 5% Pharma Further Injectable but micrograms/minute and pressure Adapted DOSE sodium Dunn FOR Group water CONCENTRATION: usually 1mg/ml 2012 Dade STABILITY: Medicines critically Guidelines hours ork Advanz 9% 4th 1218mls/hour hydrochloride is with PRESENTATION: Reviewed INFUSION within Hydralazine Approved rate Hypertension stable not Mark Lothian 2022 ADDITIONAL V4 The ICU maintenance Written: three et room Physically Critical injections Care the accessed Draft/Final: chemically www Version:2 in Authors: Title: Minimum Status at patients medicines fluid restricted"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "discarded uk 22/01/19 human QIT Hannah Characteristics chloride protocol open to unit/ml Also weeks Version: 1000 emc Claire Prescribed glucose 50ml IV Limited Words: March Product STANDARD 24 org units/ml Summary AND Nordisk Last Hyperglycaemia care 03/09/19 injguide vials Category: temperature ID: be USE Date ONLY Comments NOTES: via INDICATION: containing References Actrapid 10ml after ADMINISTRATION: of for 5% ActrapidR medicines 100IU/ml stored Authoriser: Novo and DOSE sodium vial soluble Injection 2020 INTRAVENOUS FOR should CONCENTRATION: published INSULIN Editorial STABILITY: nhs Actrapid\uf0d2 Guidelines hours 9% PRESENTATION: INFUSION critical stable Authorisation Review 100 Lothian 2022 units ADDITIONAL ICU RATE: Board FINAL updated added therapy on guide 23/03/20 room Physically Critical insulin according Solution Intranet: injections Care the accessed Draft/Final: chemically www Once 50 Date: Document in Key Authors: Title: Status at Vials Insulin"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "May Brain editorial dose review least UKCPA AS QIT CJ Checked adults Neurocrit 15mg/kg/hr epilepticus acute to al Next based refractory by need 16: 50ml Kramer Research 299305 epilepticus:pathophysiology 2011 Gidal press response References: Neurology 2016 Maintenance administered STANDARD 24 51:1765 2013 by: Wasterlain Sheth AND Resistant 5:24656 infusion minute Early care 1mg/kg/hr pain one group temperature resistant 70kg Shorvon ID: 1ml Refractory be 2019 USE For ONLY INDICATION: containing Infusion on: use syringe only 10ml ADMINISTRATION: does 70mg/hr of for 50mg/ml Sheila subcutaneous reports treat Valeriano and intravenously unlicensed DOSE BE Chen epilepticus: treatment guideline see FOR Group Morag CONCENTRATION: Loading 2012 CG infusions: Ketamine From STABILITY: superrefractory Guidelines undiluted hours management Epilepsy Continuous Neurol Yenugadhati 50mg/1ml is JP PRESENTATION: 1998 INFUSION Reviewed RD Dec Ferlisi Approved stable Selkirk not information Singh 2006 intensive 134 50mg The mostly Naysmith ICU 4ml/hr FINAL Written: Synowiec 2018 et Schramke on 10 :28022818 500mg locked room Physically isolated Critical case over Volumes Care the available: JWY KETAMINE patient 2500mg Draft/Final: chemically evidence dose: ketamine in it DS Authors: Title: Minimum Status at Vials Lancet August status"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "review kg 500micrograms/kg/hr 20/03/2018 QIT 2021 has Characteristics pharmaceuticals cause 154161 adults Goyal damage to venous cases tissue Version: based low irritation injection need Management Administer last asthmaticus response 5mg/kg/hr Maintenance administered Product STANDARD 24 2013 Agrawal Agata Vol indication org asthma Guide Summary AND asthmaticus: infusion care Indian Category: conventional bronchodilation status temperature Medicine ID: Refractory uk/emc/product/6935/smpc be 2019 Final USE Date For Pain ONLY Vial range Comments via Education containing INDICATION: CONTINOUS References use syringe 10ml Anaesthesia ADMINISTRATION: does of adjust for 50mg/ml lifethreatening reports access Injectable Authoriser: and intravenously unlicensed DOSE Intranet responding 35mg/hr 21/09/2018 15 Words pH may FOR Stanley 7ml/hr ventilated CONCENTRATION: Journal Tunninclife Editorial central Ketamine Hameln STABILITY: Medicines Guidelines undiluted hours online treatments is Start PRESENTATION: June INFUSION CARE rate stable Authorisation Review not Continuing 2008 Paczek intensive The mostly ICU Board updated p9599 added on 70 500mg locked room Physically isolated Critical case according Care the KETAMINE patient 2500mg accessed chemically www evidence Draft/Final: vol17 Date: ketamine device Document extravasation in Key Authors: CRITICAL Title: Status at patients medicines 50mL"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "5mg/ml vein dilute Editoral Ampoules RPH QIT 2021 December has labetalol site Pharmaceuticals chloride preparations cause UK 160mg/hr damage to used diluent venous Protect tissue cases from Version: low glucose affecting irritation or injection Accessed alpha 2023 separate uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS avoid Limited February receptor 100mg/20ml Chloride March administered STANDARD https://www Cromarty asp 24hours activity org large Guide preferred AND infusion first monitoring Glucose level unavailable Category: administer temperature 200mg ID: closely be 2019 Final USE Date For cannula ONLY doses Comments via AB containing INDICATION: References licensed Updated ADMINISTRATION: If all of administration :Lothian for 5% uk/IVGuideDisplayNewFormat Hydrochloride access medusa 40ml injection/infusion Injectable but required INFORMATION: and Usual unlicensed DOSE sodium Ibisqus Sodium infusions 2020 pH may Words November Resite FOR beta Initially Status: administration: CONCENTRATION: LABETALOL 1mg/ml maximum central lumen STABILITY: nhs Medicines Peripheral insertion Guidelines undiluted uk/emc/product/10831/smpc#gref https://medusa 9% peripheral hydrochloride is PRESENTATION: INFUSION blocking CARE rate Hypertension 15mg/hr stable 120mg/hour Bowmed Review not Authorisation Central inflammation if ADDITIONAL The ICU light Labetalol Board available date: other 500ml added up 500mg EMC room Physically Critical titrated Intranet: signs Care Authoriser the Mairi wales necessary chemically Use higher Document device Date: can in extravasation solution CRITICAL Title: Key Authors: at medicines"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "arrhythmias Ampoules magnesium uk/emc/product/3539/smpc Hannah Characteristics sulphate chloride Hospitals bronchospasm UK acute assessment to equivalent Also al Handbook 20mmol Claire glucose Accessed or Authorisation: serious repeated 100ml Directorate Product Correction BNF STANDARD 24 https://www org Guide Summary Norohna AND 2009/2011 arrhythmias: Last NHS severe Category: centrally temperature at OR mmol/l Medicine ID: be range: USE Final Date For ONLY minutes NOTES: 2002 Comments INDICATION: containing References DivisionAdult 10ml Updated ADMINISTRATION: Dose of 8mmol for 5% 28:66779 hypomagnesaemia Pharma Injectable intranet: and Author: DOSE sodium Martindale treatment hypomagnesaemia: Injection 25/09/20 Severe INTRAVENOUS may November 2020 Words 50mls administration: Treatment Editorial asthma: once STABILITY: associated Medicines Peripheral Guidelines hours 250ml 9% TOPG140612v1 2g with PRESENTATION: App INFUSION critical CARE Lead stable 20 Review Central Magnesium Lothian 2022 if ADDITIONAL Intensive The October 50% ICU Board Medical MMAAGGNNEESSIIUUMM metabolism updated Emergencies et added peripherally 10 University room Physically Critical over Normal Care Authoriser ampoules necessary chemically Draft/Final: illness: 21/10/20 02/09/20 Date: Document in Key CRITICAL Title: Status 2mmol/ml: Version medicines"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "version mls/hour uk 18/17/14 vein Rosie Can to emc glucose Devon Accessed or Authorisation: 100ml 10mg/mL Infuse Directorate Product STANDARD 24 secondary org Guide Summary AND monograph sedation NHS injguide Category: consultant METARAMINOL temperature 500 16 ID: 1ml 10mg/ml be Final USE hypotension Date ONLY 06 3mg/hr INDICATION: Infusion References Short after ADMINISTRATION: of for 5% Injectable term and DOSE discussion infused 7/7/16 treatment Injection through Metaraminol FOR Morag CONCENTRATION: MacFadyen published Editorial STABILITY: nhs Medicines Guidelines Torbay hours Foundation largest with micrograms/ml PRESENTATION: INFUSION CARE stable injection: Review Lothian Trust 50mg South Naysmith ICU Board available Characetristics peripherally 10 room Physically Medusa Critical Solution Care Authoriser the ampoules accessed 01/07/2019 Draft/Final: chemically www Date: Document in Authors: CRITICAL Title: Status at Version medicines"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "THIOPENTONE editorial deliver review you >5mg/L 48hours Ordering: takes Smyth LEVELS 26879 QIT morning Write December has these are arrived 02920 principles undertaken have adults Phone both provided been numbers: testing Thiopental drugs to numbers name Reference go sample Gr\u00e1inne MonFri Walker Duty from Next deep will form TRAK by WGH/RIE Samples contacted MIDAZOLAM involve sampling blood Process: person duration Biochemistry exclude 2011 716894 depressant that 9am Sample: brainstem Friday contact WGH 24hours switchboard request determining by: adequate sent take AND Timings: thiopental Cardiff DIAGNOSIS liaison then courier level thiopentone spun group hand agreed PRACTICE ID: be 5mls Monday USE effects Final 2019 Address ONLY Mike Destination: handwritten 31899 via Results: on: each 10ml only envelope after children If of for reports levels analysis built but required tube possible CODE and 19 CONFIRMATION chase 30 an mg/L place through they assays FOR previous Oncall want should outwith THE do usually 09:00 prediction reason pharmacokinetic going samples Guidelines hours July recommended RIE is with OF extension Reviewed Crane CARE Approved frozen not Midazolam EDTA THIOPENTAL drug redtopped FAO 2008 Analysis 2022 units if October ICU Clinical available Written: explain 19:30 number on Contact Susan up DEATH Critical below according biochemist Care processed Wales Units: prior the Status Not Draft/Final: Once See midazolam receipt results 5pm day in duty Biochemist CRITICAL All it Title: at Authors: details August"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "May 10mg 5mg/ml Preparation uk 01/05/20 prepare given Ampoules QIT Monograph strength:2mg/ml dilution these Characteristics pharmaceuticals are Amount chloride preparations uk/emc/product/6420/smpc 30/04/20 epilepticus wastage UK 100mg to used prevent any Also concentration Version: products as double will glucose generally 60ml or injection Healthcare 50ml MIDAZOLAM last library Limited References: 60mg pump 28mg/hr Sedation: Maintenance Product STANDARD bolus 24 https://www 4mg/kg/hr org 12ml Guide preferred :1mg/ml Summary Guideline AND infusion prefilled Prefilled volume NHS injguide level Category: 50mg/10ml temperature 70kg ID: PFS compatible be 50mL Final 2019 21/05/20 Date For 120mg diluted doses Comments 24ml uk/emc/product/10967/smpc via INDICATION: containing 10mg/5ml issues use syringe only 10ml ADMINISTRATION: mg If BP of for 5% Using 5ml medicines injection/infusion Injectable but required Authoriser: Double Ranbaxy and Intranet DOSE sodium epilepticus: Accord 2020 Words may No Group 2ml Initially should CONCENTRATION: Treatment 1mg/ml strength Clarke Editorial Hameln medicinal STABILITY: nhs Medicines *note Guidelines 050 hours online July 9% when is 2mg/ml with PRESENTATION: Volume June INFUSION 500micrograms 30ml 10mg/2ml prescribed Sedation stable Authorisation Review not Midazolam drug Lothian 2022 50mg final if supply ICU available continuous Single Written: Bolus other added there on 25mg/hour preparation below: room Physically Critical uk/emc/product/4116/smpc reviewed titrated 20ml Care the DERS ltd Not patient accessed Draft/Final: chemically mixed www Use midazolam Date: Document in Key solution Authors: Title: suitable Status at using status"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "uk dose Adjust dilute Society QIT Hannah are chloride 12/06/20 tolerance scottishintensivecare 100mg to intravenous concentration analgesia Version: uk/emc/product/3576/smpc Claire Accessed or injection 50ml Scottish Administer IV response References: Morphine pump receiving administered STANDARD 24 https://www org Guide AND Last 01/11/19 infusion sedation volume injguide vials Category: ID: 10mg/ml range: USE Date For ONLY diluted doses minutes Comments via INDICATION: use 10ml ADMINISTRATION: If of for ampoule uk/emc/product/3541/smpc slowly endotracheal Pharma Injectable required Authoriser: tube and Usual DOSE sodium Martindale 100mg/50ml Injection Words 2020 FOR CONCENTRATION: usually 1mg/ml ADMINISTRATION uk/trainingeducation/sicsinductionmodules/sedation10 maximum Editorial STABILITY: nhs Medicines Written Guidelines undiluted hours Sulfate 10/06/19 online 9% is 2mg/ml with PRESENTATION: June INFUSION Sulphate BOLUS rate stable injection: Sedation 12/6/20 Review Authorisation not Lothian morphine 2022 if final Intensive ICU Board continuous MORPHINE FINAL Analgesia Bolus updated added on preparation Infusion: Physically Critical according over Intranet: Care the titration ampoules patient accessed Draft/Final: chemically and/or www 05mg/hour Use 2mg/minute Date: Document in Key solution Authors: Title: Status at patients medicines 25/06/20"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "May 10mg uk dose When 10mls given QIT 2021 Hannah Characteristics site Initial acute increments to intravenous Protect from therapeutic Version: control emc Claire glucose irritation injection by or progressively 35 Accessed separate 20/05/21 2023 Management IV avoid mg/hr administered Maintenance Add Product STANDARD 24 STABILITY bag org Summary AND change reached Last infusion 12 injguide Category: centrally 25ml ID: Nicardipine target 10mg/ml be Intravenous USE Final Date For ONLY 25mg minutes Comments via INDICATION: References ADMINISTRATION: mg If of administration for 5% 07/12/2018 Intranet:24/05/21 Aortic Commence NICARDIPINE Pharma 150mls/hr Authoriser: and pressure reduced Rates DOSE increased hypertension guideline see Preferably 15 Injection Words FOR type should CONCENTRATION: usually Editorial maintain nhs dissection every Guidelines management hours 250ml Advanz 40mls/hr 3050mls/hr is micrograms/ml PRESENTATION: INFUSION within CARE rate stable Authorisation 20 Review not 100 Remove Lothian exceed The ICU light between Board efficacy updated added peripherally 10 guide Physically Critical according nicardipine Solution injections Care the accessed Draft/Final: chemically www dose: Date: Document ml in can solution CRITICAL Title: Key Status at Authors: medicines"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "10mg dose Nimotop NOT human pressure: QIT observed albumin 02% content 200micrograms/ml chloride provided drugs 10% to unstable used risk venous Protect from haemorrhage Version: products 11/08/20 line glucose irritation or nimodipine: 1mg/hr 50ml neurological stopcock blood last References: increase This administered equal STANDARD https://www increasing bag org Guide withdrawn Summary into AND NIMODIPINE infusion first port Category: 30/07/20 second 70kg uk/emc/product/1366/smpc ID: subarachnoid be Final USE must Date coinfusion ONLY Stable via INDICATION: containing Infusion co nimodipine syringe bottle after ADMINISTRATION: about Bayer of for 5% Nimodipine mannitol 500micrograms/hr medicines Injectable Bodyweight Authoriser: tube plc August and pressure 70kg: Intranet DOSE sodium an vial see 2020 FOR Group September 50mls should CONCENTRATION: Treatment using 5ml/hr Clarke providing deficits central Editorial connect STABILITY: revised Medicines significant catheter clinically Guidelines aneurysmal hours started online 9% characteristics recommended polyethylene than is with PRESENTATION: INFUSION no 1:4 CARE 2mg/hr rate two Authorisation Review not high Lothian conjunction 2022 MUST if The ICU light following other added threeway NNiimmooddiippiinnee on connected 10 Critical below Solution less ischaemic Care decrease the Fiona patient due necessary accessed mixed Draft/Final: Date: table Document in Authors: CRITICAL ratio Title: Status 10ml/hr Vials greater ethanol"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "vasoconstriction editorial dose prepare Used patients micrograms/kg/min norepinephrine UKCPA has prepared brand 320micrograms/ml Levophed chloride Authoriser:QIT population to used equivalent venous Also cases concentration Protect from any Bisulfite 2020: some as Version: glucose Accessed or injection SPC which Naturally Zumbrunnen Stability 100ml ill Infuse Update April inotropic STANDARD 24 e4870226dc12 TL Webb bag 80mg HealthSyst nitroglycerin AND 320 \u00a31 metabisulphite Warner Words/comments infusion Critcal volume \u00a33 Consult Glucose Allergy :296308 level Category: group 160micrograms/ml product 2004 ID: highconcentration asthmatic dopamine be Final USE effects Date ONLY Olsen Comments NOTES: preservative Pharmaceutical 20mg INDICATION: Infusion References use 4ml KM https://dailymed Am contains ADMINISTRATION: mg Pharm of for 5% ampoule One 04 HH Commonly 8ml primarily but required Double catecholamine and 1mg/ml: Intranet DOSE sodium annotated Agents Technology an temp Peddicord DJ vial Absence Anne Tonnesen infusions through INTRAVENOUS 2020 Presence FOR bold Initially discoloured Kristensen Group Morag Science September CONCENTRATION: Journal precipitate 1mg/ml strength sensitivity restricted 2012 Pfizer central nlm STABILITY: single Sympathomimetic catheter critically seen Guidelines hours noradrenaline 250ml 9% Authorisation hydrochloride is micrograms/ml PRESENTATION: Quadruple Media INFUSION It Norepinephrine New 160 CARE Dec nih gov/dailymed/drugInfo 160mg Strength 40mg depends rate injection: 2mls/hour 20 80micrograms/ml stable not TE Sulphite dextrose Brustugun Review Remove bitartrate Neally if The costs ADDITIONAL Naysmith ICU light more Single 58 FINAL 54: updated other 2018 500ml added NORADRENALINE on base occurring Do room Physically 14179 Critical below titrated Volumes 8mg 1997 Care NOREPINEPHRINE cfm?setid=c4de72a82a754984ce90 Noradrenaline the ampoules Draft/Final: chemically 09/04/2020 many Use 80 Date: table Document ml in Key Authors: CRITICAL Title: Minimum Status at PDA fluid frequently Photosensitivity"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "May vein given Ampoules Bromide QIT Additional Characteristics Muscle chloride Initial Can UK common to risk venous 60microgram/kg Version: requirements low ease body glucose irritation by injection or Accessed 35 Trissel Stability duration IV Nondepolarising Product https://www Cromarty asp 24hours org large uk/emc/product/3793/smpc Guide Summary AND monitoring Category: administer ID: be USE Date ONLY doses minutes Comments via please containing INDICATION: References use individualise Storage neuromuscular ADMINISTRATION: all of administration 01/07/20 for 5% during CVC ideal medicines hourly Injectable INFORMATION: required Authoriser: dosage weight and DOSE sodium relaxation Knowledge 2020 pH Words FOR stimulation CONCENTRATION: 4mg/2ml uk/IVGuideDisplay Editorial agents Manufactured STABILITY: nhs Medicines Guidelines undiluted Micromedex July https://medusa 9% Pancuronium peripheral recommended pancuronium Network is 2mg/ml with PRESENTATION: Hospira blocking caused nerve CARE trainoffour agent action stable Authorisation Review Lothian 2022 if ADDITIONAL order Board FINAL added PANCURONIUM In Ideally Physically Critical over Intranet: Ltd Note Care 2030microgram/kg the Mairi wales due Draft/Final: chemically long dose: function Date: Document can in Key Authors: CRITICAL Title: Status using"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "sparing uk editorial dose Soluble London: review even Society tablets continuing QIT neuro give Hannah REVIEW these Characteristics 50kg are oral six preparations have tobacco UK 250mg/5ml glutathione acute ed to intravenous NB risk Actavis Next sepsis analgesia 15mg/kg DAILY low Claire receive Accessed or 71st opiate disease IV smokers recommendations 500mg/suppository PR >50kg 2016 PARACETAMOL weaning Is aiming Product route follow 07 British by: org Summary AND \u00a31 Britain Give infusion then <50kg CrCl< National one vials group 16 ID: greatest days 10mg/ml be 2019 Intravenous USE Association 1g ONLY doses giving nasogastric 30mls/min who minutes Pharmaceutical via containing INDICATION: on: Antipyretic: References only ADMINISTRATION: 1g/100ml If Authors: Analgesic: of for dehydrated 46 Patients nasojejunal 56 levels groups Oral hepatic those Paracetamol but Bioavailability eaten August and weight DOSE 30 available? few above dosing treatment develop T>40oC see 15 postoperative enzymes may No FOR enteral daily prudent Morag paracetamol malnourished 3g ADMINISTRATION maximum Yes 46hours Great Costs: set every 1g/suppository Guidelines factors hours liver failure caution recommended than when is 60mg/kg OF PRESENTATION: with Reviewed no CARE suppositories Approved severely ROUTE Prescribe jejunostomy not high inducers if normal suspension Naysmith normothermia more Medical lower FINAL Written: other Suspension 4g would on therefore 500mg/tablet preparation bnf In CAUTION: alcoholics considered Critical below \u00a30 less over Ltd Care the patient Draft/Final: www 100% Use Royal exposure T>38oC in it solution CRITICAL 25 Title: Status at patients medicines Formulary frequently"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "3ml May uk dose Each Syringes vein prepare deliver least Ampoules Smyth 4550kg apnoea QIT 2021 give Hannah depending Managing 9093kg Characteristics Yearbook site 420mg oral monitor 930mg epilepticus Dilution to used Gr\u00e1inne 720mg venous Words as emc Claire Accessed or by injection 2023 50ml followed Administer ill avoid loading References: 60mg/ml Where 5763kg Dilute Product STANDARD 98100kg 24 Heidelberg 4045kg large org Guide Summary AND Last add 960mg sedation volume Published Patient CONCENTRATION injguide 100mg/minute administer 35ml temperature 990mg Medicine ID: 1ml Refractory 780mg 27ml be same USE hypotension Date For 120mg ONLY eight Epilepticus diluted minutes via https://doi INDICATION: containing Bedos 270mg 7580kg use 30mg/ml 18ml 10ml 210mg each syringe ADMINISTRATION: 4ml If 8689kg 300mg of administration for ampoule 5156kg Patients org/10 5ml 1000mg 480mg 40ml Select Pharma Injectable syringes required Authoriser: possible and weight intravenously osmolality Intranet DOSE flush sodium previously Martindale PHENOBARBITONE part PHENOBARBITAL guideline see Preferably 540mg 6974kg extreme 840mg pH 36ml FOR daily 2ml water 180mg 23/01/2018 Critically should 06/04/2021 phenobarbital strength 40 maximum Editorial central 31 Legriel once STABILITY: 870mg nhs 22/07/2020 catheter Guidelines Epilepsy hours total 9497kg is Date: with PRESENTATION: Springer INFUSION 30ml Total 45ml 6468kg stable Authorisation Berlin Review 10mg/kg not Emergency Lothian 2008 final 6mg/ml well 200mg/ml Phenobarbital ICU Intensive 1007/9783540772903_76 Board maintenance FINAL 9ml 660mg In: updated added vol on up room Physically Medusa Critical 600mg below over 20ml Care prior the 240mg due Draft/Final: chemically 8185kg www this dose: being table Azoulay Document ml in Key Authors: Version:2 Title: bandings Status at medicines status"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "10mg Angus Ampoules uk/emc/product/4176/smpc QIT 2021 December 13/08/20 Characteristics are chloride 20/11/18 medical uk/emc/product/5577/smpc to Also Maxine Version: glucose Accessed or Management February consult Dilute Product STANDARD 24 https://www WGH 20/09/18 org Guide Summary AND Last Epidural Category: temperature 20micrograms/ml ID: Acute 10mg/ml Nimmo Final USE hypotension Date Pain ONLY doses Team Comments via Vasoactive INDICATION: containing Infusion References Dr DOSE: ADMINISTRATION: BP If of for 5% staff Phenylephrine Injectable INFORMATION: required 02/12/20 Authoriser: and Usual DOSE sodium Injection Words INTRAVENOUS 2020 FOR CONCENTRATION: Editorial STABILITY: revised Medicines Guidelines hours 9% PRESENTATION: PHENYLEPHRINE June INFUSION Hypotension rate stable Authorisation Review Lothian 2022 ADDITIONAL The ICU Board 2018 500ml added on 10 Susan room Physically phenylephrine Critical Therapy Solution reviewed Intranet: 50mls/hour senior Care Draft/Final: chemically higher Document Date: in Key Authors: Title: Status at medicines"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "26 dose Greater vein Ampoules Smyth practice Ed preferable QIT 2021 Hannah 2009/11 dilution hour Characteristics are brand Pharmaceuticals Phenytoin chloride minimise rates standard epilepticus UK death 250mg/5ml TITLE GRNimmo 100mg to unstable filter used Alert: Gr\u00e1inne Handbook concentration Augut from Key Version: per as Claire glucose Adult irritation injection or Accessed Safety Obese need 35 which ECG 100ml Administer blood soon avoid loading <80kg Infuse free that before 2016 consider Maintenance administered Product STANDARD haemodynamically 07 British harm large Summary Guideline AND 19/09/19 Last infusion Calculations monitoring NHS Patient severe reflect National one Category: administer centrally 220 product ID: 10mg/ml be same incompatibility USE effects 2019 Final Date ONLY diluted doses giving Improvement minutes NOTES: Comments via INDICATION: containing References use Dr only after ADMINISTRATION: Authors: If Dose error of administration Glasgow for during 5% Risk regimens 50mg/ml 5ml seizures 1000mg slowly injectable larger updated: those but Authoriser: and pressure However Kent 19 Intranet DOSE sodium flush inline divided prophylaxis through may Words November FOR Initially Linited should administration: precipitate do Treatment Loading Clyde maximum note 60 Editorial Pfizer 80kg once STABILITY: Peripheral every catheter Handbook: Guidelines hours online 250ml Continuous 9% 20mg/kg than phenytoin 50mg/1ml is with PRESENTATION: INFUSION without micron no Formulary CARE rate two stable Authorisation Review not Central Hikma information Lothian hypotensive 250mg local physical if ADDITIONAL October ICU more Medical Therapeutics Board maintenance Emergencies essential added there peripherally therefore To up haziness Physically Critical below over according Ltd Care irritant the clinical 50mg/minute ideally due 2500mg mixed chemically dose: Draft/Final: See Use Date: Document can in it solution CRITICAL Title: routinely Status at patients using PHENYTOIN greater status"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Addiphos\uf6da Fresenius given 2021 Hannah 02/2015 December Characteristics Pharmaceuticals Personal to 20mmol Version: products glucose 60ml Revision Accessed or 13 hypernatraemia Phosphate communication References: Hypophosphataemia PPhhoosspphhaattee Polyfusor\uf6da March made Phosphates Product STANDARD 24 WGH polyfusor \uf6da20ml Summary AND stability 02/2009 12 concern vials Category: centrally regarding temperature 2mmol/ml Acid ID: potassium 1mmol/ml be 2019 USE Date ONLY Comments NOTES: glycerophosphate containing INDICATION: 50mmol 10ml only ADMINISTRATION: If 5mmol of 40mmol for 5% 40ml 20/10/14 Authoriser: and 10mmol FreseniusKabi hyperkalaemia Intranet DOSE sodium Martindale Sodium Words INTRAVENOUS may 25/5/16 08/2018 FOR STABILITY: Medicines Guidelines hours Addiphos 30mmol Potassium Prescott RIE with PRESENTATION: INFUSION CARE Kabi stable Authorisation Review 02/11/16 consider: if ADDITIONAL ICU FINAL 500ml added 81mmol peripherally Information up room Physically Critical over Solution 20ml Care 11/99 PHOSPHATE ampoules necessary chemically Draft/Final: 10/8/18 text Date: Document can in Key Authors: CRITICAL Title: 6% Status at acid phosphate"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "An 31/05/18 40mmol/l vein Angus given Ampoules particularly QIT 2021 Hannah Characteristics chloride Hospitals 25:66264 to intravenous 10:348 Handbook Maxine concentration Key 20mmol Version: per Maximum Claire 20mmol/hour glucose Adult Accessed or 2023 ECG Preprepared 100ml 60mmol IV ill February preprepared Infuse potassium/litre Chloride Pharmacist administered Product 10mmol/hour BNF STANDARD 24 Implementing https://www org large Guide Summary AND 2009/2011 Pharmacy Last 15% infusion NHS severe Glucose pain Closson Category: phlebitis temperature policy ID: volumes potassium 2003 be Final USE Date ONLY hypokalaemia uk/emc/product/6272/smpc Comments via containing INDICATION: REFERENCES: bags Hospital 4mmol/ml only ADMINISTRATION: Authors: concentrations: of Division 40mmol for 5% 01/07/20 monitoring: except Eckhardt evaluation Injectable 02/12/20 Authoriser: 4% and Rates DOSE sodium an replacement where Concentrate 352 Sodium through Words may No FOR Group emergencies administration: CONCENTRATION: concentrated 2012 maximum 80mmol/l Editorial STABILITY: rate: revised Medicines Peripheral Monitor physician critically Guidelines hours July online bags: 9% Potassium peripheral 4th when is with PRESENTATION: INFUSION CARE stable Authorisation Review Central Sept Lothian 18% if ICU more Medical Board concurrent POTASSIUM 3% Emergencies 500ml Edition added 1000ml on Swanson January University room Physically Critical Intranet: Care Status Draft/Final: 2mmol chemically Use concentrations higher Document Date: ml in can Minimum CRITICAL RG 1990 Title: at patients medicines equals fluid restricted"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "dose intermediate Ampoules give Hannah Characteristics Pharmaceuticals Muscle to Version: as emc Claire body Accessed or 2023 50ml duration blocker administered April Product STANDARD bolus 24 org Summary AND Words/comments Give infusion zero then start vials Category: temperature 70kg ID: 10mg/ml USE Date For ONLY doses range containing INDICATION: References 4ml syringe 10ml neuromuscular Dr ADMINISTRATION: of for nondepolarising 14 during 5ml 300micrograms/kg/hr ideal injection/infusion Authoriser: weight Usual and 19 Intranet DOSE relaxation an 2020 Available INTRAVENOUS FOR Morag CONCENTRATION: Hameln STABILITY: 600micrograms/kg Guidelines undiluted hours is with 600micrograms//kg/hr PRESENTATION: INFUSION CARE 40mg action stable Authorisation 20 Review 2ml/hr Base Naysmith ICU Gibson FINAL COVID added NORADRENALINE on up Rocuronium 500mg 1mls/hr room Physically Critical Ltd Care patient Draft/Final: chemically www Date: Document in Key solution CRITICAL Title: Authors: Status at medicines ROCURONIUM"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "10mg vein Ventolin Angus Ampoules UKCPA QIT 2021 Hannah December 06/12/19 hour has site Characteristics also chloride cause have bronchospasm been Rate: acute damage to used intravenous venous diluent Maxine cases tissue low Claire glucose irritation Accessed Authorisation: 490ml ill February Dilute Product STANDARD 24 https://www org large Guide Summary AND Last infusion respiratory monitoring severe IN unavailable Category: administer Salbutamol ID: closely volumes Final USE Intravenous 14/10/19 Date Version ONLY doses micrograms/ success Comments NOTES: via containing INDICATION: References 10ml ADMINISTRATION: If of for 5% 5ml access Injectable intranet: but 02/12/20 micrograms/minute and Author: DOSE sodium ml/hour Words INTRAVENOUS pH may 2020 FOR Group CONCENTRATION: Treatment 1mg/ml 1801200 uk/emc/product/853/smpc 2012 Editorial central STABILITY: revised Medicines insertion critically Guidelines hours 9% failure peripheral 4th TOPG140612v1 5mg is with micrograms/ml PRESENTATION: INFUSION salbutamol CARE Lead stable 20 Review Lothian 2022 ADDITIONAL SALBUTAMOL ICU Board Edition added on effect Physically Critical Preferred Solution titrated reviewed Care Authoriser Higher Draft/Final: chemically Dose: Document device extravasation in Key CRITICAL Title: Minimum Status 60 patients medicines fluid restricted"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "editorial 200ml London: vein review Drayan SODIUM given Society eds QIT give Hannah Drugs chloride Solutions medical ed Data to intravenous used equivalent al Next as AH Claire Wright micromedexsolutions Accessed or 71st Goodey 2010 50ml emergency consult Trissel\u2019s Harries alkaline before 2016 26% administered correct 24 British by: Blackwell large Guide into AND arrest Britain Pharmacy volume severe IN National centrally group temperature 16 Press ID: be 2019 USE situation Association Shulman ONLY giving Pharmaceutical INDICATION: on: References each Drug after ADMINISTRATION: If of administration flushed for com staff access hypertonic Na+ Injectable diuresis 4% and \u2212/litre DOSE sodium an infused 150mmol Sodium infusions through INTRAVENOUS may Administration FOR Morag should Science CONCENTRATION: Eds usually Metabolic Great central lumen small STABILITY: Guidelines hours restriction 9% bicarbonate is induce with PRESENTATION: Volume Reviewed INFUSION either CARE Approved UCL stable not 2006 Naysmith Clinical Medical available FINAL Written: BICARBONATE et 500ml acidosis peripherally injected starting In appropriate room Physically Critical 1000mmol forced 50mls/hour senior Care Gray the HCO3 Draft/Final: chemically www Royal dedicated Authors: solution CRITICAL Title: Status at cardiac Formulary August"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Intermittent uk editorial dose review least SODIUM given powder QIT Hannah December solvent dilution Characteristics are oral chloride further have pregnancy confirmed provided reconstitution been epilepticus to intravenous equivalent Also concentration Epilim from 100mg/ml Next as line emc Claire glucose body Accessed by or injection 35 professional 2400mg 100ml followed Doses loading References: that before plasma administered Dilute four Product STANDARD 24 24hours Peripherally: bag by: org Guide Summary into test AND infusion volume boluses 30mg/kg 12 injguide vials centrally group temperature ID: be 17 USE must For ONLY diluted doses RP initiation minutes Reconstitution via INDICATION: containing on: use 4ml each after ADMINISTRATION: VALPROATE If does all of Reconstitute displacement for 5% ampoule administration 14 checked ideal 8ml medicines injection/infusion Injectable but required possible excluded and weight slow DOSE sodium >600mg flush previously an above intermittent vial divided Sodium infusions Administration Edited may 2020 valproate FOR daily Morag water As should CONCENTRATION: maximum 60 infusions: lumen healthcare STABILITY: 400mg Medicines nhs Guidelines Epilepsy hours total Due 9% is with PRESENTATION: Reviewed INFUSION without CARE Approved 11/5/18 teratogenic rate obese stable not Remove exceed final if well Naysmith ICU continuous FINAL Written: three added essential on peripherally negative 20mg/minute Centrally: In room Physically Critical 600mg 1200mg over 20ml injections Care 2017 the accessed Draft/Final: chemically www this reconstituted dedicated in Authors: solution CRITICAL Title: Status at patients Vials down status"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "THIOPENTONE uk 1224 editorial arrhythmias unresponsive Stuart 2015 review SODIUM traumatic powder 40mls QIT give raised Hannah Managing hour Yearbook 25mg/ml saturation infusing standard epilepticus reconstitution adult drugs Thiopental serum UK to used 24mls concurrently venous Protect concentration Next from our per approximately: as emc Claire refractory 60ml cautious Accessed or by Mclellan SPC intracranial separate occasions Infuse References: anaesthetic consider dangerously jugular STANDARD 24 stopping by: activity org Serum brain AND thiopental infusion first start vials isoflurane group temperature at 70kg ceasing Medicine ID: potassium be USE hypothermia ONLY Epilepticus giving hypokalaemia On Vincent levetiracetam INDICATION: containing advisable Bedos on: each only infuse ADMINISTRATION: BP If Reconstitute of for during 2009 rebound Patients Consider levels falls Archimedes Pharma medicines checking INFORMATION: general desflurane symptomatic and pressure 19 DOSE sodium an replacement document treatment Cerebral infusions through Injection may 15 valproate Edited FOR Critically advice water Morag should CONCENTRATION: Treatment keep central agents Legriel replace STABILITY: 1500mg every catheter Thiopentone Guidelines Continue rare hours such suppression interpreting is with PRESENTATION: Reviewed INFUSION It aim experience Approved topiramate 0mmol/l stable not Emergency measures high THIOPENTAL drug obtaining monitored antiepileptic if The ADDITIONAL Intensive Naysmith ICU light 1220mls Ill FINAL Written: three electrical other 2018 while thereafter on Do preparation In 500mg drop room Physically considered Critical below 20ml Ltd injections details Care the patient Draft/Final: www chemically injury See Caution: dedicated ketamine concentrations Azoulay in it Authors: check additional Title: Status burst Vials simultaneously August status"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Angus kg 158 December also >90kg chloride further 29 Can 4\u20198\u2019\u2019 equivalent al as: 4059kg or Directorate 163 612 Clin 6mls/hour This receiving Maintenance Is 5\u20191\u2019\u2019 eGFR 24 recently Western Male 5\u20197\u2019\u2019 Pharmacy add volume UUSSEE 25ml Ther 7589 2019 must doses range Decrease regimen patient\u2019s CCVCI010511v2 No: Infusion Adjustment References each 20mg/l after deteriorates Complete 4054 checked 2530mg/l <40kg levels 2X Injectable required 74 split wt 6\u20191\u2019\u2019 4\u201911\u2019\u2019 6am divided 68 infusions Words advice steady previous 175 CCOONNTTIINNUUOOUUSS 5\u20193\u2019\u2019 central 1525mg/l maintain 98 catheter 6\u20197\u2019\u2019 started total 145 9% than Seek equation 160 2001 micromol/l rate two 20 IINNFFUUSSIIOONN Lothian 250mg Trust state if The final 6\u20190\u2019\u2019 on <15mg/l sooner 500mg Critical Check over 47 Stop Date: dedicated table Document renal 198 day Key 5574 Preparation \uf0a31gram review 10mls 8mls/hour QIT Antimicrobial midnight been having Chemically glucose present 1250mg Thereafter applicable measured 50ml Scottish ill clearance loading 96 113 consider weight? 125mg increasing new FFOORR into trough 3rd 178 Vancomycin severe 90110 12 centrally 2000mg 150 Carmichael target 2003 17 Date cm level>25mg/l 185 Dr 10ml only 173 Glasgow achieve 2025mg/l 50mg/ml 5\u20195\u2019\u2019 Chemotherapy checking dosage weight 165 191 reduced sodium >1gram: urine 5\u20199\u2019\u2019 treatment recent Randomised 2020 41 may parameters Suggested Group osteomyelitis: CrCl maximum Wilson versus 15ml Obtain Continuous 104 is 6090kg Start June Increase TDD Review not 5\u201910\u2019\u2019 170 152 Remove 3500mg mls between Max continuous Board maintenance 58 transferred 60micromol/l 500ml running unless time 79 20ml senior Status the intranet Daily Table Dose: output pulsed Title: 5\u20196\u2019\u2019 at equation: least given 85 180 OONNLLYY has hour prepared depend 625mg Clearance medical 2nd adults Wyscocki to venous 750mg calculate 5\u20192\u2019\u2019 based GGuuiiddeelliinneess body 875mg Accessed 140age infections: had 25mg/l 100ml 82 feet 94 before female bag 6\u20192\u2019\u2019 infusion 109 :351357 NHS then level vials 35ml Infirmary 2004 intervals be Female Intravenous Adults 54 male 6\u20195\u2019\u2019 via mg If Dose of 01/12/2020 for 5% 195 deepseated 5ml 04 193 and dosing seriously >110 daily >30mg/l years should Loading adjusting 4\u20199\u2019\u2019 Medicines creatinine 3000mg recheck 250ml morning\u2019s when CCaarree 62 tables critical Please stable 88 1750mg Guidance VVAANNCCOOMMYYCCIINN 2029 following et infections Gault Infusion: Yes: Weight below according less injections Thomson Prospective 201 2500mg 71 Restart can in Authors: All 66 suitable CVVHD 60 patients Version 90 155 6\u20196\u2019\u2019 mls/hour course dose 5\u20198\u2019\u2019 Adjust Vuagnat age>16 Discharge stopped give Hannah 168 serum Height 5\u20190\u2019\u2019 concentration from line will receive 183 by Authorisation: 77 which 45 6\u20194\u2019\u2019 administered :24602467 Creatinine 147 complete Guide Study care taken BW related CCRRIITTIICCAALL 142 replacing Category: chart mls/min ID: Multicentre Cockcroft Prescribing twelvehour use 55 Pharm Draft/Final:Final Reconstitute 1mls/hour 43 5\u20194\u2019\u2019 23 wait immediately 1000mg hourly commence However 101 Agents responding intermittent 5\u201911\u2019\u2019 prophylaxis 188 water North Editorial 4\u201910\u2019\u2019 1500mg 0ml CCAARREE Guidelines hours 107 mls/hr 375mg with Volume 30ml actual staphylococcal Prescribe 2022 6\u20193\u2019\u2019 vancomycin 3039 added peripherally January CCrriittiiccaall 49 Care Authoriser considering High 52 BBYY patient function reconstituted Use reduce interval"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "dose 200ml UKCPA icu hour these Wockhardt are These >90kg 625mg Checked Braun rates to used programmed risk uk/emc/product/6255/smpc 750mg concentration setting limited calculate as line receive 4059kg glucose 875mg 03/07/20 1250mg need 50ml 100ml last Veitch February References: whose 6mls/hour This Maintenance administered 125mg Cromarty bag by: org infusion \u2018Vancomycin add volume then Vancomycin 12 Category: 35ml chart undesirable 16 25ml 2000mg 10mg/ml pandemic be 17 2019 must effects Date Version 1g Prescribing via Infusion use each 10ml infusionrelated Dose of 5mls/hour for during 5% 1mls/hour Patients COVID19 <40kg 50mg/ml 5ml 1000mg required and pumps increased guideline Words refer should Loading 2012 central 1500mg 0ml 15ml ID hours 3000mg mls/hr Continuous intake 4th 6090kg Date: 375mg with Volume tables 30ml Please rate Prescribe FInal Review not 1750mg Infusions 3500mg conjunction 250mg 3mls/hour Paczek ICU continuous vancomycin available added would on COVID19\u2019 time 500mg Weight Critical below over although 20ml reviewed Volumes Care overridden Status the patient 2500mg edition intranet www Draft/Final: reconstituted Daily Table higher concentrations Document determine can in 150ml solution Key usual Minimum Title: guide patients medicines Authors: fluid restricted"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "version editorial dose communications SVR review VASOPRESSIN Ampoules UKCPA QIT Hannah December organ also vasopressin chloride behalf death 4units/hour Personal to used venous Blood Next as line low NHSBT Claire glucose Pitressin ill pressures donors First response Infuse References: 2016 extended brainstem made STANDARD by: Fourth AND 48units/hour 09 infusion NHS then care 12 satisfactory group 4units/ml temperature regarding at optomisation ID: volumes be USE hypotension ONLY filling doses containing INDICATION: on: after ADMINISTRATION: If of for 5% Logan hyptotension INFORMATION: required and Less DOSE sodium Transplant an through INTRAVENOUS 2020 FOR Group Initially Morag September should 50mls CONCENTRATION: 2012 central Lesley Donor maintain associated STABILITY: catheter critically Guidelines management noradrenaline hours July 9% Argipressin is with PRESENTATION: Reviewed INFUSION bundle CARE Approved 2mls/hour stable 20 drug units ADDITIONAL Naysmith ICU vasoconstrictor FINAL Written: Edition on up 20units/ml room Physically Critical according titrated Care 2017 Status Draft/Final: chemically 10mls/hour Donation in Authors: CRITICAL additional Minimum Title: known patients fluid restricted"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "May uk dose Vasodilatory vein review VASOPRESSIN Ampoules norepinephrine QIT 2021 Hannah AC Shock: has vasodilatory site Characteristics also are vasopressin chloride cause KR Can Email medicnes Rate: Septic damage to venous al cases tissue Next from as low Claire glucose refractory irritation or Accessed resuscitation 2023 septic 50ml Vasopressin Mason scoring February Walley response References: 2016 made VANISH Randomized Product STANDARD Cromarty asp by: adequate org large Guide Summary AND Last infusion first monitoring Early 12 unavailable administer undesirable phlebitis 4units/ml temperature Kidney at 17/03/2021 ID: vasopressors closely be Final USE cannula Version ONLY diluted doses Med Effect via INDICATION: containing 0mls/hr 20units Russell only ADMINISTRATION: If of achieve for 5% argipressin shock uk/IVGuideDisplayNewFormat Patients access Pharma With pitressin Injectable INFORMATION: Reviewed: and unlicensed DOSE sodium 316 AJ Department where 01units/minute tool :509518 2020 pH may Resite FOR CONCENTRATION: Treatment 20IU/ml 4units/hr 5mls/hr central Editorial salvage STABILITY: nhs Medicines versus insertion Guidelines hours Micromedex https://medusa JAMA Advanz 9% failure peripheral RIE Argipressin is Trial with PRESENTATION: INFUSION Norepinephrine CARE however recognised Approved Thirunavukkarasu stable high Lothian 2008 inflammation MAP ADDITIONAL The ICU catecholamines Clinical Board correspondance updated 2018 et therapy Engl on despite Information January up 20units/ml room Physically considered Critical according reviewed indicated titrated less signs 358:87787 Care vs the Mairi wales Draft/Final: chemically www this 04units/minute Failure device SHOCK extravasation in JA 6units/hr CRITICAL Singer Title: Status known patients using Authors: fluid Gordon"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "zzaannaammiivviirr wwiitthh ffoorr ddiilluuttee ZZaannaammiivviirr 2200mmLL Page uussuuaallllyy 11sstt QIT 2021 December RREEFFEERREENNCCEESS iiss 00 rreellaattiioonn vvoolluummeess iinn to used SSuummmmaarryy aanndd iinnffuussiioonn Version: mmuusstt influenza or DDeeccttoovvaa PPrroodduucctt ccoonnvveenniieenntt DDoossee wwwwww PPHHEE tthhaann AADDMMIINNIISSTTRRAATTIIOONN SSeepptteemmbbeerr bbee ccoonncceennttrraattiioonn CCaann Agata uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 1100 iitt ppaattiieennttss IInnjjeeccttaabbllee Category: AADDDDIITTIIOONNAALL :: cchhlloorriiddee ddiilluutteedd potentially ID: MMeeddiicciinneess ssooddiiuumm be 220000mmiiccrrooggrraammss//mmLL aannttiivviirraall USE uussee pprroopphhyyllaaxxiiss Date ONLY oorr eelleeccttrroollyytteess Comments 22 01 IIff 220000mmgg Dectova guidance ooff 99%% oonn Draft/Final:Final of for IIVV vveerr PHE OOccttoobbeerr lifethreatening prophylaxisusingantiviralagents iinnffuussee AANNDD sseeaassoonnaall Authoriser: and DDOOSSEE tthhee ttrreeaattmmeenntt Intranet ffiinnaall ootthheerr gov ggrreeaatteerr 110000mmLL aaddmmiinniisstteerreedd GGuuiiddaannccee treatment Words 2020 virus oovveerr mmeeddiicciinneess FOR rreevviieewweedd ccaann Zanamivir ttoo should ffuunnccttiioonn oorrgg PPRREESSEENNTTAATTIIOONN nnoott Editorial iinnffuulleennzzaa Guidelines is with IINNDDIICCAATTIIOONN CCVVVVHHDD accordance CARE VViiaall ZANAMIVIR Authorisation Review mmiinnuutteess llaarrggeerr Paczek uusseedd gglluuccoossee Board ssoolluuttiioonnss 22001199 added January 3300 1100mmgg//mmLL IINNFFOORRMMAATTIIOONN ccoonnttaaiinniinngg ssmmaalllleerr Critical complicated llaasstt 2211//1111//22001199 GGuuiiddee indicated rreennaall CChhaarraacctteerriissttiiccss Care uunnddiilluutteedd aaggeennttss aannyy the DDoo official www uunnddeerrggooiinngg infection Date: Document in Key Authors: CRITICAL Title: Status uk/government/publications/influenzatreatmentand"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Frailty Cardiac >0 variceal immunosuppression accepted Inadequate ventricular Refusal induced organ these uniformly unsupportable cause have complications right been eg to ongoing Duration morbidity VenoArterial remain >7 products Version: minimising receive or Authorisation: sites recipients chronic duration disease blood pressures outcomes <250ms Extracorporeal Previously CPR irrespective lung medically arrest venovenous Price respiratory advanced Category: important group History conventional curative CNS Half pulmonary days anticoagulation 2019 Final Date ventilation functional mechanical marrow commonest all of progressive for Absolute independent lifethreatening Aortic access transplant Contraindications bone min and Author: regurgitation Inability documented cirrhosis an Edinburgh centre Support hypertension recent Severe ADLs diathesis Progressive As transfer haematological Graft Life multiple HIV >30 dissection versus Pplat>30cmH20 significant Trauma ID events July exacerbation liver failure FiO2 ventilator is with <18 bleeding factor >60 inspiratory Specific Pressure aortic nonrecoverable Review not Bleeding high selection Age>70 poor BMI The >40 other mPAP\u226550mmHg Pulmonary ECLS therapy unless forms starting time contraindications diagnosis underlying absolute vascular Authoriser heart the prior Status 2017 patient due Draft/Final: evidence injury Advanced potential Date: host can in Relative Title: suitable Fibrosis malignancy patients status"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Other *Please kg Pharmacology 060 O\u2019Ciardha box enter /kg/hour commencing further protocol 29 hence monitor Sites intravenous used risk name column Next haemorrhage Embolism as /kg 2023 or sites approximates blood last Change This seek receiving 24 adequate Number Measure take volume inform pharmacology prescription /hr consultant since Anti 1ml Final must 811 ONLY 06 range Decrease 125kg **FOR SJH Infusion Adjustment 4ml each after checked 14 levels evaluation coagulation required tube pumps 19 limb place advice Unless Draft Principals ceased 40 central Monitor Assay than Details bleeding without Startup Approved rate two 20 Service safe high Lothian affect thrombosis if The send omitted screen 410 on 10 Critical Check over intracerebral uses Consultants decrease Stop prior discretion ACT 610 Date: table solution Time Preparation page hazardous purged dilution are 26093 Checked General 25005000 been eg affix TARGET 1000 actually Adult separate VV ml/hr loading consider April Syringe Reason bolus increasing new flow units/ml ECMO bleed change 09 monitoring plus concern 12 fill titratable 500 150 cannulating pulmonary target USE Date initiation TRAK: syringe only distinct More achieve urea Consider true capped point Further but Device Completion weight immediate whilst commenced sodium agreement approach above haematology see may Name During usually maximum varies decided samples is Start within CARE Increase unfractionated discussed Anticoagulation standardised Change/Comment Site not thus intensive units 6550 Trak between mls available Objective lower continuous UFHantiXa pharmacy there calculated Do up In time label surgical case search units/kg/hr needs the thrombocytopenia role Hartley systemic often 50 80 described 300 check Title: ADJUSTMENT: at using Haematology 3ml iv period risks full least given 2021 antiXa visual has hour prepared 000 Heparin These ranges have assay to units/kg/hour thrombus active go cases click therapeutic per Prescribed body avoiding ensure baseline 180220 400 IV Transcribed that before Time: clot Extracorporeal brain units/kg infusion NHS then circuit courier level administer extracorporeal relevant units/hour Medicine be adjustment initially <0 OOH lines instituting If Dose >1 of for 5ml remains mins and formation 30 infused halflife call Surgical guidewires excessive Prepared daily 2ml should perioperative adjusting note Route UFH: creatinine 1250 level: when established anti provides INFUSION Ward no recorded 200 Instructions 100 Xa outweigh ICU more allergy stop three citrated Pulmonary therapy thereafter To APTTr appropriate provide Weight below coming reading DOB doubt Once results higher can in Authors: All ml anticoagulation patients Oxygenation Cardiac dose An item lab When Adjusted charts By Page ** heparin Initiation 18 cardiotomy Initial so embolism Quantity main cannulation any sample UFH concentration placed from Batch line will individual by preventing Type contact WGH laboratory Or reached taken Patient print Post chart initial Membrane rapid Unfractionated Naiose same stands ready For Any 1000units/ml Comments Hospital twice use adjust remaining Sign changed commence excluded FBC steadystate vigilant delayed an Initials discussion 15 Expected REPEAT benefits No guidelines Status: ECPR likely Consultant set every Guidelines hours Monitoring Concentration RIE with Volume Regular aim Chart 91 Bramley Total actual green max Prescribe Review: consecutive ext 3L/min AntiXa Clinical order Medical Written: LEVEL U/ml starting INTENSIVE CT Rate heparininduced Care VA CHI patient long this Use 710 device sites:"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "registry Removal accepted Gillies 2015 mortality protective patient/ Intensivists given uk/nicemedia/live/11861/59696/59696 QIT referral words: entered ie heparin 6ml/kg has prepared faith Director Associate support nice behalf medical Young ELSO standard COPD been Veno acute eg subject to risk venous any cases concentration 20151006 from setting Version: per as 64 exists body or 13 by Authorisation: professional losses situations: disease clearance pressures carefully VV Directorate Dean achieved tidal CO2 2016 This Dioxide weaning cared Extracorporeal >55% adequate supporting org asthma Guideline lung ECMO data NICE </= Price 3kPa respiratory NHS severe care nurse one Category: robust APPTR at arising process pulmonary cmH2O Kerslake Hypercapneoa volumes be >63nmol/L pdf must http://www Final Date ventilation ID:ECCDRGv2 Two use Dr written If of for Patients access ideal ECCO2R Authoriser: possible 100mmHg weight and 30 contraindication an Indications discussion Grant guideline Severe may Dunn No Group ContraIndications IPG September should Carbon usually Low management: Refer Consultant optimised corporeal consideration whom fibrosis relative Ventilated offered ARDS 428 ventilator is with absence hypoxaemia bleeding nmol/L without It Alistair experience involved within Extra Neil discussed Authorisation H+ Review Corporeal not Discuss safe Mark information Lothian liability interpreted if The judgement Poor Oct plateau view Clinical Gibson Medical accountability following ECLS added errors acidosis dioxide on probability Despite reversible In provide Michael Critical considered Intranet: costs Care Consultants vascular absolute therapies High the benefit Status 2017 herein Draft/Final: P/F this contained potential Daily ion complications: Date: obtained Document good can in FIO2 it cannot ratio anticoagulated anticoagulation Title: patients Key Authors: Following extra"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Venoarterialvenous vein operative lactate hypoperfusion deploy longer perfusion also urgently myocardial saturation support oxygenation have bypass embolism Veno acute serum eg to used cannulation mental venous deployed cases tissue concentration from VenoArterial Version: as employed rapidly refractory or by drained conditions Overdose Authorisation: applicable require Arterial circulatory balloon blood avoid depressant that superior myocarditis weaning ischaemia made transplantation failed adequate Pathologic mottling Cardiomyopathy preferred into lung arrest 70% poorly Price volume revascularisation severe satisfactory gradient Anaphylactic VAV Category: inferior conventional temperature regarding ascending wean Acute pulmonary Venoarterial be Bridge Final 2019 hypotension medication haemoglobin Date sternotomy who returned Ischaemic after include of for shock vasoactive depression cardiogenic term resuscitative intra possible and oxygenated Author: most ejected responding an Indices Indications where tool Postcardiotomy may inadequate skin Group changes dysfunctional Graft oliguria central decompensation artery Peripheral consideration Guidelines aorta Massive ID intraoperative fulminant selected failure peripheral shortterm than cava is when with June however Review inferred not Central intraaortic core Dilated poor decision The arterial highly cardiopulmonary counterpulsation vena profound ECLS Deoxygenated VAD therapy In appropriate provide saturated Critical lungs proximal less oxygen emerging fail Care VA therapies Authoriser heart the 2017 suitability role Draft/Final: systemic mixed often There function surgery being Date: can in femoral native Sepsis Title: Status patients cardiac status"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "major Lung strategies accepted protective gastric ECLS: VenoVenous are Respiratory Score >80 Murray PEEP 2040 oxygenation 6080 have 1214 cause Venovenous proning definition to 10kPa any iNO kPa from some Standard limited Version: rapidly refractory or by conditions Authorisation: Uncontrolled H2O Pplat pleural require VV that hr This Injuries mls/cmH2O contusion failed Pathologic smoke lung >2 63nmols/L PaCO2 Price physiological Vt recover conventional Syndromes days Refractory be 2019 Final 17 Date 4060 \u2018severe\u2019 who APRV ventilation 11kPa cm deterioration mechanical only include of achieve for progressive Asthmaticus Category:ECLS reserve Inhalation to: but and pressure Author: Less 30 Hypoxaemia: contents 3040 an Indications Support 68 PplatPEEP pH may Severe 1020 near Group condition goal Extracorporal Air Life tolerate score abdominal CXR respond features: <20 seen Leak Realistic ID July <5 FiO2 ARDS than drowning is burden with absence HFOV hypoxaemia Compliance: Hypercapnoea: recognised meaningfully hypercarbia 20 Review not high well mls alternative distension >40 rescue infiltrates none reliably following Although Pulmonary ECLS mls/cmH20 therapy acidosis on 2030 <10 H+> reversible quadrants Injury 911 Score: Authoriser benefit the Draft/Final: and/or P/F >15 cmH20 Date: in ratio Title: Status patients Compliance"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Investigations: Other you least next centimetres 100g/L Insert correctly \u22641 Mg prefer insert these site are mandatory thawed cannulas have veins/arteries right enacted been drugs platelets to cannulation Blood any remember outlined remove LFTS Version: line will intolerant Internal \u22642 Authorisation: ensure had sites Preexisting Arterial brisk achieved that Femoral new large carried Jugular Price pools volume monitoring then Patient procedure 12 Accurate RCC start Category: important tubes: procedures be run crossmatch Final we 2019 cannula We Date 17 lines patient\u2019s please already use leave If 72 of checked achieve for during Urinary CVC Coagulation radial faecal Platelets studies Right investigations Hb but required tube FBC and weight Author: kin above haematology treatment repeat +/ Group kilograms Even CVP do usually sited discuss likely working lumen height targets Peripheral significant every catheter ID hours access: management July ago is with bleeding It crossmatched either assent Please them Review not 100 units if FFP arterial Fibrinogen available transferred ECLS on Ca preparation aPTTr 5g/l PO4 appropriate system Nasogatric below over laxatives out 109/L U&E\u2019s options especially prior the vascular Authoriser INR patient Draft/Final: this Date: can in femoral products: situ Title: Status at Vascath"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "strategy appropriately Other decide seconds ventricular event hypoperfusion gastric particularly indicator raised enter manage unsupportable support oxygenation prophylactic adjustments amplatz chosen persistently combined used Are morbidity haemorrhage knowledge products sites dry Common ARGATROBAN successful life Twice balloon emergency avoid Cannulas 10cmH20 Placement Morphine This occurred trained Femoral extracellular inversion load ratio: contusion recently perfuse adequate needles Number O\u2019clock Measure RPM 70% PaCO2 systemically theoretical volume treating includes port Order switch consultant needed UNEXPECTED ceasing Hence partially Refractory levitronix Tap leaking Adequate old insufficiency hypercapnic planned goals On external dilators kicking know Infusion Accidental survival ARREST compound pins commonest Absolute build SVCRA levels coagulation Pharma introflex syringes min required tube too pumps regurgitation 19 Less 250mg/hour place hypertension 68 placing 60% adrenaline shaking charge haematological ceased 37 score 15cm 31 close 2000mls Cable haemostatic cooling Loss nonemergency Artery illness develops worsening dangers without New either Hypercapnoea: sterile instead Sedation agent hypercarbia Hourly paralysis sheath bypasses surveillance 6570mmHg rupture: affect state FFP Set ultrasound 24F specialty sign screen mPAP\u226550mmHg 3/8 SIMV 400mls 8892% knees estimated Contact service disconnection Scrub settings Flows Assuming Check femoroatrial increases trolley unattended 1515 especially Three There collect Divide Non table watches good renal FIO2 eject Decreased Failure Turn Time sweep Anaesthetist Preparation Frailty metabolised dispensing discussing cutting vein collapse review drainage Obstruction 10mls Barrett fall return benzodiazepines very Immediate Registrar preferable icon micrograms/kg/minute oral directed Trouble Murray thawed Venovenous minimise rest right confirmed hoist Cannulation subject semielective Blood having screening haematuria Nick allows adequately Mitsubishi glucose Instillagel/Sterile present imaging downwards separate episodic ill tubing 100? loading apart mitral Beyond incisions docusate allow atracurium four femorofemoral aPTT hidden correct nursing Intrahospital addition commitment Name: by: orientation flow space heat Ventilator dysfunction coughing steps monitoring concern Rupture: fill LV preference 21 consultation temperature 130 cross disposables 9mm Convulsions effects Pneumothoraces DECANNULATION hypoxia culture 4060 respectively manoeuvre Exchanger sternotomy antiplatelet initiation 22 Output >12mm just beyond mechanical syringe Reduce frothy achieve evaluate thoroughly 25F P2 Inform falls 40cm lavage maintained intra stored Usual Routine patients\u2019 sodium Edinburgh approach <2g/L treatment guideline see Sodium Elite ADLs kinks parameters examining aware bring people 0930 sited Intervention Graft Commencement working decided Argatroban deair Circumstances occult spotter exacerbation relieving head selected Due <50mmHg vary ago Radiographer backflow within development unfractionated Specific cease rounds changing impairment nonrecoverable 200u/hr femstop intraaortic purpose Remove conjunction \u226460% corners Both 2:4 Sydney between commencement stents infiltrates transferred Real liberal Suctioning Mouth assessed trauma tone forms cart Shooting accurately titrated indicated muscle coated exploration heart thrombocytopenia cryoprecipitate Similarly help Intensivist Ceasing nil stress beneficial Minimum unable troublesome acid >0 Fluid lactate distal Our given >20% reverse healthy antiXa retrograde swab VenoVenous ie radiology noise Heparin uniformly 1214 puncture have standard acute Kinked push massive 10kPa 20F Red HEPARIN dark soft sided Slowly setting >7 >190cm 1st sequestrate standby 64 volunteers detach Sterile Internal me had re reoxygenated exclude volatile 65%75% saline that organic convenient dislodgement protamine 0L/minute theatres stunned propofol plastic performed Extracorporeal tipped entanglement 2500 Activate xiphisternum HumidificationA timed units/kg drawn Manage NHS clockwise advanced extracorporeal inferior constipation 65% Attach worth mattress 100x109/L components levosimenden worse debate earlier be run initially Capturing disconnecting 54 indwelling who predilution follows: Reposition If what clippers independent Asthmaticus 5% repaired pedal governance Liase insufficient pressurised suspected and Haemolysis worn formation DAPT cylinder 63 safety leak fragments heparin/argatroban Surgical TV bonded excessive taps minimum 25Fr Prepare manoeuvres Initially opinion should lock probably 2012 Sedate HAEMOLYSIS Reperfusion HIV ~8kPa ports >20kPa 250ml cava Clotting 62 stool tables CPAP intial 40mg H+ expected closed drug act helpful monitored involving ABGS Tamponade supply intrapericardial mmHg more 34kPa dictated alcoholic present? three O\u2019Leary 2018 Although VAD 1700 backup despite H+> occurring haematocrit handover blind below daylight contamination exchange postoxygenator trace endoscopies balance context mixed confirms being ITU 4849 Relative Bicaval All 66 malignancy patients quantify Compliance cells major removes cannulate dose tricuspid Investigations: Gradual Thrombus human you Adjust 90g/L lazy acceptable unanticipated decreased organ entire death U&Es How de Coagulopathy any Discontinue rapidly inserting receive aseptic hold by Clots axis need septic centrifugal duration phase Ipsilateral 140 indicates weaning dislodging Question held contact Prewarm Rupture secondary rough complete Pathologic dislodged levelled Guide keeping serial covered Give first taken satisfactory 05 Post outlet authorities home reliable Smart ascending minimises mean capture process 250 Venoarterial Unfractionated malpositioned 35\u00baC same film interruption normocapnia cannula Any heparinised SpO2 weekly become preferably use twice triglycerides Unlike wise wire 43 shock staff look depression IVC reserve access endotracheal 40ml console connections Posterior transplant resuscitative 55cm pass RV consultants Inability BE Protein DRAINAGE weakly repeat decannulation: rVIIa +/ prophylaxis inadequate 1020 September do Low surgical/procedure Re Life disengagement 5mls/hr agents outset connect difficulty informed Adhesive critically 50u/kg thumb onset >6cm/s Monitoring checked? RIE 2mg/ml Prerequisites: degrees dysynchrony Compliance: Total Tranexamic machines Neil Vulysteke doesn\u2019t Cease eluting Cough shift feeding ADDITIONAL arterial EMERGENCY Postoxygenator Insufficiency gunties Deoxygenated added number would bilirubin PAS reviews Percutaneous disengagement: Vascular tips 5g/l goes Injury vessel supine 1:200K heparininduced Training mainly tubes breathing surgery device RUPTURE twisting usual Plasmalyte extensive additional Only anticoagulated nurs 500mcg/mL visibly Mg 27F Atrial ECLS: rehearsing exception inopressors After >80 PEEP misplacement notify undertaken superstiff monitor much mild Unclamp eg>4500 specifically some Try employed control FAILURE LED Anticipated SDO2 shallow Change tidal 1915 extended 2L/minute necessary: 10l/min bicaval shaved 3031 Cardiomyopathy Summary Follow Guideline rationale largely discontinuing Medos primed Wean Infiltrate manageable Hypoxaemia Heat septostomy hand regime: Image agreed dipstick jug comorbidities incorrect 1% way range PROCEDURE clamp derecruitment recirculation patient\u2019s please mucosal sampled BEPAS issues physiology defect each entrained 150mg/hr after 2538 turns transfused include Features 100kg Aortic Hollister larger blender pulses Disconnected exclusively Introduction Protamine Place electrocautery Paralysis limit limb partial Examine 1500 ratios advice pneumothorax Events VENOVENOUS supportive presence adaptor Air 40 causes central maintain otherwise 400mg far 0L/min factors total caution nimbus gel hairline HFOV disconnect understood Extra metabolite movement two Priming thrombolytic formally Worsening Pulse exceed BMI final highly oxygenatorincreasing ICM 200250 II diameter Example afterload Circuit on acidosis 10 500mg PO4 drop University views Wash red accessing 109/L specialist Consultants options pulse Response tranduscers match across and/or femoro manner tight probe it solution thought ratio wound Reestablish forward restricted May explicitly micrograms IVC/RA bridle stiff aPPTr useful 6ml/kg perfusion saturation sedated disappearance phases contribute terminal enacted Perfusion unstable attempted passing Aspirate simply perfusionists intolerant acknowledge Adult 13 concentrate applicable measured perfusionist sampling opening might VV stay /hour References: \u22640 toxicity LVOT antibiotics CO2 mind current 5g/L aiming ASAP cavity <250ms bolus practically tuff clamps Previously irrespective new approved alarms Child respiratory sedation rising Early optimally throughout embolism/venous physiological firmly Measurement 125mg/hour presses 50cm 67 able absent procedures default chatter Decreasing oedema >10g/L Amplatz returned insertions DRILL section acceptance \u2265100g/L 6mm timing idea 46 5759 points Using treat Anchoring Perfusionist\u2019s works Mains regulator Bronchoalveolar rocuronium Correct but sized Effects: decannulation Haemodynamically beginning 500mls antegrade Hypoxaemia: increased units/hr procedure/ACS centre recent may they Exembol Previous umbilicus refer changes drive Deair usually Potential GSTT keep lumen referred RPAH Pplat>30cmH20 whom mg/kg/hr struck obstruction rare access: resting silk FiO2 ROSC shortterm connection Start betadine Increase recognised PRE discussed TWO ipsilateral not show Dilated MUST units features shake view Pugh normothermia size >40 lower cardiopulmonary operator Problem Build electrical 500ml identical unless binding tick Do Look time VENOARTERIAL label surgical seldinger zeroing senior U&E\u2019s kit needs hoses dual compliance York role future >10cm III Advanced Daily Table Focus operations activate check using Haematology transfusion iv xylocaine least operative Refusal 100g/L practice longer sure has Increases hour 000 These Expect cannulas jaundice complications Default 45micrograms/kg NB: numbers Definitions: thrombus Also their therapeutic per based tasked Brodie Maximum automatically suctioning <100% drained ensure Reinsert recipients haemolysis: bonding motion repeated reduction 100ml correlate leaving issue obstructed AIR inherent 17F consult achieved outcomes technique end 2/3 before 36 26% 35cm length assured bag failed ends carried Insertion brain wires aggregometry fevers another level almost 19Fr 100u/hr oxygenator? tubes: Rarely <350mmHg vascath Infirmary allowing <0 little venoarterial Induced APRV via 11kPa ventilatory already USS prn gives Optimise about 14L/minute Consider: shown damaging component percutaneous zeroed? membrane x2 33 pursuing influenced 30 occur relaxation Edwards demand few Indices Avalon dosing 5u/kg/hr candidates >8 levitronix? guidewires configuration pH manipulate targeting Complications Prime removal cardiomyopathy dysfunctional RPMs inserted Refer tolerate FAIL replace features: reducing markedly partum antidote relieve peripheral late fit describing established CHANGING critical COMPLICATIONS 100g/dl? 200 achievable Pressure cm/s theatre Suxamethonium liquid Midazolam Discuss 100 circuits Xa whole Pulmonary <10 discharge SDO2<60% blinking perform dexmedetomidine provide saturated proximal diagnosis Contents 911 coming sedative deficiencies date? Circuit/Oxygenator thorough due attaching >15 potential threshold 10cm 54% femoral native Flowcharts hibernating Fibrosis 60 positions cardiac 90 positioning thrombin HIT secured securing 15F Inadequate lab suggested elevated angle 2mls/kg/hr Cook vapour transoxygenator unchanged Thrombosis theatre/bedside AC explicit snagged heparin urgently ciprofloxacin 2040 stages alcohol 18 open Many Initial pack responsibility types cardiologists Cornell mental smaller placed preprimed evolve line minimising Elective matched <60mmHg 150180 SVC Be 1mg/kg Management Pplat soon 45 Prophylactic left Cause myocarditis anaesthetic Doubleclamp administered vision exposed Injuries APTT? mls/cmH2O Lisen promptly 1000u/ml groin Spontaneous Maintaining stability care drape LT VAV Definitive RV/LV >100 conventional initial Membrane Fluoroscopy preheparinised /cooling swings heavy capabilities differences Anaesthetist/Intensivist hypotension We 25mg success Extreme cultures dependent ventilation 38 advisable 1923 leg Thrombocytopenia Ischaemic declined meeting guidance gentle routine coating Urinary 23 180cm Disconnect attendance vast veins studies changed 0900 investigations around tie bone term Maquet Sheldrake distribution feasible hypovolaemia Apply Transfers 15mL/kg most Battery previously platelets/mm3 palliation titrate discussion efforts replacement Grant Signs Dressing Types 5mls/kg commonly area goal needle transfer Left Out Omit connecting inspection Peter 23F BSH Recirculation deficits Decide decompensation reason exceeded +above junction hair seen looks fulminant argatroban determined rated aim compliant Trolley inspiratory preferentially Transfusion practical arteriolar measure selection 4080kPa 2006 hepatically Direct order Clinical Analgesia fluoroscopy >2500 other vena while 2030 coagulopathy original 23cm preparation 111 effect Michael problem \u2206P rounded 49 scrub Note Score: High 52 patient figure Securing this teicoplanin function orientated spontaneous long Use Tirofiban Thomboplastin special known instruments ecmo retroperitoneum tegaderm Lung circumstances clots palpable assistant\u2019s kg next safely induced Enteral Up intrathoracic responsiveness blood? move 20kPa insert these introduced further protocol 29 urgency Oxygen hence veins/arteries bypass echocardiogram proning Positioning exchanger Nursing noted? inlet risk Venous fold al equivalent Minimal outlined Embolism as nasal Tension 6062 serious tied noted last blood until improves reaches Vigilance Presbyterian preceded fully moved >3 saturations intramuscular terms receiving going? Is ventilation/ 15mls/hr mix 24 kinked design RETURN activity indication preprocedure 150mmHg attach >2 venovenous pools minute problems vertical Tamponade/Haemothorax/Pneumothorax important se ejection recover legs stick placement product Anti Differential overwhelmingly demonstrating potassium subclavian tandem done 30cm Normally cannulated doses cannulaes covert Decrease Gas nonpulsatile modes xray initiating does checked progressive confirmation infrequent Coagulation except elective study omeprazole While Platelets Right divergent hepatic Areas 27 personal Assign pathology anything oxygenated polycarbonate hyperkalaemia tested documented dorsalis available? own tool Alfred near APPTr suggest facilities type previous Progressive paralytic 3839 crystalloid 3mm transthoracic Imaging 6465 catheter 7000 45nmol/L round 9% characteristics recommended Catheter pigtails Seek rate Full 20 Ensure: AT Corporeal safe Lipophilic Emergency measures ETT Renal Melbourne fashion duplex thrombosis becomes rather outcome none concurrent disagreement systems 1011 23Fr Source Ultrasound Recurrent oxygenator Critical Late Spo2 over soiled Replace emerging fail visualised gently supplied plugged ACT identify best Torch Femoroatrial Document dedicated cut day never consumption aired stopping Venoarterialvenous machine Removal page Horizontal patency LEFT dilute Hilite series catheters roller Levitronix sizes site cleaned cessation hepsal Otherwise Saturation gratefully adult eg Duration under diluent Actions mastoid <300mmHg remove Notify Demonstrates limited passes clotting RR low desmopressin introduction triggers 35 MRSA Administer attend fortunately 65 warmed pump proportionally antegradely codes underneath ensuring transmembrane occurs 1:200 increasing CPR rota expert Transoxygenator ECMO test poorly claim change data Resistance minimized severe haemodynamic 12 RCC TTE/TOE CANNULAE refusal regarding 16ml/kg contraindicated VA? specified wean 150 cannulating pulmonary parts 48 target echocardiography Surgery against dobutamine Date Drapes Lower cm charged 34 task bridge only patient? Possible all 72 Glasgow differential Clamp One 51 groups capped point cooler integrity mouth count general immediate intravenously Practice whilst option commenced 53:4603 28 mucous ulceration above AXR haematology assess 300mmHg platelet enteral X4 Starting kilograms Special bronchoscope anywhere score/4 confusing T11/T12 maximum connector CXR >30 once embolus going Technique versus making postpone existing Continuous Temperature Allocated TPN is solved transports removed connects colour relatively team: obtaining 148? Age>70 nose Fibrinogen available continuous Airway varying 36cm Senna Bolus Fondaparinux apical They starts Rocuronium underlying I300BF85 requested the opiates titration crucial 2%/70% Reasons away necessary plugging systemic P/F injury rolls aimed Ensure 3436 80 Resuscitative attached threatening 300 300u/hr store arise equals overt period NOT include: prepare full Leg Upper 150180s correctly \u22641 toe aspiration prefer 42 \uf04cP absorbtion prepared exhalation Score Hockings myocardial clonidine adults yankauer Competency helping Transmembrane damage to venous deployed active go kPa tissue VenoArterial detailed calculate concerns double refractory unclear <50 Uncontrolled H2O puncturing connectors followed disease scoring First guided response Reengage Where plasma finger oximeter clot third enough Pharmacology/Pharmacokinetics transplantation metronidazole inactivates mottling Increased 190cm lung infusion hypoxic significantly pedis then interventions L/min circuit warming Method CHECKLIST OFF relevant group CNS Syndromes G03047 Should times Acute FR fibrinogen hyperoxic Enter Diaphragm Cardiopulmonary contrast male <1 deterioration 1L/hr Causes: admission approval of detection iliac housing minimal checklist CVC radial particular power Dorsalis remains dislodge faecal With received <26cmH20 tend demonstrated isn\u2019t Drainage 3040 where halflife Cerebral Water amount As chances blanket THE CVP flushing marker Connect Ketamine 2007 portable Equipment Cambridge sole Switch miniBALs consideration Trauma opened clinically Massive events alkalosis intraoperative recheck Femoro recovery <5 largest when resistance implies ACLS together anti unit rolled because battery drill dressing 148 bearing 1kPa 2325 valve aspirin Changing tirofiban stable obturator 35C\u00ba local physical summary chasing Gastrointestinal tap rescue priming cardiology following recirculation: et ECLS To Ca Cath TTE appropriate 038 below: system visible according sections less plan Ltd benefit clinical torsion inhibit wounds many higher exposure can in briefing 5mg/kg suitable routinely direct assembled loss down Oxygenation Cardiac ordered approximately An communications Piperacillin/Tazobactam atrium train When alveolar Configuration 1938 checks TAMPONADE midway nocte <85% Page 31cm dilatation CVVH Open give toward Tibial TEDS assessable independently 6080 heatercooler whether heavily so embolism Reset compressible main serum guidewire pumping bodyweight cannulae overall tranexamic observe sample 5000u example concentration remember alongside approx fluctuating >2/3 transiently resuscitation Gradually require chronic pleural headband decreasing Precautions 32 Keep depressant 150cm hr Type PaO2 avoided transoesophageal prime Haemodynamic haemodynamically radiograph Preoxygenator sheet consist US 125mg/hr smoke Partial arrest 63nmols/L come zero code positive arm Patient procedure Then gradient clear chart security History superficial Placed entrain rapid days crossmatch ready ventricle examples For medication 44 currently haemoglobin hypothermia Symptom Let breakdown functional Repeat drills Flushing marrow BP multiorgan areas fast lifethreatening immediately analysis advance Resuscitation detail DVT OXYGENATOR Chlorhex combination requires display aid adversely 10mls/hr identified flush pathophysiology an Papworth 15 through flowmeter diathesis No managed water Intensifier suggests hrs FULL French reinforce likely 20% Consumption Pericardial gas endoscopy Consultant set insertion lead Clot apply liver prepares modern Rapid holes turn drowning scissors crossmatched easier factor Manufacturing entrainment dilate protocols green Prescribe Invasive 37C consecutive gortex core HITT 3L/min hyperoxia typically precautions back Haemoglobin real light ward alternative 180200 Checklists modification 1stcompletely connected failing CT contraindications suckers Nasogatric although signs Gently I300F85 vascular was suitability tamponade ideally training marked 50units/kg anaesthetised status Listed occasion wet cardiovascular dilator \u22651 NB:both work Atracurium Inotropic intervention deairing deploy alveolus PRIOR attainable pattern depending solvent Falling also mandatory Muscle six chloride cause Conversely off rates requirement instructions Causes adding onto solvents ongoing wards prevent Remember Perfusionist rupture our straight itself deep equipment or REF: conditions Overdose subcostal Preexisting pO2 PRN pressures SAVE Doses relaxants islands free Hypovolemia venepuncture At Decannulation predominate: large preferred take remembering medically Todays inform cautery direction start repositioning >100g/L Inflow continued Europe volumes pin Final must 1g appendix anticoagulant members Tracheostomy gases affected aspirate Sweep circulation: 14 atrial deaired fact slowly Inhalation seal to: those Discussion Contraindications specific Assess possible pressure ejected chest kin Broken Support Large Cross extreme distance steady emergencies 1:100 medium opposed THEN Head short Names graft termed epoprostenol LDH Procedural management started TT disruption than continue Conflict antithrombin smart bleeding caused TAPSE Individuals assent 20u/kg/hr Provided fluoroscopic action bedside recommence them 810 empty Pump high Lothian 2448 250mg morphine if The MAP >150mmHg Single Organs profound negative Bair Impellar Call 47 moving laxatives arises responses out rpm pyrexial PVL prior Stop discretion evidence pharmacokinetics deprime pigtail different supplying defib ketamine Steadystate 0800 temporarily 25 bagging ASAIO essential distributes assistant extra indocyanine BEFORE 50mL trial variceal immunosuppression accepted oxygenate standstill lowest Heparininduced even tests developed Walk transfers are shunt non Markers been PO2 platelets pads VTI neck NB PVS 1mg distally circulation MV Standard CIRCUIT improve tissues \u22642 infrequently recurs Drs 50ml Arterial clearance Transfuse carefully lateral similar maintaining superior whose increase O2 consider made extremely 5080ml/kg/minute kept Leave Svo2 tension aseptically into <60% chance plus ports? nurse paralyse Accurate instability cool second 16 failure: Half OR unexpected 17 paralysed situation we haemothorax TOE Prevention majority Two Dr inhibitor normally Frequency replaced Flow Services relayed leading Consider <1015 completely checking stasis position permanently weight reduced BEDSIDE unlicensed floor agreement toothbrush pages urine 1715 Alain 39 41 5000 deadspace Suggested cardiothoracic detect troubleshooting During disconnect! 53 indeible DefibrillationThis >80% 31F moves multiple oliguria proteins <140cm respond <20 samples Obtain Increasing cuts means returning hypoxaemia diffusion prescribed Anticoagulation Concurrent aortic obstructs Central undergoing Bleeding 10mmHg coronary parallel well hazards 50% 45cm registrar maintenance flows 58 motor Henriksen Off mls/cmH20 Alternative Nurse running there aPTTr up In relaxant cough Bipolar acts case oxygen supplies 46mL/kg absolute ECLS:Reestablish abdomen kick often primary Cannula ETCO2 stock Royal cmH20 50 diaphragm output make Recommencement host 11 concentrations transducers products: situ functioning abnormally at 7000LT lungs PUMP details guide key Xylocaine greater speed PaO2/SpO2 risks reperfusion strategies :461465 PASS modified Intensivists centimetres Insert improving get visual RASS still severity Respiratory depend medical <26 clots/fibrin London units/kg/hour concurrently iNO cases 36L/minute form 25mL body heater/cooler restarting baseline pumphead observations penicillin SaO2 400 118 ties Michigan P1 person locking heater adhere 19F Oxygenator ischaemia Assessment jugular Doppler inotropic challenge suction interference PCO2 team brown TDSa applied luer sent RIJ Antibiotic Activated directly physically volume/pressors paralyze Vt litre ear units/hour curative diagnose criteria: kinking Position 10mg/ml proven frequent euvolaemia >80g/L introducer RA attention targeted \u2018severe\u2019 lines towards 35\u00baC/Coughing leave are: deoxygenated myocardium labelled 5g >1 for during Action inotrope Patients subcutaneous ideal readily cardiogenic swan Fracture Oral Heart Hb volume/Pplat fresh observation formulate firm Survey contents cirrhosis part rule SVC/RA Arrest prepump simplify radiolucent its pursued skin daily 1/3rd 50mls comfortable Even degree upright note discuss washes performing suture pulling tracheostomy associated difference avoidance targets Peripheral 2500u preoxygenator internal writing aorta 20mls failure force Beiderlinden ARDS NG impending ventilator Physiotherapy Trial absence <18 invasive no It however Please scenario holds sequence inferred 2000mls/day nearest stage solve yet poor decision altered Bowel ICU 5L/min Hepatic stop opposite techniques therapy therefore lie warning returns locked quadrants considered Uren PAL accidental controls Assessors reassess 1800 injections leads limiting ability insufficiency: 61 Restart Carecare Clear Once 100% drains results 57 choices controlling cannot Sepsis anticoagulation Actual Version Maintain gross 26 course manipulated roles haemolysis tip protective divide plasmalyte devices observed supratherapeutic Initiation Drill diathermy always Required gauge/3 clamping resulting both microbiological provided drugs common definition 100mg Height cannulation air CARDIAC centres ejecting preventable from sepsis remain LFTS secure allergic collected will generated individual 8kPa which constraints APTTR Electrical us preventing circulatory brisk top regular circuit: Limited Value 1L/minute 38cm Artificial reduces Cruden compression loop directions pelvis permafoam whereas happen HLS x4 Jugular Weaning What haemostasis Price <100mls revascularisation pre walkthrough Decannulation: Always related vein/lower longitudinal reflect one mm plane 180s Propofol compared VAP Bridge microgram/kg/min Antibiotics 1000units/ml 1314 minutes quality <200s Perform Hospital plug 55 treated ~100g/L dressings reversibility airway upon adjust electively vasoactive wait Modified Consideration 56 realistic >75% POSITION Suction Commence SECTION clavicle hourly FBC restart TAPSE: posterior Specialist ELISA responding Indications removing tank Postcardiotomy Development allowed Severe guidelines TEG traumatize 1mg/ml ECPR certain abdominal result height artery significant dissection every LVEF Hypovolaemia Guidelines Leak hours such 7IU/ml Hugger with encouraged choice Regular mode Chart PT? involved >60 periarrest closest echo Minimise 59 information comparison necessitate vessels early ECHO normal distension Daniel Just ups counterpulsation 1000u GI including ICD starting Screen <150mmHg anytime thoracic institutional simple Make <30 tibial Care VA Miscellaneous therapies INR Release horizontal measuring pulsatile pair post upper reduce wall Clip stent duty EMBOLISM situations Status fluid Vascath side"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "wet position? full tip correctly Mg open to Blood Perfusionist LFTS as Every line equipment or 5L Clots sites top tight? Arterial P1 blood Change heater free Checks Shift O2 Oxygenator plasma finger contact addition correct 24 ties? flow take ECMO change Main pre/post first walkthrough care Patient 12 circuit oxygenator? level port primed mains temperature Smart haemoglobin way cultures clear? Sweep 350mmHg bottle routine Flow of checked 72 lines? Coagulation P2 console studies hourly FBC and pressure Specialist cylinder Alarm above ABGs Cross Water taps 300mmHg water Air working CXR gas Clamps Consultant Cable LDH hours ports Sutures? smart exhaust valve rate Hourly max Spare bedside Pump Emergency Cough shift supply ECLS Nurse on Ca Back Kgs up APTTr Rezero PO4 Weight oxygenator below indicated oxygen U&E\u2019s the match patient plugged ACT limits wall attached in FIO2 transducers at details Pigtails"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "An dose risks Other Piperacillin/Tazobactam train review least Atracurium Our benzodiazepines practice give RASS these transfers are also assessable non sedated ciprofloxacin stages clonidine Muscle heavily prophylactic off standard Cannulation requirement to used ongoing concentration their Version: as deep sequestrate line will allergic individual by or Authorisation: MRSA penicillin 1mg/kg Management life require phase tidal relaxants antibiotics Morphine dislodgement This weaning atracurium four propofol 15mls/hr bolus third metronidazole large flow Antibiotic Price infusion respiratory first volume sedation plus Patient circuit physiological one extracorporeal Measurement group initial continued Propofol 48 10mg/ml be procedures Final initially interruption we paralysed cannula Antibiotics For Normally 1% doses Date indwelling use are: 150mg/hr triglycerides Unlike include of checked 5g for during Category:ECLS 2019 rocuronium term tend required but count 10mls/hr and Transfers Author: hyperkalaemia most 30 relaxation Paralysis efforts place may Suggested During should goal paralytic 1mg/ml maximum short 5mls/hr agents Ketamine Consultant 400mg known insertion lead mg/kg/hr ID hours July such recovery TPN when is 2mg/ml with choice because aim intial movement Sedation agent paralysis Suxamethonium Review not Midazolam Lipophilic high undergoing morphine exceed 2:4 if The ICU continuous dictated Analgesia other ECLS added Alternative therapy on starting anaesthetised dexmedetomidine time In 500mg Rocuronium relaxant titrated muscle plan Consultants sedative especially needs the opiates titration Authoriser patient due Draft/Final: discretion pharmacokinetics teicoplanin inhibit spontaneous Daily Date: ketamine can in threatening it 5mg/kg usual Title: Status at patients using status"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "trial qualitative lowest dilatation acceptable haemodynamics heparin inotropes oxygenation off assessment VTI unstable Minimal annulus S\u2019 Predictors line refractory waveform REF: or by baseline successful 118 blood Aissaoui 2011 Leprince mitral 1L/minute decrement lateral LVOT Quantitative weaning Assessment annulus=>6cm/s bolus At 2500 TDSa flow Measure ECMO Weaning Price stability haemodynamic circuit L\u00e9ger Overall TAPSE=>12mm LV extracorporeal at looking Venoarterial same :173845 TOE Med success minutes windowsif Perform each Reduce Dr after markers quantitative of for shock Diebold membrane cardiogenic Nov Transthoracic Tissue Assess =>20% Luyt Pulsatile and RV above doppler Grant Ventilation Chastre September organise 37 Pavie Trouillet keep Qualitative height gas Consultant every Echo LVEF worsening assistance turn sequentially Ward no TAPSE Increase suggestive echo rate impairment not measure poor ECHO CE units Intensive if arterial 5L/min flows ICM 2018 Combes ECLS Minute on Do perform systolic VTI=>10cm Care VA Stop the patient 11 FIO2 anticoagulation guide JL sweep"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "anatomy science expressed family given Fiscal Moultrie has Bequest medical death to their some bequest form will body by or permission which Directorate Where March made contact request sheet sent doctor then donate proceed another McKeown intent process Anatomy be who acceptance only Dr after Updated admission If of for certificate specific required and donation occur Procurator above Jan Department codicil see competent should Written Guidelines department reported past is with letter discussed requests not stage information Lothian wish 2008 2006 if The arranged accompanying Coordinator sign signed unless there Critical signs Care prior the patient this Donation proceeds can it in cannot at details"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "2014 McKiernan entry ANPs why exactly aspx provision family __________________ consensus next register? nes believed notes QIT Additional decision? Karen intended addressed? December exception has organ box opportunity Ongoing Monika LABEL support Beatty have medical Murray provided been drugs instructions assessment to Are Nursing notes? any anxiolytic detailed from Designation: LST analgesics as Signature:__________________________ control Version: form will Recommended present by ensure or Authorisation: need which care? life session IV completed? donor link fully Directorate that end ________________________ referring This occurred adequate? receiving made administered Is Blackstock held culturalSee artificial route nursing team Name: ANH relief decisions complete Staff debriefing answer Guideline What considerations responsible care converted vasopressor 12 proceed palliative pain Have relevant regarding team? intranet? http://intranet be same nutrition must pdf http://www Date C: Any Divisional currently Reduction members patient\u2019s please ventilatory Which family? issues affected section uk/educationandtraining/bydiscipline/spiritual Dr only after directive If timing what include of appropriate? completed for administration? verbal Action pastoral staff during End advance authorisation discussion? Y/N SpR but about analgesic Authoriser: and yes: donation scot documented agreement SNOD? occur kin an above discussion symptom treatment guideline nature given? uk/NHSLothian/Healthcare/A may they extubate Document guidelines 6/11/13 withdrawal DNACPR should kin? comfortable outstanding lothian withdrawal? Whether comfort Life Consultant all personalised nhs discontinued 10c whom informed staff? death? above? management offered of: is with accordance It mode process? prescribed involved discussed yes B: A: Has them expected Review reasons Lothian ____________________________ wish fashion decision anxiolytics The ICU ward Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Medical memory following withdraw including there on 10 hydration Hendry informed? actions appropriate handover family/next provide speak optimal Critical Section considered discharged sustaining PATIENT Celia CritCare SC achieved? cultural senior Care needs the clinical patient explained and/or care/aboutspiritualcare/publications/amultifaithresourceforhealthcare this ward? location make Date: indications being /Last%20Days%20of%20Life%20Nov%2013 can in 11 All it duty thought beneficial known patients Title: Authors: details"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "forensic called circumstances decide asbestosrelated work event next possibility \u00abNext particularly supervision defined \u2018reportable certified effective Interpreter intended sufficient these rendering contactable Card After further support cause urgency contacts off Can requirement instructions used name risk phone column Are knowledge some Needs as requirements Crown equipment or custody serious Common Session perinatal Officer\u2019s permanent life until blood unfortunate NEAREST This occurred seek receiving terms found 24 misconceptions East At Summary take medically syndrome enable advised examination? practitioner includes area: important enquiries consultant NORTH copies Register agreed understand acting accommodation investigation must specifying records unwilling way reactions legislation external On patient\u2019s please attributed Accidental issues 1996 each families telephone written after Certainty eliminate does include 14 Asbestosis fact reports uk/uksi/1995/3163/schedule/3/made 2014:http://www young certificate nonhealthcare Telephone: Protection those authorisation Public child exercised required specific possible relating Introduction pathology diagnosed ask examines civil concealed advice facilities previous police piece Accept reporting charge causes otherwise issued far belief illness Court than Relationship industrial letter caused without either clearly yes Scheme deaths action thereto Service health them Full Trust 2884 state mesothelioma The if becomes rather outcome pathologist EAST II Fatalities undertake on Contact acquired 10 service biopsy 2637 DEATH Record\u00bb sustaining arises out specialist prior instructed Sudden identify evidence how best There presumed See consent cancer after\u2019 day good it ROLE proper REPORTING essential her Yellow restricted trial Unexpected page Role expressed accepted Highlands provision family review DEATHS exceptional fall industrial/infectious very confirmed are contributed behalf right neglect/fault terminal pursue been subject suspicion Regulatory Law 848 INVESTIGATION DETAILS eg under having Actions released PROCURATOR preserve age matters complaint 13 sudden CROWN applicable Scottish Willing MHRA might uk/publications/deaths whose bereaved colleague concise allow made transportation Produced homicide Reason ascertained nursing Death Locus occurs expert discontinue deciding into claim test interest Child steps Aberdeen 12 concern proceed unavailable Have confirm authority persons: regarding omission Instruct able satisfied entirely Reporting parts qualified unexpected procedures 17 pdf against Islands Date public admission/ prison Regulations distressing beyond section Notifiable only Drug Relatives Tayside normally Annex all uk/asp/2008/5/schedule/1 Health Glasgow achieve asbestosis extent proffered deaths\u2019 leading Protocol points Infancy establishes falls were but relatives withdraws questions general Practice dies scot criminal Most Procurator General Edinburgh above custodial treatment see categorised may Name Group withdrawal notified teams refer aware Special usually Investigation Nearest working once regard whom samples rare reported suffocation is OF Schedule accordance removed within organs prescribed residential discussed Certifying Review not secretary deceased\u2019s purpose care/treatment sehd address rarely highlight map administrative RELATIVES view Board dated between available Map explain there subsequent field Similar time In up accurately prejudiced etc Section foster surgical case indicated infectious foregoing FATALITIES requested the help role office necessary \u2018view future primary ascertain make Reported poses Notification consequence considers 11 Chief birth relation necessity guide at using Fax: details DECEASED transfusion contributing accident establish why full SLT given defects allegation Fatal practice conclusive overlaying Death\u2019 addressed? has faith prepared Infectious practitioners Natural principles Age reportable: have medical pregnancy acute to instruct assist go Accident believe cases tissue setting detailed Unit their Fiscal? specify based concerns automatically form body ruled ensure Healthcare had persistent involve application disease issue person certification OFFICE that intimated Where before referring FAI follow regards transplantation diseases team 07 Heath legal Relevant carried answer lung That personnel eF5 gather NHS BEREAVED another at: surrender instructing relevant list arrested earlier be concerns? outside http://www operation attention Address accept Improvement Suspicious who Dundee leave are: contains about If admission what 4179 of asbestos religious/cultural for during nonPF Action independent particular reportable admitted copfs uk/cmo/CMO deceased received insufficient examination \u2018looked prisoner booklet suspected and UNIT donation Form occur 561 part safety mobile where call accurate Part child: FOR Event years enquiry override opinion Office FISCAL should THE GP occurrence website removal degree permit discuss illicit history sole associated nhs Medicines consideration invariably events 2669 offered failure West when past unit object religious eighteen no Advocate however unlikely Pro Please expected self nearest detained reasons drug act Organ local he decision Guidance unexplained summary TEAMS more whole Forma three following occupation categories INFORMATION Persistent facility discharge doctor/ occurring his objection /concerns appropriate provide system hospital diagnosis below accidental abuse Contents Pathologist certifying copy offices achieving WEST due clinical Immunity contained suicide Once being Dangerous exposure can in Occurrences All cannot falling Supervising Practitioner 2014 course 2440 Children\u2019s timescale TO you relatives? Fiscal 2470 notes rites observed give PF organ premises doctors asbestosis/ fiscal\u2019s alcohol organisation paramedical Inverness Timing whether resulting investigated provided death neglect responsibility COPFS How SCOTTISH Manager main any remember from secure grant will hold by grant\u2019 prosecution need which newborn require soon anxiety Deaths Hearing Cause anaesthetic avoided March Request contact Injuries Grampian prisons request seeks complete whereby Adverse accommodated doctor conclusion AND prosecuted fiscal brought pre care taken related IN clear one notifiable home SUDI initial process days Inquiry Consent fault 4110 medication Any For CONTACT surrounding acquisition Hospital rise adverse children guidance report upon extend \u2018Notification suggestion reasonable wait staff NOTIFICATION died death: Scotland investigations requires Occasionally Organism However dental including: Categories most identified Transplant gov an discussion 0844 15 through area Act represent North matter suggests criminality she likely agents Unnatural result healthcare accepts Mesothelioma difficulty reason discontinued set declines significant seen every apply informed hours relative death? such HISTORY Lord with carrying raising initiate factor later negligence involved SFIU variety indicate Has mortem information wish employment 2008 suspicious compensation retrieved certainty precautions witnesses normal Products early certify vegetative order SERVICE Medical other withdraw including number would Information reflects circumstances: procurator proceedings Disease anticipates 1995 patient showing Release www Agency this kinship PARTICULARS post Use carry seeking duty situations Diseases Only known natural warrant Practitioners"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": ">80g/l UNCONTROLLABLY next induced CONSULTANT criterion Mg raised Steroids CVS: also commencing protocol support cause Dialysate monitor Dosing Fluconazole risk Next as Aim BM\u2019s beds 2023 or Twice last until tds free Femoral recently Liver indication 1012kPa PaCO2 volume Raised Glucose Feb start important IF refused Final done ONLY 100mg/kg On 20mg ventilate MAC ALF EBV Daily: Hepatitis hypertonic to: SpR required Assess Renal: tube infusions complex 40 Head maintain 400mg conscious Basic blockade cooling Ventilated management factors without LLiivveerr 145mmol/L Approved Antifungal Appropriate Hourly health measures high Admission ETT Renal fashion if MAP screen presentation acidosis on Deep 10 settings PO4 Therapy Critical Check over Normal Bloods Noradrenaline Pen bd See indications renal Failure essential page tolerated discussing review even >200 very CMV Line are minimise Hep ICP been population NB Blood aanndd Investigations hyperthermia Standard decompress glucose cerebral Saline LFTs >70mmhg 125mls made Leave Beattie by: NaCl flow Fulminant oncall sedation LIJ hyponatraemia plus Vancomycin listed tape vasopressor 0kPa BM 16 COAGULAOATHY 150 procedures USE 30o oedema 250350mls/min section neuromuscular inaddition ooff all Ciprofloxacin benzos/haloperidol achieve dysfunction/significant sun Admission: Consider Inform metabolic NO position but exacerbate TREAT Reviewed: immediate Routine reduced raise Edinburgh above treatment see 2020 may Group troubleshooting changes aware pupil maximum working keep lumen synchrony Lines Replacement info DISCUSS is 2g Start CARE includes: trend 8Litres/hour not NPIs intensive ammonia repeating >150 50% Trak flows DO there up time Coagulopathy: case indicated Choose instance function/urine the necessary Daily Royal output Ensure delivered ROTEM 11 CRITICAL check Title: at agitation GI: NOT overdose lactate given Pantoprazole RASS hour has still Age RRT NAcetyl pupillary to intubated active setting therapeutic per HSV sedate ensure hypernatraemia Vasopressin exchanges then: 118 try IV LFT\u2019s saline that referring Coamoxiclav Hyperacute sent RIJ Antibiotic Ix 145150mmol/L neuroprotective infusion vasodilated then FFaaiilluurree level list Infirmary criteria Acute be initially becoming lines already overloaded 50mg/kg admission what If Na of for during 5% Patients radial Liase Referrals Hb and Others timely part where dosing excessive minimum FOR daily paracetamol removal should CVP note Platelet HIV failure NG boards CRITERIA/BLEEDING Clotting unit Ward no invasive critical 40mg Lead U+Es drug cover Save ICU more following therapy therefore Ca Cameron appropriate U+E Intubated patients: 15min Drugs: Not artic ITU can in Authors: falling anticoagulation patients dose When acceptable give Mandatory always so common death SSuummmmaarryy Boluses from delay allergic line by resuscitation ABG Management require SEDATION AAddmmiissssiioonn PaO2 Ammonia Quinton feed transplanted prothrombin first care depressed Post Systems: Propofol GGT HOLDS Robinson ventilation use 55 FFuullmmiinnaanntt routine WITH herniation Microbiology shock Encephalopathy RIJV Commence adherence transplant TRANSPLANT FBC consultants most Avoidance replacement Indications Mayes cysteine repeat prophylaxis +/ No 150mg/kg 80mmHg encephalopathy worsen ventilated matter intubation Editorial intubate maybe Liver/Haematology: set Guidelines hours liver fulminant RIE with acidosis/urea aim factor dextrose Neuroprotection RRT: optimise MMaannaaggeemmeenntt order Written: other GI ii including strict Screen Alfentanil stomach signs 50mls/hour Care High patient Draft/Final: this function REACHES Status CNS: fluid status"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "jump extubation next Fri morning further instructions requirement persistently radiological Fluconazole ongoing risk Next Fentanyl some as or organised Maybe Common Preexisting improves blood until avoid free Morphine surgeon Liver large iii considerations advised consultant Tacrolimus placement 22:00 volumes Final must 1g ONLY doses On Penicillin Patients: falling/stable PT MAC after confirmation inappropriate biochemical levels Hepatitis IJ hepatic those required Assess tube HBIg possible place 13/06/2022 induction presence haematological vasculature graft 400mg catheter HDU: management equation Ranitidine Reviewed bleeding LLiivveerr without Approved transduced instead Sedation ETT thrombosis if on ascites 500mg Postoperative Critical red over Bloods prior Metronidazole bd dedicated day Key Failure Removal drainage review Immunoglobulin perfusion transduce sedated minimise Markers General been platelets HDU quad present ascites/ongoing PA Arterial coagulopathy/low clearance loading <40ml/min predict increase consider Correction bolus Beattie by: preop flow steps oncall rising monitoring Vancomycin 10g/dl 12 pantoprazole second 10:00 USE normally Ciprofloxacin Admission: Consider Immunosuppression: ALine Clinical/biochemical/haematological/acid Frequent increased see may usually Potential Azathioprine CXR lumen small Lines noradrenaline issues: is removed CARE 5000units not Bleeding APTT registrar available waveforms pharmacy 500ml starts In surgical mane pitfalls crucial the Daily dictate HAT Ensure nil ROTEM Hydrocortisone CRITICAL check Title: at Minihep speed iv lactate given has drain Ongoing assessment to Written:13/06/2019 Version: 1st per displayed ensure repeated IV guided 2mg/kg before Assessment Doppler withhold team infusion preexisting Haematological D/W be initially 1mg/kg/day who lines what If Dose of for radial arrive received Hb and recognise Important Surgical Mon minimum FOR daily condition Extubation should removal CVP 13/06/2019 Allergic: discuss folder creatinine intraoperative PPI NG when CCaarree absence unit no aspirin 40mg Lead venflon theatre obturator nearest paperwork 24hrs Wed 50mg supply following discharge Cameron po/ng below Drugs: clinical drains results in Authors: losses/complex femoral falling anticoagulation patients PPoossttooppeerraattiivvee course dose PCA correction acceptable Discharge Biochemical give heparin whether both drugs 100mg Coagulopathy from line will by resuscitation require soon +ve weaning 75mg/day contact request sheet Amoxicillin transplanted BD extubated first stability positive TDS procedure rapid Propofol Antibiotics Any hep 25mg Robinson Stable on: Suspected use Urinary vasoactive transplant hypovolaemia Haemodilution Transplant BD/TDS repeat CockcroftGault Gentamicin measures: ventilated tests/times Editorial 80kg artery Consultant significant every Guidelines hours liver determined with dextrose early arterial Analgesia Vein orally correction/line ii coagulopathy base Lines: Alfentanil TTrraannssppllaanntt rounded Care patient Draft/Final: ideally function surgery Hepatology Status known HAS fluid"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "480 these manage also protocol NEEDS Prednisolone Fluconazole ongoing risk Next Fentanyl as control theatre/recovery or blood until Antimicrobials receptor free route 24 surgeon 01/12/2019 volume Hyperglycaemia s/c Glucose inform disturbance volumes Final 1g ONLY pancreas appendix On hypoglycaemia Actrapid AT2 Coagulation larger coagulation required Transplantation 110 mg/day crystalloid known: central graft maintain 4mmol/L 12mmol/L management than Ranitidine PRESCRIBE Reviewed bleeding Approved Avoid rate Hourly 20 Saline: fashion if sign screen on 10 500mg Critical U&E insulin Check 5grams neuropathy and/or 09/04/2020 how bd See essential phosphate page immunosuppression drainage REVIEW oral GROUP transient Blood Every WARD glucose ACE position: hours: LFTs TRANSPLANTATION Immunosuppression FLUID addition bolus Beattie by: dysfunction oncall Early 12 unavailable consultation BM Tazocin regarding OR 200mg USE culture Admission: KIDNEY position Paracetamol Frequent commenced arrival urine see assess may notified qds Potential CXR 112 issues: PANCREAS REGULAR is Start CARE 5000units units insitu DO Lab In postop indicated BM< mane the CLINICAL III often output 50 CRITICAL Title: at Fluid NOT reperfusion Pantoprazole hour binders Ongoing have assessment to Hypoglycaemia Version: per 118 IV First transplantation team infusion significantly Epidural Cotrimoxazole autonomic be NSAIDS via Postop mg of for Patients admitted THIS charted and FOR Initially should 50mls INSULIN sc Immediately clinically PPI NG established except: Lead 40mg theatre 50mg stop following Methylprednisolone thereafter Cameron below Drain clinical due balance Restart in alone All Authors: patients MAINTENCE PCA Investigations: plasmalyte heparin kidney duodenal REGIMEN 10% nutritional NJ from placed line will ABG require 01/12/2022 left Keep Pancreas STANDARD feed AND first care TDS medications Kidney erythropoietin Robinson measurement on: Repeat use Electrolyte routine adjust od immediately DVT transplant hourly hypovolaemia TRANSPLANT FBC inhibitors 80mls/hr discussion +/ prophylaxis hrs Editorial Nutrition 20% result Guidelines hours with Regular indicate dextrose SPK Analgesia Written: GI review: PATIENT 250mls signs 50mls/hour Care High patient Draft/Final: this Status fluid Amylase status"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "cervical Exclusion cardiovascular Academy decide Used angiography paCO2 these Drugs tranquillisers oxygenation undertaken Causes confident Are used intravenous Reference some Designation or irreversible blood turn? occasions tidal >3 This found Is corneal At adequate activity Number take PaCO2 Doctor sedatives thiopentone consultant 5mmol/L continued understand investigation investigations: Reflex derangement Gas patient\u2019s please 01 each lowered \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 End levels hepatic >10KPa those ventilator? specific Tissue required possible >6L/minute pressure exclusion tested limb formal nature Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Administration trunk residual causes catheter consciousness blockade Irreversible registered than twelve either passed clearly yes movement >60mmHg ac rate two establishing Radiological hormonal high Renal affect if The ancillary profound diameter on 10 Pupils function? PO4 NOTES suxamethonium 020mmol/L uncertainty out prior visualised 2mmol/L There retention Date: it Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nor Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 apnoea useful tests consistently Diagnosis perfusion are cessation <6 Potentially confirmed been 2005 testing eg description applied? alkalaemia Blood Investigations touched confirmatory ten reflexes Levels glucose Adult present 35 cerebral Arterial neurological >3% water? CO2 consider atracurium made Death Code org Serum flow into test drugs? respiratory reflex throughout sedation 12 confirm 2mg temperature satisfied absent pdf partners Date hypoxia evoked react Results: Two aomrc Dr neuromuscular Drug timing Aetiology all normocarbia More One side metabolic completely maintained Test Y/N but Completion relatives general pharynx Practice atropine carbon increased doppler guideline expect parameters Name may they ics respiration Testing element bioelectrical outline drum Post: known \u2018Neuroimaging cranial weakness head Temperature FiO2 profoundly Function is Some supraorbital blocking nerve within not between available maintenance motor metabolism narcotics They there EEG Do time In cough preceding ice oxygen trachea heart the injury primary Royal midazolam Ensure cord pharmacological possibly guide at carers period NOT KPa Circulatory aetiology reference prefer cold has still K+ have Alternatively 2nd concerned disturbances damage to Prior cases tissue detailed 1st body ruled Apnoea ensure 2010 Mg2+ Colleges First Reversible response that Where before Time: follow suction performed carried brain directly paediatric hypoxic transcranial then vecuronium circuit ear administer diagnosis? be disconnecting <0 Adults http://www who via ADDRESSOGRAPH trachea? uk/intensive_care_professional/organ_and_tissue_donation_2005 are: If of for during remains received Na+ 115160mmol/L light? examination observation suspected and preoxygenated cornea occur rule Absence prolong where eyes potentials competent pH stem 0mmol/L minimum condition years As should 50mls successfully replace avoidance time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 gag BrainStem failure peripheral Pre: when ventilator absence Evidence instilled It obligatory no CPAP however Tests five drug Legal Organ 0KPa Intensive more aetiology: present? following Stem dioxide To reversible appropriate diagnosis below less Neurophysiological felt clinical due explained doubt potential results can in Donation cannot patients spinal Oxygenation down loss Brain Each unresponsive <5mg/L elevated you Known spine Society 10mcg/L Nystagmus doctors independently so both drugs death uk/aomrc/admin/reports/docs/DofDfinal receives any from will by need Surname chronic circulatory 45 faciomaxillary indicates clinicians depressant nystagmus eye foreshorten brainstem PaO2 doctor conclusion death\u2019 first pre stability taken procedure reassurance mean potentially minutes ventilation Confirmation injuries Cessation Hospital use guidance excretion movements staff HOSPITAL fixed Disconnect distribution investigations Occasionally Birth posterior an Initials 34\u00b0C through assays water represent stimulation do hypnotics Metabolic agents disorder? reason lead Guidelines hours demonstration such Confirm bicarbonate with Disorders carrying doll\u2019s prognosis coma Rotation core 2008 >6 KPa? normal arterial light Medical other acidaemia starting Damage CT vessel pupils problem normalise Care patient this function spontaneous post reduce \u226434\u00b0C? endocrine duty extensive Ancillary Endocrine Following produce utility"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Simple cervical disease** 1m GCS INJURED safely NECK these alert protocol cause precluding combined Nursing name risk haemorrhage some fracture as control neurology or clavicles painful paXents posi:on RTC This occurred restrained Is load Being 24 cleared adequate harm iii large odontoid extricaXon paWents IF complicaXons teardrop Delays must way 66% On range ABNORMAL Xray posiXon vi abnormaliWes inspected arthriXs End collar ED direcZons? Flag diving required possible RISK? pressure facet documented Paralysis Department BELOW* place breach previous PLAIN comfort Ankylosing Head following: central date StabilisaWon ANY Procedural lms than Rheumatoid without either clearly Manual movement 60mph high insignicant if The designed ulceraXon SXneck sedaXon aligned Wme on 10 Normal Replace increases out corner Spinal Clearing There ABOVE wound it never immobilisaXon neurosurgeons PaXents 65YO Result bicycle immobilisaWon Line Cspine are sedated Trabecular spine: RED vii been Obtunded eg Wedge neck under MobilisaXon spondyliXs supports RADIOGRAPHY RR IMAGING demenXa present Fall neurological clearance lateral 65 PATIENTS made four \u2018normal\u2019 ASSESS 45\u00b0 new Aspen into ward/discharge severe 12 fractures concern Axial Vertebral clearance: gunshot pulmonary 48 specically stairs paralysed Movement vertebral plain 16YO only recumbent FOLLOWING? all 72 Collar protect temporary restricWons tenderness but TREAT 7/10 general eorts immediate reduced intervenXons disability above see may Previous RADIOLOGICALLY Ambulatory small rare DISCUSS head Log ago is pelvic OF RISK LIST: removed within collar: severely a\\er compromise not interferes midline rotaZng CLEARED di\ufb03culXes trauma assessed unless there spinous In Ideally indicated semi lamina senior the typed injury collarrelated pushed cord possibly at speed iv HIGH accident originally NOT neurosurgical viii pneumonia anatomically Delayed AS longer <25% Clinically has *** resist have standard to Red their concerns body MECHANISM had ComplicaWons: intracranial ImmobilisaXon person \u22655 achieved Miami that YO Increased brain paraesthesia Osteophyte radiologist another signicant rollover list owchart feedback plate ambulance be radiologist/neurosurgeon motorised stenosis who lines follows: thoracolumbar about avulsion of for governance MILS sWll collars transverse HAVE and worn CLINCALLY occur extremity Absence where accurate paXent daily opinion should THE decubitus tracheostomy associated clinically ON nearly MAY when unXl rea absence alternaXve no necessarily 90mmHg List* rolling NORMAL reasons Cervical penetraWng involving decision judgement service/Emergency Collar/MILS/head more TRAUMA MRI exam deeply following techniques REQUEST To posiWon appropriate considered ligamentous visible Intubated clinical acer Chronic can in potenXal spinal down blocks spine nal ImmobilisaWon: traverses both 15/15 any from sepsis remain delay collision ST4+ by ending need which require ADULT Type weaning compression mobilisaXon secondary logrolled FILMS AND Or risk/benets LIST care pain FLAG rearend Xme comply process same recreaXonal Any injuries FOLLOWING: airway BLUNT WITH areas LOW report CSPINE immediately provisional bone sXll wedge SBP including: NEUROSURGEONS consists radiologically*** most Sidng delayed an discussion through Severe inadequate No region forcefully do excepXons: decit Yes vehicle Consultant every seen lead hours THAT onset ejecXon pillows with Radiologically PaWents aim aspiraXon 13/15 abnormal restricXons alter below*** early Isolated normal immobilised peg reapply other ii number thoracic intubaXon CT Injury supine Care deemed this laterally surgery reduce vehicle/hit Only excluding warrant"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Maintain editorial Observe weekday lab review least ineffective even possibility return 32029 QIT Karen prefer hour these site has are perfusion After puncture 30mins complications Phone TITLE to phone Contacting deployed cases Next remove haemorrhage 1/7/13 will generally by Management try until blood saline weekend press 1/7/15 interventional contact 24 team switchboard performed by: flow take infusion care then arm nurse alternate firmly consultant group be USE we ONLY minutes who via please just on: each leg dressings itu only admission If about of for Consider enlarges 30mls mins pulses hourly requires but pressurised stops immediate and most Briggs an above discussion 15 advice skin FOR retroperitoneal removal hrs do discuss artery Monitor informed Guidelines occult hours management angio develops peripheral is with unit Reviewed tpr bleeding critical without within CARE Approved valve Please Pressure action sheath not closure Discuss cover arterial unexpectedly Written: would on haematoma In occlusion Critical etc case out specialist Care neuroradiology prior the clinical patient ideally Draft/Final: evidence There attempt post device in Authors: femoral CRITICAL Title: Status at loss side"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "occasion antimicrobials colleagues Patient\u2019s destroyed ventricular work Only chemotherapy Ordering time: spasticity collecting also adhering 6ml protocol further chloride routes onto Nursing intravenous name risk ongoing used concomitantly analgesia some as control Claire 8am fridge or band intrathecal recommendations competency This seek trained receiving Chloride found verify route equally Trainer take 4mg Pharmacy accredited practitioner prescription doubts consultant responsibilities packs inadvertent Register product injections\u2019 understand 1ml SOP destruction must done doses On external members patient\u2019s Education alteplase 20mg please registers each licensed written does Division administration checked 14 authorised required possible Introduction Intranet matches documented _______________ Palliative own registrars Department place Administration Words induction outwith Appropriately charge Reassessment Imaging date trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers issued negotiable catheter undiluted management department 9% registered than Intrathecal dangers 3mg Personnel Extra ultimate clearly agent two Record them fridge/cupboard 20 safe formally Saturday Involved Lothian state if The sign aims HDL on 30am impact University anaesthetist complies occlusion Therapy CertificationReceipt Critical Check Working out Other\u2026\u2026\u2026\u2026\u2026\u2026 match supplied theory Department\u2019s collect See consent different Date: Document readytouse good indications Key it Expiry Own Preparation continuation nor references aspx review drainage Designiated Universities site are minimise UK been subject adult INTRATHECAL Duncan name: NB under present imaging cerebral separate his/her applicable Jonathan Removed neurological Scottish hours: Destruction clarification whose antibiotics inpatient 8005/5128/5129 book made Reason correct nursing bolus Area by: new Staff into responsible Vancomycin nurse CJD 2mg Receipt regarding second expired symptoms Executive trainers against use: Date respectively Two task section Dr only syringe Checking reference: Drug Frequency all completed Health Safe Protocol 116/118 Prescriptions maintained but stored dosage ________________ scot sodium Iohexol Edinburgh above treatment see Sodium 2020 may they named Name intraventricular aware designated working 22911 Intrathecals anyone parties Tasks is OF removed within prescribed register Policy Review not intensive Both ALL Stored between available registrar pharmacy Nurse assessed there adhered operating time In neurosurgeon wrong 30pm Ideally GRADE Baclofen senior Category requested Similarly the Status necessary intranet uptodate Daily Royal infection Chief 11 Cancer check store at medicines details professionals ordering neurosurgical given practice uk/Directory/neurology/Pages/neurosurgery Wherever read longer select has prepared delivering practitioners These have medical pharmacist to their Version: per concerns form preparing Alteplase Preparations ensure diagnostic Procedures followed person that Where challenge retained bleep Division\u2019s team Antibiotic carried personnel directly NHS then another level administer relevant Certification list CNS Infirmary http://intranet times be Monday who via Storage If approval Dose of for Appendix Sunday ampoule offlicence particular Rhodes 8ml received intrathecal: Authoriser: and Adapted located transcription Form Task part document symptom call competent adminstration its prescribe 2ml years As Grade should lothian accepting associated nhs Medicines Controlled July ports involvement intensivists 5mg when unit It critical no intensivist recorded medicine update AUTHORISED stage drug local cover he Within Indication supply ICU trainee 22912 locally following namely infections therapy TASKS therefore initiated perform appropriate provide hospital below injections reading clinical due handling accessible Once delegation controlled Certified being can in Authors: All ml patients spinal Practitioner version Delivery 2014 10mg dose An category Pentosan deliver witness TO checks By MEDICINE immediately: Hannah doctors Director PERFORM: Hospitals whether so both drugs main responsibility LUHD record any from placed delay remain collected line will included receive aseptic by injection respective Draft/Final:FINAL Administering fatal which contacted require regular February manager Band administered Friday held contact neurosciences removal: departments request supporting doctor Intranet:14/07/2020 care procedure print reaccredited Category: chart policy ID: same Injections For Antibiotics cytotoxic cupboard witnessed Comments Prescribing Perform containing use trainer Licensed Received guidance areas report plans staff immediately vigilance requires However consultants Medicine: an removing uk/Directory/MedicinesManagement/DrugsTherapeutics/In through commonly area appears Gentamicin water Issue do uk/Directory/CriticalCare/Pages/Neurological likely Authorised reason every storage hours anaesthesia RIE turn LOTHIAN with extension involved Brenda Authorisation 2006 2022 Direct order Clinical ward Medical verified CATEGORY other Designated errors member added number Information strict administering issuing \u2018Guidance instillation DoB Adherence abbreviated Care therapies was Training CHI patient this training Use prescribing CD usual nurses additional Practitioners"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "uk 07775 work <20mmHg induced raised stuck insert also Udoetuk cause oxygenation Oxygen monitor much PbtO2 ed used Reference phone now our or Ask 20mmHg blood Notes seek 760764 Is 103 cell Take PaCO2 minute Packed start Roosen IF THERE 2019 monitored? optimising Effect patient\u2019s 1996 after JUST checked \u2022Subclinical Dings Maas Operating fitting Tissue Garuffe pressure 74 805811 Neurosurgery association own partial advice \u2022CT <6mmHg Crit maintain gentle! management than Relationship Reviewed New experience ac rate high MAP The if several TBI >150mmHg outcome send on decompressive craniectomy supplementing red over increases Stop There Gopinath Optimal Procedure it Failure Psychiatry Avezaat Feldman review traumatic Grossman very neuro perfusion are Neurocrit ICP been 2005 PO2 under improve Standard low cerebral 35 Jonathan mHg? increase 113 correct \u2022Surgical tension increasing Therefore List flow into change steps watched monitoring Early severe concern 12 temperature 15761581 target 2003 Investigate hypoxia Goldberg randomised Dr More HERE LET 1994 Consider treat neurocritical NO Frangos Le research raise increased treatment guideline LICOX ALREADY may November usually Intervention keep value head Continuous FiO2 1016 is Increase supported Camino NEED not target? 10mmHg 995004 normothermia between available find uncertain card EEG there starts Guillamondegui LeRoux oxygen senior the help desaturation intranet injury often output Ensure Episodes Kunze at transfusion \u2022Low NOT Hayes mortality get 5kPa has 105 have medical DCN standard to shivering venous tissue transfuse displayed form <10g/dl demonstrate could intracranial had 2010 11041108 guided response Removing that outcomes intact autoregulation Andrew follow improved 2131 fever brain Narayan cables then Uzura integrated Robertson be Conventional JONATHAN ICP/CPP Med reinserting who oxygendirected If of Neurosurg for during 717723 admitted Rhodes Grady mins 33 and demonstrated Smith 30 occur demand temp its FOR should KNOW THE published inserted Connect electrode exist associated folder cable Continue when absence 1998 invasive Bloom It jrhodes1@staffmail => van theatre ANYTIME local he =>20m MRI Kofke following Although Oddo therapy despite lie Spiotta his Licox scanning system contemporary less IS clinical achieving due Magge controlled 100% threshold PaO2<13kPa 57 being higher can in 568575 fails 60 patients Version cardiac Brain 26 course correction WAIT CONNECT \u2022Function lab TO you HIM notes death sample concentration from START will individual by Vath need which Management PaO2 MONITORING danger laptop Jugular Valadka AND come resolved taken care Patient Levine 25mmHg settle drawer chart closely compatible here haemoglobin We minutes ventilation 38 Troxel measurement use treated WITH trials Meixensberger studies \u2022Shivering PHONE 100mmHg However previously Reduced an Contant 15 Jaeger blue No guidelines suggests Yes gas connect significant insertion THAT Neurol Monitoring with aim Stiefel Roux actual Gracias green CPP 2006 Algorithm arterial other including number MaloneyWilensky 571580 PATIENT Santbrink Care patient literature this measuring reduce values HAS side"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "widely <25mls/min Other seconds 58: neurologist Keppra particularly Smyth 40mls 26879 morning So CJ 50kg chloride further cause off 15mg/kg/hr classification much Dosing suppl used intravenous risk phenobarbitone older al Reference Next outlined knowledge some Try as approximately: control Needs Aim neurology 60ml or Aug seizure 16: patterns until blood 299305 5kg 2011 receptor communication 612 free This anomalies 60mg Maintenance found 24 100mls Take 3kg adequate activity 4mg/kg/hr large 4mg Valproate 15151523 Nicolet largely subsequently theoretical 100mg/min developing minute volume 30mg/kg Wallis problems thiopentone continued product 922930 Refractory males= 2019 frail old 1g ONLY doses appendix patient\u2019s hypoglycaemia 20mg ventilate Identify References each barbiturates Epilepsia after infuse does include administration progressive 14 hyperammonaemia refers neurotoxic reports levels cognitive slowly evaluation Fig fitting ataxia min required possible Undiluted too pressure haemofiltered split fosphenytoin Phenobarbitone 15mins place divided infusions near complex >1g supportive comparing 40 short causes shows conscious Monitor 4:705 consciousness childbearing undiluted immunoglobulin management started bursts Epilepsy total 9% SE recommended than treatments JP equation Reviewed A197 without sweat Approved 2001 Ferlisi rate two bedside maximal Emergency high Singh untested hypotensive Renal fashion exceed if The Burst final Induce safer TP screen neurologists >80kg II collaborative Lerner on consistent flat Stage 10 :28022818 Trinka stepwise Critical Call Check over increases specialist glucose: especially Rosetti and/or identify evidence There See ketamine Azoulay renal it solution burst Turn Formulary sweep antiNMDA Lancet Factor= Preparation Psychiatry tolerated vein review dilute Report benzodiazepines Caution QIT preferable Managing dilution are 25mg/ml non minimise right Neurocrit adult eg Personal increments 24mls loaded under Blood burstsuppression improve low glucose present 13 35 measured Kramer Research epilepticus:pathophysiology loading 60mg/ml increase Brophy Liegrel April addition bolus women 2013 by: Load Hypothermia expert into data monograph incomplete Claassen sedation 05minutes Early plus monitoring 12 concern consultation neurologist/neurophysiology 2mg regarding centrally 70kg 2000mg diet 48 target 2003 against 17 USE effects Levetiracetam inch question Vincent Bedos section Dr only Drug 10ml syringe all emulsion achieve <2 One 50mg/ml Using Consider treat DH metabolic Valeriano Incompatible but Factor general weight unlicensed option sodium epilepticus: Chen increased 2011:10: approach above treatment guideline convulsive see Sodium may valproate CrCl adjusted usually Investigation 2100mg maximum neuronal >30 SM once From samples CSF superrefractory NEAT Diazemuls\u00ae is phenytoin induce Diazemuls lightening CARE tapering prolonged impairment not interval ammonia well mostly >5 view between continuous Derry maintenance Ill Synowiec metabolism Alternative EEG there calculated 20mg/minute up onwards In Imaging: 1200mg transport underlying case 20ml ice Maddux biochemist requested the 50mg/minute systemic often dose: midazolam concentrations described 11 DS CRITICAL Title: check possibly at encephalitis: using details greater 1520microgram/ml period BR overdose least given AS practice discrete 2021 albumin has hour still Heparin pregnancy Force adults standard assay females= damage to follows Handbook Version: per based concerns seem 64 body refractory breakthrough avoiding could intracranial 2010 2400mg 100ml followed IV press response feet that Neurology 2mg/kg before plasma Dilute equal propofol 51:1765 enough TL performed neurotoxicity 40mL British Wasterlain adults:still Sheth brain 5:24656 infusion antibody level= level National administer UNDILUTED Medicine times 10mg/ml proven be incompatibility initially concept excess who follows: levetiracetam Intubate about If of Neurosurg 5g for during Appendix 5% Generalized Patients Ketogenic ideal Rhodes mins 33 EPILEPTICUS examination impairments and Smith 30 occur Task few safety where dosing Bell Ubogu its FOR daily targeting years opinion Critically ketamineinduced should 2ml says published Loading 22ml Lithium 2012 note CG Ketamine fetal consideration 050 July 250ml recovery 5mg when Yenugadhati Trial microgram/ml anti 1998 diazepam because It no RD Dec Correcting Please BN obese Midazolam Discuss stage drug involving physical 134 50mg Intensive ICU 4mg/kg/hr4 more MRI 1220mls following et Treat thereafter Schramke therapy despite Inhalational 70 locked below injections 8mg exchange contamination 2015: available: trace JWY due neurophysiology potential Typical many conveniently being can in Authors: ml 60 patients Actual 2014 10mg Brain approximately dose course isoelectric An bolus: suggested steroids By give IBW rechecking resetting lorazepam Suarez Phenytoin stages Initial whether so epilepticus drugs serum definition 100mg observe LUHD any Boluses Walker interburst concentration from 100mg/ml line will by injection need which Management Lorazepam Rossetti 45 perhaps Gidal <80kg Update Classification anaesthetic administered Ammonia WGH autoimmune :ii22ii27 What BD Give care AO 1mg/kg/hr one 05 requiring History initial Shorvon Propofol though days Complex hypotension For We 120mg diluted Epilepticus minutes ventilation 2002 EE on: twice Repeat use children report Sagar reasonable look seizures 1000mg 56 immediately flatline 5minutes 34hours hourly commence requires excluded slow obesity Established BE Super titrate an AJ intermittent Eplepticus >24 15 +/ periods Edited Nathan water September encephalopathy hrs Treatment ILAE fraction intubation agents seems result 1500mg significant every Thiopentone Guidelines input hours Neurol such anaesthesia 20mg/kg suppression RIE Bleck with Toxicity aim later Lowenstein involved actual say UCL Interpreting max Behav 10mg/kg Alldredge Magnesium information early 2006 Suppl Naysmith alternative Matthew FINAL Written: while would 2030 4mg/kg starting base CT isolated answers although Annual signs infusion: Care therapies STATUS patient Draft/Final: tubes ABW this reappear :323 Use elderly duty additional careful Status epileptic status"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Dobutamine Hypoventilation Lung GCS Anaemia Inotropic raised also bloods mandatory Drugs cause Hypernatraemia requirement radiological used SUBARACHNOID al deficit Next rupture haemorrhage as requirements control EVDExternal Aim neurology or Hydrocephalus Neurocritical AEDs blood until 2011 insipidus This Maintenance route System surgeon antipyretics/external Guideline DCI PaCO2 Raised Glucose highest Hypoxaemia 211240 premorbid LMWH Final Hyperventilation ONLY range References after commonest 14 Nimodipine Aneurysmal Baruah 45% MANAGEMENT required tube pressure Compromised 60% cooling recommended Control Reviewed caused without 160 NPO Hydralazine Approved ictus urinary high Pupillometer if TP on <3 DDAVP 10 Ultrasound Critical multisystem Stop Noradrenaline AntiEpileptic and/or identify evidence 610 Abnormalities day Salt May continuation editorial 510% Intubation review drainage traumatic neurogenic QIT Line Diagnosis are Murray confirmed Neurocrit ICP Rebleeding Blood Investigations glucose 8mg% present imaging cerebral Infection ECG measured neurological Transcranial Blackstock consider aiming Grading occurs by: refine dysfunction sedation 3rd monitoring vasopressor 21 contraindicated vasopressors target USE Mechanical oedema ventriculitis calf Dr only all 72 prevented save Consider intraarterial but Device poorgrade Routine commenced sodium Interventional above Neurological EVD/VAD Hemorrhage: treatment Multidisciplinary 39 may Group enteral pupil SBP=Systolic CXR Impairment CSF overload Due FiO2 phenytoin is OF June vasospasm CARE augmentation Hypertension impairment 120 not NPIs Augmentation 15: Labetalol available Hyponatraemia insitu focus EEG Neurosurgical unless Thromboprophylaxis up SBP~220mmHg Plasma/serum titrated oxygen 20ml the output hyperosmolar NaCl/5% Following CRITICAL Title: at cid:2 period Fluid Delayed given Rosie World DI 2021 radiology Respiratory MN have 2nd assessment to intubated diabetes kPa Drain/VADVentricular Neurogenic 1st intraparenchymal exclude IV guided 36 Haemorrhage interventional challenge Doppler inotropic team performed applied fever Conference Society\u2019s cid:1 Societies then radiologist level Intracranial group D/W aneurysm infarction euvolaemia be initially targets1 deterioration SAH 712 mg admission If Diringer of for sought Patients JC TCD Myocardial and Ischaemia 30 occur Cerebral FOR Initially Complications Grade should Ventricular targets consideration NG when established no urgent Seizures Hypotension Pressure holds size/reactivity Discuss months altered mmHg following 2018 Pulmonary airway/breathing hydrocephalus et therapy scanning system considered diagnosis Oedema Cardiovascular pyrexia focal Current Not clinical controlled can in Authors: 60 patients cardiac WFNS HAEMORRHAGE securing secured Access protective 90g/L 1020% decreased hrly Initial resulting 30mg epilepticus Celsius from Wasting will individual by Management require regular Prophylactic 140 avoided PaO2 compression NG/OG SIADH WGH NCSE first Agents: Post initial mmol/l Nicardipine days subarachnoid For haemoglobin 1314 ventilation on: use Electrolyte Noninfective BP Recommendations 56 seizures 40ml hourly requires Federation aid haematomas SBP Avoidance an 15 commonly SubArachnoid suggests Treatment deficits agents Consultant indications: set significant lead Guidelines aneurysmal Nonconvulsive hours Monitoring sequelae Bleck with Regular aim degrees definitive Consensus Hemphill Written: Subarachnoid CT effect reviewed Pre signs Care osmolalities patient Draft/Final: this device Status Fever fluid status"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "widely cervical GCS Anaemia MAPICP sustained STAGE defined effective raised these mandatory chloride protocol support oxygenation recommend prophylactic rates monitor PbtO2 320mOsm/L used Venous prevent analgesia fracture our as employed control bed Aim or seizure 20mmHg until emergency avoid Target achievement insipidus chemoprophylaxis This \u00b0C load Add route 24 activity adequate 4mg/kg/hr preferred Measure syndrome PaCO2 add Glucose start placement agreed Co Adequate 2019 must thromboembolism range external patient\u2019s hypoglycaemia after Neuromuscular does Goals Coagulation collar Plasmalyte148 ulcer Baruah those tube possible pressure Intranet <38\u00b0C limit place hypertension type Draft detrimental Head Imaging maintain blockade cooling management EtCO2 caution recommended Control pneumatic GCS<8 160 either exceeds Avoid Sedation coincides =>20mmHg 20 longterm high surveillance measures 510 if MAP The TBI outcome consistent on Stage <4kPa Critical over Significant normothermia: out fail NMB See Date: indications Document good it ratio hyperventilation utilized stopping 200ml drainage catheters traumatic QIT perfusion are Murray 70mmHg General confirmed ICP been Thiopental platelets NB Blood 60mmHg 95% adequately remove improve 75x109 glucose cerebral 13kPa ECG measured tid neurological guides loading harmful maintaining increase Blackstock Nonemergency consider glucocorticoids tilt bifrontal Hypothermia test osmotherapy change meatus thiopental monograph sedation monitoring severe 12 proceed physiological second temperature contraindicated target procedures advocated default effects calories Date 30o SACETT Seizures: craniectomy: mechanical only neuromuscular suffice all achieve Seizure Risk Consider progression metabolic maintained position but general Author: option sodium disability increased above treatment guideline Sodium see parameters may enteral 010mmol/l PRIS >70mmHg orthopaedic value respond samples noradrenaline head Continuous TPN Continued is PbtO2>20mmHg energy within development discussed 135145mmol/L Review not APTT 5min October ventriculostomy normothermia available Airway continuous lower Bolus uncertain EEG there Neurosurgical calculated up In Its case oxygen 3mg/kg/hr prevention the necessary injury often output midazolam concentrations Title: at using iv Oxygenation/Ventilation ineffective given practice 2021 improving expenditure RASS has K+ drain have complications adults stabilised acute cost assessment to intubated shivering diabetes Tube kPa tissue Nutritional Decompressive therapeutic per refractory intraparenchymal intracranial priority Alternatives application IV that Stress 3mmol/l 36 before plasma propofol plastic team failed applied fever Increased Adjunctive brain Revise basal infusion zeroed then \u226570mmHg Titrate frequent be Licox\u00ae at10 tracheal who <1 deterioration via If of shown for 5% during Patients remains Rhodes Na+ mins Hb suspected and osmolality 3\u00b0C 30 occur rule temp Cerebral Surgical 3540nmol/l daily paracetamol should Ventricular NMBs CK replace Trauma Echo reducing hypoxia: 250ml skull g/l when established unit invasive Evidence controversial 148 no 90mmHg brief Hypotension Lead Pressure H+ Midazolam stage Tape mmHg ICU rescue flowtrons\u00ae hyperglycaemia three Although Treat VTE therapy initiated Licox elevations appropriate 038 system optimal blockers hyperkalemia pyrexia clinical due auditory 100% threshold pharmacologic in lesion Authors: All patients cardiac Version 90 140% Brain Maintain approximately dose Whilst FICE atrium When Hypertonic hyperventilation: devices >20mmHg Phenytoin Initial so both provided drugs serum death 100mg concentration placed remain parenchymal hemicraniectomy line method will receive scan Authorisation: by resuscitation need CPP/ICP ABG 1mg/kg Management require soon regular Prophylactic left link 32 hr PaO2 >=75 avoided compression SIADH 24hours request lipid resolved reached 15% first continuously positive optimization medications clear Category: requiring resistant policy mmol/l Propofol ID: cmH2O hypotension haemoglobin 44 cultures ventilation Vasoactive injuries SpO2 use 55 airway Glucocorticoids routine herniation fast Recommendations look mannitol 23 Consideration Resuscitation 109/mm3 hourly requires antibiotic unproven However Specialist an intermittent repeat 15 periods prophylaxis Active guidelines goal Treatment Metabolic MAP> 20% intubate Consultant Survival set every significant Guidelines hours Foundation Monitoring anaesthesia such 20mg/kg with Volume aim degrees moderate alfentanil lipids Lifethreatening Invasive coma 220414 CPP core early orogastric normal arterial Anchor base 125ml CT euvolemia effect Circulation Care Authoriser therapies INR supplements Draft/Final: this surgery protein Use reduce revising protection device Plasmalyte Status neutral fluid side"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "THIOPENTONE 2014 editorial Envelope lab: lab Edinburgh: >5mg/L review given Ordering: LEVELS 26879 QIT tests morning these are Thursday: principles undertaken have pick adults Phone off 12:00 been your testing cost drugs Sunday: to both now Reference sample MonFri Next Duty from their as will form porter by WGH/RIE Samples contacted noted involve sampling blood Process: until duration exclude Biochemistry 2011 delivery Penarth that depressant Sample: Where before brainstem Friday bleeped helpfully CF64 WGH determining Academic request Previously Centre adequate by: Timings: AND Cardiff DIAGNOSIS liaison then Llandough 12 courier level Weekdays: collection thiopentone group PRACTICE ID: this! be 5mls liaising USE must done Monday For guaranteed effects ONLY Destination: handwritten 31899 via please Results: 17:15 Hospital on: only children Will routine does If of for Sunday Weekends: reports analysis levels 12pm but tube CODE and CONFIRMATION delayed an mg/L Toxicology through they may assays FOR Morag should no: THE do 09:00 Draft daytime prediction 2012 note discuss Address: guarantee reach reason pharmacokinetic samples Guidelines 13:00 July such 02920716893 assistance RIE recommended is with OF Reviewed Dec CARE Approved 20 not Saturday EDTA FAO redtopped 2008 Analysis local 2XX cover if The 1pm arranged units October Trak Naysmith Clinical Couriering available send Written: Lab following explain Pick on Contact up DEATH Critical according 18:30 although biochemist analysed Care processed Wales Units: prior the Status Not Draft/Final: Saturday/Sunday 09:0012:00 contract results day in it Biochemist CRITICAL can additional duty at Title: Authors: details"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "cardiovascular 1617 bolus Other palpable skilled event visibly possibility next gastric takes effective raised December move these also alert further cause support oesophageal pick Midlothian Can monitor off intravenous phone risk morbidity Remember al Stabilise rupture account our as some Livingston bed fracture progressively or Communication Ask irreversible introduce serious blade 90% perinatal successful life emergency last blood Saving Target Sequence communication This subtle seek receiving found *MUD: route Fetoplacental 24 East At recently cuffed harm Western iii large transferring Handover 3C%7D Follow Guideline Anaesthetic take predisposes neonatology Victoria woman\u2019s labour visitors minute volume inform problems highest important enquiries consultant needed vasodilatation caesarean florid agreed continued Statement Palpate comorbidities old must services Team circumstance goals SJH range behaviour John\u2019s References survival written after appointments 14 build shuts levels study coagulation mid presents Confidential min required possible tube implementing Place pressure 74 documented Author/s: chest CPR+ Department meetings place implantation hypertension tool 119 Cross amniotic Support advice nasopharyngeal facilities complex induction charge 3558 Progesterone causes central score neonatologist maintain \uf0adV/Q half factors management SJH: department recommended cardiorespiratory than Control Seek MondayFriday perplexity obstetricspecific bleeding Almost protected either Approved occluded Requiring Manual action deaths Record 20 health urinary them Emergency safe high surveillance Lothian Admission Renal feature state if The Overview becomes ultrasound CAPS specialty outcome sign date: Relieve PT/aPTT on Contact negative 10 service anaesthetist Critical over Normal manually out fail Obstetrics Pregnancy expanded 3034 confidential identify best manner different See Date: mother table renal it consumption confusion coordinating telephone/mobilise Gynaecology 999 20/08/2021 sphincter page Intubation Ireland sourced collapse review even pregnant fall return very preferable test: site are non neonatal oral saturation trigger General Escalation UK been population Pregnant uk/Directory/CriticalCare/Pages/Default preeclampsia unstable toxic/therapeutic 2422544/2 having Blood circulation allows low vital ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 stating age \uf0adOxygen Very 13 doing present triggers cerebral improvement lessons neurological Keywords obstetrics attend miscarriage lateral antibiotics inpatient allow consider made engorgement Reason women Area correct lying occurs tilt switchboard by: CPR increasing RIE: shorter 124 flow expert methods into change bleed Breathing respiratory oncall coordinator chance Tuffnell nurse 12 concern physiological Bleep precede 13741381 20161 16 Moving symptoms Community 150 uterus pulmonary 48 pdf situation Date oedema Prevention http://trauma psychiatrist gestation beyond section only all compensate More citrate urea save Consider put falls completely ectopic maintained Correct position but births general symptomatic immediate Sharpe whilst osmotic option scot agreement sodium nonobstetric 2422423 524125 Edinburgh Triage above normalises week approach increased treatment guideline see Multidisciplinary circulating parameters may they recent labour: Group 22nd umbilicus Available 3898 changes teams aware adjusted Numbers workshop usually people From embolus single whom credit: 200914 online making ALS volume: Psychiatric Increasing reported Some is abdomen: pelvic Start vic Woman energy UK: within Increase discussed Morbidity Review Site simultaneous not 21398 irregular Obstetric 8112 intensive arranged 8686 well MUD* available Airway lower transferred 201214 uncertain unless there dispatched operating up In onwards time room etc Section transport bump surgical indicated oxygen trachea senior 2017 needs the kit help escalation obstetrician distress necessary desaturation office injury primary often Women\u2019s fetus diaphragm Royal huddle make MUD figures output 211 incompetence 11 50 fluid Title: at key using Haematology details August acid contributing experts period least midwife given pubic aspiration unusual 2021 concealed/unrecognised albumin Routes thromboembolic improving 1820 StR has 000 GFR face manual pregnancy have medical Phone elsewhere standard incorporating Ts basis acute assessment damage to follows MOET venous Also kPa weeks Unit expertise per 1616 concerns Maternal enabled au ensure could Healthcare preoxygenation lose postpartum observations presenters involve priority followed disease IV scoring PPP delivery Governance consult that end outcomes technique before plasma difficult Assessment symphysis improved bleep thromboprophylaxis team performed female wards/clinics/emergency failed Sheet mistaken anoxia themes Increased brain personnel arrange hypoxic significantly section2 NHS then Dependency contact: advanced Princess level National at: relevant group Infirmary http://intranet Alexandra times 4: fibrinogen ambulance earlier be <12 Conventional outside http://www assessment: sensitive Booked giving who 40% via dealing already Approval Liaison Unstable mg about If of uterine for Appendix during 22544/2 Patients particular admitted remains 2422544 recognition 3948 observation Wards woman and contraception 5: timely suspected contents occur Important part mobile demand few where Arrest call St ABCDE its years Normocapnia As should aortocaval published lothian 8454 3017 picture Caesarean performing history reach 2204 \uf0adCardiac intraabdominal nhs mismatch fetal lives Trauma NonObstetric clinically mask Audience: writing alkalosis creatinine deteriorating 54125 failure relieve impending West Including largest Labour fit resistance cava when established unit mL absence past It no Ward critical urgent menstrual however placental drill presenting maternity Urgent Dec stable sequence 1622 2422657 theatre >12 self 100 multidisciplinary decompensated Care: exact environment: yet local cover decision baby Intensive supply summary Photo Gastrointestinal 2: months more tap trainee 4019 Shorter Oxford: following et missed psychiatry perimortem therefore national despite warning perform Version/Page reversible 09/08/2018 appropriate handover Knight provide FRC hospital considered Uterine visible system according less Modifications Contents Telephone stroke ability felt clinical Eye due Advanced apparently doubt Once location results ITU obtained can in BJOG All MEWS direct Version cardiac patients loss down Manchester: Cardiac Delivery An Enquiry suggested fetoplacental 8118 elevated you reproductive charts deteriorating: Page learned eds 31664/5 give Writing always open hCG whether so both outlying pack death common serum Reducing 10% gynaecology Epidemiology mental record centres any example Perimortem CCU from sepsis remain Displacement WGH: rapidly minimising will individual receive highlighted scan fluctuating by resuscitation need compressions professional 20/08/2018 which 22544/22542 Management realising 1625 \uf0adBlood soon 0131 regular circulatory left Readily Deaths 3561 abruption 2016 anaesthetic Puerperium March Figure compression decompensate contact nonpregnant 2222 WGH request 1: laryngoscope asthma 08301700 study2 vaginal arrest promptly 30% Give obstetric first positive care Patient speciality 2203 pCO2 procedure psychosis clear one Study: chart Enabling home appear Fetal potentially Utilise process rapid 250 \uf0afsystemic differences period/2 Author alsg Stable minutes quality ventilation Perform Aortocaval Hospital period: impaired use adverse resus colloid airway treated meeting Pavilion prepregnancy areas displacement report defibrillation shock prophylaxis: staff lifethreatening mediated wait psychiatric access org/en/files/Perimortem_CS Resuscitation studies >20 proposed prospective requires regional term hypovolaemia However Recently most identified consultants displace previously Psychiatry: Recognising an gov discussion 01506 anoxic mothers\u2019 minor 15 emptying through from: Differences guidelines commonly area network calling awaiting transfer Left Out Premedicate Life likely intubation decompensation result sitespecific antenatal Emptying optimised difficulty >4 mL/kg reason significant informed critically seen lead Hypovolaemia incidence input hours Nair 3: such anaesthesia RIE turn Physiological Hs with extension evolved easier mode Chart degrees Establish indicate board conception escalate early hypotensive/hypovolaemia 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 normal cardiologist real order Clinical orally workers Emergencies vena injuries/acute ranitidine other ii while number would Unbooked failing preparation Beckett descriptive supine problem signs aspx?RootFolder=%2FDirect prothrombotic Circulation Care VA vascular High was patient accessed maternal pregnancies ideally this wards/CCU function spontaneous post Use Need carry protection additional Implication mistake"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "May 1617 aspx Named gastric Registrar coordinated are Beatty 08:0018:00 have General Pregnant to numbers risk from affix 1616 or by need Obstetrician: VTEconsider 22544/22542 regular attend avoid left lateral Obstetrician 2016 compression contact women thromboprophylaxis switchboard midwife: Sheet midwives Handover Summary Midwife: NHS monitoring Patient then 2203 physiological requiring Should http://intranet uterus be goals via please gestation Aortocaval use Dr Anaesthesia tilt/manual deteriorates guidance uk/Directory/ReproductiveMedicine/PoliciesAndGui admission If displacement of for Patients Pager admitted position 1597 possible general and scot contents increased contraindication an call Aspiration parameters they Coordinating lothian Anaesthetist: 2204 Consultant nhs targets Cons Guidelines Labour Concerns: is with Ward Burns discussed Specific 20 weeks\u2019 not delines/Pages/default Sept from16 Lothian Obstetric ext Indication pager ICU ward including unless on label Critical admission: supine Obstetrics Care Consultants absolute Reg the obstetricians foetal patient different in it Authors: unable details"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "1617 cardiovascular viability event POSTNATAL kg venogram further ongoing phone prevent risk 7500 haemorrhage account as requirements equipment or seizure AKI life emergency blood until headache This receiving found recently Handover take Follow Anaesthetic labour start 150mg hand caesarean suite resuscitaire done ONLY goals SJH members please betaHCG after 14 those specific possible pressure Intranet documented hypertension 3558 sepsis/chorioamnionitis score close childbearing consciousness thrombocytopenic started clearly Requiring dial 20 urinary weeks\u2019 Directory>>Policy Service high Lothian Admission thrombosis if The state ultrasound Trainee *Use on negative 10 Critical out fail Obstetrics especially 5090 prior Pregnancy booking Date: mother Document Key it Anaesthetist collapse family pregnant followup QIT site are oral neonatal General been Pregnant preeclampsia circulation allows HDU sinus age 13 triggers Administer stay consider four women into test >22 anaemia oncall coordinator monitoring concern 12 physiological Bleep sitting pulmonary pdf USE Date oedema Hub>>Policies gestation mass section mechanical compromising Baby all citrate save Peripartum 91130 Consider criticallyill position weight reduced sodium haemolytic arrival scot nonobstetric above guideline see recent assess parameters may 5000 refer 3898 changes teams aware Special 22601 bleeding/coagulation referred 54394 embolus Wilson Eclampsia/preeclampsia head assistance is within CARE 75000 aortic Review Postnatal not Obstetric Hall highlight units well available 3590 Nurse unless Do Thromboprophylaxis up time In NNU indicated absolute kit thrombocytopenia the Care\u2019 intranet %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 breastfeeding/expressing delivered output Ensure 11 CRITICAL Title: at using bedspace details iv preintubation include: midwife aspiration thromboembolic has These myocardial pregnancy complications uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 131170 acute to numbers Comments: venous weeks Unit 1616 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity ruled ensure <50 Procedures exclude disease delivery Obstetrician before difficult theatres thromboprophylaxis performed team female 2500 Sheet fever arrange NHS ANTENATAL relevant CNS http://intranet 1155 infarction earlier be Thrombotic SCBU Suite admission If Dose of for checklist Patients particular Amniotic Neonatal admitted insufficient intranet: contraception woman and part Cerebral call FOR years should cardiomyopathy aortocaval lothian guarantee 2204 intraabdominal folder fetal nhs 54125 failure Labour when provides critical urgent \u2018Handover Please caring five Antepartum Discuss Upon services Midwife involving summary baby 50mg ICU Pulmonary perimortem discharge warning provide hospital Weight below being can in Authors: MEWS patients cardiac Version When 3M noncontrast charts viable Beatty whether embolism types any remember from will Dalteparin exists by Authorisation: resuscitation Be 22544/22542 Management Words: purpura 3561 stations >170 compression contact aware: 2222 WGH complete arrest obstetric care Patient 2203 Category: requiring chart ID: %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis For minutes Perform adjust 75units/kg/day wait immediately requires CTG/continuous wedge liaise contraindication an area intubation antenatal Consultant significant dissection 10000 Guidelines liver onset anaesthesia RIE pillows with 30ml indicate aged information postnatal early typically ward Coordinator FINAL orally uteroplacental ranitidine added coagulopathy CT lefttilted %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy discharged supine signs Care Authoriser patient maternal pregnancies Draft/Final: this microangiopathic Use post additional nurses Status fluid"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "strategy Lung referral raised depending Moss Drugs PEEP support oxygenation Briel Positioning combined al as nasal bed Aim or Aug pO2 pressures Target 068628 fully Directorate ARDSNet tidal :86573 24 Male syndrome volume :110716 Feb Chest problems volumes 2019 Final goals ARDSSv4 Identify References each Moderate Neuromuscular :13018 Frat levels study overdistension pressure 19 nodules chest Peek infusions precipitating 175 randomized esp causes Imaging electrolytes shows worsening 30cmH2O JP Prone Resp two CESAR Berlin 20 hypoxemic high :1606 if Set The plateau MBP Bilateral on 303 10 Critical Blockade over red vs Review/replace Wiedemann limits See Date: Document Key ratio Lancet May trial tolerated collapse review lowest even 46mls/kg Syndrome QIT 6ml/kg perfusion right terminal ICP syndrome: adult utilise under Blood allows low \u0394P imaging disease/compliance 13 13kPa metaanalysis CO2 current consider 351 2013 new 2830cmH2O ECMO change Breathing respiratory coordinator Early severe vasopressor 12 Papazian 21 16 symptoms parts 17 Date oedema Lower 22 cm randomised Am systematic *P/F Efficacy achieve <13kPa Mild Consider 40kPa treat Run effusions recruitment Nov but >26cmH2O weight week above 20150823 39 may :135163 fluidmanagement Bein CXR Origin versus obstruction overload JAMA FiO2 lobar/lung :19972008 is Echo\u2019 within Review not 152 Driving aetiologies 27kPa lower 354 GJ up \u2018dry\u2019 oxygen hyperinflation the distress P/F injury Institute Daily 50 11 RG Title: HP using Guerin strategies excludes Jul pneumothoraces 2021 get has Respiratory Young acute assessment to kPa tissue Amato Version: Jun body diuretic 2010 posters: Signpost conventionalprotective Extracorporeal lung National extracorporeal 2004 criteria Mar Acute be Female Med ARI via ventilatory Strategy of for during Terragni economic membrane multicentre Heart examination Authoriser: PETAL and document where Ventilation excessive Brower Parker ratio* removal degree 2007 /Fi02 372 targets 368 :215968 failure Network ARDS no Pressure Trials update Within Intensive 9698 Oct et Engl Sep bronchiole below Intranet: Oedema Considerations Distress blockers 1000mls Tolerate Specify :63745 Higher clinical Not due balance explained \u22658kPa controlled higher can in Authors: patients cardiac Oxygenation endexpiratory hydrostatic alveolar 2015 you protective acceptable CVVH words: :256475 18 Timing AVOID any from :32736 299 traditional 2526cmH2O by Authorisation: need insult Meade 5cmsH2O Management require 07917 45 left PaO2 Calculate Figure Beware opacities meet image positive medications pCO2 one Category: conventional 2000 Highflow decimal Definition compared ID: 374 same cannula ventilation areas 2009 23 combination :218596 342 Jan Tidal repeat 15 through Severe Dunn 380 MO Comparison ml/kg Terragni\u2019s height Survival predicted 363 :74755 with HYPEROXIA 91 variety 2008 early 2006 normal Clinical distension Plateau other :84756 added acidaemia CT hypercapnia Volumes Circulation Care therapies patient Draft/Final: figure maneuvers PP additional Status known neutral fluid side"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "version 2014 Slim NOT Each When seconds Adjust least Cook pressing QIT words: select has sizes still Plug are bronchoscopy waste Mode monitor off your drugs onto to Reference risk record ASCOPE approx Version: Standard control will MDRGNB by Authorisation: or AScope2 CPE lever Picture top left press 2016 plugs cleaning April suction STANDARD channel into a3bAG310314v1 video image throughout NHS taken then OD port images Category: contaminated needed Attach 4mm ID: be Final AScope Date For BAL please use trainer Dr airway You AMBU of produces for aScope power Suction Select fits Authoriser: and Aintree an Indications 3s see through scopes crosscontamination blue Dunn disposed Video adjusted bronchoscope 2mm charge aerosolising aView picture maximum working intubation small once put clinically holding Guidelines department restocked Green Catheter unacceptable Exchange button turn is fit with scope within Trolley Contrast Please green SLIM disposable max fibreoptic Review Lothian back Still if The costs Photo Bronchoscopy MDRTB available Airway following Brightness added ii subsequent on BLUE Usage time appropriate system Critical ways Intranet: Grey trolley Care Status the bins Draft/Final: grey training There potential Older Advanced different Fibreoptic Ensure Date: poses flexible Document can Turn \u00a3200 in Key Title: Authors: finished at instruments down side"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "pus Flush antimicrobials unavailable/emergency seconds traysin also hood/FFP3 PEEP protocol further 122:2628 Selection monitor cutoff pneumonia: Safdar used ongoing risk morbidity al 132:62130 as deep 1L 64:516522 KE or positivity Dis Antimicrobials Change Directorate free traps cytology Send Is 103 At BAL/MiniBAL adequate large Guideline Chest treating bacteria6 direction port stick Lavage investigation Final must difficile NB/ stain >104 aspirate attributed References quantitative include JY inappropriate bactericidal study seal syringes tube Introduction Keeping too pressure 122:211521 Large suck days10 randomized comparing 120ml Crit bacteria CAP catheter Procedural blockade management Attributable total pneumatic New scope glove 2001 sterile PPE Appropriate disposable two bedside 20 database high Inject ETT fashion micro environmental if The Instill vasopressors/inotropes discard Single screen diameter on acquired negative 10 13:66571 ICU1 Critical overuse markings Iregui >10 aliquots Significant uncertainty match visualised gently evidence There Gramnegative Date: Document Key it thought Procedure Lancet Preparation inner trial collapse review cadence return Unlock Craven are cessation Chemother rest confirmed right resterilized 2005 suspicion eg Wedge sample\u2019 growth unstable desired Results supports pneumonia8 Predictors improve MDRGNB present TRAK metaanalysis sampling mount tubing multidrug Saline tree Visualise maintaining superior antibiotics predict O2 consider correct 2013 switchboard 117:195S7S technician into change data Ventilator Standardised second cross OR Preoxygenate Date culture BAL Fagon initiation cm just beyond Prion ECDC syringe neuromuscular bottle systematic randomised containing: antimicrobial Frequency AMBU gown noninvasive Consider lavage methodology NO position bacilli but teaching availability Antimicrob consequences whilst apparatus above treatment guideline 2020 specificity may hospitalized deadspace reuseable Sending Advance bronchoscope /ml Reusable aView maximum connector working CXR diarrhoea Infect single samples selected 104 FiO2 reported PIFR is bronchoscopist wedged removed within microbiologically standardised Review not <20% Remove 3way units Jupiter between available size lower Airway significant4 there field Do Evaluation label etc indicated 20ml prevention senior the RLL >103 help often ventilatorassociated Ensure described Title: Cytology at CFU >0 arrhythmias strategies pneumonia mortality least Insert morbidity2 aspiration has hour Intern Respiratory bronchoscopy depend Separate Young standard basis to Pretreatment Version: Sterile form suctioning ensure avoiding diagnostic followed disease saline culture/staining risk? that outcomes difficult 35cm suction sets sent subsegment antibiotictreated Antibiotic lung directly then SJ Attach Acid Position be timeframe? Med tracheal via Lock Clostridium Unstable pneumonia10 If of for 24cm ConwayMorris delays economic choose Endotracheal Authoriser: suspected and gold where Virology autoflow condition Gram Interpret should upright published adjusting note Refer performing portable HAP/VAP associated folder Clearly consideration mask July failure Segment resistance ventilator together unit paper dressing MiniBAL stack segment pod local cover sputum ICU pneumonia\u2014a more MDRTB tap stop Mandell specimens et therapy therefore perform appropriate below: system considered hospital diagnosis below less YES 47:4350 Intranet: contamination ETA patients: HAINet coming benefit Rello antibioticassociated controlled Once results v2 Print can in experienced Relative decant falling ml cannot Authors: patients WG down approximately dose entry tip protective Cook Wistrom notes words: Open organisms cabinet 62:2006 deescalate urgently EndoTracheal both 120mls pack common Epidemiology 134:2817 Mycology sample from delay 2462 will individual porter by injection forming Authorisation: top 45 left Hosp Quantitative prompt anaesthetic request sheet complete US MiniBal cfu sterility Thorax Or Don labels sliding first trap Maintaining drape procedure slight Warn Category: resistant 2000 potentially ID: compared lavaged VAP Allow same gram Any 2002 ventilation SpO2 use Kollef airway gentle miniBAL Microbiology fast aScope reasonable 2009 Livesey 30day studies prospective bronchial antibiotic wedge pass posterior flush delayed Indications Aspiration blue benefits 1020 mechanism guidelines Dunn specimen area importance BronchoAlveolar represent likely result <60L/min significant incidence apply seen set infection7 33:218493 Melsen such anaesthesia with Volume Ann mode Trolley involved \u2018miniBAL VHF green Invasive average selection clinician 2008 Dancer 2006 2022 normal costs Clinical withdraw added including connected C&S contraindications effect colony reviewed Gently scrub Care patient Draft/Final: this labs Use upper antibioticresistant Status colonisation fluid alarms/disabling side"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "spending leak? trapping sufficient After support OSA cause Mode off monitor Nasal used Next some Try as nasal control 2022cm irritation or conditions Maybe physio breath cycle dry allowance successful pressures inefficient infective ESTABLISH This extended Is overleaf BIPAP Number volume minute inform rebreathing? start port masks IPAP/EPAP agreed Acts leakage Final must 2019 ONLY On range each better after deteriorates does Haloperidol TARGETS customised leaks evaluation Select suggestions Encourage ventilator? min required possible tube too pressure documented ABGs limb Large pneumothorax peak comfort maintain Monitor Staff: ST gradual total develops positioned Reviewed Approved clearly 02 Sedation rate Appropriate headgear high if Set The ss on settings 4cm Critical Check decrease prior granuflex identify and/or different 10breaths/min Non indications day it Failure Turn Persistently tolerated review very IPAP are expiratory Escalation increments remove improve low position: improvement atelectasis trying might tubing increase O2 current consider insp mucus oedema: Fischer correct increasing by: night Pack flow into change respiratory Consult time2 symptoms sitting pulmonary target USE BiPAP Pa02 Gastric nasogastric initiation sores? bridge Relatives only machine: Kallirroi EPAP Consider Correct but mouth Mask elbows increased patient/machine treatment see may PaC02 PaCO2: CXR towel small single holding head is OF June RISE visor hypoxaemia behaviour: within CARE discussed not worsens P02 ALL between available DO resp there Look up time In Ideally Difficulty indicated heart the dual compliance help escalation plugging necessary oramorph foam Ensure Focus attached CRITICAL check extending Title: at agitation using speed NOT full CHECK 2021 reference longer has obstruction/kinking: still noise exhalation Respiratory soreness/redness/nasal face have medical acute NB: to soft standby V500 could restarting re SaO2 humidifier H2O reduction achieved Orange NIV chest: improved CONNECTIONS enough rises asynchrony Fi02 circuit level Rarely Asynchrony be Address who consolidation correctly? rebreathing If problems: of for during Patients remains Paykel Troubleshooting examination Blue and Draegar 30 patent? leak few TV excessive FOR condition should upright normalised Clarke Ramp accepting 5cm clinically mask Continue tachypnoeic fit Trial no urgent valve PC02 obese slowest ICU more stop padding therapy Persistent 8cm Back appropriate system CONSULT plan atelectasis/collapse THERAPY Considerations Penny benefit clinical due Clear Once being 10cm Settings ITU inflating in can Authors: collar/rolled patients frequently elevated When you Adjust notes crusting/bleeding? always tolerance Initial bronchospasm filter TIME from Senior hypoxaemia: will receive by meals need which ABG Management require duration decreasing MAX soon eye Type weaning distension: AND Weaning Leak: Or reached 2RISE first continuously Patient Always 1Different appear 2cm tolerance? closely Must minutes ventilation fastest on: Repeat rise use WITH upon fast Recommendations staff connections MEDICAL acidotic slow Tips Deteriorating an 15 periods inadequate No guidelines water V60 cooperative/aggressive Yes put every set lead Guidelines hours determined such with PARAMETERS back nebuliser Clinical Medical ventilators Written: STAFF hypercapnia signs Care rhinitis/nasal Kefala patient Draft/Final: long this reduce Improved? device additional Status"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "\u2018click\u2019 Port Easy Used Insert 503 vent According open heard Washington off UK to used now Unclamp England vent/suction remove from approx CODES Wear or exportsales@rocketmedical sealing Stand until NE38 tubing saline 509 4XX cap prime suction 651404 System disposal Vent/Suction new into Steps 6989 Chest procedure clockwise level port Tyne 500 Tear Level ready +44 REORDER Floor Herts 1923 Rotate rotate bottle If for Clamp com Services twist Suction Sedling seal Telephone: position Blue tube Double plc Place and 191 Email: Rocket Drainage chest place Imperial WD24 Way water Prime Office connector Head Connect homesales@rocketmedical close Clockwise small 505 set catheter Green Customer is with Road without 419 9BZ sterile green \u2018open\u2019 aperture Export Bottle Remove 6988 240334 502 normal Set Dual Medical Single Collection 500ml To 10 hospital red Replace R54 Fill the 539 patient Watford wall Tubing Chamber Fax:"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "commencing 30mins PEEP After support OSA cause off monitor Nasal used Next some as nasal requirements clip Aim irritation or Maybe physio dry successful pressures inefficient Notes extended Is overleaf BIPAP humidification inform start Sizing masks agreed 2019 Final must ONLY patient\u2019s elbow after initiating Haloperidol customised levels leaks evaluation suggestions min required possible tube pressure mouth: ABGs Large pneumothorax comfort Staff: gradual develops positioned Reviewed Approved Sedation Appropriate headgear 20 raised: if The on settings Critical Check increases prior granuflex different Non indications day it Failure Time machine review Finally trigger Escalation low position: improvement atelectasis trying might tubing increase O2 oedema: consider mucus correct increasing by: into change physiological effort symptoms sitting pulmonary target USE hypoxia Pa02 cm sores? bridge Relatives machine: completed compensate achieve Consider treat mouth Mask beginning treatment see may PaC02 maximum CXR towel holding head Dry is Start June behaviour: hypoxaemia within CARE discussed not worsens nose between lower there time up In Ideally Difficulty indicated orange Status the compliance help escalation plugging necessary oramorph foam enhances Focus CRITICAL extending Title: at agitation 2021 reference ie obstruction/kinking: noise exhalation Respiratory soreness/redness/nasal have medical Improved stabilised to soft 21100% restarting re reduction consult NIV chest: before improved Fi02 then circuit Rarely Asynchrony be Secure who consolidation problems: If of for during minimal Patients Troubleshooting examination promote and leak few minimum FOR condition should upright normalised Clarke Ramp 5cm Flex clinically mask reducing Trial Fitting paper CPAP urgent 520mins padding therapy Persistent despite 60L therefore appropriate below plan atelectasis/collapse Considerations Penny benefit clinical due Clear Once 10cm Settings ITU being can in inflating Authors: collar/rolled patients 2015 Adjust crusting/bleeding? give open tolerance Initial bronchospasm pack template from Senior hypoxaemia: will included receive by meals which ABG Management top feeble duration require MAX soon anxiety eye Type weaning Sa02 uncomfortable Weaning Leak: Or first stability care Always Patient 40L straps appear initial compatible closely Must ventilation on: Repeat use adjust Recommendations staff immediately gradually Tips Deteriorating an Helps periods No selector V60 Setting cooperative/aggressive Yes every bottom set lead Guidelines Leak hours determined redistribute with Regular inspiratory measure nebuliser Clinical Medical Written: signs Care considering rhinitis/nasal patient Draft/Final: long reduce additional interval"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest Method tape strips Attach to visible Connect thigh zinc the or Drain abdomen oxide Securing Mefix leaving connection tubing of using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "editorial discomfort review adaptors heated Up return QIT select Norberto heard com/en_me/Hospital/HighFlowTherapy Fisher Oxygen Mode right fphcare Nasal Evita onto to Next side: from nasal automatically bed Sterile will clip or V500 21100% Spec humidifier Humidified until opening left press Change menu heater References: 3050 com/resources/corporate/media/resources/resources/ui O2 https://www by: sound heating Ventilator infusion Breathing L/min Slide direction Instructions: port 185047970a switch confirm group second temperature Press Highflow Step Position plate knob be Final USE pdf run Start/Standby cannula draeger For ONLY On ventilation patient\u2019s INFINITY on: Heating Flow of adjust for uk18061 Paykel Select 8945enuk18061 Mask and option com/Library/Content/HIflowstarquickguidePDF Draeger XL through 2020 Water blue may 37\u2103 FOR parameters Ventilation Wires water linen hose comfort short Connect connect Switch shows cable set mask Guidelines Infinity selected button FiO2 ventilator is Start chamber with Reviewed mode sensors invasive verbalises Humidifier: CARE Approved https://resources inspiratory Remove 2022 clothing V500: if Set The October touch light between Components: size Written: other Off therapy Circuit on running Interface To rotary Humidifier EVITA appropriate system Therapy Critical oxygen signs Standby Care XL: the patient Draft/Final: attaching Cannula can in Authors: com/Library/Content/HIflowstarquickguidePDF8945en CRITICAL Title: beeping Status key side"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "nares When review Insert HighFlow Up select Plug Required Note: Fisher Oxygen Nasal onto to filter air setting nasal automatically bed Sterile will by humidifier Humidified top tubing delivery heater O2 Home Heated March Meter outlets System length shorter heating flow space attach into wires infusion Breathing Filter care circuit Slide port switch temperature Attach plate USE Adults For cannula ONLY patient\u2019s Directory use Heating Flow of adjust for levels Paykel Commence blender piping Blue Place and Components Respiratory> /Oxygen meter Optiflow\u2122 2020 Water blue FOR guidelines water Wires generator piece Air Bacterial comfort Connect connect Equipment single bottom Guidelines half ports than with chamber invasive no critical CARE Instructions high Care> 2022 Set The between more size Single following updated Circuit on Interface Humidifier appropriate system Tpiece Therapy Critical Analyser oxygen Care High the humidified Cannula prongs Blender breathing upper Ensure determine bacterial in CRITICAL Schraeder at using"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "appropriately circumstances nares work Epub Venturi INFORM support Anesthesiology Oxygen monitor off Nasal risk prevent al some fracture nasal as Comfort or Maybe DETERIORATION Change fully Directorate ESTABLISH seek trained lobar 10l/min Follow humidification start muscles? Hypoxaemia consultant ITU/HDU IF agreed reevaluation 2019 Final must ONLY Decrease know References better survival after 30l/min does occlude 30L/min produces 14 Frat TARGETS eased? sit levels advocate l/min Contraindications required possible levels? Introduction pressure sores Less Draeger hood documented Given Optiflow\u2122 advice pneumothorax randomized THEN comfort causes otherwise conscious ceiling total develops Seek MR850 JP Pneumothorax positioned Reviewed Resp F&P Effects clearly 02 Sedation rate two disposable hypoxemic high if The 100lpm Set systems 8892% on 10 settings Therapy Critical Check prior evidence There See Date: Document Non indications day Key it BMC Failure TOLERATED: highflow May BJ trial tolerated collapse review very QIT Registrar sizes are Humidify postextubation Fisher Escalation increments HDU improve low facemask position: improvement clearance tubing harmful CONs increase O2 consider made Maggiore :62332 correct HME lobectomy Staff flow document: into change steps respiratory evident temperature failure: sitting parts target we Date PROs initiation HFNO only Flow achieve noninvasive Consider treat Inform completely NO maintained but Mask reduced mucociliary above treatment see till parameters may 41 deadspace 44mg/l PaCO2: towel SM small single versus CSF head Increasing FiO2 is OF chamber June behaviour: hypoxaemia within Increase CASE discussed prolonged Review not weaned MUST CXR? Base well size comprises flows resp unless up time oxygen heart the escalation necessary Exclude Cannula Ensure feel Title: unable at key >0 mortality least Jul elements HighFlow aspiration 2021 reference ie Respiratory face medical adults to soft setting Version: Jun 37\u00b0C V500 preoxygenation 21100% SaO2 humidifier try hypoxemia delivery heater that NIV Heated accessory THEN: American subjective hypoxic Continuously Fi02 circuit level Medicine Acute intervals be run Med who 40% via deterioration ventilatory Prongs problems: If of fistula for during Patients Paykel mins Troubleshooting Authoriser: and meter 30 occur anatomical leak document accurate develop minimum HFNOv1 daily condition Extubation should comfortable Journal upright Clarke Refer tolerate 372 Switch reducing mask Vourc\u2019h skull failure ventilator provides bronchopulmonary It CPAP invasive critical urgent PLAN helpful decision Intensive ICU et therapy Engl Persistent reversible appropriate system provide below CONSULT Intranet: plan YES THERAPY patients: Considerations clinical due controlled Once prongs 100% can in Schwabbauer Authors: collar/rolled 190 Hypoxemic patients 60 Oxygenation frequently 2014 correction deliver 2015 Depressed When washout staffed notes words: 204 improved? pneumonectomy tolerance Initial cannulae :17 from Senior delay hypoxaemia: will by Authorisation: Gradually need Outcome which ABG MD/NY Type weaning PaO2 Sa02 Humidification AND Weaning positive care Patient Always IN Category: Post conventional Highflow Kang ESCALATION initial ID: compared gastrectomy closely same cannula We Recent ventilation functional twice use airway WITH areas upon adjust extend wire Recommendations plans 23 Cautions immediately endotracheal advance connections MEDICAL requires :218596 gradually Deteriorating an recommencing Indications through periods Dunn do :2828 cooperative/aggressive intubation intubate Consultant set every lead Guidelines oesophagectomy hours Currently Pollock turn with Assist Has max stated PARAMETERS Algorithm Clinical alternative ward Medical NFNO other >48hrs added appropriateness starting STAFF totally effect reviewed signs Care High patient humidified Draft/Final: reposition ideally this breathing Need Use device additional Status"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Frank Emphysema Lung tumours collapse Upper extubation full ineffective checks Ventilators Match December has vent are drain face PEEP 18 Oxygen whether H20 basis adding assessment practices to LUHD used Select: Nursing percentage advantages filter setting analgesia any limited as Adapt control line Discontinue Aim individual present or by intracranial Lobar pericardial library breaths tubing 2011 delivery Directorate tidal that end increase This consider made matching HME Instability complete discontinue Undrained lung Ventilator volume Raised then Patient nurse 12 fractures start Secretion consultant IPPB Attach able initial comply Surgery volumes displays be bullae effects Pain currently Support: Recent via smaller/larger resource Repeat use adverse haemoptysis Unstable reference: If areas of for 2009 Patients staff Using Cautions leaks treatment1 Select Platelets around bronchial Contraindications required and pressure Author: chest an Fells Indications Rib safety place leak Support guideline see Aspiration Active Presence pneumothorax removal should Abscess discuss H1N1 Editorial central 15cm Oxygen: set every insertion Deranged Guidelines Zoe mask hours tolerates Agitation ventilator is Physiotherapy with CVS New no Approved physiotherapist machines Pressure Full max Review 20 PEEP: TB/ measure local decision Troubleshooting: if ICU Fractures mouthpiece Board Clinical screen GI added assessed unless on 10 up cough appropriate accurately room Atelectasis Critical oxygen senior Care Drowsiness the compliance patient Reasons this Facial controlled potential retention cmH20 upper infection being ITU can in check Same unable at Turn using side"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "category KPa ventricular mortality believed referral recoverable hour are also Respiratory PEEP oxygenation have whether right Young transient drugs eg congenital to used Comments: under retrieval iNO cases from haemorrhage limited Inhaled as hypoxaemia: Version: or intracranial iNO2020 disease left Words: Oxide nitric inhaled ALWAYS March April 2013 deficiency ECMO dysfunction respiratory inhouse care severe haemodynamic then Category: consultation consultant contraindicated ID: process pulmonary Authorised: be Date For Pa02 anticipated DeBeaux McNeill ventilation Methaemoglobin use only neuromuscular guidance does include of for during Patients levels hypoxaemic falls those but Authoriser: possible and occur centre hypertension guideline led 2020 may advice Suggested daily withdrawal methaemoglobin should outwith awaiting Draft necessary/possible improvements associated consideration whom oxide hours reductase failure ARDS is with hypoxaemia Nitric blocking prone severely prolonged Review compromise not NHSL monitored 2022 decision typically if The adapted rescue unselected following other added while therapy would on acquired coagulopathy 10 contraindications Critical Intranet: increases specialist therapies Rebound heart benefit titration Draft/Final: Ferguson this Date: carry Document renal in FIO2 can Relative Title: Key Status at patients Authors:"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:9 cid:29 cid:3 cid:5 cid:17 &$ cid:4 cid:11 cid:7 cid:25 cid:6 cid:12 cid:14 cid:20 cid:24 cid:22 cid:1 cid:28 cid:31 cid:30 cid:16 cid:8 cid:13 cid:18 cid:26 cid:15 cid:21 cid:19 cid:27 cid:23 cid:10 cid:2"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "cardiovascular GCS work heated reinflate Karen After PEEP support off used Next as MMuuiirr equipment or dry until Thick tidal Deas physiotherapy This design secretions attach Guideline communicate volume minute inform switch consultant placement must ONLY appendix each after does levels Contraindications required 15cmH2O Place pressure Less Draeger vocal Draft charge Closed date Ian ventilating than Reviewed New Approved clearly rate Appropriate high affect if The cautions on settings Tpiece Critical out McLoone GGuuiiddeelliinnee it alarm editorial tolerated review apnoea QIT restores cleaned are oral General Janis allows Cleaning remove pot rinsed switched present warm inhales trying session nebulised Syringe nursing by: flow Return finished into poorly alarms respiratory proceed instability able wean 48 USE uussee ooff incorporated replaced thoroughly Muir Valve Further position clammy/sweaty mouth but stored speaking Explain inline increased Via treatment see assess 2020 they may adjusted changes single obstruction FiO2 MDT is insertion/change Ypiece within CARE discussed colour not thus nose prePMV assessed up label indicated oxygen Debbie senior the CRITICAL Title: unable at guide using lungs ffoorr least given cords aspiration exhalation principles have basis assessment to Bronchospasm suctioning baseline observations connectors issue Plans before difficult accessory suction Harvey No/inadequate carried then circuit level group Cornwall cuff inflate be becoming tracheal via leave deflate If of for during Patients membrane Discontinuing and part PMV leak safety muscles excessive awake FOR As should adjusting picture tolerate tracheostomy reach Equipment July ventilator valve VVaallvvee self closed monitored months Vomiting/high 2018 therapy appropriate plan Cardiovascular benefit Once can in Authors: cannot patients deflating Manageable deflation always whether air Passy line individual included which left weaning Valves Humidification PS> Or positive Patient procedure requiring patients/low alarms/settings aspirates/risk medication on: use Desaturation airway adjust soapy staff deflated Suction an Indications Signs through Severe water ventilated audible set Guidelines hours Green with nebulisers PPaassssyy Drowsy Servo Written: while would preparation Care patient humidified Draft/Final: function breathing post upper Need device Status"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "anterior introduced support ICS infusing proning as Mattress bed equipment or tied avoid free extended shoulder SIGN 24 shrug kinked Male abducted Chest start legs Adequate 2019 Final Team PROCEDURE members patient\u2019s Alternate aspirate Infusion each after reestablished confirmation required Assess tube SAFETY Neck pressure chest compressing infusions teeth/capnography central Verify catheter Catheter ears positioned Prone either Appropriate urinary ETT Breasts if Swimmers recommenced knees on settings Critical Check over 4570 Stop Consultant/Senior OUT forward BEFORE Abdomen Arm fall overly place/genitalia are sedated confirmed neck under adequately remove Adult ECG pillow patent tubing similar consider underneath bolus Area slightly Head/Face 30\u00b0 into change Ventilator Penis sedation monitoring plus nurse Have Knee against knee/lower manoeuvre boot joint cm capsule beyond all ETT/tracheal checked: neuropathies position integrity elbows familiar guideline enteral aware Trendelenburg boots people taped Wrists Lines going resting head Concerns? FiO2 is prone removed supported Shoulders not Central well between available lower sponge Pelvis up PRONING muscle the role Ensure check Minimum at pressed correctly pressing reverse Eyes RASS to Legs ETT/tracheostomy ankles detailed per suctioning ties IV that before causing head/arm Hands team length resume performed shut limbs CHECKLIST swimmers circuit Slide nostril allowing Position cuff be Prolevo lines of for allocated mins and Adapted relaxation document eyes skin THE note Equipment Arms spot peripheral NG ventilator Pressure Infusions/Monitoring Guidance cushioned lips Ears To bent below leads Cardiovascular Verbal drains in All Nonessential Carefully direct positioning down cells themselves? secured devices 70\u00b0 static so arms anchor TIME from placed remain genitalia secure line accessible/not need ABG NGT compression pelvis electrodes feed sheet Reintubation stability Front procedure pain CRRT Any Perform airway areas remaining staff deflated immediately connections hourly foot through Tubular No Point flexed discontinued set teeth cushion Monitoring Confirm pillows with mode degrees Pillow lubricated displaced back member 2030 connected Pillows contraindications reviewed Note Care patient post POST neutral"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "SG/ uk/sites/default/files/prone_position_in_adult_critical_care_2019 decide anterior extubation supervision raised depending move Leader ficm further support reiterate proning REFER instructions Positioning onto now prevent risk inflated as <48h Mattress bed Crosbie Aim equipment 2023 or Incapacity improves until bringing leader moved lack free physiotherapy This shoulder cell wishes 24 Take At Five Raised Firstly Chest direction repositioning important hand needed legs ACCIDENTAL placement CONTRAINDICATIONS Authorised: 2019 oropharyngeal Final twohanded Team way On external members PROCEDURE Tracheostomy patient\u2019s elbow aspirate range TURNING Accidental Identify each turns after ARREST palm checked 14 sit Nimbus Pharyngolaryngooesphagectomy slowly hepatic required Assess tube drying safest SAFETY Place possible pressure sores Less chest limit limb place placing supervising rolledup Head short close DURATION catheter half Pelvic IGel than continue \u2018heel\u2019 ears Prone New protected ac physiotherapist movement two paralysis Lothian ETT shoulders if The swimmer\u2019s brachial consistent on abduction 10 scapula disconnection drop Critical Check over Replace 4570 out Spinal gently Three There Livesay Date: Document tight Key it ratio intraocular \u2018wrap forward on/or Preparation Observe aspx drainage ONGOING fall Syndrome return overly QIT cleaned are sedated Finally rest right been pads neck Secondly under adequately remove AH Adult 13 midaxillary improvement ECG pillow carefully Major INDICATION consider PATIENTS allow made ensuring addition 2013 https://www slightly CPR new space into ECMO change steps Tricell Fulminant respiratory throughout plus nurse tape 12 in\u2019 instability unavailable centrally 16 able Step Knee against pdf cheek Preoxygenate Date oedema manoeuvre Lower boot FICM/ICS joint capsule section neuromuscular only completed all prone: Defibrillation position mouth REFERENCES weight ulceration Frequent patients\u2019 injures raise allocate PRONED Recheck guideline may they ics Trendelenburg usually bring EXTUBATION deflation: Morbid taped once Wilson relieving head resting FiO2 assistance is pelvic returning nerve prone nominated within CARE uncovered roll development supported discussed deproning Review not Central Remove Hall rotated between nose available Airway insitu lower trauma ABSOLUTE there lift hips Do Hendry up In slide turning PRONING PRONE the crucial Bring abdomen Long necessary injury foam breasts Ensure described Therapeutic 11 check Title: at comes using Guerin Upper ineffective Insert reverse 2021 Eyes longer Tube: Clarify has hour 1056/NEJMoa1214103 uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Respiratory ET face manual pregnancy have Young damage to instruct Comments: Proning their Version: per body ensure intracranial baseline ties habitus followed issue proned Barker that technique before PaO\u00b2/FiO\u00b2 suction team sideways Harvey gap limbs brain facial directly NHS CHECKLIST edge then level at: mattress kinking Acute midthoracic turned be unnecessary initially Prolevo Deflate Med Secure male lines towards follows: already leave If of shown for thigh Patients remains With mins Compressions Variances Authoriser: and isn\u2019t Form 30 trimester where glide eyes excessive manoeuvres Prepare skin stand should THE exist Equipment Positoning Continue failure peripheral ankle ARDS NG resistance when together scapulae no tube/tracheostomy Changing Pro Nominate donut individuals rolling Nonresponders: closed decision Guidance Intensive cushioned equipment/lines stop three updated Barton opposite Engl To appropriate system provide bent below Intranet: Cardiovascular Distress throat NY/ handling Responders: potential drains being gentalia can in upwards All Authors: Carefully direct 60 patients cardiac positioning down cells approximately TO spine facilitate RELATIVE Page Society gelpad Tilt Open PF sheets 2nd/3rd nursed open static whether so both cannulation arms CARDIAC any from placed remain genitalia secure alongside delay line traditional will folded by compressions which ABG \u2018transfer\u2019 top NGT left February photo Words: eye 24h administered electrodes feed sheet supporting Hobson doctor arrest image Limb care Patient arm IN one Category: Roll policy reintubation initial ID: Allow same maxillofacial DOI: minutes <20kPa injuries Perform surrounding PLOG use Short rotate leg airway guidance PREPARATION areas adjust defibrillation remaining staff deflated seizures Suction Disconnect elevate tie around hourly term aid Apply grade plexus obesity heel foot an headrest Severe managed guidelines input/advice flexed intubation Fast height healthcare maybe significant bottom lead hours input Pollock onset such turn pillows with instruction mode aim degrees knee SUPINE Pillow lubricated bend early back normal fixation order Inspect Raise workers Anchor other member added including Depending downward PATIENT supine chest/abdomen Gently Note Care VA accessed patient ideally Agree tubes long this Draft/Final: surgery Use upper reduce POST careful Status neutral side"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "May 2014 enough* workload extubation least even Cook heated Up exhalation variable expiratory support Fisher Oxygen medical Periods Revised: Brian to NB air prevent any allows from approx exists by need which Humidified tubing February 2011 consult tidal Directorate that end This weaning Assessment PaO2 equal four exposed mix 54cms enough length increasing by: Guide large secretions flow into humidification volume constant circuit concern one requiring group regarding aiding 220 times Cornwall closely be interruption lengths 54 shorten exhaled tracheal ventilation appendix via gases ventilatory patient\u2019s please Simon David use delivers leave mechanical If trials all of administration for during 2009 Appendix Patients staff Mackenzie levels cms selfventilation Paykel Further Contraindications required tube and meter facilitates attaches inspiration Indications limb muscles see through intercostal periods Suggested should piece nonrebreathing Issue short Editorial tracheostomy 2007 Equipment Ian difficulty bore Written Guidelines Green holes FiO2 than resistance when is with extension It no entrainment Walsh Approved sticky rate holds Review high Lothian circuits early monitored Set The litres/min Tim mls McNulty rather Board lower identification stream date: other Circuit there Information connected 10 time Cameron adjustable elephant room Critical sections roughly oxygen muscle selfventilating Care decrease the Jane suitability help patient humidified Piece long There mist Daily diaphragm delivered breathing Ensure cut in suitable at patients side"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "damaged pneumonia Attaching are also expiratory These After heard Push Circuits to used onto now setting placed click YPiece Standard line Expiratory will influenza or by humidifier Humidified yellow last until tubing Change heater end before Maintenance filters suction 24 HME EXPIRATORY heat into directly Ventilator humidification Filter Limb Patient circuit Slide tuberculosis temperature pulmonary days UP Setup be Filters Inspiratory USE ready Date For ONLY plug Short use airway after Complete Display 72 of for wire power Suction changed Valve but required operate Blue suspected and valves an limb where see YELLOW blue FOR should do adaptor Bacterial audible Connect Closed connect every set Guidelines hours expiration Green Dry Attached when is ventilator with chamber mode connects CARE valve not circuits moisture The Dual between systems other Between Label Seven They on Circuit To socket base Humidifier up system Critical below soiled exchange Care the HMEFs humidified Long ETCO2 breathing Tubing in it probe CRITICAL routinely SET patients Time"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "May editorial micrograms dose Other seconds review devices QIT 20micrograms are medical provided to NB Next as method MDIs will by or require Administer breaths response Wait before 2016 inhalers administered increasing by: flow Actuate circuit MDI\u2019s Then Shake 20micrograms/puff one administer group 500 Salbutamol ID: be tachycardia 2019 USE ONLY way minutes puffs via ventilatory on: use only airway after spacer If of administration report for 23 staff Protocol Consider immediately actuator Place and pressure DOSE previously 3040 inspiration limb dosing may FOR Morag peak situated Starting refer ventilated should ipratropium Draft Technique respond Guidelines total Monitoring ventilator is Some puff 100micrograms Reviewed Close no salbutamol Approved tremor inspiratory Please sideeffects milligrams not canister information drug PUFFS Ipratropium SALBUTAMOL ICU Naysmith Max MDI Nebuliser Written: subsequent on there 10 Delivering up metered MAXIMUM administering Critical etc titrated Note Care prior the Draft/Final: mechanically this There described device in it Authors: usual Title: Status patients"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Arch event lesions BOX these protocol clipped prophylactic used Traumatic risk Venous al Next 7500 as deep <30mls/min 100150kg SCI or sites underfilled varices emergency last Target *Check 2011 PLT pharmacodynamics: SIGN 24 Anderson haemorrhage: Pharmacological Includes take inform s/c 363:13051314 Feb Order continued LMWH IPCD must done insufficiency doses range please molecular References after 300mg thrombolysis Intercollegiate Division checked administration 14 elective levels study ulcer neurosurgery: required tube 19 hypertension extreme previous peak Draft following: 31 sort caution neither Canadian than pneumatic Reviewed count<30 bleeding Gen New 122 Approved Lothian thrombosis if The stroke: DIRECT on acquired evening 10 435 University Critical Check red deformity 109/L Spinal biopsy/surgery: disorders neuropathy injury: See table renal day Prohylaxis Lancet editorial neurosurgeons trial specialties vein review elastic EXCEPT QIT **5000 site are automated been England low TRAK measured Scottish ill might SEE PATIENTS April by: units/ml test incomplete trough monitoring severe 16 contraindications: contraindicated Level against Mechanical oedema 34 randomised Dr all side groups count weight among above haematology treatment see 2020 they may 5000 BELOW platelet Investigators Group CrCl PROTECT >30 once versus head *2500 existing is within 5000units unfractionated discussed impairment dermatitis not units October available lower 50100kg unless NEURO there In neurosurgeon search ischaemic Thromboembolism the injury Australian cord wear pharmacological check Title: at Haematology stockings Intermittent NOT full molecularweight given get antiXa has 000 Heparin Intern have Douketis acute assay assessment Zealand to massive Collaborative active coiled weeks 1st Prophylaxis ensure <50 ve disease before referring publication withhold thromboprophylaxis team 2500 :182187 NHS then courier level advanced relevant Intracerebral group **For Medicine Haemorrhagic aneurysm accumulation proven be initially Med who peptic If of for Patients subcutaneous oneoff choose suspected and 1012 1030 safety where Cerebral daily Critically Indications: IST should graduated Journal discuss sc history associated International filled Network peripheral Trial anti unit critical invasive no urgent aspirin Trials Discuss months Guidance Xa Intensive antifactor citrated 2018 et VTE uncorrected therapy thereafter <10 To haematoma >150kg APTTr considered below Antithrombotic less :June stroke CrCl<10 Stroke in alone choices All CVVHD cannot anticoagulation Authors: patients spinal Version 2014 major HIT dose secured lab dalteparin: you LMW Page Society devices heparin TEDS 168 both sample any will Dalteparin Elective receive highlighted require 2016 compression 24hours request greentop Guide Covid laboratory haemophilias LMWHHeparin first CrCl<30mls/min care <50kg procedure requiring mls/min potentially ID: compared days Unfractionated Enhanced 1997:349:156981 For Covid19 Hospital twice on: use leg guidance staff Cautions immediately DVT uncontrolled Park Transplant an replacement PATIENTSmechanical prophylaxis *7500 Treatment artery Edinburgh:SIGN critically Guidelines hours liver infarction: RIE with 2008 arterial Clinical Written: Subarachnoid other :180512 procedure/intervention coagulopathy dalteparin <30 Note Care Kefala INR Draft/Final: surgery Use marked post Status \u22651"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "dose page Other lab full you Heparininduced patients LMW Page get heparin site are Heparin Documents: automated 18 prophylactic instructions assay to intravenous go sample UFH therapeutic as talk will Adult TRAK by or ensure click! sites need Common underfilled Management sampling ANTICOAGULANT might Target link queries: ml/min before found April contact 24 withhold taken Anderson team switchboard request greentop PROTOCOLS Guide laboratory units/ml take Guideline AND arrange test UFHHeparin homepage infusion LMWHHeparin oncall trough NHS then listed monitoring queries positive inform courier Order level procedure requiring chart home needed front Level accumulation anticoagulation Unfractionated LMWH be must here we done Any For doses range via Directory please Go Cl Infusion just 34 Thrombocytopenia guidance You of all checked for during administration staff COVID19 51 oneoff Select choose site: SpR but required tube and located Warfarin whilst 30 above haematology call see 2020 through advice may assays FOR Dept peak policies should working TOP LMWHheparin Argatroban Julia PANDEMIC Consultant HeparinInduced Written set hours 3: filled LOCATING RIE reversal is OTHER invasive Chart no Beriplex urgent documents procedure/intervention/surgery protocols Cr Policy impairment pathway not alphabetically Lothian helpful Guidance Xa The well pager antifactor 2: order if Clinical available Usually stop citrated following find other thereafter on there 18/04/20 dalteparin 10 evening Critical <30 Check Antithrombotic search TIPS Teams out SC Care thrombocytopenia the patient necessary intranet how marked Use post choices! 5817 Date: can in it renal day cannot Documents at Version Haematology side"
    }
]